Psyllid ID: psy14632

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------
Protein Sequence
MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT
Secondary Structure (PSIPRED)
cEEHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccEEEEEccccHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcHHHHHcccccccccc
Coil and Loop (DISEMBL)
MFITNQVTVATVKALNYLKEELKIIhrdvkpsnilldrrgaiklcdfgisgQLVVEVVLPflqinfgt
Flexible Loop (DISEMBL)
MFITNQVTVATVKALNYLKEElkiihrdvkpsnillDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT
Low Complexity Region (SEG)
MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT
Disordered region (IsUnstruct)
**ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINF**
Disordered Region (DISOPRED)
MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFG*
Disordered Region (DISEMBL)
MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT
Disordered Region (DISPRO)
MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINF**
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	68	2.2.26 [Sep-21-2011]
P47809	397	Dual specificity mitogen-	yes	N/A	0.764	0.130	0.807	2e-18
P45985	399	Dual specificity mitogen-	yes	N/A	0.764	0.130	0.807	2e-18
Q07192	446	Dual specificity mitogen-	N/A	N/A	0.764	0.116	0.788	9e-18
Q20347	363	MAP kinase kinase mkk-4 O	yes	N/A	0.75	0.140	0.725	6e-16
Q4KSH7	419	Dual specificity mitogen-	no	N/A	0.764	0.124	0.75	9e-16
Q8CE90	535	Dual specificity mitogen-	no	N/A	0.764	0.097	0.75	9e-16
O14733	419	Dual specificity mitogen-	no	N/A	0.764	0.124	0.75	9e-16
Q23977	1178	Dual specificity mitogen-	no	N/A	0.764	0.044	0.730	9e-16
Q05116	395	Dual specificity mitogen-	N/A	N/A	0.764	0.131	0.634	9e-15
Q91447	388	Dual specificity mitogen-	N/A	N/A	0.764	0.134	0.634	9e-15

>sp|P47809|MP2K4_MOUSE Dual specificity mitogen-activated protein kinase kinase 4 OS=Mus musculus GN=Map2k4 PE=1 SV=2

 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct: 202 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 253

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|P45985|MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1

 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct: 204 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 255

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q07192|MP2K2_XENLA Dual specificity mitogen-activated protein kinase kinase 2 (Fragment) OS=Xenopus laevis GN=map2k2 PE=1 SV=1

 Score = 88.6 bits (218), Expect = 9e-18,   Method: Composition-based stats.
 Identities = 41/52 (78%), Positives = 46/52 (88%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLD  G IKLCDFGISGQLV
Sbjct: 251 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDTNGNIKLCDFGISGQLV 302

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q20347|MKK4_CAEEL MAP kinase kinase mkk-4 OS=Caenorhabditis elegans GN=mkk-4 PE=3 SV=3

 Score = 82.8 bits (203), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 37/51 (72%), Positives = 43/51 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +   +TV TV AL+YLK+ELKIIHRDVKPSNIL+D  GA+KLCDFGI GQL
Sbjct: 169 VVGHITVCTVDALDYLKKELKIIHRDVKPSNILVDGTGAVKLCDFGICGQL 219

Activity is required in presynaptic neurons, in a dose-dependent manner, for normal presynaptic development and morphology.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q4KSH7|MP2K7_RAT Dual specificity mitogen-activated protein kinase kinase 7 OS=Rattus norvegicus GN=Map2k7 PE=1 SV=1

 Score = 82.0 bits (201), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 39/52 (75%), Positives = 44/52 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVA VKAL YLKE+  +IHRDVKPSNILLD RG IKLCDFGISG+LV
Sbjct: 218 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 269

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q8CE90|MP2K7_MOUSE Dual specificity mitogen-activated protein kinase kinase 7 OS=Mus musculus GN=Map2k7 PE=1 SV=1

 Score = 82.0 bits (201), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 39/52 (75%), Positives = 44/52 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVA VKAL YLKE+  +IHRDVKPSNILLD RG IKLCDFGISG+LV
Sbjct: 234 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 285

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens GN=MAP2K7 PE=1 SV=2

 Score = 82.0 bits (201), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 39/52 (75%), Positives = 44/52 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVA VKAL YLKE+  +IHRDVKPSNILLD RG IKLCDFGISG+LV
Sbjct: 218 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 269

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q23977|HEP_DROME Dual specificity mitogen-activated protein kinase kinase hemipterous OS=Drosophila melanogaster GN=hep PE=1 SV=2

 Score = 82.0 bits (201), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 38/52 (73%), Positives = 45/52 (86%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +VTVATV AL+YLK++  +IHRDVKPSNIL+D RG IKLCDFGISG+LV
Sbjct: 295 ILGKVTVATVNALSYLKDKHGVIHRDVKPSNILIDERGNIKLCDFGISGRLV 346

Required for the epithelial cell sheet movement called dorsal closure (DC), which allows establishment of the dorsal epidermis. Controls the expression in the dorsal epithelium edges of another dorsal closure gene, puckered (puc). Phosphorylates and activates the MAP kinase bsk; bsk signal transduction pathway mediates an immune response and morphogenesis.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q05116|MP2K1_XENLA Dual specificity mitogen-activated protein kinase kinase 1 OS=Xenopus laevis GN=map2k1 PE=1 SV=2

 Score = 79.0 bits (193), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 165 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 216

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates the MAPK/ERK cascade, ultimately leading to phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q91447|MP2K1_SERCA Dual specificity mitogen-activated protein kinase kinase 1 (Fragment) OS=Serinus canaria GN=MAP2K1 PE=2 SV=1

 Score = 79.0 bits (193), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 158 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 209

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements.

Serinus canaria (taxid: 9135)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	68
156554395	441	PREDICTED: dual specificity mitogen-acti	0.764	0.117	0.865	1e-18
332030763	438	Dual specificity mitogen-activated prote	0.764	0.118	0.865	1e-18
328707315	424	PREDICTED: dual specificity mitogen-acti	0.764	0.122	0.865	3e-18
307201888	436	Dual specificity mitogen-activated prote	0.764	0.119	0.865	4e-18
357616721	409	putative dual specificity mitogen-activa	0.764	0.127	0.846	5e-18
427796013	409	hypothetical protein, partial [Rhipiceph	0.764	0.127	0.846	6e-18
195330662	424	GM26332 [Drosophila sechellia] gi|195572	0.764	0.122	0.865	7e-18
7024504	424	JNK kinase 2 [Drosophila melanogaster]	0.764	0.122	0.865	7e-18
17137538	424	MAP kinase kinase 4, isoform A [Drosophi	0.764	0.122	0.865	7e-18
220942584	425	Mkk4-PA [synthetic construct]	0.764	0.122	0.865	7e-18

>gi|156554395|ref|XP_001603456.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase 4-like [Nasonia vitripennis]

 Score = 97.1 bits (240), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 45/52 (86%), Positives = 49/52 (94%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATVKALNYLKE+L+IIHRDVKPSNILLDRRG IKLCDFGISGQLV
Sbjct: 244 ILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRRGNIKLCDFGISGQLV 295

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332030763|gb|EGI70439.1| Dual specificity mitogen-activated protein kinase kinase 4 [Acromyrmex echinatior]

 Score = 97.1 bits (240), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 45/52 (86%), Positives = 49/52 (94%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATVKALNYLKE+L+IIHRDVKPSNILLDRRG IKLCDFGISGQLV
Sbjct: 241 ILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRRGNIKLCDFGISGQLV 292

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328707315|ref|XP_001949896.2| PREDICTED: dual specificity mitogen-activated protein kinase kinase 2-like [Acyrthosiphon pisum]

 Score = 95.5 bits (236), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 45/52 (86%), Positives = 48/52 (92%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATVKALNYLKE+LKIIHRDVKPSNILLD RG IKLCDFGISGQLV
Sbjct: 229 ILGKITVATVKALNYLKEKLKIIHRDVKPSNILLDSRGNIKLCDFGISGQLV 280

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307201888|gb|EFN81517.1| Dual specificity mitogen-activated protein kinase kinase 4 [Harpegnathos saltator]

 Score = 95.5 bits (236), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 45/52 (86%), Positives = 48/52 (92%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATVKALNYLKE+L IIHRDVKPSNILLDRRG IKLCDFGISGQLV
Sbjct: 239 ILGKITVATVKALNYLKEKLMIIHRDVKPSNILLDRRGNIKLCDFGISGQLV 290

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357616721|gb|EHJ70363.1| putative dual specificity mitogen-activated protein kinase kinase 4 MAPKK4 [Danaus plexippus]

 Score = 95.1 bits (235), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 44/52 (84%), Positives = 49/52 (94%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++T+ATVKALNYLKE+LKIIHRDVKPSNILLDRRG IKLCDFGISG+LV
Sbjct: 208 IIAKITLATVKALNYLKEKLKIIHRDVKPSNILLDRRGNIKLCDFGISGKLV 259

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|427796013|gb|JAA63458.1| hypothetical protein, partial [Rhipicephalus pulchellus]

 Score = 94.7 bits (234), Expect = 6e-18,   Method: Composition-based stats.
 Identities = 44/52 (84%), Positives = 48/52 (92%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATVKALNYLK++L IIHRDVKPSNILLDRRG IKLCDFGISGQLV
Sbjct: 220 ILGKITVATVKALNYLKDKLNIIHRDVKPSNILLDRRGNIKLCDFGISGQLV 271

Source: Rhipicephalus pulchellus

Species: Rhipicephalus pulchellus

Genus: Rhipicephalus

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195330662|ref|XP_002032022.1| GM26332 [Drosophila sechellia] gi|195572515|ref|XP_002104241.1| GD20857 [Drosophila simulans] gi|3158392|gb|AAC39036.1| MAP kinase kinase 4 [Drosophila melanogaster] gi|194120965|gb|EDW43008.1| GM26332 [Drosophila sechellia] gi|194200168|gb|EDX13744.1| GD20857 [Drosophila simulans]

 Score = 94.4 bits (233), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 45/52 (86%), Positives = 47/52 (90%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATV ALNYLKEELKIIHRDVKPSNILL RRG IKLCDFGISGQLV
Sbjct: 224 ILAKITVATVNALNYLKEELKIIHRDVKPSNILLHRRGDIKLCDFGISGQLV 275

Source: Drosophila sechellia

Species: Drosophila sechellia

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|7024504|gb|AAF35430.1|AF061255_1 JNK kinase 2 [Drosophila melanogaster]

 Score = 94.4 bits (233), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 45/52 (86%), Positives = 47/52 (90%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATV ALNYLKEELKIIHRDVKPSNILL RRG IKLCDFGISGQLV
Sbjct: 224 ILAKITVATVNALNYLKEELKIIHRDVKPSNILLHRRGDIKLCDFGISGQLV 275

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|17137538|ref|NP_477353.1| MAP kinase kinase 4, isoform A [Drosophila melanogaster] gi|281361348|ref|NP_001163551.1| MAP kinase kinase 4, isoform B [Drosophila melanogaster] gi|442618004|ref|NP_001262375.1| MAP kinase kinase 4, isoform C [Drosophila melanogaster] gi|3158390|gb|AAC39035.1| stress activated MAP kinase kinase 4 [Drosophila melanogaster] gi|7299057|gb|AAF54258.1| MAP kinase kinase 4, isoform A [Drosophila melanogaster] gi|17944358|gb|AAL48071.1| RE70055p [Drosophila melanogaster] gi|220952800|gb|ACL88943.1| Mkk4-PA [synthetic construct] gi|272476869|gb|ACZ94848.1| MAP kinase kinase 4, isoform B [Drosophila melanogaster] gi|440217201|gb|AGB95757.1| MAP kinase kinase 4, isoform C [Drosophila melanogaster]

 Score = 94.4 bits (233), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 45/52 (86%), Positives = 47/52 (90%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATV ALNYLKEELKIIHRDVKPSNILL RRG IKLCDFGISGQLV
Sbjct: 224 ILAKITVATVNALNYLKEELKIIHRDVKPSNILLHRRGDIKLCDFGISGQLV 275

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|220942584|gb|ACL83835.1| Mkk4-PA [synthetic construct]

 Score = 94.4 bits (233), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 45/52 (86%), Positives = 47/52 (90%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVATV ALNYLKEELKIIHRDVKPSNILL RRG IKLCDFGISGQLV
Sbjct: 224 ILAKITVATVNALNYLKEELKIIHRDVKPSNILLHRRGDIKLCDFGISGQLV 275

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	68
FB|FBgn0024326	424	Mkk4 "MAP kinase kinase 4" [Dr	0.764	0.122	0.865	1e-17
UNIPROTKB|J3KTI6	161	MAP2K4 "Dual-specificity mitog	0.764	0.322	0.807	1.2e-17
UNIPROTKB|J3QQP9	162	MAP2K4 "Dual-specificity mitog	0.764	0.320	0.807	1.2e-17
UNIPROTKB|F1LP57	273	Map2k4 "Protein Map2k4" [Rattu	0.764	0.190	0.807	1.2e-17
ZFIN|ZDB-GENE-060512-98	404	map2k4a "mitogen-activated pro	0.764	0.128	0.807	1.9e-17
UNIPROTKB|F1P3T1	366	MAP2K4 "Uncharacterized protei	0.764	0.142	0.807	2.1e-17
UNIPROTKB|F1SS51	376	MAP2K4 "Uncharacterized protei	0.764	0.138	0.807	3.1e-17
UNIPROTKB|F1PBB6	377	MAP2K4 "Uncharacterized protei	0.764	0.137	0.807	3.1e-17
ZFIN|ZDB-GENE-080721-13	417	map2k4b "mitogen-activated pro	0.764	0.124	0.807	3.5e-17
MGI|MGI:1346869	397	Map2k4 "mitogen-activated prot	0.764	0.130	0.807	3.8e-17

FB|FBgn0024326 Mkk4 "MAP kinase kinase 4" [Drosophila melanogaster (taxid:7227)]

 Score = 221 (82.9 bits), Expect = 1.0e-17, P = 1.0e-17
 Identities = 45/52 (86%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++TVATV ALNYLKEELKIIHRDVKPSNILL RRG IKLCDFGISGQLV
Sbjct:   224 ILAKITVATVNALNYLKEELKIIHRDVKPSNILLHRRGDIKLCDFGISGQLV 275

GO:0004708 "MAP kinase kinase activity" evidence=NAS;TAS

GO:0006468 "protein phosphorylation" evidence=IDA;NAS

GO:0008545 "JUN kinase kinase activity" evidence=NAS;IDA

GO:0007257 "activation of JUN kinase activity" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0046330 "positive regulation of JNK cascade" evidence=IGI;IPI

GO:0048666 "neuron development" evidence=IMP

GO:0030424 "axon" evidence=IDA

GO:0048082 "regulation of adult chitin-containing cuticle pigmentation" evidence=IGI

UNIPROTKB|J3KTI6 MAP2K4 "Dual-specificity mitogen-activated protein kinase kinase 4" [Homo sapiens (taxid:9606)]

 Score = 215 (80.7 bits), Expect = 1.2e-17, P = 1.2e-17
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct:    86 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 137

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

UNIPROTKB|J3QQP9 MAP2K4 "Dual-specificity mitogen-activated protein kinase kinase 4" [Homo sapiens (taxid:9606)]

 Score = 215 (80.7 bits), Expect = 1.2e-17, P = 1.2e-17
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct:    76 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 127

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1LP57 Map2k4 "Protein Map2k4" [Rattus norvegicus (taxid:10116)]

 Score = 215 (80.7 bits), Expect = 1.2e-17, P = 1.2e-17
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct:    78 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 129

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

ZFIN|ZDB-GENE-060512-98 map2k4a "mitogen-activated protein kinase kinase 4a" [Danio rerio (taxid:7955)]

 Score = 218 (81.8 bits), Expect = 1.9e-17, P = 1.9e-17
 Identities = 42/52 (80%), Positives = 48/52 (92%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR+G IKLCDFGISGQLV
Sbjct:   209 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRKGNIKLCDFGISGQLV 260

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0048263 "determination of dorsal identity" evidence=IMP

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

UNIPROTKB|F1P3T1 MAP2K4 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 216 (81.1 bits), Expect = 2.1e-17, P = 2.1e-17
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct:   171 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRNGNIKLCDFGISGQLV 222

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

UNIPROTKB|F1SS51 MAP2K4 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 215 (80.7 bits), Expect = 3.1e-17, P = 3.1e-17
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct:   181 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 232

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1PBB6 MAP2K4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 215 (80.7 bits), Expect = 3.1e-17, P = 3.1e-17
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct:   182 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 233

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

ZFIN|ZDB-GENE-080721-13 map2k4b "mitogen-activated protein kinase kinase 4b" [Danio rerio (taxid:7955)]

 Score = 216 (81.1 bits), Expect = 3.5e-17, P = 3.5e-17
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct:   222 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRNGNIKLCDFGISGQLV 273

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0060027 "convergent extension involved in gastrulation" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

MGI|MGI:1346869 Map2k4 "mitogen-activated protein kinase kinase 4" [Mus musculus (taxid:10090)]

 Score = 215 (80.7 bits), Expect = 3.8e-17, P = 3.8e-17
 Identities = 42/52 (80%), Positives = 47/52 (90%)

Query:     3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct:   202 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 253

GO:0000165 "MAPK cascade" evidence=IPI

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001934 "positive regulation of protein phosphorylation" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005829 "cytosol" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0006915 "apoptotic process" evidence=IEA

GO:0006950 "response to stress" evidence=IEA

GO:0007254 "JNK cascade" evidence=ISO

GO:0007257 "activation of JUN kinase activity" evidence=ISO

GO:0008545 "JUN kinase kinase activity" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=ISO

GO:0032839 "dendrite cytoplasm" evidence=ISO

GO:0033267 "axon part" evidence=ISO

GO:0043065 "positive regulation of apoptotic process" evidence=ISO

GO:0043204 "perikaryon" evidence=ISO

GO:0043525 "positive regulation of neuron apoptotic process" evidence=ISO

GO:0045740 "positive regulation of DNA replication" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P45985	MP2K4_HUMAN	2, ., 7, ., 1, 2, ., 2	0.8076	0.7647	0.1303	yes	N/A
P47809	MP2K4_MOUSE	2, ., 7, ., 1, 2, ., 2	0.8076	0.7647	0.1309	yes	N/A
P10506	BYR1_SCHPO	2, ., 7, ., 1, 2, ., 2	0.5166	0.8823	0.1764	yes	N/A
Q20347	MKK4_CAEEL	2, ., 7, ., 1, 2, ., 2	0.7254	0.75	0.1404	yes	N/A

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	68
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-33
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-26
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-25
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-23
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-16
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-16
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-15
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-14
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-13
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-12
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-12
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-12
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-11
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-10
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-09
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-08
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-08
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-08
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-08
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-08
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-08
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-07
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-06
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-06
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-05
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-05
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-05
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-05
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-05
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-05
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-04
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-04
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-04
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-04
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	0.001
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	0.001
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	0.002
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.002
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	0.002
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	0.002
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	0.002
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.002
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	0.003
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.003
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.003
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.003
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	0.003
TIGR01982	437	TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase	0.003
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	0.003
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.003
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.003
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.004
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	0.004
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.004
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	0.004
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.004

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  114 bits (288), Expect = 2e-33
 Identities = 45/52 (86%), Positives = 47/52 (90%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++ VATVKALNYLKEELKIIHRDVKPSNILLDR G IKLCDFGISGQLV
Sbjct: 108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 96.7 bits (241), Expect = 2e-26
 Identities = 37/53 (69%), Positives = 44/53 (83%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
            I  ++TVA VKAL+YLKE+  +IHRDVKPSNILLD  G +KLCDFGISG+LV
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.8 bits (239), Expect = 2e-26
 Identities = 35/53 (66%), Positives = 42/53 (79%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
            I  ++ VA +K L YL E+ KIIHRDVKPSNIL++ RG IKLCDFG+SGQLV
Sbjct: 100 RILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 92.5 bits (230), Expect = 8e-25
 Identities = 32/52 (61%), Positives = 41/52 (78%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++ V+ VKAL YL  +L +IHRDVKPSN+L++R G +KLCDFGISG LV
Sbjct: 104 ILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 88.3 bits (219), Expect = 4e-23
 Identities = 31/52 (59%), Positives = 44/52 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++++A ++ L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 81.2 bits (200), Expect = 2e-20
 Identities = 33/52 (63%), Positives = 44/52 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 104 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 1e-19
 Identities = 30/60 (50%), Positives = 43/60 (71%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFL 62
           I  ++ VA V+ L YL    +I+HRD+KPSNIL++ RG IKLCDFG+SG+L+  +   F+
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 77.6 bits (191), Expect = 3e-19
 Identities = 30/48 (62%), Positives = 38/48 (79%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           +T A VK L +LKEE  IIHRDVKP+N+L++  G +KLCDFG+SG LV
Sbjct: 107 ITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 76.7 bits (189), Expect = 7e-19
 Identities = 29/42 (69%), Positives = 35/42 (83%), Gaps = 1/42 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           K L+YL    KIIHRD+KPSNILL R+G +KLCDFG+SG+LV
Sbjct: 116 KGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.6 bits (188), Expect = 1e-18
 Identities = 31/52 (59%), Positives = 44/52 (84%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A ++ L YL+E+ +I+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 71.5 bits (176), Expect = 5e-17
 Identities = 24/53 (45%), Positives = 36/53 (67%), Gaps = 4/53 (7%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            +I  Q+    +K L+YL  +  IIHRD+KPSN+L++ +G +K+ DFGIS  L
Sbjct: 102 AYIARQI----LKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.7 bits (173), Expect = 1e-16
 Identities = 32/60 (53%), Positives = 43/60 (71%), Gaps = 1/60 (1%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQIN 65
           ++ VA VK L YL   LKI+HRDVKPSN+L++ RG +KLCDFG+S QLV  +   ++  N
Sbjct: 99  RIAVAVVKGLTYL-WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTN 157

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 69.1 bits (170), Expect = 3e-16
 Identities = 25/52 (48%), Positives = 32/52 (61%), Gaps = 5/52 (9%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           F   Q+    + AL YL     I+HRD+KP NILLD  G +KL DFG++ QL
Sbjct: 101 FYLRQI----LSALEYL-HSKGIVHRDLKPENILLDEDGHVKLADFGLARQL 147

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 65.7 bits (161), Expect = 6e-15
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            ++ L YL     IIHRD+KP NILLD  G +K+ DFG++ +L
Sbjct: 107 ILRGLEYLHSN-GIIHRDLKPENILLDENGVVKIADFGLAKKL 148

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 64.9 bits (159), Expect = 1e-14
 Identities = 24/47 (51%), Positives = 29/47 (61%), Gaps = 1/47 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    +K L YL     IIHRD+K +NILL   G +KL DFG+S QL
Sbjct: 103 VCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (155), Expect = 6e-14
 Identities = 28/52 (53%), Positives = 33/52 (63%), Gaps = 5/52 (9%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           FI  +V       L YL EE KI HRD+K +NILL   G +KL DFG+SGQL
Sbjct: 102 FILREVL----LGLEYLHEEGKI-HRDIKAANILLSEEGDVKLADFGVSGQL 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 62.7 bits (153), Expect = 8e-14
 Identities = 25/44 (56%), Positives = 29/44 (65%), Gaps = 1/44 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           T+K L YL    K IHRD+K  NILL+  G  KL DFG+SGQL 
Sbjct: 108 TLKGLEYL-HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 61.0 bits (149), Expect = 3e-13
 Identities = 23/40 (57%), Positives = 26/40 (65%), Gaps = 1/40 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           AL YL    KI+HRD+KP NI L   G +KL DFGIS  L
Sbjct: 115 ALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 60.2 bits (147), Expect = 6e-13
 Identities = 26/45 (57%), Positives = 31/45 (68%), Gaps = 1/45 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           V AL YL   L II+RD+KP NILLD  G IKL DFG++ +L  E
Sbjct: 103 VLALEYL-HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 1e-12
 Identities = 25/47 (53%), Positives = 30/47 (63%), Gaps = 1/47 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V   T+K L YL  E   IHRD+K +NILL   G +KL DFG+S QL
Sbjct: 106 VCRETLKGLAYL-HETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 1e-12
 Identities = 23/43 (53%), Positives = 30/43 (69%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           T++ L YL E  K+IHRD+K  NILL +   +KL DFG+S QL
Sbjct: 122 TLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 3e-12
 Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            ++A+ Y      IIHRD+KP NIL+   G +KLCDFG +  L
Sbjct: 109 LLQAIAYC-HSHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 58.3 bits (142), Expect = 4e-12
 Identities = 23/65 (35%), Positives = 33/65 (50%), Gaps = 5/65 (7%)

Query: 4   TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQ 63
           T Q+    ++ L YL     I+HRD+K +NIL+D  G +KL DFG + +L          
Sbjct: 107 TRQI----LEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161

Query: 64  INFGT 68
              GT
Sbjct: 162 SVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 58.1 bits (141), Expect = 4e-12
 Identities = 22/52 (42%), Positives = 31/52 (59%), Gaps = 1/52 (1%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           +    T+  ++ L YL     I+HRD+KP+NI LD  G IKL DFG + +L 
Sbjct: 100 VIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 57.6 bits (140), Expect = 6e-12
 Identities = 23/40 (57%), Positives = 27/40 (67%), Gaps = 1/40 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            V AL YL     IIHRD+KP NIL+D  G +KL DFG+S
Sbjct: 102 IVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLS 140

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 56.9 bits (138), Expect = 8e-12
 Identities = 22/40 (55%), Positives = 27/40 (67%), Gaps = 2/40 (5%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGIS 50
           ++ L YL     IIHRD+KP NILLD   G +KL DFG+S
Sbjct: 102 LEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLS 140

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 57.1 bits (139), Expect = 1e-11
 Identities = 18/38 (47%), Positives = 27/38 (71%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + L Y     +I+HRD+KP NIL++R G +KL DFG++
Sbjct: 109 RGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLA 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 55.4 bits (134), Expect = 4e-11
 Identities = 23/53 (43%), Positives = 30/53 (56%), Gaps = 6/53 (11%)

Query: 6   QVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +  +ATV     K L YL      IHRD+K  NILL   G++K+ DFG+S  L
Sbjct: 101 EAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASL 152

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 4e-11
 Identities = 18/29 (62%), Positives = 22/29 (75%)

Query: 22  LKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           L  IHRD+KP N+LLD +G IKL DFG+ 
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 55.3 bits (134), Expect = 4e-11
 Identities = 21/47 (44%), Positives = 29/47 (61%), Gaps = 1/47 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
            ++ L YL     +IHRD+K  NILL + G++KL DFG + QL  E 
Sbjct: 125 VLQGLEYL-HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 54.8 bits (132), Expect = 8e-11
 Identities = 24/43 (55%), Positives = 31/43 (72%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            +K LNYL     IIHRD+K +NIL+D +G IK+ DFGIS +L
Sbjct: 115 ILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKL 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.3 bits (131), Expect = 1e-10
 Identities = 21/43 (48%), Positives = 31/43 (72%), Gaps = 1/43 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           ++   T++A+N+   +   IHRDVKP NIL+ ++G IKLCDFG
Sbjct: 104 KIIWQTLQAVNFC-HKHNCIHRDVKPENILITKQGQIKLCDFG 145

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 1e-10
 Identities = 21/39 (53%), Positives = 27/39 (69%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V AL+ +  +L  IHRD+KP NIL+D  G IKL DFG+ 
Sbjct: 111 VLALDSV-HKLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 54.2 bits (131), Expect = 1e-10
 Identities = 21/42 (50%), Positives = 29/42 (69%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V AL YL  +  IIHRD+KP NILLD +G + + DF I+ ++
Sbjct: 110 VLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKV 150

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 53.7 bits (130), Expect = 2e-10
 Identities = 18/36 (50%), Positives = 24/36 (66%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + L YL     I+HRD+K SNIL++  G +KL DFG
Sbjct: 111 EGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFG 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.7 bits (129), Expect = 2e-10
 Identities = 20/30 (66%), Positives = 24/30 (80%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +L  IHRD+KP NIL+DR G IKL DFG+S
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 53.6 bits (129), Expect = 2e-10
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V +A +KAL++L  +  +IHRD+K  +ILL   G +KL DFG   Q+  EV
Sbjct: 120 VCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 3e-10
 Identities = 19/48 (39%), Positives = 31/48 (64%), Gaps = 1/48 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           +    + AL Y+  ++ +IHRD+K +NIL+   G +KLCDFG++  L 
Sbjct: 106 IIREVLVALKYI-HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 53.1 bits (128), Expect = 4e-10
 Identities = 15/38 (39%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + Y+     I+HRD+KP+N+L+   G +K+ DFG++
Sbjct: 110 KGVAYM-HANGIMHRDLKPANLLISADGVLKIADFGLA 146

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 52.6 bits (127), Expect = 4e-10
 Identities = 22/47 (46%), Positives = 28/47 (59%), Gaps = 5/47 (10%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           F   ++    + AL YL     IIHRD+KP NILLD+   IK+ DFG
Sbjct: 106 FYAAEI----LLALEYL-HSKGIIHRDLKPENILLDKDMHIKITDFG 147

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (127), Expect = 4e-10
 Identities = 19/41 (46%), Positives = 29/41 (70%), Gaps = 1/41 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + L YL E+  +IHRD+K +NIL  + G +KL DFG++ +L
Sbjct: 110 QGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKL 149

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 5e-10
 Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 5/52 (9%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++  Q+     +ALN+L    K+IHRD+K  NILL   G +KL DFG+S + 
Sbjct: 107 YVCRQML----EALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 52.0 bits (124), Expect = 7e-10
 Identities = 23/42 (54%), Positives = 32/42 (76%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +K L+YL  E KI HRD+K +N+LL  +G +KL DFG++GQL
Sbjct: 111 LKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQL 151

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 52.0 bits (124), Expect = 7e-10
 Identities = 23/42 (54%), Positives = 32/42 (76%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +K L+YL  E KI HRD+K +N+LL  +G +KL DFG++GQL
Sbjct: 111 LKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQL 151

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 51.8 bits (125), Expect = 9e-10
 Identities = 22/47 (46%), Positives = 30/47 (63%), Gaps = 5/47 (10%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +I  Q+    +KAL Y+     +IHRD+KPSNILL+    +KL DFG
Sbjct: 111 YIMYQL----LKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFG 152

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 51.6 bits (123), Expect = 1e-09
 Identities = 25/54 (46%), Positives = 36/54 (66%), Gaps = 6/54 (11%)

Query: 5   NQVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++  +AT+     K L+YL  E KI HRD+K +N+LL   G +KL DFG++GQL
Sbjct: 99  DETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQL 151

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 1e-09
 Identities = 15/38 (39%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
            ++ L +      I+HRD+KP N+L++  G +KL DFG
Sbjct: 107 LLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFG 143

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 51.5 bits (124), Expect = 1e-09
 Identities = 17/35 (48%), Positives = 26/35 (74%), Gaps = 1/35 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
            + +L  +  I+HRD+K SN+LL+ RG +K+CDFG
Sbjct: 118 GVAHL-HDNWILHRDLKTSNLLLNNRGILKICDFG 151

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 1e-09
 Identities = 20/45 (44%), Positives = 28/45 (62%), Gaps = 1/45 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           Q     V  +  L +   IIHRD+KP N+L+D+ G +KL DFG+S
Sbjct: 101 QYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLS 144

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 2e-09
 Identities = 23/46 (50%), Positives = 28/46 (60%), Gaps = 4/46 (8%)

Query: 9   VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
              V AL+    EL  IHRD+KP N L+D  G IKL DFG+S  +V
Sbjct: 111 FEAVDALH----ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 50.8 bits (121), Expect = 2e-09
 Identities = 25/42 (59%), Positives = 30/42 (71%), Gaps = 1/42 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           T++ALNYL E  KIIHRD+K  NIL    G IKL DFG+S +
Sbjct: 112 TLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAK 152

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 50.9 bits (122), Expect = 2e-09
 Identities = 19/42 (45%), Positives = 28/42 (66%), Gaps = 1/42 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
             L YL +    +HRD+K +NIL+D  G +KL DFG++ Q+V
Sbjct: 113 LGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 50.6 bits (122), Expect = 2e-09
 Identities = 23/48 (47%), Positives = 29/48 (60%), Gaps = 5/48 (10%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
            F   QV +A    L YL   L I++RD+KP N+LLD  G IK+ DFG
Sbjct: 104 RFYAAQVVLA----LEYL-HSLDIVYRDLKPENLLLDSDGYIKITDFG 146

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 50.7 bits (122), Expect = 2e-09
 Identities = 23/52 (44%), Positives = 29/52 (55%), Gaps = 5/52 (9%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           F    V    V A  YL     II+RD+KP N+LLD  G +KL DFG + +L
Sbjct: 97  FYIACV----VLAFEYL-HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 50.4 bits (121), Expect = 3e-09
 Identities = 22/52 (42%), Positives = 33/52 (63%), Gaps = 4/52 (7%)

Query: 2   FITNQV---TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           F  +QV    +  ++ L YL E   IIHRD+K SN+LL  +G +K+ DFG++
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENF-IIHRDLKVSNLLLTDKGCLKIADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 3e-09
 Identities = 21/37 (56%), Positives = 26/37 (70%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+YL     IIHRD+KP N+L+   G IKL DFG+S
Sbjct: 116 ALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 3e-09
 Identities = 23/43 (53%), Positives = 30/43 (69%), Gaps = 1/43 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           V AL YL    +I++RD+KP NILLD+ G IKL DFG + +L 
Sbjct: 111 VCALEYL-HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.6 bits (121), Expect = 3e-09
 Identities = 19/42 (45%), Positives = 30/42 (71%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V A++ +  ++  +HRD+KP N+L+DR G IKL DFG + +L
Sbjct: 112 VLAIHSV-HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 50.2 bits (120), Expect = 4e-09
 Identities = 23/41 (56%), Positives = 30/41 (73%), Gaps = 1/41 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           AL++L   L II+RD+KP NILLD  G IKL DFG+S + +
Sbjct: 110 ALDHL-HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 50.1 bits (120), Expect = 4e-09
 Identities = 17/25 (68%), Positives = 21/25 (84%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFG 48
           IIHRD+KP NIL+ + G +KLCDFG
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFG 145

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.4 bits (118), Expect = 7e-09
 Identities = 18/25 (72%), Positives = 21/25 (84%)

Query: 25  IHRDVKPSNILLDRRGAIKLCDFGI 49
           IHRD+KP NIL+DR G IKL DFG+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 9e-09
 Identities = 16/27 (59%), Positives = 24/27 (88%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGI 49
           +++HRD+KP N+L+DR GA+KL DFG+
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.0 bits (117), Expect = 1e-08
 Identities = 21/36 (58%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL YL   L II+RD+KP NILLD +G + L DFG+
Sbjct: 108 ALGYL-HSLNIIYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 1e-08
 Identities = 16/28 (57%), Positives = 22/28 (78%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +L  +HRD+KP N+LLD+ G I+L DFG
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 48.3 bits (116), Expect = 1e-08
 Identities = 14/38 (36%), Positives = 21/38 (55%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + YL E    IHRD+   N L+     +K+ DFG+S
Sbjct: 114 RGMEYL-ESKNFIHRDLAARNCLVGENLVVKISDFGLS 150

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 48.5 bits (115), Expect = 1e-08
 Identities = 22/41 (53%), Positives = 29/41 (70%), Gaps = 1/41 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           ++AL YL   +KIIHRD+K  N+LL   G IKL DFG+S +
Sbjct: 120 LEALQYL-HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (115), Expect = 1e-08
 Identities = 22/39 (56%), Positives = 28/39 (71%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V AL +L +   I++RD+KP NILLD  G I LCDFG+S
Sbjct: 106 VLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLS 143

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 48.6 bits (114), Expect = 2e-08
 Identities = 24/43 (55%), Positives = 29/43 (67%), Gaps = 2/43 (4%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQL 53
           + AL YL     IIHRD+KP NILLDR G  +KL DFG++  L
Sbjct: 111 LSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152

Length = 384

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 48.3 bits (116), Expect = 2e-08
 Identities = 14/38 (36%), Positives = 21/38 (55%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL E    +HRD+   N L+     +K+ DFG+S
Sbjct: 113 KGMEYL-ESKNFVHRDLAARNCLVTENLVVKISDFGLS 149

Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 47.9 bits (114), Expect = 2e-08
 Identities = 21/51 (41%), Positives = 30/51 (58%), Gaps = 5/51 (9%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           F T Q     ++ L YL  +  I+HRD+K  N+L+D  G  K+ DFGIS +
Sbjct: 112 FFTEQ----VLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKK 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 47.9 bits (115), Expect = 2e-08
 Identities = 14/38 (36%), Positives = 21/38 (55%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + YL E    IHRD+   N L+     +K+ DFG+S
Sbjct: 113 RGMEYL-ESKNFIHRDLAARNCLVGENLVVKISDFGLS 149

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 47.9 bits (114), Expect = 2e-08
 Identities = 16/36 (44%), Positives = 25/36 (69%), Gaps = 1/36 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + YL     I+HRD+KPSN+L++    +K+ DFG+S
Sbjct: 181 IAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVS 215

Length = 353

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 47.8 bits (114), Expect = 2e-08
 Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            V A++Y+ +   I+HRD+K  NI L + G IKL DFGIS  L
Sbjct: 110 IVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.8 bits (114), Expect = 3e-08
 Identities = 21/41 (51%), Positives = 27/41 (65%), Gaps = 1/41 (2%)

Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T   V AL+ +   +  IHRDVKP N+LLD+ G +KL DFG
Sbjct: 148 TAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 47.7 bits (113), Expect = 3e-08
 Identities = 20/31 (64%), Positives = 24/31 (77%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +IIHRDVK +NILL   G +KL DFG+S QL
Sbjct: 148 RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 47.5 bits (113), Expect = 3e-08
 Identities = 22/45 (48%), Positives = 31/45 (68%), Gaps = 1/45 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           V AL++L  +L II+RD+K  NILLD  G + L DFG+S + + E
Sbjct: 115 VLALDHL-HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 47.2 bits (113), Expect = 3e-08
 Identities = 14/27 (51%), Positives = 21/27 (77%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I+HRD+KP NIL+   G +K+ DFG++
Sbjct: 128 IVHRDLKPQNILVTSDGQVKIADFGLA 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 47.1 bits (113), Expect = 4e-08
 Identities = 15/25 (60%), Positives = 21/25 (84%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFG 48
           +IHRD+KPSNIL++    +K+CDFG
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFG 148

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.3 bits (112), Expect = 4e-08
 Identities = 18/29 (62%), Positives = 23/29 (79%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ++  IHRD+KP NIL+DR G IKL DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.1 bits (112), Expect = 5e-08
 Identities = 22/40 (55%), Positives = 27/40 (67%), Gaps = 1/40 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           TV AL YL     I+HRD+KP N+L+   G IKL DFG+S
Sbjct: 110 TVLALEYL-HNYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 46.9 bits (112), Expect = 5e-08
 Identities = 14/28 (50%), Positives = 21/28 (75%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            ++HRD+KP+NI LD    +KL DFG++
Sbjct: 130 TVLHRDLKPANIFLDANNNVKLGDFGLA 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 5e-08
 Identities = 20/36 (55%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL  L  +  +I+RD+KP NILLD +G I LCDFG+
Sbjct: 105 ALENL-HKFNVIYRDLKPENILLDYQGHIALCDFGL 139

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 47.1 bits (112), Expect = 5e-08
 Identities = 19/44 (43%), Positives = 29/44 (65%)

Query: 9   VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           V  V AL YL +E +I+HRD+ P+NI+L     + + DFG++ Q
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.9 bits (111), Expect = 6e-08
 Identities = 20/39 (51%), Positives = 29/39 (74%), Gaps = 1/39 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           TV A++ +  +L  IHRD+KP N+LLD +G +KL DFG+
Sbjct: 110 TVLAIDAI-HQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.5 bits (111), Expect = 7e-08
 Identities = 18/35 (51%), Positives = 27/35 (77%), Gaps = 1/35 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           +NYL E   I+HRD+K +NIL+D +G +K+ DFG+
Sbjct: 128 INYLHEN-HILHRDIKAANILIDNQGILKIADFGL 161

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 7e-08
 Identities = 20/39 (51%), Positives = 29/39 (74%), Gaps = 1/39 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           TV A++ +  +L  IHRD+KP N+LLD +G +KL DFG+
Sbjct: 110 TVLAIDSI-HQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.6 bits (111), Expect = 7e-08
 Identities = 17/37 (45%), Positives = 26/37 (70%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L Y+    KI+HRD+K +NIL+ + G +KL DFG++
Sbjct: 131 GLYYIHRN-KILHRDMKAANILITKDGILKLADFGLA 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 46.4 bits (111), Expect = 7e-08
 Identities = 18/40 (45%), Positives = 28/40 (70%), Gaps = 1/40 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T++ L YL     I+HRD+KP+N+L+   G +KL DFG++
Sbjct: 111 TLRGLEYL-HSNWILHRDLKPNNLLIASDGVLKLADFGLA 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 8e-08
 Identities = 21/51 (41%), Positives = 31/51 (60%), Gaps = 1/51 (1%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +T + T   ++ + YL     I+HRD+K +NIL D  G +KL DFG S +L
Sbjct: 105 VTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.5 bits (110), Expect = 9e-08
 Identities = 20/31 (64%), Positives = 23/31 (74%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           K IHRDVK +NILL   G +KL DFG+S QL
Sbjct: 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 46.3 bits (110), Expect = 9e-08
 Identities = 15/28 (53%), Positives = 24/28 (85%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +++HRD+KP N+L+D +G IKL DFG++
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.2 bits (109), Expect = 1e-07
 Identities = 21/41 (51%), Positives = 28/41 (68%), Gaps = 1/41 (2%)

Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T   V AL+ +   + +IHRDVKP N+LLD+ G +KL DFG
Sbjct: 148 TAEVVLALDAI-HSMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.0 bits (109), Expect = 1e-07
 Identities = 19/37 (51%), Positives = 25/37 (67%), Gaps = 1/37 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           V A  YL     II+RD+KP N+LLD +G +K+ DFG
Sbjct: 128 VLAFEYL-HSKDIIYRDLKPENLLLDNKGHVKVTDFG 163

Length = 329

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 46.0 bits (109), Expect = 1e-07
 Identities = 18/42 (42%), Positives = 24/42 (57%), Gaps = 1/42 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +    ++ L YL    + IHRD+K  NILL   G +KL DFG
Sbjct: 120 ICHGALQGLAYL-HSHERIHRDIKAGNILLTEPGTVKLADFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 45.8 bits (109), Expect = 1e-07
 Identities = 18/37 (48%), Positives = 24/37 (64%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L +L E   II+RD+K  N+LLD  G IK+ DFG+ 
Sbjct: 108 GLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMC 143

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 45.9 bits (109), Expect = 1e-07
 Identities = 20/36 (55%), Positives = 27/36 (75%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL +L  +  II+RD+KP NILLD +G +KL DFG+
Sbjct: 112 ALEHL-HQQGIIYRDLKPENILLDAQGHVKLTDFGL 146

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.8 bits (108), Expect = 1e-07
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V ++ ++AL+YL  +  +IHRD+K  +ILL   G IKL DFG   Q+  EV
Sbjct: 123 VCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 45.6 bits (108), Expect = 1e-07
 Identities = 20/52 (38%), Positives = 33/52 (63%), Gaps = 2/52 (3%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-IKLCDFGISGQL 53
           +    T   ++ L+YL E  +IIHRDVK +N+L+D  G  +++ DFG + +L
Sbjct: 104 VIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.8 bits (108), Expect = 2e-07
 Identities = 18/38 (47%), Positives = 28/38 (73%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 142

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 45.6 bits (108), Expect = 2e-07
 Identities = 15/28 (53%), Positives = 24/28 (85%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 45.4 bits (107), Expect = 2e-07
 Identities = 22/47 (46%), Positives = 32/47 (68%), Gaps = 1/47 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V+  T++ L YL  + K+ HRD+K +NILL   G +KL DFG+S Q+
Sbjct: 111 VSRETLQGLYYLHSKGKM-HRDIKGANILLTDNGHVKLADFGVSAQI 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 45.2 bits (108), Expect = 2e-07
 Identities = 14/38 (36%), Positives = 21/38 (55%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL    K +HRD+   N L+     +K+ DFG+S
Sbjct: 116 KGMEYL-ASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 45.4 bits (107), Expect = 2e-07
 Identities = 21/51 (41%), Positives = 33/51 (64%), Gaps = 1/51 (1%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +T + T   ++ ++YL   + I+HRD+K +NIL D  G +KL DFG S +L
Sbjct: 107 VTRKYTRQILEGMSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 45.0 bits (106), Expect = 2e-07
 Identities = 17/39 (43%), Positives = 30/39 (76%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L+Y  +  KI+HRD+KP N+L++ +G +KL DFG++
Sbjct: 113 LRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.0 bits (106), Expect = 3e-07
 Identities = 19/36 (52%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL YL   + I++RD+KP NILLD +G + L DFG+
Sbjct: 108 ALGYL-HSINIVYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.0 bits (106), Expect = 3e-07
 Identities = 18/39 (46%), Positives = 29/39 (74%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ LNY     K++HRD+KP N+L++ RG +KL DFG++
Sbjct: 114 LRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 44.7 bits (105), Expect = 4e-07
 Identities = 19/42 (45%), Positives = 29/42 (69%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++ L++L +  K+IHRD+K  N+LL     +KL DFG+S QL
Sbjct: 121 LRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 44.4 bits (105), Expect = 4e-07
 Identities = 14/27 (51%), Positives = 23/27 (85%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KPSNIL++    +K+CDFG++
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLA 155

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 4e-07
 Identities = 14/28 (50%), Positives = 23/28 (82%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +++HRD+KP N+L+  RG +KL DFG++
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 44.4 bits (105), Expect = 4e-07
 Identities = 15/30 (50%), Positives = 26/30 (86%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           E +++HRD+KP N+L+++RG +KL DFG++
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLA 147

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 44.4 bits (105), Expect = 4e-07
 Identities = 17/28 (60%), Positives = 21/28 (75%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           KI+HRD+K  NI L + G IKL DFGI+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIA 148

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 44.5 bits (105), Expect = 4e-07
 Identities = 20/42 (47%), Positives = 29/42 (69%), Gaps = 2/42 (4%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           AL+++  +L I+HRD+K  NILLD+   + K+ DFGIS  L 
Sbjct: 113 ALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 44.2 bits (104), Expect = 5e-07
 Identities = 21/36 (58%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL YL   L I++RD+KP NILLD +G I L DFG+
Sbjct: 108 ALGYL-HSLNIVYRDLKPENILLDSQGHIVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 44.2 bits (104), Expect = 5e-07
 Identities = 20/36 (55%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           A+ YL   L II+RD+KP NILLD +G + L DFG+
Sbjct: 108 AIGYL-HSLNIIYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 43.9 bits (104), Expect = 5e-07
 Identities = 19/38 (50%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V  L YL E  KI++RD+K  N+LLD  G +K+ DFG+
Sbjct: 111 VLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.2 bits (104), Expect = 5e-07
 Identities = 21/41 (51%), Positives = 27/41 (65%), Gaps = 1/41 (2%)

Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T   V AL+ +   +  IHRDVKP N+LLD+ G +KL DFG
Sbjct: 148 TAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 43.9 bits (103), Expect = 7e-07
 Identities = 21/51 (41%), Positives = 33/51 (64%), Gaps = 1/51 (1%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +T + T   ++ ++YL   + I+HRD+K +NIL D  G +KL DFG S +L
Sbjct: 107 VTRKYTRQILEGVSYLHSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 7e-07
 Identities = 14/27 (51%), Positives = 23/27 (85%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLA 153

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.8 bits (103), Expect = 7e-07
 Identities = 17/29 (58%), Positives = 22/29 (75%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ++  IHRD+KP NIL+D  G IKL DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 43.7 bits (104), Expect = 7e-07
 Identities = 11/23 (47%), Positives = 16/23 (69%)

Query: 26  HRDVKPSNILLDRRGAIKLCDFG 48
           HRD+KP N+L+     +K+ DFG
Sbjct: 122 HRDLKPENLLVSGPEVVKIADFG 144

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.6 bits (103), Expect = 7e-07
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 105 VSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 43.7 bits (103), Expect = 8e-07
 Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 1/45 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL +L    ++IHRD+K  NILL   G++KL DFG   Q+  E
Sbjct: 125 LQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.5 bits (102), Expect = 8e-07
 Identities = 16/28 (57%), Positives = 21/28 (75%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +L  +HRD+KP N+LLD  G I+L DFG
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.4 bits (102), Expect = 9e-07
 Identities = 15/28 (53%), Positives = 24/28 (85%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K++HRD+KP N+L++ RG +KL DFG++
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 43.6 bits (103), Expect = 9e-07
 Identities = 13/27 (48%), Positives = 23/27 (85%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KP N+L+++ G +KL DFG++
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (102), Expect = 1e-06
 Identities = 20/51 (39%), Positives = 33/51 (64%), Gaps = 1/51 (1%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +T + T   ++ ++YL   + I+HRD+K +NIL D  G +KL DFG S ++
Sbjct: 107 VTRRYTRQILQGVSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRI 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 43.5 bits (102), Expect = 1e-06
 Identities = 17/31 (54%), Positives = 22/31 (70%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           K+IHRD+K  N+LL     +KL DFG+S QL
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 43.1 bits (102), Expect = 1e-06
 Identities = 17/45 (37%), Positives = 23/45 (51%), Gaps = 1/45 (2%)

Query: 9   VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V     + YL E  + IHRD+   NILL     +K+ DFG+   L
Sbjct: 104 VQIANGMRYL-ESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 43.1 bits (101), Expect = 1e-06
 Identities = 23/51 (45%), Positives = 32/51 (62%), Gaps = 1/51 (1%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V +A +KAL+ L  +  +IHRD+K  +ILL   G +KL DFG   Q+  EV
Sbjct: 121 VCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 43.1 bits (101), Expect = 1e-06
 Identities = 16/31 (51%), Positives = 25/31 (80%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +I++RD+KP NILLD RG I++ D G++ Q+
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQI 152

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 1e-06
 Identities = 20/36 (55%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ALN+L E   II+RD+K  N+LLD  G IKL D+G+
Sbjct: 108 ALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 43.2 bits (101), Expect = 1e-06
 Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 1/45 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL++L    ++IHRD+K  NILL   G++KL DFG   Q+  E
Sbjct: 125 LQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 42.9 bits (101), Expect = 1e-06
 Identities = 16/29 (55%), Positives = 25/29 (86%), Gaps = 1/29 (3%)

Query: 23  KIIHRDVKPSNILLDRR-GAIKLCDFGIS 50
           +++HRD+KP N+L+DRR  A+KL DFG++
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLA 150

Length = 294

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 42.7 bits (100), Expect = 2e-06
 Identities = 19/47 (40%), Positives = 31/47 (65%), Gaps = 1/47 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           T++ L YL  + K+ HRD+K +NILL   G +KL DFG++ ++   +
Sbjct: 115 TLQGLAYLHSKGKM-HRDIKGANILLTDNGDVKLADFGVAAKITATI 160

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 42.7 bits (100), Expect = 2e-06
 Identities = 17/42 (40%), Positives = 28/42 (66%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +KA+++  +   I+HRD+KP N+L+     +KLCDFG +  L
Sbjct: 110 IKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.7 bits (100), Expect = 2e-06
 Identities = 16/28 (57%), Positives = 21/28 (75%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +L  +HRD+KP NIL+D  G I+L DFG
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.4 bits (99), Expect = 2e-06
 Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 1/45 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL +L    ++IHRD+K  NILL   G++KL DFG   Q+  E
Sbjct: 126 LQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.4 bits (100), Expect = 2e-06
 Identities = 16/38 (42%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + L YL     I+HRD+KP N+L++    +K+CDFG++
Sbjct: 114 RGLKYL-HSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 42.3 bits (99), Expect = 2e-06
 Identities = 15/27 (55%), Positives = 21/27 (77%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I+HRD+KP NIL+   G +KL DFG++
Sbjct: 129 IVHRDLKPENILVTSGGQVKLADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 42.3 bits (99), Expect = 2e-06
 Identities = 20/55 (36%), Positives = 32/55 (58%), Gaps = 2/55 (3%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLV 54
           +F+    +    +AL Y+  +  I HRD+KP N+L+D     +KLCDFG +  L+
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222

Length = 440

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 42.4 bits (99), Expect = 2e-06
 Identities = 21/36 (58%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ALNYL E   II+RD+K  N+LLD  G IKL D+G+
Sbjct: 108 ALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 2e-06
 Identities = 15/40 (37%), Positives = 26/40 (65%), Gaps = 5/40 (12%)

Query: 15  LNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGIS 50
           ++YL     ++HRD+KP+NIL+      RG +K+ D G++
Sbjct: 121 VHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 42.3 bits (99), Expect = 2e-06
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 4/60 (6%)

Query: 2   FITNQVTVAT---VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVV 58
           F   +V + +   V AL +L  +L II+RD+K  NILLD  G + L DFG+S +   + V
Sbjct: 102 FKEQEVQIYSGEIVLALEHL-HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 42.1 bits (99), Expect = 3e-06
 Identities = 19/36 (52%), Positives = 27/36 (75%), Gaps = 1/36 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           LNY  ++   +HRD+K SNILL+ +G IKL DFG++
Sbjct: 129 LNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLA 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.9 bits (98), Expect = 3e-06
 Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 1/45 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           + AL +L  +L I++RD+K  NILLD  G + L DFG+S + + E
Sbjct: 115 ILALEHL-HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.0 bits (99), Expect = 3e-06
 Identities = 12/27 (44%), Positives = 22/27 (81%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KP N+L++    +K+CDFG++
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLA 152

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 41.9 bits (98), Expect = 4e-06
 Identities = 24/58 (41%), Positives = 34/58 (58%), Gaps = 6/58 (10%)

Query: 5   NQVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           N+  +ATV     +AL YL  +  +IHRD+K  +ILL   G +KL DFG   Q+  +V
Sbjct: 115 NEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 41.6 bits (98), Expect = 4e-06
 Identities = 14/27 (51%), Positives = 23/27 (85%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLA 155

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 41.6 bits (97), Expect = 4e-06
 Identities = 19/45 (42%), Positives = 29/45 (64%), Gaps = 1/45 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL +L    ++IHRD+K  N+LL   G++KL DFG   Q+  E
Sbjct: 125 LQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 41.3 bits (97), Expect = 4e-06
 Identities = 16/30 (53%), Positives = 21/30 (70%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           E KI+HRD+K +NILL     +K+ D GIS
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGIS 150

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.5 bits (97), Expect = 5e-06
 Identities = 17/38 (44%), Positives = 27/38 (71%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + L++L    +++HRD+KP NIL+   G IKL DFG++
Sbjct: 121 RGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLA 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 41.5 bits (97), Expect = 5e-06
 Identities = 16/31 (51%), Positives = 24/31 (77%)

Query: 20  EELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + L I++RD+KP N+LLD+ G IK+ DFG +
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178

Length = 340

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 41.2 bits (96), Expect = 6e-06
 Identities = 19/38 (50%), Positives = 28/38 (73%), Gaps = 1/38 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL+YL    KI++RD+K  N++LD+ G IK+ DFG+
Sbjct: 105 VSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 6e-06
 Identities = 24/55 (43%), Positives = 30/55 (54%), Gaps = 1/55 (1%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT 68
           AL YL   L I++RD+KP NILL   G I L DF +S Q  VE       +  G+
Sbjct: 115 ALEYL-HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 7e-06
 Identities = 20/42 (47%), Positives = 24/42 (57%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++AL YL     IIHRDVK  NI LD      L DFG + +L
Sbjct: 195 LEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235

Length = 392

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 40.6 bits (95), Expect = 8e-06
 Identities = 19/53 (35%), Positives = 33/53 (62%), Gaps = 5/53 (9%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            F T Q+    +  L +L +  +II+RD+KP N+LLD  G +++ D G++ +L
Sbjct: 100 CFYTAQI----ISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 40.7 bits (95), Expect = 9e-06
 Identities = 14/33 (42%), Positives = 24/33 (72%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            + I++RD+KP N+LLD +G  +L D G++ +L
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 40.8 bits (95), Expect = 9e-06
 Identities = 20/36 (55%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ALN+L E   II+RD+K  N+LLD  G IKL D+G+
Sbjct: 108 ALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 40.4 bits (94), Expect = 1e-05
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L+Y+ +   I+HRD+KP N+L+   G +KL DFG++
Sbjct: 113 LRGLSYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 40.2 bits (94), Expect = 1e-05
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           L  L  E +I++RD+KP NILLD  G I++ D G++ ++
Sbjct: 115 LEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 40.1 bits (93), Expect = 1e-05
 Identities = 19/42 (45%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +T   ++ L YL     +IHRD+K  NILL   G +KL DFG
Sbjct: 130 ITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFG 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 40.3 bits (94), Expect = 1e-05
 Identities = 18/38 (47%), Positives = 25/38 (65%), Gaps = 1/38 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
             AL +L ++  II+RD+K  N+LLD  G  KL DFG+
Sbjct: 106 TSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 40.2 bits (94), Expect = 1e-05
 Identities = 16/27 (59%), Positives = 20/27 (74%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +IHRD+K +NILL   G +KL DFG S
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFS 190

Length = 496

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 39.8 bits (93), Expect = 2e-05
 Identities = 20/53 (37%), Positives = 33/53 (62%), Gaps = 6/53 (11%)

Query: 2   FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQL 53
           F T Q+    ++ L YL  + +I+HRD+K  N+L++   G +K+ DFG S +L
Sbjct: 112 FYTKQI----LEGLKYL-HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 40.0 bits (93), Expect = 2e-05
 Identities = 19/42 (45%), Positives = 24/42 (57%), Gaps = 1/42 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +T   ++ L YL     I HRD+K  NILL   G +KL DFG
Sbjct: 126 ITHGALQGLAYLHSHNMI-HRDIKAGNILLTEPGQVKLADFG 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 39.8 bits (94), Expect = 2e-05
 Identities = 19/40 (47%), Positives = 26/40 (65%), Gaps = 2/40 (5%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGIS 50
           V+ALN L +   IIH D+K  N+L DR +  I LCD+G+ 
Sbjct: 119 VEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157

Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 40.0 bits (93), Expect = 2e-05
 Identities = 22/49 (44%), Positives = 28/49 (57%), Gaps = 4/49 (8%)

Query: 5   NQVT---VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           NQV    V    AL YL E+  I+HRD+K  N+ L R   IK+ D GI+
Sbjct: 102 NQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIA 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 40.0 bits (93), Expect = 2e-05
 Identities = 16/39 (41%), Positives = 27/39 (69%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+  +  I+HRD+KP N+L+   G +KL DFG++
Sbjct: 113 LRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.0 bits (93), Expect = 2e-05
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 105 VSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 39.8 bits (93), Expect = 2e-05
 Identities = 15/32 (46%), Positives = 23/32 (71%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGISGQLVV 55
           II+RD+K  N+LLD+ G IK+ DFG+  + + 
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 39.8 bits (93), Expect = 2e-05
 Identities = 12/28 (42%), Positives = 22/28 (78%), Gaps = 1/28 (3%)

Query: 24  IIHRDVKPSNILLDR-RGAIKLCDFGIS 50
           ++HRD+KP N+L+D+ +G +K+ D G+ 
Sbjct: 131 VMHRDLKPQNLLVDKQKGLLKIADLGLG 158

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 39.6 bits (93), Expect = 2e-05
 Identities = 15/36 (41%), Positives = 21/36 (58%), Gaps = 1/36 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + YL E    +HRD+   N+LL  R   K+ DFG+S
Sbjct: 108 MAYL-ESKHFVHRDLAARNVLLVNRHQAKISDFGMS 142

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 39.8 bits (93), Expect = 2e-05
 Identities = 12/30 (40%), Positives = 23/30 (76%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + +I++RD+KP N+LLD  G +++ D G++
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 39.6 bits (92), Expect = 2e-05
 Identities = 17/37 (45%), Positives = 26/37 (70%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L  L +E +I++RD+KP NILLD  G I++ D G++
Sbjct: 114 GLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 39.6 bits (92), Expect = 2e-05
 Identities = 21/42 (50%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           VT   ++ L YL     +IHRDVK  NILL   G +KL DFG
Sbjct: 120 VTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 39.3 bits (92), Expect = 2e-05
 Identities = 14/27 (51%), Positives = 21/27 (77%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           IIHRD+KPSNI++     +K+ DFG++
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLA 165

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 39.5 bits (92), Expect = 3e-05
 Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 1/39 (2%)

Query: 10  ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
             ++ L YL  + +IIHRDVK  NI ++    + + D G
Sbjct: 165 QILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLG 202

Length = 357

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 39.2 bits (91), Expect = 3e-05
 Identities = 17/39 (43%), Positives = 26/39 (66%), Gaps = 1/39 (2%)

Query: 10  ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + ++A+ YL E  +IIHRD+K  NI ++  G + L DFG
Sbjct: 190 SVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFG 227

Length = 391

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.1 bits (91), Expect = 3e-05
 Identities = 14/28 (50%), Positives = 19/28 (67%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K IHRD+   NILL     +K+CDFG++
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLA 220

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 38.9 bits (90), Expect = 4e-05
 Identities = 16/38 (42%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL     +K+CDFG++
Sbjct: 190 KGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLA 226

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 38.8 bits (91), Expect = 4e-05
 Identities = 14/25 (56%), Positives = 17/25 (68%), Gaps = 1/25 (4%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFG 48
           I HRD+KP NIL+     +KL DFG
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 39.0 bits (91), Expect = 4e-05
 Identities = 16/39 (41%), Positives = 26/39 (66%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++AL Y+     + HRD+KP NIL +    +K+CDFG++
Sbjct: 113 LRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLA 150

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 38.8 bits (91), Expect = 4e-05
 Identities = 12/26 (46%), Positives = 20/26 (76%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFG 48
            +IHRD+KPSN+L++    +++ DFG
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFG 152

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 38.8 bits (90), Expect = 4e-05
 Identities = 19/37 (51%), Positives = 23/37 (62%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVL 59
           K++HRD+K +NI L   G IKL DFG S Q    V L
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Length = 478

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 38.6 bits (90), Expect = 5e-05
 Identities = 11/37 (29%), Positives = 21/37 (56%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLP 60
            +HRD+ P+NI ++ +G  K+ DFG++ +        
Sbjct: 140 FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Length = 335

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 38.7 bits (90), Expect = 5e-05
 Identities = 14/30 (46%), Positives = 20/30 (66%), Gaps = 3/30 (10%)

Query: 24  IIHRDVKPSNILLDRRGA---IKLCDFGIS 50
           I+HRD+KP NI++ + G     K+ DFGI 
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 38.4 bits (89), Expect = 5e-05
 Identities = 14/28 (50%), Positives = 19/28 (67%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K IHRD+   NILL     +K+CDFG++
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLA 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 38.4 bits (89), Expect = 6e-05
 Identities = 17/48 (35%), Positives = 29/48 (60%), Gaps = 1/48 (2%)

Query: 9   VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           V   K +NYL EE +++HRD+   N+L+     +K+ DFG++  L  +
Sbjct: 116 VQIAKGMNYL-EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 38.2 bits (89), Expect = 6e-05
 Identities = 14/26 (53%), Positives = 20/26 (76%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGI 49
           II+RD+K  N++LD  G IK+ DFG+
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 38.1 bits (89), Expect = 6e-05
 Identities = 13/40 (32%), Positives = 22/40 (55%), Gaps = 1/40 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + + YL EE   +HRD+   N+L+      K+ DFG++
Sbjct: 111 VCEGMEYL-EEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 38.2 bits (89), Expect = 7e-05
 Identities = 14/38 (36%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K ++YL    + IHRD+   NIL++    +K+ DFG++
Sbjct: 120 KGMDYL-GSQRYIHRDLAARNILVESEDLVKISDFGLA 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 37.9 bits (88), Expect = 7e-05
 Identities = 15/39 (38%), Positives = 24/39 (61%), Gaps = 1/39 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           L +L  + KI+HRD+K  N+ LD    +K+ D G++  L
Sbjct: 114 LAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 38.0 bits (88), Expect = 8e-05
 Identities = 16/32 (50%), Positives = 23/32 (71%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGISGQLVV 55
           II+RD+K  N++LDR G IK+ DFG+  + V 
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 37.8 bits (88), Expect = 8e-05
 Identities = 14/36 (38%), Positives = 25/36 (69%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL ++  + +I+HRD+KP+N+ +   G +KL D G+
Sbjct: 118 ALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 38.0 bits (88), Expect = 8e-05
 Identities = 18/32 (56%), Positives = 23/32 (71%), Gaps = 1/32 (3%)

Query: 23  KIIHRDVKPSNILLDRRGAI-KLCDFGISGQL 53
           KI+HRD+K  NI L + G + KL DFGI+ QL
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 37.8 bits (88), Expect = 8e-05
 Identities = 16/38 (42%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            AL YL E  + +HRD+   N+L+     +KL DFG+S
Sbjct: 118 TALAYL-ESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 38.1 bits (88), Expect = 9e-05
 Identities = 13/27 (48%), Positives = 20/27 (74%)

Query: 22  LKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + I+HRD+KP N+L+   G +K+ DFG
Sbjct: 328 IGIVHRDIKPENLLVTVDGQVKIIDFG 354

Length = 507

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 37.9 bits (88), Expect = 9e-05
 Identities = 16/38 (42%), Positives = 25/38 (65%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + YL E  + IHRD+   N L+D +G +K+ DFG+S
Sbjct: 111 EGMAYL-ESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 37.5 bits (87), Expect = 1e-04
 Identities = 18/36 (50%), Positives = 23/36 (63%), Gaps = 1/36 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL +L     +I+RD+K  NILLD  G  KL DFG+
Sbjct: 108 ALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 37.6 bits (87), Expect = 1e-04
 Identities = 12/27 (44%), Positives = 22/27 (81%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +++RD+KP+NILLD  G +++ D G++
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 37.3 bits (87), Expect = 1e-04
 Identities = 15/33 (45%), Positives = 22/33 (66%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           IIHRD+KPSNI ++    +K+ DFG++     E
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 37.3 bits (86), Expect = 1e-04
 Identities = 12/27 (44%), Positives = 22/27 (81%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +++RD+KP+NILLD  G +++ D G++
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 37.3 bits (86), Expect = 1e-04
 Identities = 16/35 (45%), Positives = 25/35 (71%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVV 58
           II+RD+K  N++LD  G IK+ DFG+  + +V+ V
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 37.3 bits (86), Expect = 2e-04
 Identities = 15/26 (57%), Positives = 20/26 (76%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGI 49
           I++RD+K  NILLD  G IK+ DFG+
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 37.3 bits (86), Expect = 2e-04
 Identities = 16/37 (43%), Positives = 23/37 (62%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L  L  E   ++RD+KP NILLD  G I++ D G++
Sbjct: 114 GLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 36.9 bits (85), Expect = 2e-04
 Identities = 14/32 (43%), Positives = 21/32 (65%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLD 37
           Q+   T  AL+Y   EL ++H D+KP NIL++
Sbjct: 235 QIIFQTGVALDYFHTELHLMHTDLKPENILME 266

Length = 467

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 36.9 bits (85), Expect = 2e-04
 Identities = 14/35 (40%), Positives = 24/35 (68%), Gaps = 1/35 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
            + ++ E+ +++HRD+K  NI L + G +KL DFG
Sbjct: 112 GVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFG 145

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 36.6 bits (85), Expect = 2e-04
 Identities = 16/37 (43%), Positives = 22/37 (59%), Gaps = 1/37 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           YL E L  +HRD+   N L+ +   IK+ DFG+S  L
Sbjct: 145 YL-ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 36.5 bits (85), Expect = 2e-04
 Identities = 14/34 (41%), Positives = 19/34 (55%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL E    IHRD+   NIL+      K+ DFG++
Sbjct: 118 YL-ESRNYIHRDLAARNILVGENLVCKIADFGLA 150

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 36.8 bits (85), Expect = 2e-04
 Identities = 17/46 (36%), Positives = 27/46 (58%), Gaps = 1/46 (2%)

Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           T   +  + YL     ++HRD+K +N++L   G IKL DFG + +L
Sbjct: 108 TKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 36.5 bits (84), Expect = 3e-04
 Identities = 16/48 (33%), Positives = 31/48 (64%), Gaps = 1/48 (2%)

Query: 9   VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           V   K ++YL EE++++HRD+   N+L+     +K+ DFG++  L ++
Sbjct: 116 VQIAKGMSYL-EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 36.4 bits (84), Expect = 3e-04
 Identities = 19/37 (51%), Positives = 24/37 (64%), Gaps = 1/37 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           V AL+ L  E  I+ RD+ P+NILLD RG I+L  F 
Sbjct: 95  VVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFS 130

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 36.3 bits (84), Expect = 3e-04
 Identities = 15/33 (45%), Positives = 20/33 (60%), Gaps = 1/33 (3%)

Query: 24  IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVV 55
           I+HRDVKP NI+     G+ K+ D G +  L V
Sbjct: 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRV 308

Length = 566

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 36.2 bits (83), Expect = 4e-04
 Identities = 14/27 (51%), Positives = 21/27 (77%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           IIHRD+KPSNI++     +K+ DFG++
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLA 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 36.1 bits (83), Expect = 4e-04
 Identities = 14/26 (53%), Positives = 20/26 (76%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGI 49
           II+RD+K  N++LD  G IK+ DFG+
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 35.9 bits (83), Expect = 4e-04
 Identities = 14/38 (36%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +A+ YL E    IHRD+   N L+     +K+ DFG++
Sbjct: 111 EAMEYL-ESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 36.2 bits (83), Expect = 4e-04
 Identities = 14/27 (51%), Positives = 21/27 (77%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           IIHRD+KPSNI++     +K+ DFG++
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLA 173

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 35.8 bits (82), Expect = 5e-04
 Identities = 11/27 (40%), Positives = 20/27 (74%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGI 49
           +++HRD+KP+N+ +   G +KL D G+
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 35.7 bits (82), Expect = 5e-04
 Identities = 14/38 (36%), Positives = 25/38 (65%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + YL E +K++HRD+   N+L+     +K+ DFG+S
Sbjct: 138 RGMQYLAE-MKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 35.4 bits (81), Expect = 6e-04
 Identities = 14/27 (51%), Positives = 21/27 (77%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           IIHRD+KPSNI++     +K+ DFG++
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLA 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 35.4 bits (81), Expect = 6e-04
 Identities = 15/39 (38%), Positives = 26/39 (66%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++
Sbjct: 130 LRGLKYI-HSADIIHRDLKPSNLAVNEDCELKILDFGLA 167

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 35.4 bits (81), Expect = 6e-04
 Identities = 13/29 (44%), Positives = 22/29 (75%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           IIHRD+KPSN+ ++    +++ DFG++ Q
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQ 167

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 35.5 bits (82), Expect = 6e-04
 Identities = 19/46 (41%), Positives = 25/46 (54%), Gaps = 8/46 (17%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGA-------IKLCDFGIS 50
             AL+YL E+ K++H +V   NIL+ R G        IKL D GI 
Sbjct: 111 ASALHYL-EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 35.5 bits (82), Expect = 6e-04
 Identities = 12/38 (31%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + +L    K IHRD+   N+L+     +K+ DFG++
Sbjct: 143 RGMEFL-ASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 35.4 bits (81), Expect = 7e-04
 Identities = 11/27 (40%), Positives = 20/27 (74%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGI 49
           +++HRD+KP+N+ +   G +KL D G+
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 35.3 bits (81), Expect = 7e-04
 Identities = 16/41 (39%), Positives = 26/41 (63%), Gaps = 1/41 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           +K L Y+     IIHRD+KP N+ ++    +K+ DFG++ Q
Sbjct: 128 LKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 34.9 bits (80), Expect = 0.001
 Identities = 19/46 (41%), Positives = 27/46 (58%), Gaps = 4/46 (8%)

Query: 6   QVTVAT---VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           QVT      + A++Y+  E  IIHRD+K  N+L++    I L DFG
Sbjct: 261 QVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFG 305

Length = 461

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 34.8 bits (80), Expect = 0.001
 Identities = 13/26 (50%), Positives = 17/26 (65%)

Query: 25  IHRDVKPSNILLDRRGAIKLCDFGIS 50
           IHRDV   N+LL      K+CDFG++
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLA 259

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 34.7 bits (80), Expect = 0.001
 Identities = 15/34 (44%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL EE   IHRD+   NIL+      K+ DFG++
Sbjct: 119 YL-EEQNSIHRDLAARNILVGEDLVCKVADFGLA 151

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 34.7 bits (80), Expect = 0.001
 Identities = 14/38 (36%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K ++YL EE +++HRD+   N+L+     +K+ DFG++
Sbjct: 120 KGMSYL-EEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 34.5 bits (79), Expect = 0.001
 Identities = 15/38 (39%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K +++L  +   IHRD+   NILL      K+CDFG++
Sbjct: 225 KGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLA 261

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 34.5 bits (79), Expect = 0.001
 Identities = 14/40 (35%), Positives = 24/40 (60%), Gaps = 1/40 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            +  L Y+     IIHRD+KP N+ ++    +K+ DFG++
Sbjct: 126 MLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLA 164

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 34.7 bits (79), Expect = 0.001
 Identities = 17/35 (48%), Positives = 24/35 (68%), Gaps = 1/35 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           A+ Y+ ++ K+IHRD+K  NI L+  G I L DFG
Sbjct: 279 AVEYIHDK-KLIHRDIKLENIFLNCDGKIVLGDFG 312

Length = 501

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 34.7 bits (79), Expect = 0.001
 Identities = 15/42 (35%), Positives = 26/42 (61%), Gaps = 1/42 (2%)

Query: 9   VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V   K + YL EE +++HRD+   N+L+     +K+ DFG++
Sbjct: 116 VQIAKGMMYL-EERRLVHRDLAARNVLVKSPNHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 34.2 bits (78), Expect = 0.002
 Identities = 15/39 (38%), Positives = 21/39 (53%), Gaps = 1/39 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + YL   L  +HRD+   N L+     IK+ DFG+S  L
Sbjct: 142 MKYLAS-LNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 34.1 bits (78), Expect = 0.002
 Identities = 17/45 (37%), Positives = 23/45 (51%), Gaps = 9/45 (20%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGA--------IKLCDFGIS 50
           AL++L E+  + H +V   N+LL R           IKL D GIS
Sbjct: 112 ALHFL-EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 33.8 bits (77), Expect = 0.002
 Identities = 16/45 (35%), Positives = 27/45 (60%), Gaps = 1/45 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           Q ++   + + YL E  K++HRD+   NIL+   G  K+ DFG++
Sbjct: 104 QFSLDVAEGMEYL-ESKKLVHRDLAARNILVSEDGVAKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 34.0 bits (78), Expect = 0.002
 Identities = 14/36 (38%), Positives = 21/36 (58%), Gaps = 1/36 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + YL E  K +HRD+   N L+     +K+ DFG+S
Sbjct: 143 MAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLS 177

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 33.9 bits (78), Expect = 0.002
 Identities = 11/36 (30%), Positives = 18/36 (50%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
             + YL    K +HRD+   N ++     +K+ DFG
Sbjct: 130 DGMAYL-AAKKFVHRDLAARNCMVAEDLTVKIGDFG 164

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 33.8 bits (77), Expect = 0.002
 Identities = 14/36 (38%), Positives = 25/36 (69%), Gaps = 2/36 (5%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++Y+ +  +I+HRD+K  NI L +   +K+ DFG+S
Sbjct: 119 VHYMHQR-RILHRDLKAKNIFL-KNNLLKIGDFGVS 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 33.8 bits (77), Expect = 0.003
 Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 9/57 (15%)

Query: 5   NQVTVATVKAL--------NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +++TV+ V  L         YL E    +HRD+   N+LL  +   K+ DFG+S  L
Sbjct: 90  DEITVSNVVELMHQVSMGMKYL-EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 33.8 bits (77), Expect = 0.003
 Identities = 14/49 (28%), Positives = 25/49 (51%), Gaps = 1/49 (2%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV 55
           +    +  L Y+ E   I H D+KP NI++D      + D+GI+   ++
Sbjct: 131 IMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYIIDYGIASHFII 178

Length = 294

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 33.8 bits (77), Expect = 0.003
 Identities = 13/43 (30%), Positives = 25/43 (58%), Gaps = 1/43 (2%)

Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T    + + +L  +   +HRD+   N+LL +   +K+CDFG++
Sbjct: 243 TYQVARGMEFLASK-NCVHRDLAARNVLLAQGKIVKICDFGLA 284

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 33.7 bits (77), Expect = 0.003
 Identities = 15/39 (38%), Positives = 22/39 (56%), Gaps = 1/39 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + YL   L  +HRD+   N L+ +   IK+ DFG+S  L
Sbjct: 143 MKYL-SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 33.7 bits (77), Expect = 0.003
 Identities = 12/26 (46%), Positives = 18/26 (69%)

Query: 25  IHRDVKPSNILLDRRGAIKLCDFGIS 50
           IHRD+   N+LLD    +K+ DFG++
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLA 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase

 Score = 33.8 bits (78), Expect = 0.003
 Identities = 13/28 (46%), Positives = 17/28 (60%)

Query: 26  HRDVKPSNILLDRRGAIKLCDFGISGQL 53
           H D+ P NI + + G I   DFGI G+L
Sbjct: 280 HADLHPGNIFVLKDGKIIALDFGIVGRL 307

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 33.6 bits (77), Expect = 0.003
 Identities = 12/26 (46%), Positives = 18/26 (69%)

Query: 25  IHRDVKPSNILLDRRGAIKLCDFGIS 50
           IHRD+   N+LL     +K+CDFG++
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLA 188

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 33.6 bits (77), Expect = 0.003
 Identities = 16/37 (43%), Positives = 21/37 (56%), Gaps = 4/37 (10%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGIS 50
           YL EE   IHRD+   N LL  +G     K+ DFG++
Sbjct: 131 YL-EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 33.5 bits (77), Expect = 0.003
 Identities = 14/36 (38%), Positives = 20/36 (55%), Gaps = 1/36 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDF 47
           + AL+Y+  +   IHR VK S+ILL   G + L   
Sbjct: 111 LNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 33.4 bits (76), Expect = 0.004
 Identities = 16/45 (35%), Positives = 24/45 (53%), Gaps = 1/45 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           Q        + YL E+ + IHRD+   N+L+    A K+ DFG+S
Sbjct: 123 QFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKIADFGLS 166

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 33.1 bits (75), Expect = 0.004
 Identities = 14/43 (32%), Positives = 24/43 (55%), Gaps = 1/43 (2%)

Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T    + + YL  + K IHRD+   N+L+     +K+ DFG++
Sbjct: 143 TYQVARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLA 184

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 33.1 bits (75), Expect = 0.004
 Identities = 14/37 (37%), Positives = 23/37 (62%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            ++YL ++ + IHRD+   NIL+      K+ DFG+S
Sbjct: 124 GMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLS 159

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 33.2 bits (76), Expect = 0.004
 Identities = 13/38 (34%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL    + +HRD+   NIL++    +K+ DFG++
Sbjct: 119 KGMEYL-GSKRYVHRDLATRNILVESENRVKIGDFGLT 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 33.1 bits (76), Expect = 0.004
 Identities = 15/33 (45%), Positives = 17/33 (51%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
                H D  P NIL+   G I L DFGI G+L
Sbjct: 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315

Length = 517

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	68
KOG0594|consensus	323		99.58
KOG0599|consensus	411		99.54
KOG0600|consensus	560		99.52
KOG0581|consensus	364		99.52
KOG0661|consensus	538		99.51
KOG0583|consensus	370		99.51
KOG0615|consensus	475		99.51
KOG0575|consensus	592		99.5
KOG0592|consensus	604		99.47
KOG0197|consensus	468		99.46
KOG0595|consensus	429		99.45
KOG0616|consensus	355		99.45
KOG0591|consensus	375		99.44
KOG0193|consensus	678		99.42
KOG0593|consensus	396		99.41
KOG0611|consensus	668		99.4
KOG0578|consensus	550		99.37
KOG0659|consensus	318		99.36
KOG0598|consensus	357		99.36
KOG0198|consensus	313		99.33
KOG0588|consensus	786		99.33
KOG0663|consensus	419		99.32
KOG0192|consensus	362		99.31
KOG0585|consensus	576		99.29
KOG1035|consensus	1351		99.28
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.27
KOG0658|consensus	364		99.26
PHA03211	461	serine/threonine kinase US3; Provisional	99.26
PTZ00267	478	NIMA-related protein kinase; Provisional	99.25
PHA02882	294	putative serine/threonine kinase; Provisional	99.25
PTZ00283	496	serine/threonine protein kinase; Provisional	99.24
KOG1187|consensus	361		99.24
KOG0660|consensus	359		99.24
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.23
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.23
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.22
PHA03207	392	serine/threonine kinase US3; Provisional	99.21
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.2
PHA03210	501	serine/threonine kinase US3; Provisional	99.2
KOG3653|consensus	534		99.2
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.2
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.19
KOG0614|consensus	732		99.19
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.19
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.18
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.18
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.18
KOG0666|consensus	438		99.18
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.18
KOG0694|consensus	694		99.18
PHA03212	391	serine/threonine kinase US3; Provisional	99.18
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.17
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.16
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.16
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.16
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.16
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.16
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.16
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.15
KOG0662|consensus	292		99.15
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.15
KOG0033|consensus	355		99.15
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.15
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.14
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.14
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.14
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.14
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.14
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.14
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.14
KOG0604|consensus	400		99.14
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.14
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.13
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.13
KOG0580|consensus	281		99.13
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.13
KOG0589|consensus	426		99.13
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.13
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.13
KOG0586|consensus	596		99.13
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.13
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.13
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.13
KOG0596|consensus	677		99.12
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.12
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.12
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.11
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.11
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.11
PTZ00036	440	glycogen synthase kinase; Provisional	99.11
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.11
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.11
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.1
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.1
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.1
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.1
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.1
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.1
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.1
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.1
KOG0664|consensus	449		99.1
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.09
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.09
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.08
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.08
PRK09188	365	serine/threonine protein kinase; Provisional	99.08
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.08
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.08
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.08
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.08
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.08
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.07
KOG0032|consensus	382		99.07
PHA03209	357	serine/threonine kinase US3; Provisional	99.07
KOG0667|consensus	586		99.07
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.07
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.07
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.07
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.07
KOG0986|consensus	591		99.06
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.06
KOG0584|consensus	632		99.06
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.06
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.06
KOG0669|consensus	376		99.05
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.05
KOG0984|consensus	282		99.05
KOG0603|consensus	612		99.05
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.05
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.05
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.04
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.04
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.04
PLN00181	793	protein SPA1-RELATED; Provisional	99.04
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.04
KOG4717|consensus	864		99.03
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.03
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.03
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.03
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.02
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.02
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.02
KOG4721|consensus	904		99.02
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.02
KOG0597|consensus	808		99.02
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.01
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.01
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.01
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.01
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.01
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.01
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.0
KOG4250|consensus	732		99.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.0
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	98.98
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	98.97
KOG0605|consensus	550		98.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	98.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	98.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	98.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	98.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	98.96
KOG0579|consensus	1187		98.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	98.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	98.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	98.96
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	98.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	98.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	98.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	98.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	98.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	98.94
PTZ00284	467	protein kinase; Provisional	98.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	98.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	98.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	98.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	98.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	98.93
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	98.92
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	98.92
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	98.92
KOG0983|consensus	391		98.92
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	98.92
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	98.92
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	98.92
KOG0582|consensus	516		98.92
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	98.92
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	98.91
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	98.91
KOG0196|consensus	996		98.9
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	98.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	98.9
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	98.9
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	98.9
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	98.9
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	98.89
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	98.89
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	98.89
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	98.89
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	98.89
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	98.89
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	98.89
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	98.89
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	98.88
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	98.88
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	98.88
KOG4278|consensus	1157		98.88
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	98.88
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	98.88
KOG1989|consensus	738		98.88
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	98.88
KOG0690|consensus	516		98.88
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	98.88
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	98.87
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	98.87
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	98.87
KOG4257|consensus	974		98.87
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	98.86
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	98.86
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	98.86
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	98.86
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	98.86
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	98.86
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	98.86
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	98.86
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	98.86
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	98.86
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	98.86
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	98.86
KOG0665|consensus	369		98.86
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	98.86
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	98.85
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	98.85
KOG0608|consensus	1034		98.85
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	98.85
KOG1027|consensus	903		98.85
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	98.85
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	98.85
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	98.85
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	98.84
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	98.84
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	98.84
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	98.84
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	98.84
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	98.84
PRK12274	218	serine/threonine protein kinase; Provisional	98.84
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	98.84
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	98.84
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	98.84
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	98.83
PLN03224	507	probable serine/threonine protein kinase; Provisio	98.83
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	98.83
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	98.83
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	98.83
KOG1026|consensus	774		98.83
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	98.83
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	98.83
KOG4236|consensus	888		98.82
smart00090	237	RIO RIO-like kinase.	98.82
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	98.82
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	98.82
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	98.82
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	98.82
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	98.82
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	98.82
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	98.81
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	98.81
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	98.81
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	98.81
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	98.81
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	98.8
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	98.8
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	98.8
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	98.8
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	98.8
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	98.8
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	98.8
KOG4279|consensus	1226		98.79
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	98.79
KOG4645|consensus	1509		98.79
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	98.79
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	98.79
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	98.79
KOG1345|consensus	378		98.78
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	98.78
KOG0194|consensus	474		98.78
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	98.78
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	98.78
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	98.78
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	98.78
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	98.78
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	98.78
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	98.78
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	98.78
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	98.78
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	98.78
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	98.78
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	98.78
KOG0200|consensus	609		98.78
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	98.78
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	98.77
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	98.77
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	98.77
KOG0668|consensus	338		98.77
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	98.77
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	98.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.77
PHA02988	283	hypothetical protein; Provisional	98.77
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	98.76
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	98.76
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	98.76
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	98.76
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	98.75
KOG1095|consensus	1025		98.75
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	98.75
KOG1163|consensus	341		98.75
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	98.75
PLN00009	294	cyclin-dependent kinase A; Provisional	98.75
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	98.75
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	98.74
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	98.74
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	98.74
KOG1164|consensus	322		98.74
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	98.74
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	98.74
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	98.73
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	98.73
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	98.73
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	98.72
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	98.72
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	98.72
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	98.72
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	98.72
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	98.72
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	98.72
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	98.72
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	98.71
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	98.71
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	98.71
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	98.71
KOG2052|consensus	513		98.71
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	98.7
KOG1165|consensus	449		98.7
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	98.7
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	98.7
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	98.69
KOG1094|consensus	807		98.69
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	98.69
KOG0612|consensus	1317		98.69
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	98.68
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	98.68
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	98.68
KOG2345|consensus	302		98.67
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	98.67
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	98.67
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	98.67
PTZ00024	335	cyclin-dependent protein kinase; Provisional	98.66
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	98.66
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	98.66
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	98.66
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	98.66
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	98.66
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	98.66
KOG0577|consensus	948		98.66
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	98.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.65
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	98.65
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	98.65
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	98.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.65
PTZ00266	1021	NIMA-related protein kinase; Provisional	98.65
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	98.64
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	98.64
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	98.64
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	98.64
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	98.64
KOG0201|consensus	467		98.64
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	98.63
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	98.63
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	98.63
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	98.63
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	98.62
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	98.61
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	98.6
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	98.59
KOG0610|consensus	459		98.59
KOG0574|consensus	502		98.58
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	98.58
KOG1025|consensus	1177		98.58
KOG0199|consensus	1039		98.58
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	98.57
KOG0696|consensus	683		98.57
KOG0587|consensus	953		98.56
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	98.55
KOG1152|consensus	772		98.55
KOG1006|consensus	361		98.54
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	98.54
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	98.54
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.53
PRK14879	211	serine/threonine protein kinase; Provisional	98.53
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.52
KOG1151|consensus	775		98.5
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	98.49
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	98.48
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	98.44
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	98.43
KOG1290|consensus	590		98.42
KOG0607|consensus	463		98.39
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	98.37
KOG1167|consensus	418		98.36
COG0515	384	SPS1 Serine/threonine protein kinase [General func	98.35
PRK10345	210	hypothetical protein; Provisional	98.31
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	98.28
KOG0590|consensus	601		98.27
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	98.26
KOG0670|consensus	752		98.24
KOG0671|consensus	415		98.21
KOG0695|consensus	593		98.17
KOG1024|consensus	563		98.14
KOG4158|consensus	598		98.07
KOG0576|consensus	829		98.07
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.04
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	97.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	97.82
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	97.79
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.78
KOG1240|consensus	1431		97.72
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	97.7
KOG1166|consensus	974		97.7
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	97.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.58
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.5
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	97.49
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.17
KOG0590|consensus	601		96.96
KOG3087|consensus	229		96.88
KOG1033|consensus	516		96.81
KOG0606|consensus	1205		96.73
KOG1023|consensus	484		96.45
PRK09902	216	hypothetical protein; Provisional	96.26
KOG0603|consensus	612		96.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	96.16
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	95.64
KOG3741|consensus	655		95.46
KOG0601|consensus	524		94.58
KOG1266|consensus	458		93.98
KOG1243|consensus	690		93.53
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	91.92
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	91.53
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	91.25
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	90.95
PRK05231	319	homoserine kinase; Provisional	90.83
KOG0601|consensus	524		90.81
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	90.67
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	90.24
KOG2137|consensus	700		90.15
COG0478	304	RIO-like serine/threonine protein kinase fused to	89.91
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	89.74
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	88.84
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	88.51
COG0661	517	AarF Predicted unusual protein kinase [General fun	88.06
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	87.98
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	87.77
PF01636	239	APH: Phosphotransferase enzyme family This family	87.69
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	86.75
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	86.73
PRK10271	188	thiK thiamine kinase; Provisional	85.77
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	85.45
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	84.95
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	84.71
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	83.04
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	81.31
PLN02236	344	choline kinase	80.21

>KOG0594|consensus

Probab=99.58  E-value=5.8e-15  Score=79.64  Aligned_cols=51  Identities=31%  Similarity=0.685  Sum_probs=47.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.+++|++.|+.|+|+. +++|||+||.|++++..+.+|++|||+|+...
T Consensus       121 ~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen  121 LIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            5889999999999999996 99999999999999999999999999998665

>KOG0599|consensus

Probab=99.54  E-value=1.1e-14  Score=77.91  Aligned_cols=61  Identities=39%  Similarity=0.585  Sum_probs=53.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .+.+++|+..++.|+|.. .++|++++++|+++..+..++++|||+++.+.+.+   .....|||
T Consensus       125 tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGT  185 (411)
T KOG0599|consen  125 TRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGT  185 (411)
T ss_pred             HHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccceeeccCCch---hHHHhcCC
Confidence            467899999999999996 99999999999999999999999999999998875   33444444

>KOG0600|consensus

Probab=99.52  E-value=4.4e-14  Score=79.63  Aligned_cols=55  Identities=29%  Similarity=0.485  Sum_probs=50.7

Q ss_pred             hHHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          2 FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         2 ~~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+++.++.|++.|+.|+|.+ +++|||+|..|++++..+.++++|||+|+.+..+.
T Consensus       218 ~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  218 PQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             HHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            46889999999999999997 99999999999999999999999999999776654

>KOG0581|consensus

Probab=99.52  E-value=3.1e-14  Score=77.50  Aligned_cols=54  Identities=50%  Similarity=0.961  Sum_probs=49.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.+++.|+.|+|...+++|||+||.|++++..+.+|+.|||.++.+.++
T Consensus       179 ~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  179 VLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            456789999999999996458999999999999999999999999999998876

>KOG0661|consensus

Probab=99.51  E-value=3.5e-14  Score=79.64  Aligned_cols=54  Identities=26%  Similarity=0.512  Sum_probs=50.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+++++.|++.|+.|+|.. ++.|||+||+|+++.....+|++|||+||.+.+..
T Consensus       111 ~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen  111 DIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCC
Confidence            5789999999999999996 99999999999999989999999999999987654

>KOG0583|consensus

Probab=99.51  E-value=6.6e-14  Score=77.25  Aligned_cols=63  Identities=35%  Similarity=0.510  Sum_probs=51.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .++.+++|+++|+.|+|+. +++|||+|++|++++.. ..+++.|||++....  .......+.+||
T Consensus       121 ~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGs  184 (370)
T KOG0583|consen  121 EARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGS  184 (370)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCC
Confidence            3567899999999999996 99999999999999988 999999999998774  111344455554

>KOG0615|consensus

Probab=99.51  E-value=3.9e-14  Score=78.44  Aligned_cols=61  Identities=34%  Similarity=0.555  Sum_probs=50.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC---CcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~---~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .+-++.|++.++.|+|+. ++.||++||+|+++..+   ..+|++|||+|+.....   ....+.|||
T Consensus       278 ~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGT  341 (475)
T KOG0615|consen  278 GKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGT  341 (475)
T ss_pred             hHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCC
Confidence            356789999999999996 99999999999999876   55799999999988744   455566666

>KOG0575|consensus

Probab=99.50  E-value=6.3e-14  Score=79.96  Aligned_cols=62  Identities=32%  Similarity=0.451  Sum_probs=53.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      ++.+..||+.|+.|+|+. +++|||++..|++++.+..+|+.|||+|..+..+.  ....+.|||
T Consensus       120 ary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGT  181 (592)
T KOG0575|consen  120 ARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGT  181 (592)
T ss_pred             HHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCC
Confidence            567889999999999996 89999999999999999999999999999998654  344455665

>KOG0592|consensus

Probab=99.47  E-value=1.6e-13  Score=78.00  Aligned_cols=53  Identities=43%  Similarity=0.681  Sum_probs=48.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ++-++.+|+.++.|+|.. +++|||+||+|++++.+..++++|||.|+.+.+..
T Consensus       176 aR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  176 ARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             HHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            456789999999999996 99999999999999999999999999999987654

>KOG0197|consensus

Probab=99.46  E-value=1.6e-13  Score=77.10  Aligned_cols=60  Identities=23%  Similarity=0.368  Sum_probs=52.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQ   63 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~   63 (68)
                      ...+++.||++|+.|+.+. +++|||+...|++.+....+|++|||+||...++.+....+
T Consensus       304 ~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~  363 (468)
T KOG0197|consen  304 QLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG  363 (468)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence            5678999999999999885 99999999999999999999999999999777776654433

>KOG0595|consensus

Probab=99.45  E-value=1.9e-13  Score=75.45  Aligned_cols=54  Identities=37%  Similarity=0.593  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC------CcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR------GAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~------~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|++++|.+ +++|||+||.|+++...      ..+|++|||+||.+.+..
T Consensus       110 t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~  169 (429)
T KOG0595|consen  110 TARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS  169 (429)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence            3567889999999999997 99999999999999764      458999999999998654

>KOG0616|consensus

Probab=99.45  E-value=2.2e-13  Score=73.11  Aligned_cols=53  Identities=40%  Similarity=0.625  Sum_probs=48.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ++=++.|++.+++|+|+. .++.|+++|+|+++++.+.+++.|||+|+.+....
T Consensus       146 arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT  198 (355)
T KOG0616|consen  146 ARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT  198 (355)
T ss_pred             HHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCcE
Confidence            445788999999999996 99999999999999999999999999999987753

>KOG0591|consensus

Probab=99.44  E-value=1.9e-13  Score=73.29  Aligned_cols=64  Identities=33%  Similarity=0.485  Sum_probs=54.6

Q ss_pred             HHHHHHHHHHHHHHHHhh--C-CCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKE--E-LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~--~-~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .+|+++.|++.++..+|.  . ..++||++||.|++++.++.+|+.|||+++.+....  ...+..+||
T Consensus       125 ~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGT  191 (375)
T KOG0591|consen  125 TVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGT  191 (375)
T ss_pred             HHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCC
Confidence            578999999999999998  3 149999999999999999999999999999988765  445555555

>KOG0193|consensus

Probab=99.42  E-value=2.2e-13  Score=78.19  Aligned_cols=51  Identities=33%  Similarity=0.589  Sum_probs=47.2

Q ss_pred             ChHHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          1 MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         1 ~~~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      |+.+.+|++|+++|+.|+|.+ +|+|+|+++.|+++.....+++.|||++..
T Consensus       487 m~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  487 MNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             HHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceee
Confidence            578899999999999999996 999999999999999999999999998743

>KOG0593|consensus

Probab=99.41  E-value=3.4e-13  Score=72.83  Aligned_cols=52  Identities=37%  Similarity=0.759  Sum_probs=48.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+++++.|++.++.|+|+. +++||+++|+|+++..++.+++.|||+||.+..
T Consensus       102 ~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen  102 LVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             HHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            5788999999999999997 899999999999999999999999999999873

>KOG0611|consensus

Probab=99.40  E-value=4.6e-13  Score=74.95  Aligned_cols=52  Identities=35%  Similarity=0.614  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ++.+++||++++.|+|.. +++|++++.+|++++.+.+++++|||++-.+.+.
T Consensus       155 aRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  155 ARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             HHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            567899999999999997 9999999999999999999999999998766554

>KOG0578|consensus

Probab=99.37  E-value=2.8e-12  Score=72.92  Aligned_cols=63  Identities=35%  Similarity=0.536  Sum_probs=54.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      ++..|++.++.|+.|+|.. +++|+++++.|+++...+.+++.|||++..+.....  ...+-+||
T Consensus       370 qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGT  432 (550)
T KOG0578|consen  370 QIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGT  432 (550)
T ss_pred             HHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCC
Confidence            5778899999999999996 999999999999999999999999999999887763  44444555

>KOG0659|consensus

Probab=99.36  E-value=1.9e-12  Score=68.81  Aligned_cols=54  Identities=31%  Similarity=0.562  Sum_probs=49.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.+++.|+.|+|.. -++|||+||.|++++.++.+|++|||+++.+.++.
T Consensus       102 ~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen  102 DIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             HHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            3678889999999999996 89999999999999999999999999999987543

>KOG0598|consensus

Probab=99.36  E-value=2.4e-12  Score=70.21  Aligned_cols=61  Identities=41%  Similarity=0.556  Sum_probs=50.0

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      +=++..++.|+.|+|+. +++||++||+|++++..+.+++.|||+++......  ....+-|||
T Consensus       128 rfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT  188 (357)
T KOG0598|consen  128 RFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGT  188 (357)
T ss_pred             HHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCC
Confidence            34567889999999996 99999999999999999999999999998755443  334445666

>KOG0198|consensus

Probab=99.33  E-value=8.5e-12  Score=67.71  Aligned_cols=52  Identities=40%  Similarity=0.733  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~~   55 (68)
                      .++.+.+|++.|+.|+|+. +++|+++++.|+++.. +..++++|||.++....
T Consensus       118 ~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen  118 LVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            5788999999999999986 9999999999999998 68999999999887663

>KOG0588|consensus

Probab=99.33  E-value=2.7e-12  Score=74.63  Aligned_cols=61  Identities=31%  Similarity=0.553  Sum_probs=51.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      +..+++|++.|+.|+|.. +++|++++++|++++....++++|||+|..-.++   .+..+.||+
T Consensus       114 aa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---klLeTSCGS  174 (786)
T KOG0588|consen  114 AAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---KLLETSCGS  174 (786)
T ss_pred             HHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCC---ccccccCCC
Confidence            567899999999999985 9999999999999998888999999999775554   456666663

>KOG0663|consensus

Probab=99.32  E-value=4.7e-12  Score=69.15  Aligned_cols=54  Identities=30%  Similarity=0.586  Sum_probs=49.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++-++.|++.|+.|+|.. -++|||+|+.|+++...+.+++.|||+||.+.+..
T Consensus       178 evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  178 EVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            3566788999999999996 89999999999999999999999999999988763

>KOG0192|consensus

Probab=99.31  E-value=8.3e-12  Score=68.90  Aligned_cols=53  Identities=38%  Similarity=0.763  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC-ceeeccCCCcEEEcCCC-cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK-IIHRDVKPSNILLDRRG-AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~-~~h~~l~~~~~~~~~~~-~~~~~~~g~~~~~~~~   56 (68)
                      .+.+++.+++.|+.|+|.. . ++|+|+|+.|+++.... .+|+.|||+++.....
T Consensus       143 ~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  143 VRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            4567899999999999997 7 99999999999999886 9999999999887653

>KOG0585|consensus

Probab=99.29  E-value=7e-12  Score=70.83  Aligned_cols=50  Identities=42%  Similarity=0.740  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.+++.++.|+.|+|.+ +++||++||.|+++...+.+|++|||.+-..
T Consensus       211 ~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~  260 (576)
T KOG0585|consen  211 QARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVKISDFGVSNEF  260 (576)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEEeeccceeeec
Confidence            5688899999999999997 9999999999999999999999999988655

>KOG1035|consensus

Probab=99.28  E-value=1.3e-11  Score=75.18  Aligned_cols=50  Identities=38%  Similarity=0.719  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      -.|.++++|++|+.|+|.. +++|||+||.|++++....+++.|||+|...
T Consensus       698 ~~wrLFreIlEGLaYIH~~-giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~  747 (1351)
T KOG1035|consen  698 EAWRLFREILEGLAYIHDQ-GIIHRDLKPRNIFLDSRNSVKIGDFGLATDL  747 (1351)
T ss_pred             HHHHHHHHHHHHHHHHHhC-ceeeccCCcceeEEcCCCCeeecccccchhh
Confidence            3678999999999999996 8999999999999999999999999999883

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.27  E-value=2.7e-11  Score=65.66  Aligned_cols=50  Identities=30%  Similarity=0.634  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       176 ~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~  225 (338)
T cd05102         176 LICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIY  225 (338)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccc
Confidence            456788999999999996 99999999999999988999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0658|consensus

Probab=99.26  E-value=1.3e-11  Score=67.44  Aligned_cols=55  Identities=38%  Similarity=0.622  Sum_probs=48.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVVEVVL   59 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~~~~~   59 (68)
                      ++-+..|+..|+.|+|+ .+++|||+||.|++.+.. +.+|+.|||.|+.+...++.
T Consensus       127 iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn  182 (364)
T KOG0658|consen  127 IKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN  182 (364)
T ss_pred             eHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence            45578899999999999 499999999999999864 88999999999998876654

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.26  E-value=2.4e-11  Score=68.81  Aligned_cols=52  Identities=33%  Similarity=0.473  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       261 ~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        261 QVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            4567899999999999996 999999999999999989999999999876543

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.25  E-value=3.4e-11  Score=68.22  Aligned_cols=52  Identities=38%  Similarity=0.519  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       171 ~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        171 VGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            455788999999999996 9999999999999999999999999999876543

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.25  E-value=4.6e-11  Score=63.89  Aligned_cols=50  Identities=28%  Similarity=0.586  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       128 ~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~  177 (294)
T PHA02882        128 IKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYIIDYGIASHFI  177 (294)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence            567889999999999996 99999999999999988889999999998764

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.24  E-value=3e-11  Score=68.84  Aligned_cols=51  Identities=33%  Similarity=0.556  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       145 ~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~  195 (496)
T PTZ00283        145 AGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA  195 (496)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence            456788999999999996 999999999999999999999999999877654

>KOG1187|consensus

Probab=99.24  E-value=1.9e-11  Score=67.46  Aligned_cols=53  Identities=40%  Similarity=0.565  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCC--CceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEEL--KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~--~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      ...+||.+++.|+.|+|...  .++|+++++.|++++.+...|++|||+++..+.
T Consensus       175 ~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  175 TRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             HHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence            45689999999999999864  599999999999999999999999999966554

>KOG0660|consensus

Probab=99.24  E-value=1.2e-11  Score=67.53  Aligned_cols=50  Identities=36%  Similarity=0.720  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +-+..|++.|+.|+|+. +++||++||.|++++.+..+++.|||+||....
T Consensus       128 q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  128 QYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             HHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeeccc
Confidence            45678999999999997 999999999999999999999999999999864

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.23  E-value=4.5e-11  Score=64.74  Aligned_cols=50  Identities=44%  Similarity=0.628  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        97 ~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          97 RAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            3566789999999999996 9999999999999999999999999988654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.23  E-value=4.2e-11  Score=64.33  Aligned_cols=52  Identities=29%  Similarity=0.617  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc----CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD----RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~----~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.    ....+++.|||+++....
T Consensus       109 ~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868         109 MVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence            3567899999999999996 999999999999983    446799999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.22  E-value=5.3e-11  Score=64.37  Aligned_cols=50  Identities=34%  Similarity=0.555  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        96 ~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          96 RARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            3556788999999999996 9999999999999999999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.21  E-value=4.2e-11  Score=66.32  Aligned_cols=52  Identities=38%  Similarity=0.521  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       186 ~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        186 QAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            4567889999999999996 999999999999999999999999999876654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.20  E-value=1.4e-10  Score=62.71  Aligned_cols=51  Identities=35%  Similarity=0.587  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|+..+++|+++++.|+++.....+++.|||+++..
T Consensus        96 ~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          96 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            355678899999999997338999999999999999999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.20  E-value=6.6e-11  Score=67.45  Aligned_cols=51  Identities=35%  Similarity=0.577  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       269 ~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~  319 (501)
T PHA03210        269 TRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK  319 (501)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEeCCCceecCc
Confidence            456889999999999996 999999999999999999999999999987654

>KOG3653|consensus

Probab=99.20  E-value=5.1e-11  Score=67.25  Aligned_cols=65  Identities=28%  Similarity=0.342  Sum_probs=56.7

Q ss_pred             HHHHHHHHHHHHHHHhhCC--------CceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEEL--------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~--------~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      ..+++..++.|+.|+|...        .+.|||+++.|+++..+..+.+.|||+|..+.+.........++||
T Consensus       309 ~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  309 LCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             HHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhh
Confidence            4567888899999999752        6899999999999999999999999999999988877777778887

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.20  E-value=8.5e-11  Score=64.81  Aligned_cols=50  Identities=42%  Similarity=0.665  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+.
T Consensus       144 ~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         144 AKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            556788999999999996 99999999999999999999999999987764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.19  E-value=8.5e-11  Score=63.60  Aligned_cols=49  Identities=41%  Similarity=0.641  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        98 ~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          98 ARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            456789999999999996 9999999999999998899999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0614|consensus

Probab=99.19  E-value=4e-11  Score=68.64  Aligned_cols=52  Identities=38%  Similarity=0.652  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      +=++..++++..|+|.. +++.|+++|+|++++..+++|+.|||+|+.+....
T Consensus       523 rF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  523 RFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            34567788999999996 99999999999999999999999999999998775

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.19  E-value=9.1e-11  Score=63.37  Aligned_cols=51  Identities=33%  Similarity=0.577  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus        97 ~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          97 RARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            3456789999999999996 99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.18  E-value=7.1e-11  Score=63.83  Aligned_cols=51  Identities=31%  Similarity=0.628  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|+++.....+++.|||+++...
T Consensus       104 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859         104 HHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            3567889999999999996 99999999999999999999999999987653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.18  E-value=1.1e-10  Score=63.43  Aligned_cols=50  Identities=40%  Similarity=0.618  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        96 ~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          96 RTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            3566789999999999996 9999999999999999899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.18  E-value=1.1e-10  Score=63.16  Aligned_cols=51  Identities=35%  Similarity=0.505  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       106 ~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614         106 EVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            3566788999999999996 99999999999999999999999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0666|consensus

Probab=99.18  E-value=5.5e-11  Score=64.85  Aligned_cols=54  Identities=26%  Similarity=0.563  Sum_probs=48.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC----CcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~----~~~~~~~~g~~~~~~~~~   57 (68)
                      .++++..|++.|+.|+|++ =++||+++|.|++....    +.+++.|+|++|.+.+..
T Consensus       133 mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~pl  190 (438)
T KOG0666|consen  133 MVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPL  190 (438)
T ss_pred             HHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccc
Confidence            5788999999999999997 79999999999999765    789999999999876654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.18  E-value=1e-10  Score=62.57  Aligned_cols=51  Identities=29%  Similarity=0.516  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       140 ~~~i~~~i~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         140 LLHVALQIASGMKYLSSL-NFVHRDLATRNCLVGENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccCcchhheEEcCCccEEECCCccceeccc
Confidence            567899999999999996 899999999999999989999999999876543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0694|consensus

Probab=99.18  E-value=8.6e-11  Score=68.38  Aligned_cols=62  Identities=32%  Similarity=0.455  Sum_probs=52.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      ++=++..++.|+.|+|.. ++++||+|..|++++..+.++++|||+++......  ..+.+-|||
T Consensus       470 arfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGT  531 (694)
T KOG0694|consen  470 ARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGT  531 (694)
T ss_pred             HHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCCC--CccccccCC
Confidence            344678899999999996 99999999999999999999999999998866333  455666676

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.18  E-value=1.2e-10  Score=64.69  Aligned_cols=50  Identities=34%  Similarity=0.597  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       183 ~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        183 DILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            3567889999999999996 9999999999999998899999999998653

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.17  E-value=1.3e-10  Score=62.58  Aligned_cols=49  Identities=43%  Similarity=0.638  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++..
T Consensus        95 ~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~  143 (312)
T cd05585          95 ARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLN  143 (312)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence            456788999999999996 9999999999999999999999999998754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.16  E-value=1.8e-10  Score=63.56  Aligned_cols=52  Identities=27%  Similarity=0.558  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       213 ~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         213 DLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence            3567889999999999996 999999999999999888899999999876543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.16  E-value=1.5e-10  Score=62.34  Aligned_cols=51  Identities=31%  Similarity=0.576  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       111 ~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108         111 LLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             HHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccC
Confidence            456788999999999996 999999999999999989999999999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.16  E-value=1.7e-10  Score=62.48  Aligned_cols=50  Identities=38%  Similarity=0.598  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        97 ~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          97 RARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            3566789999999999996 9999999999999999999999999988753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.16  E-value=1.6e-10  Score=62.44  Aligned_cols=49  Identities=41%  Similarity=0.632  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        98 ~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          98 ARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            456789999999999996 9999999999999999999999999988654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.16  E-value=1.3e-10  Score=63.50  Aligned_cols=50  Identities=36%  Similarity=0.704  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       170 ~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        170 LADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            467889999999999996 99999999999999999999999999987654

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.16  E-value=1.2e-10  Score=61.81  Aligned_cols=51  Identities=33%  Similarity=0.708  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       111 ~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T cd07862         111 TIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYS  161 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence            4567889999999999996 99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.15  E-value=1.8e-10  Score=62.17  Aligned_cols=50  Identities=38%  Similarity=0.599  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        97 ~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          97 RARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            3456788999999999986 9999999999999999999999999988653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0662|consensus

Probab=99.15  E-value=4.7e-11  Score=61.18  Aligned_cols=52  Identities=31%  Similarity=0.730  Sum_probs=47.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+++++.|++.++.++|+. .+.|++++|.|+++..++.+++.|||+++-+.-
T Consensus       102 ~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen  102 IVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             HHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            5678899999999999996 899999999999999999999999999987653

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.15  E-value=1e-10  Score=62.34  Aligned_cols=51  Identities=33%  Similarity=0.683  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++...
T Consensus       104 ~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871         104 NVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            3566788999999999996 99999999999999998999999999886543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0033|consensus

Probab=99.15  E-value=1.4e-10  Score=61.70  Aligned_cols=61  Identities=33%  Similarity=0.493  Sum_probs=49.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      +...++|+++++.|+|.+ +++||+++|.|+++..   ...+|+.+||++..+.+.   ..+.+..||
T Consensus       112 aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~Gt  175 (355)
T KOG0033|consen  112 ASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGT  175 (355)
T ss_pred             HHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccCC
Confidence            345678999999999997 9999999999999964   355899999999988844   455555554

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.15  E-value=2.4e-10  Score=63.06  Aligned_cols=51  Identities=41%  Similarity=0.625  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       144 ~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         144 ARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            456788999999999996 999999999999999999999999999876643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.14  E-value=1.4e-10  Score=62.08  Aligned_cols=50  Identities=32%  Similarity=0.662  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||.++..
T Consensus       104 ~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869         104 NVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            3567889999999999996 9999999999999999899999999988654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.14  E-value=2.5e-10  Score=60.76  Aligned_cols=52  Identities=37%  Similarity=0.553  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||++.....
T Consensus       103 ~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631         103 RAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            3456788999999999996 999999999999999888999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.14  E-value=2e-10  Score=62.07  Aligned_cols=49  Identities=37%  Similarity=0.529  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        98 ~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          98 SRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            456788999999999996 9999999999999999999999999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.14  E-value=1.9e-10  Score=62.19  Aligned_cols=50  Identities=32%  Similarity=0.490  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       102 ~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587         102 HAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            3456788999999999996 9999999999999999899999999987653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.14  E-value=1.4e-10  Score=62.80  Aligned_cols=50  Identities=34%  Similarity=0.589  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        96 ~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          96 RARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            4567889999999999996 9999999999999999999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.14  E-value=2e-10  Score=62.13  Aligned_cols=50  Identities=32%  Similarity=0.493  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       102 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616         102 HAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            3566889999999999996 9999999999999999999999999988754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.14  E-value=2.4e-10  Score=62.08  Aligned_cols=50  Identities=42%  Similarity=0.589  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        97 ~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          97 HARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            3566788999999999996 9999999999999999999999999988653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0604|consensus

Probab=99.14  E-value=1.5e-10  Score=62.89  Aligned_cols=50  Identities=32%  Similarity=0.595  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~   54 (68)
                      +..|+.||+.++.|+|. +++.|||+|++|+++..   +..+|+.|||+|+.-.
T Consensus       163 a~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  163 ASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             HHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            45788999999999999 59999999999999964   4568999999998755

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.14  E-value=1.8e-10  Score=61.78  Aligned_cols=51  Identities=29%  Similarity=0.628  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE----cCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~----~~~~~~~~~~~g~~~~~~~   55 (68)
                      ++.++.|++.++.|+|+. +++|+++++.|+++    .....+++.|||+++....
T Consensus       110 ~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867         110 VKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            567889999999999996 99999999999998    3456799999999876543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.13  E-value=2.6e-10  Score=61.76  Aligned_cols=52  Identities=37%  Similarity=0.644  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+..
T Consensus       103 ~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601         103 MAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            3456788999999999996 999999999999999999999999999876643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.13  E-value=2e-10  Score=60.82  Aligned_cols=50  Identities=16%  Similarity=0.428  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       126 ~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (283)
T cd05091         126 FVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKLNVKISDLGLFREVY  175 (283)
T ss_pred             HHHHHHHHHHHHHHHHHc-CccccccchhheEecCCCceEecccccccccc
Confidence            456788999999999986 89999999999999988889999999887654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0580|consensus

Probab=99.13  E-value=5.1e-11  Score=62.68  Aligned_cols=60  Identities=33%  Similarity=0.475  Sum_probs=49.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .+.+..|++.|+.|+|.. +++||+++|+|++++..+.++++|||++-.-+    .+...+.|||
T Consensus       126 ~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt  185 (281)
T KOG0580|consen  126 AATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGT  185 (281)
T ss_pred             hhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecc
Confidence            467889999999999996 89999999999999999999999999875433    2344444554

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.13  E-value=1.7e-10  Score=63.32  Aligned_cols=51  Identities=41%  Similarity=0.660  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       102 ~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628         102 ETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            3567789999999999996 99999999999999998999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0589|consensus

Probab=99.13  E-value=4.6e-11  Score=66.92  Aligned_cols=54  Identities=37%  Similarity=0.543  Sum_probs=48.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.++.|+|+. .+.||+++..|+++.....+++.|||+|+.+.++.
T Consensus       107 ~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen  107 RILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             HHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            3567889999999999976 89999999999999999989999999999988764

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.13  E-value=2.2e-10  Score=61.91  Aligned_cols=49  Identities=37%  Similarity=0.612  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.
T Consensus        97 ~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          97 RATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            3456788999999999996 999999999999999989999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.13  E-value=2.8e-10  Score=61.56  Aligned_cols=50  Identities=36%  Similarity=0.535  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        97 ~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          97 RARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            3456788999999999986 9999999999999999999999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0586|consensus

Probab=99.13  E-value=9.4e-11  Score=67.42  Aligned_cols=60  Identities=37%  Similarity=0.505  Sum_probs=50.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFG   67 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~g   67 (68)
                      .+.++.|++.+++|+|.+ .++|++++.+|++++....+++.|||++..+...   ...++.||
T Consensus       157 ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cg  216 (596)
T KOG0586|consen  157 ARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCG  216 (596)
T ss_pred             hhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeeccc---ccccccCC
Confidence            456789999999999997 8999999999999999999999999999888755   34444444

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.13  E-value=4e-10  Score=59.77  Aligned_cols=52  Identities=29%  Similarity=0.538  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+.+
T Consensus       110 ~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111         110 RLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            3567889999999999986 899999999999999888999999999876643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.13  E-value=2.1e-10  Score=62.65  Aligned_cols=51  Identities=29%  Similarity=0.485  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       121 ~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874         121 MSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            456788999999999996 999999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.13  E-value=2.3e-10  Score=62.09  Aligned_cols=49  Identities=41%  Similarity=0.606  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.
T Consensus        97 ~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          97 HARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            3567889999999999996 999999999999999999999999998865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0596|consensus

Probab=99.12  E-value=2.3e-10  Score=65.86  Aligned_cols=64  Identities=28%  Similarity=0.443  Sum_probs=55.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .++.+..|++.++.++|.. +++|.+++|.|+++- .+.+|++|||.|..+.++.+....-.++||
T Consensus       461 ~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT  524 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGT  524 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCc
Confidence            4667788999999999996 999999999998774 466999999999999988877777777887

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.12  E-value=3e-10  Score=61.46  Aligned_cols=49  Identities=41%  Similarity=0.584  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       102 ~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584         102 ACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            455778999999999996 9999999999999999999999999988654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.12  E-value=3.9e-10  Score=59.70  Aligned_cols=51  Identities=29%  Similarity=0.529  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       110 ~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109         110 DLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            3566789999999999996 99999999999999888889999999987764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.11  E-value=3.1e-10  Score=60.26  Aligned_cols=51  Identities=33%  Similarity=0.591  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||.+..+..
T Consensus        99 ~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          99 ACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             HHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            456789999999999996 999999999999999888999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.11  E-value=4.2e-10  Score=61.39  Aligned_cols=51  Identities=29%  Similarity=0.614  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       174 ~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~  224 (337)
T cd05054         174 DLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIY  224 (337)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence            3567889999999999996 99999999999999988889999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.11  E-value=3.5e-10  Score=61.27  Aligned_cols=50  Identities=32%  Similarity=0.494  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       102 ~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615         102 QAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            3567889999999999996 9999999999999999999999999988754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.11  E-value=3.2e-10  Score=63.82  Aligned_cols=52  Identities=37%  Similarity=0.707  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.|+.|+|+. +++|+++++.|+++... ..+++.|||+++.+..
T Consensus       171 ~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        171 LVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            3566788999999999996 99999999999999855 4689999999987643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.11  E-value=3.9e-10  Score=57.44  Aligned_cols=52  Identities=19%  Similarity=0.249  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHhh-CCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~-~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ...++.|++.++.++|. . +++|+|++|.|+++. ...+++.|||++..+....
T Consensus       119 ~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~-~~~~~liDFG~a~~~~~~~  171 (190)
T cd05145         119 AEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH-DGKPYIIDVSQAVELDHPN  171 (190)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-CCCEEEEEcccceecCCCC
Confidence            46788999999999998 6 999999999999998 7789999999998876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.11  E-value=3.9e-10  Score=59.38  Aligned_cols=49  Identities=20%  Similarity=0.369  Sum_probs=44.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       102 ~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042         102 LQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             HHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEecccccccc
Confidence            457788999999999996 9999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.10  E-value=4.2e-10  Score=59.22  Aligned_cols=51  Identities=24%  Similarity=0.463  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       114 ~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  164 (272)
T cd05075         114 LVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKKIYN  164 (272)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCcccccCc
Confidence            456788999999999996 999999999999999888999999999877643

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.10  E-value=3.2e-10  Score=61.52  Aligned_cols=49  Identities=41%  Similarity=0.610  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.
T Consensus        97 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          97 HARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            4567889999999999996 999999999999999999999999998865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.10  E-value=3.9e-10  Score=60.83  Aligned_cols=52  Identities=42%  Similarity=0.539  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus        99 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          99 DVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            3567889999999999996 999999999999999989999999998876543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.10  E-value=4.2e-10  Score=62.03  Aligned_cols=51  Identities=41%  Similarity=0.632  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       144 ~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         144 ARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            456778999999999996 999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.10  E-value=3.4e-10  Score=62.04  Aligned_cols=51  Identities=29%  Similarity=0.485  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       128 ~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         128 MSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             HHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            456789999999999996 999999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.10  E-value=2.9e-10  Score=62.25  Aligned_cols=50  Identities=30%  Similarity=0.516  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       125 ~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         125 MSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            456788999999999996 99999999999999999999999999987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.10  E-value=3e-10  Score=61.75  Aligned_cols=52  Identities=29%  Similarity=0.541  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       119 ~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878         119 HVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            3567889999999999996 999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.10  E-value=2.9e-10  Score=65.83  Aligned_cols=50  Identities=34%  Similarity=0.583  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+|+++.|++++. ...+++.|||+++.+.
T Consensus       257 i~~i~~qll~aL~yLH~~-gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~  307 (566)
T PLN03225        257 IQTIMRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR  307 (566)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccc
Confidence            457889999999999996 9999999999999975 5689999999997653

>KOG0664|consensus

Probab=99.10  E-value=1.3e-10  Score=62.80  Aligned_cols=53  Identities=30%  Similarity=0.646  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ++.+..||+.|+.|+|+. ++.||++++.|++.+.+-.+|+.|||++|....+.
T Consensus       158 vKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  158 VKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             hhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhh
Confidence            345678999999999997 99999999999999999999999999998876554

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.09  E-value=6.3e-10  Score=59.60  Aligned_cols=51  Identities=27%  Similarity=0.547  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       139 ~~~~~~qi~~al~~LH~~-givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         139 LVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDVNN  189 (304)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeecccccceEEEcCCCcEEECCCccceeccc
Confidence            456788999999999996 999999999999999888999999999876643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.09  E-value=4.3e-10  Score=60.86  Aligned_cols=50  Identities=38%  Similarity=0.590  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       102 ~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589         102 RAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            3567889999999999996 9999999999999999999999999987653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.08  E-value=5.7e-10  Score=60.61  Aligned_cols=51  Identities=33%  Similarity=0.556  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       104 ~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624         104 ARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            456788999999999996 999999999999999889999999999876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.08  E-value=3.6e-10  Score=62.22  Aligned_cols=49  Identities=45%  Similarity=0.688  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      ++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+
T Consensus       103 ~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629         103 TRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            456788999999999996 9999999999999999999999999998643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.08  E-value=6.5e-10  Score=61.62  Aligned_cols=52  Identities=25%  Similarity=0.334  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeecc-CCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDV-KPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l-~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ..++.|++.++.++|.. +++|+++ +|.|++++....+++.|||+++.+....
T Consensus       114 ~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~  166 (365)
T PRK09188        114 PAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG  166 (365)
T ss_pred             HHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence            35778999999999996 9999999 9999999877889999999998765543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.08  E-value=7.8e-10  Score=61.08  Aligned_cols=51  Identities=29%  Similarity=0.560  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       216 ~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         216 LLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence            567889999999999996 999999999999999888899999999876543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.08  E-value=4.9e-10  Score=60.80  Aligned_cols=51  Identities=41%  Similarity=0.619  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       102 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600         102 HARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            3566788999999999996 99999999999999999999999999987654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.08  E-value=6.2e-10  Score=60.46  Aligned_cols=51  Identities=35%  Similarity=0.608  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+.
T Consensus       103 ~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623         103 MARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            3556788999999999996 99999999999999988999999999887653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.08  E-value=6.6e-10  Score=58.81  Aligned_cols=50  Identities=24%  Similarity=0.523  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       126 ~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~  175 (283)
T cd05048         126 FLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY  175 (283)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCcEEECCCcceeecc
Confidence            456889999999999996 89999999999999998899999999987653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.08  E-value=5.7e-10  Score=60.68  Aligned_cols=53  Identities=38%  Similarity=0.590  Sum_probs=46.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       102 ~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573         102 TARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            3566788999999999996 9999999999999999999999999998776543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.07  E-value=5.3e-10  Score=60.45  Aligned_cols=50  Identities=34%  Similarity=0.553  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        97 ~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          97 RATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            3456789999999999996 9999999999999999999999999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0032|consensus

Probab=99.07  E-value=4.1e-10  Score=62.72  Aligned_cols=52  Identities=35%  Similarity=0.622  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC----CcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~----~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|++++++|+++...    ..+++.|||++.....
T Consensus       136 da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  136 DAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            3567889999999999995 99999999999999644    3699999999988877

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.07  E-value=5.1e-10  Score=61.41  Aligned_cols=49  Identities=29%  Similarity=0.495  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.
T Consensus       158 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        158 QALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            3567889999999999996 999999999999999999999999998864

>KOG0667|consensus

Probab=99.07  E-value=5.1e-10  Score=64.64  Aligned_cols=55  Identities=38%  Similarity=0.477  Sum_probs=46.9

Q ss_pred             hHHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC--CcEEEEecCCcccccccc
Q psy14632          2 FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR--GAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         2 ~~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~--~~~~~~~~g~~~~~~~~~   57 (68)
                      ..++.++.|++.++..+|+. +++|.||||+|+++...  ..+|++|||.++......
T Consensus       289 ~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v  345 (586)
T KOG0667|consen  289 PLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV  345 (586)
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence            46789999999999999985 99999999999999643  468999999998766543

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.07  E-value=7.8e-10  Score=59.30  Aligned_cols=52  Identities=29%  Similarity=0.541  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       110 ~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110         110 LLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             HHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccC
Confidence            3567789999999999996 999999999999998888899999999887643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.07  E-value=5.1e-10  Score=60.78  Aligned_cols=51  Identities=37%  Similarity=0.645  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...+
T Consensus       120 ~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263        120 AKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            456788999999999996 999999999999999999999999999877644

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.07  E-value=6.9e-10  Score=59.28  Aligned_cols=51  Identities=45%  Similarity=0.662  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       103 ~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612         103 GLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            456788999999999996 999999999999999889999999999876644

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.07  E-value=5.8e-10  Score=59.14  Aligned_cols=51  Identities=33%  Similarity=0.651  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       109 ~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863         109 TIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            3567889999999999996 99999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0986|consensus

Probab=99.06  E-value=4.3e-10  Score=63.73  Aligned_cols=52  Identities=29%  Similarity=0.532  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .=++.+|+.|+.++|.. .++.|+++|+|++++..+.+.++|+|+|..++...
T Consensus       290 ~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  290 RFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             HHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            34678999999999997 89999999999999999999999999999988765

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.06  E-value=1.1e-09  Score=57.84  Aligned_cols=48  Identities=17%  Similarity=0.360  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..
T Consensus       101 ~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086         101 LQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccc
Confidence            457788999999999986 899999999999999888899999998753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0584|consensus

Probab=99.06  E-value=3.2e-10  Score=65.57  Aligned_cols=55  Identities=31%  Similarity=0.459  Sum_probs=48.1

Q ss_pred             HHHHHHHHHHHHHHHHhhC-CCceeeccCCCcEEEcC-CCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEE-LKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~-~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++++++||+.|+.|+|++ -+++||+++..|+++.. .+.+|+.|+|+|..+..+.
T Consensus       144 aik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  144 AIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            6789999999999999986 47999999999999974 5889999999998776544

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.06  E-value=5.4e-10  Score=61.26  Aligned_cols=51  Identities=41%  Similarity=0.668  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       102 ~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627         102 ATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            3566789999999999996 99999999999999999999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.06  E-value=7.9e-10  Score=65.00  Aligned_cols=51  Identities=41%  Similarity=0.699  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       105 ~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610         105 MAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            4577889999999999996 99999999999999988899999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669|consensus

Probab=99.05  E-value=2.8e-10  Score=60.85  Aligned_cols=51  Identities=33%  Similarity=0.693  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      ++.++.++.+|+.|+|.. .++||++++.|+++...+.++++|||++|.+.-
T Consensus       126 Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~fs~  176 (376)
T KOG0669|consen  126 IKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARAFST  176 (376)
T ss_pred             HHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence            577889999999999986 899999999999999999999999999977653

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.05  E-value=5.3e-10  Score=61.67  Aligned_cols=50  Identities=38%  Similarity=0.635  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.+
T Consensus       102 ~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625         102 LARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            3566788999999999996 9999999999999999999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0984|consensus

Probab=99.05  E-value=4.5e-10  Score=58.52  Aligned_cols=54  Identities=52%  Similarity=0.944  Sum_probs=48.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      +=+++..++.++.++|+++.++||+.+|.|++++..+.+|+.|||.+..+.++.
T Consensus       150 lGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  150 LGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             hhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            446778889999999998899999999999999999999999999998887654

>KOG0603|consensus

Probab=99.05  E-value=6.9e-10  Score=64.21  Aligned_cols=52  Identities=38%  Similarity=0.660  Sum_probs=46.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE-cCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILL-DRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~-~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.+++.++.|+|.. +++|||+++.|+++ +..+.+++.|||.++.+.++
T Consensus       417 ~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  417 ASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             HHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            346889999999999995 99999999999999 57888999999999988776

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.05  E-value=6.9e-10  Score=60.66  Aligned_cols=51  Identities=35%  Similarity=0.593  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       132 ~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        132 VGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            3466789999999999996 99999999999999998999999999987654

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.05  E-value=8.2e-10  Score=60.01  Aligned_cols=52  Identities=35%  Similarity=0.618  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+..
T Consensus       103 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597         103 MARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            3566788999999999996 999999999999999889999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.04  E-value=6.4e-10  Score=59.73  Aligned_cols=50  Identities=34%  Similarity=0.689  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       105 ~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872         105 NVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceec
Confidence            3556788999999999996 9999999999999999999999999988654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.04  E-value=6.8e-10  Score=60.81  Aligned_cols=51  Identities=41%  Similarity=0.645  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+.
T Consensus       102 ~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599         102 ETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            3566889999999999996 99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.04  E-value=1.5e-09  Score=57.15  Aligned_cols=50  Identities=24%  Similarity=0.518  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       115 ~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~~~~~~  164 (273)
T cd05074         115 LVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGLSKKIY  164 (273)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECccccccccc
Confidence            567889999999999986 99999999999999988899999999987664

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.04  E-value=1.3e-09  Score=64.98  Aligned_cols=44  Identities=16%  Similarity=0.222  Sum_probs=34.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEec
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDF   47 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~   47 (68)
                      .+..++.|++.++.|+|+. +++|+++||.|+++.....+++.||
T Consensus        81 ~~~~i~~qi~~al~~lH~~-gIvHrDlKP~NiLl~~~~~~k~~d~  124 (793)
T PLN00181         81 ECFHVFRQIVEIVNAAHSQ-GIVVHNVRPSCFVMSSFNHVSFIES  124 (793)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCCchhEEEcccCcEEEeec
Confidence            4567889999999999986 9999999999999964333333333

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.04  E-value=8e-10  Score=60.83  Aligned_cols=49  Identities=39%  Similarity=0.641  Sum_probs=43.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..
T Consensus       102 ~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598         102 LARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            3456788999999999996 999999999999999999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4717|consensus

Probab=99.03  E-value=6.9e-10  Score=64.09  Aligned_cols=54  Identities=31%  Similarity=0.623  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-CCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~~~~   57 (68)
                      +.++++.||+.++.|+|+ +.++|++++|+|..+- ..+.+++.|||++-.+.+..
T Consensus       119 La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen  119 LAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             HHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            568899999999999998 5899999999998764 66889999999998877764

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.03  E-value=1.7e-09  Score=57.61  Aligned_cols=52  Identities=23%  Similarity=0.424  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       124 ~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~  175 (291)
T cd05094         124 QMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS  175 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEECCCCcccccCC
Confidence            3567889999999999986 999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.03  E-value=8.3e-10  Score=60.98  Aligned_cols=50  Identities=36%  Similarity=0.600  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++.+
T Consensus       102 ~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626         102 LARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            3456788999999999996 9999999999999998899999999987644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.03  E-value=7.3e-10  Score=60.95  Aligned_cols=51  Identities=31%  Similarity=0.653  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       104 ~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853         104 HVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            3567889999999999996 99999999999999999999999999887653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.02  E-value=1.6e-09  Score=56.93  Aligned_cols=51  Identities=25%  Similarity=0.463  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       115 ~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  165 (273)
T cd05035         115 LLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGLSKKIYS  165 (273)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccceeeccc
Confidence            466789999999999996 899999999999999888999999999876543

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.02  E-value=1.6e-09  Score=57.67  Aligned_cols=51  Identities=24%  Similarity=0.508  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       134 ~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         134 LVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHH  184 (293)
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCCCeEEeCcccccccccc
Confidence            456889999999999986 999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.02  E-value=1.6e-09  Score=57.19  Aligned_cols=51  Identities=24%  Similarity=0.473  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       121 ~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~  171 (277)
T cd05032         121 FIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE  171 (277)
T ss_pred             HHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECCcccchhhcc
Confidence            556788999999999986 899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4721|consensus

Probab=99.02  E-value=2.7e-10  Score=66.22  Aligned_cols=52  Identities=37%  Similarity=0.560  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ..++..+|+.++.|+|.. +++||++|+.|+++.....+|+.|||.++.+.+-
T Consensus       214 lv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  214 LVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             HHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            456667899999999996 8999999999999999999999999999988764

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.02  E-value=1.6e-09  Score=57.65  Aligned_cols=51  Identities=27%  Similarity=0.490  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       131 ~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  181 (296)
T cd05051         131 TLLYMATQIASGMRYLESL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY  181 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CccccccchhceeecCCCceEEccccceeecc
Confidence            3567889999999999986 99999999999999998999999999987653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0597|consensus

Probab=99.02  E-value=8.1e-10  Score=64.15  Aligned_cols=53  Identities=42%  Similarity=0.826  Sum_probs=48.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.+++.++.|+|+. ++.|++++|.|+++..+..+|+.|||+||.....
T Consensus       101 ~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen  101 QVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            4677899999999999996 9999999999999999999999999999887643

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.01  E-value=1.7e-09  Score=57.23  Aligned_cols=50  Identities=24%  Similarity=0.484  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       121 ~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  170 (277)
T cd05062         121 MIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY  170 (277)
T ss_pred             HHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCEEECCCCCccccC
Confidence            456788999999999996 89999999999999998899999999887553

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.01  E-value=1.8e-09  Score=57.29  Aligned_cols=50  Identities=22%  Similarity=0.503  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       126 ~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (283)
T cd05090         126 FLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLHVKISDLGLSREIY  175 (283)
T ss_pred             HHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCcEEecccccccccc
Confidence            345788999999999996 89999999999999988889999999987654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.01  E-value=2.1e-09  Score=56.62  Aligned_cols=49  Identities=24%  Similarity=0.365  Sum_probs=43.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++..
T Consensus       102 ~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087         102 LQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccc
Confidence            346788999999999996 9999999999999999889999999988653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.01  E-value=2.9e-09  Score=58.14  Aligned_cols=50  Identities=32%  Similarity=0.637  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++...
T Consensus       181 ~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         181 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence            456788999999999996 99999999999999988999999999887653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.01  E-value=1.9e-09  Score=60.25  Aligned_cols=50  Identities=26%  Similarity=0.629  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       239 ~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~~~kL~DfGla~~~~  288 (400)
T cd05105         239 LLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGKIVKICDFGLARDIM  288 (400)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCCEEEEEeCCcceecc
Confidence            467889999999999996 89999999999999988889999999987654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.01  E-value=2.5e-09  Score=57.15  Aligned_cols=51  Identities=27%  Similarity=0.482  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       131 ~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  181 (296)
T cd05095         131 TLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY  181 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccCChheEEEcCCCCEEeccCccccccc
Confidence            4677889999999999996 89999999999999988889999999987653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.00  E-value=2.6e-09  Score=56.90  Aligned_cols=51  Identities=24%  Similarity=0.439  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       121 ~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  171 (288)
T cd05093         121 QMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDFGMSRDVY  171 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEeccCCcccccc
Confidence            3567889999999999986 99999999999999998999999999987653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG4250|consensus

Probab=99.00  E-value=1.9e-09  Score=63.26  Aligned_cols=61  Identities=36%  Similarity=0.491  Sum_probs=48.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC----CcEEEEecCCcccccccccccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~----~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      ...+...++.|+.|+|.+ +++|||+||.|++....    ..-|+.|||.|+.+.++.   .....+||
T Consensus       122 ~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT  186 (732)
T KOG4250|consen  122 FLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGT  186 (732)
T ss_pred             HHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCc
Confidence            456778888999999986 99999999999988533    346899999999998875   33344444

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.00  E-value=1.3e-09  Score=57.80  Aligned_cols=51  Identities=33%  Similarity=0.711  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       101 ~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848         101 KVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            3567889999999999986 99999999999999999999999999987764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.00  E-value=1.6e-09  Score=58.62  Aligned_cols=49  Identities=39%  Similarity=0.613  Sum_probs=44.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.
T Consensus        97 ~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          97 RARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            3566788999999999986 999999999999999999999999998765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=98.98  E-value=2e-09  Score=54.97  Aligned_cols=49  Identities=16%  Similarity=0.356  Sum_probs=42.2

Q ss_pred             HHHHHHHHHHHHHHH-hhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~-~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++ |.. +++|+|++|.|+++.. ..+++.|||++....
T Consensus       119 ~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~~-~~v~LiDFG~a~~~~  168 (190)
T cd05147         119 ARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYHD-GKLYIIDVSQSVEHD  168 (190)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEEC-CcEEEEEccccccCC
Confidence            567889999999999 575 8999999999999974 679999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=98.97  E-value=3e-09  Score=56.48  Aligned_cols=51  Identities=29%  Similarity=0.468  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++.....
T Consensus        97 ~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          97 VIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            456788999999999996 999999999999999999999999998876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0605|consensus

Probab=98.97  E-value=1.5e-09  Score=62.05  Aligned_cols=51  Identities=41%  Similarity=0.634  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      ++-++.+++.|+.-+|.. +++||++||.|++++..+.++++|||++..+..
T Consensus       243 arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  243 ARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             HHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhh
Confidence            455677888999999985 999999999999999999999999999866543

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=98.97  E-value=3.9e-09  Score=56.90  Aligned_cols=50  Identities=24%  Similarity=0.543  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       136 ~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         136 LVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVH  185 (314)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeeccccceeEEEcCCCcEEEcccccccccc
Confidence            456788999999999986 99999999999999988899999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=98.97  E-value=3e-09  Score=56.65  Aligned_cols=50  Identities=24%  Similarity=0.509  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       121 ~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~  170 (288)
T cd05061         121 MIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY  170 (288)
T ss_pred             HHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcEEECcCCcccccc
Confidence            456788999999999986 99999999999999998999999999887543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=98.97  E-value=4.6e-09  Score=55.64  Aligned_cols=52  Identities=31%  Similarity=0.570  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       110 ~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057         110 YLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            3567789999999999996 999999999999999888899999999876643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=98.97  E-value=3.1e-09  Score=56.60  Aligned_cols=50  Identities=28%  Similarity=0.541  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       129 ~~~i~~~i~~~l~~LH~~-~ivH~dikp~nill~~~~~~kl~dfg~~~~~~  178 (290)
T cd05045         129 LISFAWQISRGMQYLAEM-KLVHRDLAARNVLVAEGRKMKISDFGLSRDVY  178 (290)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeehhhhhhheEEEcCCCcEEecccccccccc
Confidence            467889999999999986 99999999999999988899999999987653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=98.96  E-value=3.2e-09  Score=56.32  Aligned_cols=52  Identities=27%  Similarity=0.471  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       108 ~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080         108 QLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4567889999999999996 999999999999999989999999999876543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0579|consensus

Probab=98.96  E-value=1.5e-09  Score=64.06  Aligned_cols=51  Identities=43%  Similarity=0.673  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +++.++.|++.++.|+|++ +++|++++..|+++...+.++++|||.+....
T Consensus       131 QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  131 QIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             HHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccch
Confidence            5788999999999999997 89999999999999999999999999875543

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=98.96  E-value=3.8e-09  Score=55.92  Aligned_cols=51  Identities=22%  Similarity=0.432  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.+
T Consensus       119 ~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~  169 (280)
T cd05043         119 LVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALSRDLFP  169 (280)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCcccccC
Confidence            467888999999999986 899999999999999889999999999886643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=98.96  E-value=3.6e-09  Score=57.45  Aligned_cols=50  Identities=26%  Similarity=0.557  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       136 ~~~~~~qi~~al~~LH~~-givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  185 (334)
T cd05100         136 LVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNVMKIADFGLARDVH  185 (334)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCcccceecc
Confidence            456788999999999996 99999999999999988899999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=98.96  E-value=3.9e-09  Score=56.37  Aligned_cols=50  Identities=30%  Similarity=0.505  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+.
T Consensus       131 ~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         131 LLYMAVQIASGMKYLASL-NFVHRDLATRNCLVGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             HHHHHHHHHHHHHHHHhc-CeeccccChhhEEEcCCCcEEecccccccccc
Confidence            456788999999999986 99999999999999988889999999887654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=98.95  E-value=5e-09  Score=54.54  Aligned_cols=53  Identities=26%  Similarity=0.485  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+......
T Consensus       106 ~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192         106 DLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             HHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            4567889999999999996 9999999999999999999999999998776553

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=98.95  E-value=3e-09  Score=56.39  Aligned_cols=52  Identities=27%  Similarity=0.482  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       109 ~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081         109 KLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            3466789999999999996 999999999999999888999999999887643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=98.95  E-value=4.6e-09  Score=58.75  Aligned_cols=50  Identities=22%  Similarity=0.570  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       241 ~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~  290 (401)
T cd05107         241 LVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGKLVKICDFGLARDIM  290 (401)
T ss_pred             HHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCCEEEEEecCcceecc
Confidence            466788999999999986 89999999999999988889999999987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=98.95  E-value=3.1e-09  Score=56.28  Aligned_cols=51  Identities=31%  Similarity=0.702  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       100 ~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839         100 IVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            4577889999999999996 99999999999999998999999999887653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=98.95  E-value=3.8e-09  Score=55.50  Aligned_cols=51  Identities=27%  Similarity=0.464  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus        96 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  146 (257)
T cd05115          96 NVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALG  146 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCcccccc
Confidence            3567789999999999986 99999999999999998999999999887554

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=98.94  E-value=6e-09  Score=54.39  Aligned_cols=49  Identities=45%  Similarity=0.744  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.++|+. +++|+++++.|+++.....+++.|||.+..
T Consensus        99 ~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~  147 (260)
T PF00069_consen   99 EILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVK  147 (260)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred             ccccccccccccccccccc-cccccccccccccccccccccccccccccc
Confidence            4577889999999999996 999999999999999889999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00284 protein kinase; Provisional

Probab=98.94  E-value=3.4e-09  Score=60.00  Aligned_cols=50  Identities=34%  Similarity=0.659  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC----------------cEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----------------AIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~----------------~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.|+|...+++|+|+++.|+++....                .+++.|||.+..
T Consensus       232 ~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~  297 (467)
T PTZ00284        232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD  297 (467)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCcccc
Confidence            35678899999999999734899999999999997543                489999997654

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=98.94  E-value=3.7e-09  Score=56.78  Aligned_cols=50  Identities=26%  Similarity=0.561  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       142 ~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         142 LVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIH  191 (307)
T ss_pred             HHHHHHHHHHHHHHHHHC-CcccccccHHheEEcCCCcEEECCCccccccc
Confidence            557789999999999986 99999999999999988899999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=98.94  E-value=4.3e-09  Score=55.08  Aligned_cols=50  Identities=24%  Similarity=0.550  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       104 ~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082         104 LLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceecc
Confidence            467888999999999986 99999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=98.93  E-value=4.5e-09  Score=55.78  Aligned_cols=50  Identities=24%  Similarity=0.436  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       123 ~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  172 (280)
T cd05092         123 QMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDI  172 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCCCCEEECCCCceeEc
Confidence            3567788999999999986 9999999999999998889999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=98.93  E-value=3.4e-09  Score=57.60  Aligned_cols=51  Identities=31%  Similarity=0.662  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.++|.. +++|+++++.|+++.....+++.|||++....
T Consensus       107 ~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849         107 HIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            3566788999999999996 99999999999999999999999999887654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=98.93  E-value=4.3e-09  Score=56.06  Aligned_cols=51  Identities=31%  Similarity=0.493  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++....
T Consensus       103 ~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632         103 RALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            3567889999999999986 99999999999999988889999999886643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=98.92  E-value=5.7e-09  Score=54.88  Aligned_cols=51  Identities=27%  Similarity=0.486  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       106 ~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052         106 LLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            456789999999999986 999999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=98.92  E-value=4.9e-09  Score=54.96  Aligned_cols=52  Identities=29%  Similarity=0.489  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus        96 ~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          96 NITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence            3567789999999999986 899999999999999888899999999876643

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=98.92  E-value=6.7e-09  Score=56.46  Aligned_cols=53  Identities=58%  Similarity=1.053  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|...+++|+++++.|+++.....+++.|||+++.+.+
T Consensus       104 ~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649         104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            35678889999999999753699999999999999888999999999876643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0983|consensus

Probab=98.92  E-value=6.4e-09  Score=56.26  Aligned_cols=53  Identities=72%  Similarity=1.058  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccccc
Q psy14632          6 QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVV   58 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~   58 (68)
                      ++...++.++.|+...++++||+++|.|++++..+.+|+-|||.+.++.++..
T Consensus       195 k~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  195 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             hhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            45567788999998778999999999999999999999999999988877653

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=98.92  E-value=4.5e-09  Score=55.63  Aligned_cols=50  Identities=30%  Similarity=0.715  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++...
T Consensus       102 ~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861         102 LVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            3567889999999999986 9999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=98.92  E-value=4.4e-09  Score=55.36  Aligned_cols=50  Identities=38%  Similarity=0.645  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+.
T Consensus       113 ~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637         113 IAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             HHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            456788999999999996 89999999999999998999999999987543

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=98.92  E-value=5.3e-09  Score=55.73  Aligned_cols=50  Identities=34%  Similarity=0.557  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++....
T Consensus       104 ~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605         104 AVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             HHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            456788999999999996 99999999999999988899999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0582|consensus

Probab=98.92  E-value=5.6e-09  Score=59.04  Aligned_cols=52  Identities=44%  Similarity=0.714  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..+.++++.|+.|+|.. +.+||++|..|++++..+.+++.|||.+-.+.+
T Consensus       127 ~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  127 SIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            4677889999999999996 999999999999999999999999997655543

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=98.92  E-value=4.5e-09  Score=56.24  Aligned_cols=49  Identities=33%  Similarity=0.529  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++......++.|||++..
T Consensus       120 ~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  168 (297)
T cd05089         120 QLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKIADFGLSRG  168 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEEECCcCCCcc
Confidence            3567889999999999986 999999999999999888899999998754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=98.91  E-value=7.4e-09  Score=55.02  Aligned_cols=51  Identities=25%  Similarity=0.554  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       111 ~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079         111 QLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            467788999999999996 999999999999999888899999998876543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=98.91  E-value=4.5e-09  Score=55.06  Aligned_cols=50  Identities=28%  Similarity=0.549  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       100 ~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058         100 LIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             HHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCcccccccc
Confidence            356778999999999986 99999999999999988899999999987653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0196|consensus

Probab=98.90  E-value=1.8e-09  Score=64.31  Aligned_cols=54  Identities=26%  Similarity=0.434  Sum_probs=48.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ++..|.++|+.|+.|+. .++.+|||+...|++.+.+..||++|||++|.+.++.
T Consensus       732 QLVgMLrGIAsGMkYLs-dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  732 QLVGMLRGIASGMKYLS-DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hHHHHHHHHHHHhHHHh-hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            45678899999999995 5799999999999999999999999999999886655

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=98.90  E-value=6.8e-09  Score=55.78  Aligned_cols=52  Identities=27%  Similarity=0.558  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       142 ~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         142 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            3566788999999999986 899999999999999888899999999876543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=98.90  E-value=5e-09  Score=55.70  Aligned_cols=51  Identities=25%  Similarity=0.518  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++....
T Consensus        98 ~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          98 EMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            3567889999999999996 89999999999999988999999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=98.90  E-value=5.9e-09  Score=54.44  Aligned_cols=50  Identities=38%  Similarity=0.545  Sum_probs=43.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC-------cEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-------AIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~-------~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++....       .+++.|||.+....
T Consensus       103 ~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037         103 KLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             HHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            456788999999999986 999999999999998665       68999999887644

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=98.90  E-value=7.3e-09  Score=54.95  Aligned_cols=51  Identities=59%  Similarity=0.957  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+..
T Consensus        97 ~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          97 LGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            456889999999999996 999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=98.90  E-value=1.3e-08  Score=54.04  Aligned_cols=51  Identities=51%  Similarity=0.746  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|+. ++.|+++++.|+++.....+++.|||++....
T Consensus       104 ~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643         104 QIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEcccccccccc
Confidence            3566888999999999996 99999999999999988999999999876543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=98.89  E-value=5.9e-09  Score=55.90  Aligned_cols=52  Identities=29%  Similarity=0.605  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC----CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR----RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~----~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++..    ...+++.|||+++.+..
T Consensus       109 ~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~  164 (316)
T cd07842         109 MVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA  164 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCC
Confidence            3567889999999999986 8999999999999988    88899999998876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=98.89  E-value=5.3e-09  Score=56.19  Aligned_cols=48  Identities=29%  Similarity=0.566  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.
T Consensus       126 ~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~~kl~dfg~~~~  173 (303)
T cd05088         126 LLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRG  173 (303)
T ss_pred             HHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCcEEeCccccCcc
Confidence            567788999999999986 999999999999999888999999998753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=98.89  E-value=8.3e-09  Score=54.16  Aligned_cols=52  Identities=29%  Similarity=0.562  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. ++.|+++++.|+++.....+++.|||.++...+
T Consensus       101 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113         101 QLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            3567889999999999986 999999999999999888999999998876543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=98.89  E-value=1.1e-08  Score=54.11  Aligned_cols=50  Identities=28%  Similarity=0.492  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       124 ~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~  173 (280)
T cd05049         124 LLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY  173 (280)
T ss_pred             HHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEECCcccceecc
Confidence            456788999999999986 89999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=98.89  E-value=5.9e-09  Score=55.16  Aligned_cols=52  Identities=62%  Similarity=1.081  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|...+++|+++++.|+++.....+++.|||.++...
T Consensus       104 ~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617         104 ILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            3567889999999999974479999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=98.89  E-value=5.4e-09  Score=54.77  Aligned_cols=52  Identities=25%  Similarity=0.478  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++...+
T Consensus       101 ~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059         101 WLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            3467889999999999996 899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=98.89  E-value=7.9e-09  Score=54.04  Aligned_cols=50  Identities=30%  Similarity=0.574  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++..
T Consensus       101 ~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083         101 QLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceec
Confidence            3466788999999999986 9999999999999998889999999987654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=98.89  E-value=7.2e-09  Score=55.25  Aligned_cols=50  Identities=34%  Similarity=0.571  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||++....
T Consensus       104 ~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630         104 AVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            456788999999999986 99999999999999988889999999886654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=98.88  E-value=5e-09  Score=57.31  Aligned_cols=51  Identities=29%  Similarity=0.485  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       120 ~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850         120 MSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            456789999999999996 999999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=98.88  E-value=6.3e-09  Score=55.69  Aligned_cols=51  Identities=41%  Similarity=0.729  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..+..+++.|||++....
T Consensus       119 ~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658         119 QIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            3567889999999999986 89999999999999988899999999886543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=98.88  E-value=1.4e-08  Score=53.01  Aligned_cols=51  Identities=39%  Similarity=0.579  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus       103 ~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223         103 QVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            3567889999999999986 99999999999999988999999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4278|consensus

Probab=98.88  E-value=2e-09  Score=63.49  Aligned_cols=58  Identities=24%  Similarity=0.450  Sum_probs=51.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPF   61 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~   61 (68)
                      .+..|+.||.+++.|+... .++||++...|++.+.+..++++|||++|.+..+.+.+-
T Consensus       366 vLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH  423 (1157)
T KOG4278|consen  366 VLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH  423 (1157)
T ss_pred             HHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence            3567889999999999875 899999999999999999999999999999988776543

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=98.88  E-value=4.2e-09  Score=57.16  Aligned_cols=51  Identities=27%  Similarity=0.642  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       106 ~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857         106 HFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            3466789999999999986 99999999999999988899999999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=98.88  E-value=5.6e-09  Score=55.45  Aligned_cols=51  Identities=25%  Similarity=0.518  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..+..+++.|||.+..+.
T Consensus        98 ~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          98 EMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            4567889999999999996 89999999999999988899999999886553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1989|consensus

Probab=98.88  E-value=4.3e-09  Score=62.35  Aligned_cols=51  Identities=33%  Similarity=0.474  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhC-CCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEE-LKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~-~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      -+.+|+.+++.|+.++|.. -+++|||+|.+|+++..++..++.|||-+...
T Consensus       145 eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  145 EVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            3678999999999999985 25999999999999999999999999976553

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=98.88  E-value=1.3e-08  Score=53.66  Aligned_cols=51  Identities=29%  Similarity=0.436  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       107 ~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065         107 QLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            3567788999999999986 99999999999999988889999999886654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0690|consensus

Probab=98.88  E-value=4.5e-09  Score=58.04  Aligned_cols=58  Identities=36%  Similarity=0.535  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          8 TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         8 ~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      -..|+.++.|+|++ +++.|+++.+|++++..+.+++.|||+++.-....  ....+-|||
T Consensus       274 GaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g--~t~kTFCGT  331 (516)
T KOG0690|consen  274 GAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG--DTTKTFCGT  331 (516)
T ss_pred             hHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccchhccccc--ceeccccCC
Confidence            45788999999997 99999999999999999999999999987643322  233344554

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=98.88  E-value=7.6e-09  Score=54.01  Aligned_cols=51  Identities=27%  Similarity=0.488  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus        95 ~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          95 ELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccc
Confidence            3566789999999999986 89999999999999988889999999887544

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=98.87  E-value=1.2e-08  Score=55.54  Aligned_cols=52  Identities=62%  Similarity=1.075  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|...+++|+++++.|+++.....+++.|||++..+..
T Consensus       105 ~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650         105 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             HHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            4577889999999999743699999999999999888899999999876543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=98.87  E-value=8.3e-09  Score=54.25  Aligned_cols=51  Identities=41%  Similarity=0.677  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus       107 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645         107 QIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            3466788999999999986 89999999999999988899999999876553

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=98.87  E-value=7.9e-09  Score=55.03  Aligned_cols=50  Identities=32%  Similarity=0.642  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++..
T Consensus       104 ~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870         104 NVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            3456788999999999996 8999999999999998899999999987653

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4257|consensus

Probab=98.87  E-value=3.5e-09  Score=62.32  Aligned_cols=55  Identities=31%  Similarity=0.513  Sum_probs=50.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVL   59 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~   59 (68)
                      ...++.|++.++.|+++. +++||++...|++......+|+.|||++|.+.++.+.
T Consensus       493 L~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  493 LTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             HHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            345789999999999996 8999999999999999999999999999999887654

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=98.86  E-value=1.2e-08  Score=53.64  Aligned_cols=50  Identities=24%  Similarity=0.490  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       104 ~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069         104 LVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            456788999999999986 89999999999999998899999999987654

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=98.86  E-value=1.2e-08  Score=53.69  Aligned_cols=50  Identities=28%  Similarity=0.572  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC-----cEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-----AIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~-----~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++....     .+++.|||+++.+.
T Consensus       108 ~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~  162 (269)
T cd05044         108 LLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY  162 (269)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccccccc
Confidence            456788999999999986 899999999999998766     78999999887654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=98.86  E-value=1e-08  Score=54.47  Aligned_cols=53  Identities=85%  Similarity=1.227  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+..+++|+++++.|+++.....+++.|||+++.+..
T Consensus       108 ~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616         108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            35678889999999999744899999999999999888999999999876543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=98.86  E-value=1.1e-08  Score=54.01  Aligned_cols=48  Identities=29%  Similarity=0.560  Sum_probs=43.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG   51 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~   51 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++.
T Consensus       113 ~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047         113 QLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCCcc
Confidence            3467788999999999986 99999999999999998999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=98.86  E-value=9.4e-09  Score=53.74  Aligned_cols=52  Identities=31%  Similarity=0.538  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus        98 ~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          98 TLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccc
Confidence            3566788999999999986 999999999999999889999999998877644

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=98.86  E-value=1.1e-08  Score=53.57  Aligned_cols=51  Identities=24%  Similarity=0.492  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. ++.|+++++.|++++.....++.|||.++...
T Consensus       103 ~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039         103 QQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccc
Confidence            4567889999999999996 99999999999999988899999999887764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=98.86  E-value=1.3e-08  Score=54.18  Aligned_cols=50  Identities=28%  Similarity=0.529  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       132 ~~~~~~~i~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         132 QLCIAKQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecccccHhheEecCCCceEECccccceecc
Confidence            467889999999999986 99999999999999988899999999887643

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=98.86  E-value=1.6e-08  Score=52.76  Aligned_cols=52  Identities=29%  Similarity=0.454  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.++.+.+
T Consensus       102 ~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529         102 QVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            3456788999999999986 999999999999999989999999998876544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=98.86  E-value=1.2e-08  Score=54.07  Aligned_cols=52  Identities=42%  Similarity=0.791  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+..+..
T Consensus       101 ~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847         101 LIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            4577889999999999996 999999999999999888999999998876644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=98.86  E-value=8.3e-09  Score=55.25  Aligned_cols=50  Identities=36%  Similarity=0.722  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++...
T Consensus       105 ~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873         105 NVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            3566788999999999996 9999999999999999899999999988654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=98.86  E-value=9.7e-09  Score=54.72  Aligned_cols=52  Identities=33%  Similarity=0.639  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       107 ~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843         107 EVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            3567889999999999986 899999999999999999999999998876654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=98.86  E-value=1.2e-08  Score=54.22  Aligned_cols=52  Identities=58%  Similarity=1.028  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|...+++|+++++.|+++.....+++.|||.+..+.
T Consensus       103 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622         103 VLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            4567889999999999964489999999999999998899999999886653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0665|consensus

Probab=98.86  E-value=6.5e-09  Score=56.77  Aligned_cols=51  Identities=29%  Similarity=0.496  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..+..|++.++.++|+. +++||+++|.|++.......++.|||+++.-..
T Consensus       120 is~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen  120 ISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCc
Confidence            456778999999999996 999999999999999999999999999876543

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=98.86  E-value=7.2e-09  Score=55.39  Aligned_cols=51  Identities=35%  Similarity=0.675  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       120 ~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865         120 EIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence            4567889999999999986 99999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=98.85  E-value=1.1e-08  Score=54.44  Aligned_cols=50  Identities=26%  Similarity=0.596  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|++++. ...+++.|||.++.+
T Consensus       111 ~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837         111 TIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            4567889999999999996 9999999999999987 788999999988754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=98.85  E-value=1.1e-08  Score=55.95  Aligned_cols=50  Identities=30%  Similarity=0.602  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       122 ~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877         122 VQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence            466889999999999996 99999999999999999999999999887643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0608|consensus

Probab=98.85  E-value=1.3e-08  Score=60.21  Aligned_cols=51  Identities=37%  Similarity=0.612  Sum_probs=43.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      ++=++..+..++.++|. ++++||++|+.|++++..+.+|+.|||++.-+..
T Consensus       731 ARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  731 ARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             HHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCceeeeecccccccee
Confidence            44456677889999998 6999999999999999999999999998766543

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=98.85  E-value=1.3e-08  Score=53.93  Aligned_cols=50  Identities=44%  Similarity=0.646  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       126 ~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638         126 IAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             HHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            456788999999999986 89999999999999988889999999987654

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG1027|consensus

Probab=98.85  E-value=9.3e-09  Score=61.44  Aligned_cols=54  Identities=37%  Similarity=0.486  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-----CcEEEEecCCcccccccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-----GAIKLCDFGISGQLVVEVVL   59 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-----~~~~~~~~g~~~~~~~~~~~   59 (68)
                      +.+..|+.+|+.++|+ .+++||+++|.|+++...     ...+++|||+++++..+..+
T Consensus       609 ~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  609 ISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             HHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            4677899999999999 599999999999999752     44689999999999876543

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=98.85  E-value=1.2e-08  Score=53.48  Aligned_cols=50  Identities=42%  Similarity=0.668  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       106 ~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625         106 TRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            467789999999999986 99999999999999988899999999886553

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=98.85  E-value=1.6e-08  Score=53.84  Aligned_cols=51  Identities=43%  Similarity=0.707  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       129 ~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         129 MISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            3566788999999999986 99999999999999988889999999877644

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=98.85  E-value=1.1e-08  Score=54.51  Aligned_cols=52  Identities=35%  Similarity=0.661  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       103 ~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841         103 DIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            3567889999999999986 899999999999999999999999998876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=98.84  E-value=1.5e-08  Score=53.40  Aligned_cols=51  Identities=22%  Similarity=0.451  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       103 ~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071         103 QLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            3566788999999999996 89999999999999988889999999887654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=98.84  E-value=1.6e-08  Score=53.07  Aligned_cols=51  Identities=24%  Similarity=0.486  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       104 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068         104 QLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            4567888999999999986 89999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=98.84  E-value=1.7e-08  Score=53.08  Aligned_cols=51  Identities=29%  Similarity=0.466  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       107 ~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033         107 QLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            3567788999999999986 99999999999999998999999999887764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=98.84  E-value=1.2e-08  Score=61.88  Aligned_cols=49  Identities=27%  Similarity=0.460  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|+. +++|++++|.|++++....+++.|||+++..
T Consensus       115 iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184        115 FLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcceec
Confidence            456788999999999996 9999999999999999899999999998766

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=98.84  E-value=1.3e-08  Score=53.49  Aligned_cols=50  Identities=28%  Similarity=0.562  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       108 ~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229         108 VWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            456788999999999986 99999999999999988899999999876554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=98.84  E-value=1.1e-08  Score=54.80  Aligned_cols=51  Identities=39%  Similarity=0.698  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..+..+++.|||.+....
T Consensus       117 ~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654         117 QIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            3467788999999999996 99999999999999988899999999877643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PRK12274 serine/threonine protein kinase; Provisional

Probab=98.84  E-value=2e-08  Score=52.41  Aligned_cols=49  Identities=22%  Similarity=0.263  Sum_probs=42.2

Q ss_pred             HHHHHHHHHHHHHhhCCCceeecc-CCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          6 QVTVATVKALNYLKEELKIIHRDV-KPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~~~h~~l-~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.|+..++.++|.. +++|+|+ ++.|+++.....++++|||++....+
T Consensus        95 ~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         95 AYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             HHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            4567888999999996 9999999 68999998888899999999975443

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=98.84  E-value=1.6e-08  Score=55.01  Aligned_cols=51  Identities=41%  Similarity=0.704  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      ...++.|++.++.++|.. +++|+++++.|++++....+++.|||.+..+..
T Consensus       109 ~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852         109 KRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            455788999999999986 999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=98.84  E-value=1.6e-08  Score=53.02  Aligned_cols=52  Identities=29%  Similarity=0.505  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus        96 ~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          96 DLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             HHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            3567889999999999986 899999999999999999999999998876643

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=98.84  E-value=1.4e-08  Score=54.28  Aligned_cols=51  Identities=71%  Similarity=1.094  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|...+++|+++++.|+++.....+++.|||.+..+.
T Consensus       116 ~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618         116 LGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             HHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            457889999999999963489999999999999988999999999887654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=98.83  E-value=1.5e-08  Score=53.04  Aligned_cols=51  Identities=25%  Similarity=0.563  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       101 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114         101 MLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            3567888999999999986 89999999999999988899999999887654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=98.83  E-value=1.6e-08  Score=58.22  Aligned_cols=51  Identities=31%  Similarity=0.581  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       310 ~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  360 (507)
T PLN03224        310 VIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC  360 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence            3567889999999999986 89999999999999988899999999986543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=98.83  E-value=1.4e-08  Score=53.27  Aligned_cols=51  Identities=22%  Similarity=0.473  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       105 ~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072         105 LIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            456778999999999986 899999999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=98.83  E-value=8.3e-09  Score=54.89  Aligned_cols=50  Identities=32%  Similarity=0.686  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++..
T Consensus       104 ~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844         104 NVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECcccccccc
Confidence            3566788999999999986 9999999999999999899999999987653

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=98.83  E-value=1.4e-08  Score=53.56  Aligned_cols=50  Identities=38%  Similarity=0.579  Sum_probs=41.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc-------EEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-------IKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~-------~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....       +++.|||.+....
T Consensus       107 ~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~  163 (262)
T cd05077         107 KFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL  163 (262)
T ss_pred             HHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcccc
Confidence            467889999999999986 9999999999999975432       7889999876543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1026|consensus

Probab=98.83  E-value=6e-09  Score=61.87  Aligned_cols=55  Identities=22%  Similarity=0.431  Sum_probs=49.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVL   59 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~   59 (68)
                      ...||.||+.|+.|+.+. .++|||+-..|++.+....+|++|||++|.+-+..+.
T Consensus       605 ~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYY  659 (774)
T KOG1026|consen  605 FLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYY  659 (774)
T ss_pred             HHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEecccccchhhhhhhhh
Confidence            457899999999999775 8999999999999999999999999999998766544

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=98.83  E-value=1.3e-08  Score=54.58  Aligned_cols=51  Identities=39%  Similarity=0.662  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++..+.
T Consensus       118 ~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659         118 QIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            3567889999999999986 89999999999999999999999999886544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=98.83  E-value=1.7e-08  Score=52.84  Aligned_cols=52  Identities=27%  Similarity=0.464  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....+
T Consensus       105 ~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148         105 SLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            3466788999999999986 899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4236|consensus

Probab=98.82  E-value=1.4e-08  Score=59.11  Aligned_cols=52  Identities=37%  Similarity=0.625  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC---CcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~---~~~~~~~~g~~~~~~~~   56 (68)
                      .+-+..||+.++.|+|-. +++|.++||+|+++...   -..|+.|||+||.+++.
T Consensus       666 TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  666 TKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             HHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            344568999999999985 99999999999999754   35799999999988764

>smart00090 RIO RIO-like kinase

Probab=98.82  E-value=1.7e-08  Score=53.24  Aligned_cols=52  Identities=21%  Similarity=0.299  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCC-ceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELK-IIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~-~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      +..++.|++.++.++|.. + ++|++++|.|+++. ...+++.|||.+.......
T Consensus       150 ~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      150 EFELYDDILEEMRKLYKE-GELVHGDLSEYNILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             HHHHHHHHHHHHHHHHhc-CCEEeCCCChhhEEEE-CCCEEEEEChhhhccCCcc
Confidence            357889999999999986 8 99999999999998 6779999999988665543

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=98.82  E-value=1.6e-08  Score=53.90  Aligned_cols=52  Identities=38%  Similarity=0.623  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       102 ~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580         102 VARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            3556788999999999996 999999999999999888999999998877544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=98.82  E-value=1.9e-08  Score=52.94  Aligned_cols=51  Identities=37%  Similarity=0.660  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       107 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646         107 QIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            3456788999999999986 99999999999999988889999999887654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=98.82  E-value=3.1e-08  Score=52.22  Aligned_cols=50  Identities=38%  Similarity=0.620  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       110 ~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629         110 VRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             HHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            456788999999999986 89999999999999988999999999886543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=98.82  E-value=9.8e-09  Score=55.80  Aligned_cols=51  Identities=29%  Similarity=0.610  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       108 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855         108 HIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            3567889999999999996 99999999999999999999999999887654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=98.82  E-value=1.2e-08  Score=53.62  Aligned_cols=50  Identities=26%  Similarity=0.547  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus       108 ~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228         108 VWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             HHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            467788999999999986 99999999999999988889999999877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=98.82  E-value=1.9e-08  Score=54.97  Aligned_cols=52  Identities=31%  Similarity=0.547  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       119 ~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880         119 RIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            3567889999999999986 999999999999999888999999998876543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=98.81  E-value=2.1e-08  Score=52.25  Aligned_cols=53  Identities=26%  Similarity=0.491  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|++++....+++.|||.++.....
T Consensus       104 ~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219      104 DLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            3567889999999999986 9999999999999999889999999998766543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=98.81  E-value=2.9e-08  Score=51.91  Aligned_cols=51  Identities=33%  Similarity=0.541  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.++....
T Consensus       102 ~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219         102 ILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             HHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            456789999999999986 999999999999999888999999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=98.81  E-value=1.1e-08  Score=54.90  Aligned_cols=52  Identities=37%  Similarity=0.662  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       109 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845         109 QVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            3567889999999999996 899999999999999989999999998876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=98.81  E-value=2.2e-08  Score=52.98  Aligned_cols=52  Identities=29%  Similarity=0.607  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       100 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832         100 QVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            3567889999999999986 899999999999999988899999998876644

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=98.81  E-value=1.9e-08  Score=53.04  Aligned_cols=50  Identities=14%  Similarity=0.209  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..+..+++.|||.+...
T Consensus       108 ~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064         108 QLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            3567889999999999986 9999999999999999889999999876543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=98.80  E-value=2.2e-08  Score=52.74  Aligned_cols=51  Identities=27%  Similarity=0.422  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+..+..
T Consensus       108 ~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066         108 LVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            567788999999999986 899999999999999888899999998876543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=98.80  E-value=2.6e-08  Score=53.62  Aligned_cols=52  Identities=60%  Similarity=1.106  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|...+++|+++++.|+++.....+++.|||.++.+.
T Consensus       100 ~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615         100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             HHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            3567889999999999974479999999999999988889999999887654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=98.80  E-value=1.9e-08  Score=53.90  Aligned_cols=52  Identities=38%  Similarity=0.682  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....+
T Consensus       116 ~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656         116 QIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            3556788999999999986 999999999999999889999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=98.80  E-value=1.6e-08  Score=53.02  Aligned_cols=52  Identities=23%  Similarity=0.425  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+..+..
T Consensus       103 ~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070         103 NLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            3567889999999999986 899999999999999888899999998876543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=98.80  E-value=3.3e-08  Score=51.53  Aligned_cols=50  Identities=28%  Similarity=0.535  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.+++.++.++|.. +++|+++++.|+++.....+++.|||++....
T Consensus        95 ~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          95 LLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            456778999999999986 89999999999999998999999999887554

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=98.80  E-value=1.9e-08  Score=53.55  Aligned_cols=51  Identities=39%  Similarity=0.500  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       107 ~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613         107 VQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            455677999999999986 999999999999999989999999998876543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=98.80  E-value=1.9e-08  Score=52.50  Aligned_cols=51  Identities=45%  Similarity=0.720  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++....
T Consensus        94 ~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~  144 (265)
T cd05579          94 VARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL  144 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence            4567889999999999986 99999999999999999999999999876543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG4279|consensus

Probab=98.79  E-value=1.5e-08  Score=60.50  Aligned_cols=49  Identities=41%  Similarity=0.694  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-CCCcEEEEecCCcccccc
Q psy14632          6 QVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~~   55 (68)
                      -+..||++|+.|+|.. .++||++|-.|.+.+ ..+.+|++|||.++++..
T Consensus       679 fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  679 FYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             HHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            3568999999999997 899999999999997 568899999999988764

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=98.79  E-value=2.4e-08  Score=52.54  Aligned_cols=51  Identities=27%  Similarity=0.437  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++....
T Consensus       108 ~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063         108 QLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            3566788999999999986 89999999999999988899999999887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4645|consensus

Probab=98.79  E-value=1.7e-08  Score=62.74  Aligned_cols=52  Identities=44%  Similarity=0.662  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+.+..|++.++.|+|.. +++||++|+.|+++..++.+|..|||.|..+.+.
T Consensus      1336 t~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1336 TRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            455678999999999996 9999999999999999999999999999888765

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=98.79  E-value=1.4e-08  Score=53.38  Aligned_cols=50  Identities=42%  Similarity=0.659  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       108 ~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652         108 TRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            467889999999999986 89999999999999988899999999887543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=98.79  E-value=2.5e-08  Score=52.55  Aligned_cols=52  Identities=31%  Similarity=0.486  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       108 ~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056         108 SLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            3556788999999999986 899999999999999989999999998876543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=98.79  E-value=1.8e-08  Score=53.03  Aligned_cols=50  Identities=42%  Similarity=0.675  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ...++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       108 ~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651         108 TRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            456789999999999986 89999999999999988889999999887553

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG1345|consensus

Probab=98.78  E-value=1.8e-08  Score=54.52  Aligned_cols=50  Identities=32%  Similarity=0.637  Sum_probs=42.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC--CCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~--~~~~~~~~~g~~~~~~   54 (68)
                      .+.++.|+++++.|+|+. .++||+++.+|+++-.  ...+++.|||..+..+
T Consensus       123 ~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  123 TKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             HHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            567899999999999996 9999999999998853  3468999999887754

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=98.78  E-value=3.5e-08  Score=53.13  Aligned_cols=51  Identities=39%  Similarity=0.544  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..+..+++.|||++....
T Consensus       104 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574         104 VARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            3456788999999999986 99999999999999988899999999876653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0194|consensus

Probab=98.78  E-value=6.8e-09  Score=59.18  Aligned_cols=50  Identities=30%  Similarity=0.577  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ...++.+.+.|+.|+|+. +++|||+-.+|++++....++++|||+++.-.
T Consensus       264 k~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  264 KLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             HHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            346778899999999996 99999999999999998889999999987653

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=98.78  E-value=3e-08  Score=52.58  Aligned_cols=51  Identities=35%  Similarity=0.755  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. ++.|+++++.|+++.....+++.|||++..+.
T Consensus       101 ~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846         101 RVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            3567788999999999996 89999999999999998999999999877654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=98.78  E-value=1.9e-08  Score=52.80  Aligned_cols=50  Identities=46%  Similarity=0.756  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       115 ~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  164 (275)
T cd06608         115 IAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD  164 (275)
T ss_pred             HHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence            456888999999999986 89999999999999988889999999876543

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=98.78  E-value=4.3e-08  Score=51.94  Aligned_cols=50  Identities=30%  Similarity=0.503  Sum_probs=42.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC---CcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~---~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++...   ..+++.|||+++.+.
T Consensus       118 ~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~  170 (277)
T cd05036         118 LLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY  170 (277)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCccccccC
Confidence            456888999999999996 89999999999999754   358999999987653

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=98.78  E-value=3.3e-08  Score=52.70  Aligned_cols=50  Identities=44%  Similarity=0.684  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++...
T Consensus       111 ~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644         111 QIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            3566789999999999986 9999999999999998889999999987653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=98.78  E-value=1.5e-08  Score=53.28  Aligned_cols=51  Identities=39%  Similarity=0.670  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       107 ~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653         107 VTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            3567888999999999986 89999999999999988889999999887653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=98.78  E-value=3.8e-08  Score=51.62  Aligned_cols=51  Identities=29%  Similarity=0.554  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.+++.++.++|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus       107 ~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224         107 TIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            3567788999999999986 99999999999999988889999999877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=98.78  E-value=1.6e-08  Score=53.99  Aligned_cols=51  Identities=37%  Similarity=0.634  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus       117 ~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  167 (302)
T cd07864         117 HIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLARLYN  167 (302)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCccccccccc
Confidence            4567889999999999996 99999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=98.78  E-value=2.1e-08  Score=52.25  Aligned_cols=51  Identities=37%  Similarity=0.531  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus        86 ~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~  136 (237)
T cd05576          86 CVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE  136 (237)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence            3567788999999999986 99999999999999999999999999765443

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=98.78  E-value=3.3e-08  Score=52.12  Aligned_cols=50  Identities=42%  Similarity=0.755  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++.+.|+++.....+++.|||+++..
T Consensus       104 ~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen  104 QRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             ccccccccccccccccccc-ccccccccccccccccccccccccccccccc
Confidence            4677899999999999996 8999999999999999999999999988776

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=98.78  E-value=2.4e-08  Score=52.76  Aligned_cols=50  Identities=30%  Similarity=0.564  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       111 ~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038         111 LLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            466788999999999986 99999999999999999999999999887765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=98.78  E-value=1.7e-08  Score=54.92  Aligned_cols=52  Identities=31%  Similarity=0.655  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++.....
T Consensus       109 ~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858         109 HCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            3567889999999999986 899999999999999888999999998876543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=98.78  E-value=1.8e-08  Score=53.89  Aligned_cols=51  Identities=35%  Similarity=0.695  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       116 ~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866         116 QIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            4567889999999999996 89999999999999999999999999887654

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0200|consensus

Probab=98.78  E-value=1.6e-08  Score=59.25  Aligned_cols=54  Identities=22%  Similarity=0.405  Sum_probs=48.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ...+++.|++.|+.|+.+. +++|||+..+|+++..+..+++.|||+++......
T Consensus       419 dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~  472 (609)
T KOG0200|consen  419 DLLSFAYQIANGMEYLASV-PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKD  472 (609)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEecCCCEEEEccccceeccCCCC
Confidence            4567899999999999885 89999999999999999999999999999765544

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=98.78  E-value=1.8e-08  Score=52.99  Aligned_cols=51  Identities=47%  Similarity=0.795  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       107 ~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628         107 LVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            3567889999999999986 89999999999999998999999999887665

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=98.77  E-value=3e-08  Score=52.49  Aligned_cols=51  Identities=43%  Similarity=0.670  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++....
T Consensus       104 ~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611         104 QIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            4567889999999999996 89999999999999999999999999876543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=98.77  E-value=3.3e-08  Score=53.04  Aligned_cols=52  Identities=37%  Similarity=0.666  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|+. ++.|+++++.|+++.....+++.|||++..+..
T Consensus       116 ~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655         116 QIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            3567788999999999996 999999999999999889999999998776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=98.77  E-value=3.9e-08  Score=52.06  Aligned_cols=51  Identities=29%  Similarity=0.673  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus       108 ~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838         108 TIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            3567889999999999996 89999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0668|consensus

Probab=98.77  E-value=2.1e-08  Score=53.22  Aligned_cols=53  Identities=30%  Similarity=0.498  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~~~~   57 (68)
                      ++-++.+++.++.|+|+. +++||+.+|.|.+++. ...+++.|||+|...-+..
T Consensus       134 IryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  134 IRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             HHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            556778999999999995 9999999999999974 5779999999998876544

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=98.77  E-value=3e-08  Score=52.55  Aligned_cols=49  Identities=39%  Similarity=0.658  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++...
T Consensus       123 ~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636         123 IAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             HHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            456788999999999996 9999999999999999889999999987654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=98.77  E-value=3.2e-08  Score=51.77  Aligned_cols=51  Identities=49%  Similarity=0.718  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. ++.|+++++.|+++.....+++.|||.+..+.
T Consensus       102 ~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613         102 QIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhh
Confidence            3566889999999999986 89999999999999998899999999876654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.77  E-value=4.9e-08  Score=49.91  Aligned_cols=53  Identities=21%  Similarity=0.177  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ...++.++..++.++|.. +++|++++|.|+++.....+++.|||.+..+..+.
T Consensus       127 ~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~~~  179 (198)
T cd05144         127 PEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDHPN  179 (198)
T ss_pred             HHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCCcEEEEECCccccCCCcc
Confidence            346778899999999985 99999999999999988899999999987765543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PHA02988 hypothetical protein; Provisional

Probab=98.77  E-value=3.1e-08  Score=52.91  Aligned_cols=52  Identities=13%  Similarity=0.153  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      ...++.+++.++.++|...++.|+++++.|+++.....+++.|||+++.+..
T Consensus       124 ~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        124 KLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            4678889999999999743678999999999999999999999999876543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=98.76  E-value=3e-08  Score=52.39  Aligned_cols=50  Identities=32%  Similarity=0.557  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.. ..+++.|||.++.+.
T Consensus       101 ~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831         101 RVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            3567889999999999996 9999999999999988 889999999887654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=98.76  E-value=3.8e-08  Score=52.15  Aligned_cols=51  Identities=31%  Similarity=0.684  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       101 ~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860         101 LIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            3567889999999999986 89999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=98.76  E-value=4.3e-08  Score=52.72  Aligned_cols=50  Identities=30%  Similarity=0.493  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.||+.+..+.
T Consensus       103 ~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216         103 IAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeec
Confidence            456788999999999996 99999999999999988899999998776543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=98.76  E-value=2.6e-08  Score=52.25  Aligned_cols=50  Identities=40%  Similarity=0.659  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus        98 ~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          98 WAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            4567889999999999996 9999999999999998889999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=98.75  E-value=6e-08  Score=52.15  Aligned_cols=50  Identities=36%  Similarity=0.646  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++....
T Consensus       117 ~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607         117 IAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            456788999999999986 89999999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG1095|consensus

Probab=98.75  E-value=1.1e-08  Score=62.39  Aligned_cols=54  Identities=30%  Similarity=0.548  Sum_probs=47.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      -+..++.+++.|+.|+++. .++|||+...|++++....+|+.|||+|+.+.+..
T Consensus       803 dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~  856 (1025)
T KOG1095|consen  803 DLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKD  856 (1025)
T ss_pred             HHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchhHhhhhch
Confidence            3567889999999999885 89999999999999999999999999999665444

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=98.75  E-value=3.9e-08  Score=51.65  Aligned_cols=51  Identities=22%  Similarity=0.468  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus       103 ~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073         103 KLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            3456788999999999986 99999999999999998999999999886654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1163|consensus

Probab=98.75  E-value=3.9e-08  Score=52.51  Aligned_cols=53  Identities=25%  Similarity=0.422  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~~~   57 (68)
                      +.-++.|++..++|+|.. .++|++++|.|++.+-   ...+.++|||+++...+..
T Consensus       113 vLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen  113 VLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             HHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            344578999999999986 8999999999999864   3567899999998876543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=98.75  E-value=4.1e-08  Score=51.18  Aligned_cols=50  Identities=28%  Similarity=0.509  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++....
T Consensus        95 ~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          95 LVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceecc
Confidence            456778999999999986 99999999999999988899999999886543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=98.75  E-value=6.1e-08  Score=51.72  Aligned_cols=49  Identities=33%  Similarity=0.725  Sum_probs=42.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.. ...+++.|||++...
T Consensus       104 ~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009        104 IKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            457788999999999986 8999999999999974 456899999988654

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=98.75  E-value=4.6e-08  Score=52.16  Aligned_cols=50  Identities=42%  Similarity=0.738  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       117 ~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~  166 (285)
T cd06648         117 IATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS  166 (285)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence            467889999999999986 99999999999999998999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=98.74  E-value=4.5e-08  Score=51.82  Aligned_cols=52  Identities=42%  Similarity=0.772  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+..
T Consensus       102 ~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642         102 YIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            3566788999999999986 999999999999999888999999998876543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=98.74  E-value=3.6e-08  Score=53.87  Aligned_cols=49  Identities=29%  Similarity=0.585  Sum_probs=44.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       119 ~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879         119 VQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             HHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            456788999999999986 8999999999999999999999999988764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=98.74  E-value=4.8e-08  Score=51.43  Aligned_cols=53  Identities=36%  Similarity=0.596  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.++|...+++|+++++.|+++.....+++.|||.+.....
T Consensus       114 ~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  166 (269)
T cd08528         114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP  166 (269)
T ss_pred             HHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccc
Confidence            35678889999999999633799999999999999999999999999876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1164|consensus

Probab=98.74  E-value=2.7e-08  Score=54.23  Aligned_cols=47  Identities=30%  Similarity=0.610  Sum_probs=42.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-----CcEEEEecCCcc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-----GAIKLCDFGISG   51 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-----~~~~~~~~g~~~   51 (68)
                      +..++.|++.++.++|.. +++||+++|.|+.++..     ..+.+.|||+++
T Consensus       124 ~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen  124 VLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             HHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            567889999999999996 99999999999999754     458999999998

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=98.74  E-value=3.9e-08  Score=51.60  Aligned_cols=52  Identities=40%  Similarity=0.641  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus        94 ~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          94 TARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            3456788999999999996 999999999999999989999999999877654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=98.74  E-value=5e-08  Score=51.56  Aligned_cols=52  Identities=37%  Similarity=0.699  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+..+..
T Consensus       102 ~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917         102 YISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            3566788999999999986 999999999999999999999999998876643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=98.73  E-value=4.1e-08  Score=51.52  Aligned_cols=50  Identities=22%  Similarity=0.501  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       104 ~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067         104 LIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             HHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            456788999999999985 99999999999999999999999999887655

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=98.73  E-value=3.8e-08  Score=52.04  Aligned_cols=53  Identities=34%  Similarity=0.594  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+......
T Consensus       101 ~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840         101 QIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            4567889999999999986 8999999999999999999999999988766543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=98.73  E-value=5.1e-08  Score=51.61  Aligned_cols=51  Identities=37%  Similarity=0.602  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC-cEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~-~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.... .+++.|||.++...
T Consensus       110 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390        110 EVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            3567889999999999996 899999999999998777 89999999876654

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=98.72  E-value=4.8e-08  Score=51.97  Aligned_cols=51  Identities=39%  Similarity=0.540  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       106 ~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583         106 EVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            3556778999999999986 99999999999999988889999999887654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=98.72  E-value=5.5e-08  Score=51.37  Aligned_cols=49  Identities=16%  Similarity=0.346  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++......++.+++++...
T Consensus       119 ~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~  167 (275)
T cd05046         119 KVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSLSKDV  167 (275)
T ss_pred             HHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEccccccccc
Confidence            466788999999999986 8999999999999998888999999887643

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=98.72  E-value=6.1e-08  Score=50.56  Aligned_cols=52  Identities=48%  Similarity=0.748  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++..+..
T Consensus       100 ~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612         100 EIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            3567889999999999986 899999999999999888999999998876654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=98.72  E-value=4.9e-08  Score=52.43  Aligned_cols=48  Identities=46%  Similarity=0.703  Sum_probs=42.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.
T Consensus       103 ~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609         103 ARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            456778999999999986 999999999999999989999999998763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=98.72  E-value=4.6e-08  Score=51.86  Aligned_cols=52  Identities=38%  Similarity=0.716  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       101 ~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833         101 AVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            3466788999999999996 899999999999999999999999998776554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=98.72  E-value=4.8e-08  Score=51.20  Aligned_cols=50  Identities=26%  Similarity=0.493  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+.
T Consensus       105 ~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034         105 LVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceecc
Confidence            456788999999999986 89999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=98.72  E-value=7.5e-08  Score=50.85  Aligned_cols=52  Identities=35%  Similarity=0.758  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus        99 ~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          99 LIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            4567889999999999996 899999999999999999999999998776543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=98.72  E-value=5e-08  Score=51.55  Aligned_cols=52  Identities=29%  Similarity=0.619  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus        99 ~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          99 LIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            3567889999999999996 899999999999999888999999998866654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=98.71  E-value=7e-08  Score=50.57  Aligned_cols=52  Identities=42%  Similarity=0.703  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||++..+..
T Consensus       103 ~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610         103 IIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            3567789999999999986 999999999999999888999999998766654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=98.71  E-value=3.7e-08  Score=53.30  Aligned_cols=53  Identities=34%  Similarity=0.676  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+......
T Consensus       104 ~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834         104 HIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            3466889999999999986 9999999999999999899999999988776543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=98.71  E-value=4.4e-08  Score=51.29  Aligned_cols=52  Identities=42%  Similarity=0.715  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+.....
T Consensus       100 ~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626         100 VIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            3556788999999999986 899999999999999999999999998876643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=98.71  E-value=5.2e-08  Score=50.92  Aligned_cols=52  Identities=40%  Similarity=0.589  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221         102 MVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            3456788999999999986 899999999999999989999999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG2052|consensus

Probab=98.71  E-value=4.9e-08  Score=55.33  Aligned_cols=65  Identities=25%  Similarity=0.368  Sum_probs=50.3

Q ss_pred             HHHHHHHHHHHHHHHhhCC-------CceeeccCCCcEEEcCCCcEEEEecCCcccccccc--cccccccccCC
Q psy14632          4 TNQVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV--VLPFLQINFGT   68 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~-------~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~--~~~~~~~~~gt   68 (68)
                      ..+++..+++|+.++|...       .+.|||+|++|++...+..|.+.|+|+|-.-....  .+......+||
T Consensus       310 ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGT  383 (513)
T KOG2052|consen  310 MLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGT  383 (513)
T ss_pred             HHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccce
Confidence            4567788899999999641       58999999999999999999999999986655442  22334455665

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=98.70  E-value=6.4e-08  Score=50.60  Aligned_cols=51  Identities=24%  Similarity=0.511  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       101 ~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112         101 TLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecc
Confidence            3566788999999999986 89999999999999988889999999887554

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1165|consensus

Probab=98.70  E-value=1e-07  Score=52.86  Aligned_cols=54  Identities=26%  Similarity=0.543  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-----CcEEEEecCCccccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-----GAIKLCDFGISGQLVVEVV   58 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-----~~~~~~~~g~~~~~~~~~~   58 (68)
                      +.-+|.|++..++++|.. ..+.|+++|.|++++..     ..+.++|||+|+...+..+
T Consensus       126 V~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  126 VAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             HHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            456788999999999996 89999999999999754     3479999999999887653

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=98.70  E-value=4.2e-08  Score=53.61  Aligned_cols=51  Identities=31%  Similarity=0.574  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       119 ~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851         119 HIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            3567889999999999986 99999999999999998999999999887654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=98.70  E-value=6.5e-08  Score=50.29  Aligned_cols=52  Identities=37%  Similarity=0.674  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+.....
T Consensus       100 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627         100 LVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             HHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            3467889999999999986 999999999999999888999999998876654

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=98.69  E-value=1.1e-07  Score=50.17  Aligned_cols=50  Identities=36%  Similarity=0.675  Sum_probs=42.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|++++. ...+++.|||.+..+.
T Consensus       110 ~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624         110 IIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            445678999999999986 9999999999999975 5679999999876543

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG1094|consensus

Probab=98.69  E-value=4.6e-08  Score=57.28  Aligned_cols=55  Identities=29%  Similarity=0.480  Sum_probs=48.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVL   59 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~   59 (68)
                      ..+++.|++.++.|+.+ .+++|+++.+.|++.+....+|+.|||.+|.+-+..+.
T Consensus       639 ~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  639 GVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hHHHHHHHHHHHHHHHh-hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            35689999999999987 49999999999999999999999999999987766544

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=98.69  E-value=8.3e-08  Score=50.84  Aligned_cols=50  Identities=34%  Similarity=0.780  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+...
T Consensus       101 ~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836         101 TVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            3567889999999999986 8999999999999998889999999987654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0612|consensus

Probab=98.69  E-value=6.4e-08  Score=59.68  Aligned_cols=51  Identities=41%  Similarity=0.662  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +=++..++.|+.-+|+ ++++||+++|.|++++..+.++++|||.+-.+..+
T Consensus       178 rFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  178 RFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             HHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            3355678889999998 69999999999999999999999999987666633

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=98.68  E-value=1e-07  Score=50.49  Aligned_cols=52  Identities=23%  Similarity=0.549  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. ++.|+++++.|+++.....+++.|||.+.....
T Consensus       100 ~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830         100 VIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            4567888999999999986 999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=98.68  E-value=1.2e-07  Score=51.25  Aligned_cols=51  Identities=37%  Similarity=0.638  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       126 ~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         126 EIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            3456788999999999986 89999999999999988899999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=98.68  E-value=7e-08  Score=50.35  Aligned_cols=52  Identities=38%  Similarity=0.690  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+.....
T Consensus       103 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632         103 VIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            3556788999999999986 999999999999999889999999998766543

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG2345|consensus

Probab=98.67  E-value=1.2e-07  Score=50.66  Aligned_cols=52  Identities=33%  Similarity=0.427  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCC-CceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEEL-KIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~-~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.+++.|+.++|... +..|+|++|.|++++......+.|||.++..+
T Consensus       128 ~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~  180 (302)
T KOG2345|consen  128 QILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP  180 (302)
T ss_pred             HHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence            45678899999999999861 38999999999999999999999999876643

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=98.67  E-value=9.8e-08  Score=51.13  Aligned_cols=50  Identities=40%  Similarity=0.725  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||++....
T Consensus       117 ~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647         117 IAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            466788999999999986 99999999999999988899999999876554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=98.67  E-value=7.5e-08  Score=51.04  Aligned_cols=50  Identities=34%  Similarity=0.763  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.++.+
T Consensus       100 ~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835         100 LIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            3567889999999999986 8999999999999999999999999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=98.67  E-value=1.2e-07  Score=49.47  Aligned_cols=51  Identities=37%  Similarity=0.558  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+.....
T Consensus       105 ~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530         105 IWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             HHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            457788999999999986 899999999999999888899999998866544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=98.66  E-value=5.6e-08  Score=52.81  Aligned_cols=50  Identities=28%  Similarity=0.586  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       121 ~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~  170 (335)
T PTZ00024        121 VKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADFGLARRYG  170 (335)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCccceeecc
Confidence            456889999999999986 99999999999999998999999999887655

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=98.66  E-value=9.2e-08  Score=50.82  Aligned_cols=49  Identities=39%  Similarity=0.529  Sum_probs=40.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC-------cEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-------AIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~-------~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++....       .+++.|||.+...
T Consensus       119 ~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         119 KITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             HHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCcccCccceeeecCCcccccc
Confidence            456789999999999986 999999999999986432       3688999876543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=98.66  E-value=8.4e-08  Score=51.12  Aligned_cols=50  Identities=58%  Similarity=1.068  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++....
T Consensus       107 ~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621         107 LGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             HHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            457889999999999986 99999999999999988889999999876543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=98.66  E-value=5.9e-08  Score=51.42  Aligned_cols=50  Identities=30%  Similarity=0.579  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....
T Consensus        97 ~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          97 AIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            456788999999999996 99999999999999998999999999876654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=98.66  E-value=9.6e-08  Score=50.18  Aligned_cols=50  Identities=34%  Similarity=0.444  Sum_probs=41.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc--------EEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--------IKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~--------~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....        +++.|||++....
T Consensus       102 ~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078         102 KLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            456789999999999986 9999999999999975543        5889998876543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=98.66  E-value=9.4e-08  Score=51.25  Aligned_cols=51  Identities=41%  Similarity=0.675  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|++++....+++.|||++..+.
T Consensus       117 ~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~  167 (292)
T cd06657         117 QIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  167 (292)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence            3467789999999999996 99999999999999988889999999876554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=98.66  E-value=8e-08  Score=52.51  Aligned_cols=50  Identities=24%  Similarity=0.587  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.. ...+++.|||.++.+
T Consensus       115 ~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~dfg~~~~~  165 (342)
T cd07854         115 HARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV  165 (342)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCcccceec
Confidence            4567889999999999986 9999999999999974 456799999988765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0577|consensus

Probab=98.66  E-value=4.7e-08  Score=57.53  Aligned_cols=52  Identities=37%  Similarity=0.619  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .-|+.+.+.|+.|+|+- +.+|++++..|+++...+.+++.|||.+....+-.
T Consensus       129 AAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn  180 (948)
T KOG0577|consen  129 AAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN  180 (948)
T ss_pred             HHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence            44677889999999994 89999999999999999999999999987766544

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=98.65  E-value=6.4e-08  Score=50.86  Aligned_cols=50  Identities=34%  Similarity=0.608  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+...
T Consensus       103 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631         103 VFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            3566789999999999986 8999999999999998889999999988765

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.65  E-value=1.3e-07  Score=47.74  Aligned_cols=52  Identities=17%  Similarity=0.264  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhh-CCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~-~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+.++.+++.++.++|. . +++|+++++.|+++. ...+++.|||.+.....+.
T Consensus       116 ~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~~~  168 (187)
T cd05119         116 PEELYDQILELMRKLYREA-GLVHGDLSEYNILVD-DGKVYIIDVPQAVEIDHPN  168 (187)
T ss_pred             HHHHHHHHHHHHHHHhhcc-CcCcCCCChhhEEEE-CCcEEEEECcccccccCcc
Confidence            46678899999999998 5 899999999999998 7889999999997765533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=98.65  E-value=5.8e-08  Score=50.91  Aligned_cols=50  Identities=68%  Similarity=1.127  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHhh-CCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~-~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|. . +++|+++++.|+++.....+++.|||.+....
T Consensus       102 ~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605         102 LGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             HHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            45688999999999998 6 89999999999999998899999999876654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=98.65  E-value=1.1e-07  Score=49.71  Aligned_cols=51  Identities=41%  Similarity=0.589  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+..+..
T Consensus       103 ~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218         103 ILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             HHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            467788999999999986 999999999999999888999999998866543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=98.65  E-value=8.1e-08  Score=50.63  Aligned_cols=52  Identities=44%  Similarity=0.626  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+.....
T Consensus       103 ~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581         103 CTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            4677889999999999986 999999999999999888999999998876544

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.65  E-value=1.3e-07  Score=49.94  Aligned_cols=47  Identities=26%  Similarity=0.310  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          7 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         7 ~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+.+++.++.++|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       147 ~~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        147 QWQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             HHHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence            457889999999996 99999999999999887789999999877654

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=98.65  E-value=1.1e-07  Score=58.32  Aligned_cols=52  Identities=35%  Similarity=0.570  Sum_probs=42.2

Q ss_pred             HHHHHHHHHHHHHHHHhhC------CCceeeccCCCcEEEcC-----------------CCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEE------LKIIHRDVKPSNILLDR-----------------RGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~------~~~~h~~l~~~~~~~~~-----------------~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|..      .+++|++++|.|+++..                 ...+++.|||+++.+.
T Consensus       119 ~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~  193 (1021)
T PTZ00266        119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG  193 (1021)
T ss_pred             HHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccc
Confidence            4678899999999999973      14999999999999853                 2347999999987654

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=98.64  E-value=1.1e-07  Score=49.83  Aligned_cols=52  Identities=40%  Similarity=0.663  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....+
T Consensus       101 ~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578         101 QVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            3567889999999999986 899999999999999999999999998776544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=98.64  E-value=9e-08  Score=50.29  Aligned_cols=52  Identities=37%  Similarity=0.679  Sum_probs=44.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++... ..+++.|||.+..+..
T Consensus       104 ~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630         104 VIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            3567789999999999996 99999999999999755 4689999998876653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=98.64  E-value=9e-08  Score=51.59  Aligned_cols=50  Identities=42%  Similarity=0.686  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       117 ~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634         117 IAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            456788999999999986 89999999999999988899999999876544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=98.64  E-value=8.5e-08  Score=50.68  Aligned_cols=53  Identities=45%  Similarity=0.718  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+...
T Consensus        99 ~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          99 YIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            4567889999999999986 8999999999999999999999999988776543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=98.64  E-value=1e-07  Score=49.78  Aligned_cols=52  Identities=33%  Similarity=0.510  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHh-----hCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLK-----EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~-----~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|     .. +++|+++++.|+++.....+++.|||.+.....
T Consensus       106 ~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217         106 FIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             HHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            35678899999999999     65 899999999999999989999999998877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0201|consensus

Probab=98.64  E-value=7.1e-08  Score=54.46  Aligned_cols=59  Identities=46%  Similarity=0.719  Sum_probs=48.5

Q ss_pred             HHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          7 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         7 ~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      +.+.++.++.|+|.. +.+|++++..|+++...+.+++.|||.+-.+......  ..+-+||
T Consensus       116 ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGT  174 (467)
T KOG0201|consen  116 ILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGT  174 (467)
T ss_pred             ehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhc--ccccccc
Confidence            467888999999997 8999999999999998899999999999888765532  2444454

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=98.63  E-value=1.2e-07  Score=50.21  Aligned_cols=51  Identities=45%  Similarity=0.787  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+..+..
T Consensus       103 ~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640         103 IATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             HHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            456788999999999986 999999999999999888999999998866543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=98.63  E-value=9.1e-08  Score=50.06  Aligned_cols=52  Identities=42%  Similarity=0.777  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhh-CCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~-~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|. . +++|+++++.|+++.....+++.|||.+.....
T Consensus       100 ~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623         100 VLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             HHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            356788999999999998 6 899999999999999999999999998876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=98.63  E-value=1.1e-07  Score=49.49  Aligned_cols=52  Identities=46%  Similarity=0.652  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.+++.++.++|.. ++.|+++++.|+++.....+++.|||.+.....
T Consensus       104 ~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215         104 QILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            3467888999999999986 999999999999999889999999998766544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=98.63  E-value=1.1e-07  Score=49.15  Aligned_cols=52  Identities=46%  Similarity=0.698  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+......
T Consensus       100 ~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122         100 IAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             HHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            456788999999999985 9999999999999999889999999988776554

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=98.62  E-value=1.4e-07  Score=51.18  Aligned_cols=47  Identities=28%  Similarity=0.454  Sum_probs=40.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS   50 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~   50 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.+|+..
T Consensus       102 ~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~  148 (327)
T cd08227         102 AIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSN  148 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchh
Confidence            3567889999999999986 8999999999999988888888887643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=98.61  E-value=1.3e-07  Score=51.52  Aligned_cols=49  Identities=33%  Similarity=0.708  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+...
T Consensus       110 ~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856         110 IQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            456789999999999996 8999999999999998889999999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=98.60  E-value=3.3e-07  Score=47.66  Aligned_cols=52  Identities=46%  Similarity=0.648  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.|||.+.....
T Consensus        94 ~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          94 RARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            3566788999999999996 999999999999999988999999998766543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=98.59  E-value=2.9e-07  Score=49.79  Aligned_cols=49  Identities=39%  Similarity=0.706  Sum_probs=43.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+...
T Consensus       123 ~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         123 IAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             HHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            456788999999999986 8999999999999998888999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0610|consensus

Probab=98.59  E-value=2.4e-07  Score=52.23  Aligned_cols=49  Identities=39%  Similarity=0.569  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      ++=++..++-|++|+|. ++++.||+||+|+++..++.+-++||.++...
T Consensus       181 aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  181 ARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             HHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            45567889999999998 59999999999999999999999999987665

>KOG0574|consensus

Probab=98.58  E-value=2.3e-08  Score=54.92  Aligned_cols=60  Identities=47%  Similarity=0.702  Sum_probs=48.5

Q ss_pred             HHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          6 QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .+.+..+.+++|+|- ++-+||+++..|++++..+..+++|||.+..+.+..  +...+..||
T Consensus       133 ~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGT  192 (502)
T KOG0574|consen  133 AVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGT  192 (502)
T ss_pred             HHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccC
Confidence            455677889999996 478999999999999999999999999999988765  333344443

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=98.58  E-value=2.5e-07  Score=48.06  Aligned_cols=53  Identities=38%  Similarity=0.629  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.||+.+......
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606         102 VIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            3567889999999999996 9999999999999999899999999988776544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG1025|consensus

Probab=98.58  E-value=1.3e-07  Score=57.31  Aligned_cols=53  Identities=26%  Similarity=0.538  Sum_probs=48.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ..+++.||++|+.|+|.+ +++||++-..|.+.......++.|||+++.+.++.
T Consensus       800 lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  800 LLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            467889999999999986 89999999999999999999999999999987665

>KOG0199|consensus

Probab=98.58  E-value=5.6e-08  Score=58.01  Aligned_cols=52  Identities=31%  Similarity=0.634  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +-.++.||+.++.|+.++ +++|||+...|+++.....+|+.|||+.|.+...
T Consensus       214 Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  214 LCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             HHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            346789999999999886 8999999999999999999999999999888643

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=98.57  E-value=2.2e-07  Score=49.31  Aligned_cols=51  Identities=45%  Similarity=0.791  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. ++.|+++++.|++......+++.|||++..+..
T Consensus       103 ~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641         103 IATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             HHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            456788999999999986 999999999999999888899999998866543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0696|consensus

Probab=98.57  E-value=2.1e-07  Score=53.03  Aligned_cols=59  Identities=31%  Similarity=0.473  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          7 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         7 ~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      +|..++-++.++|++ +++.|+++..|++++..+.+++.|||+++.-.-+.  ..+.+-|||
T Consensus       455 YAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGT  513 (683)
T KOG0696|consen  455 YAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGT  513 (683)
T ss_pred             hhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccCC--cceeeecCC
Confidence            567888899999996 99999999999999999999999999987643332  233344454

>KOG0587|consensus

Probab=98.56  E-value=3.8e-07  Score=55.13  Aligned_cols=53  Identities=38%  Similarity=0.609  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      +.-+++.++.++.++|.. .++|++++-.|+++.....+++.|||.+..+....
T Consensus       125 IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen  125 IAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV  177 (953)
T ss_pred             HHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence            456778889999999986 89999999999999999999999999998877543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=98.55  E-value=2.5e-07  Score=49.20  Aligned_cols=51  Identities=57%  Similarity=1.022  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.+++.++.|+|...+++|+++++.|+++.....+++.|||++...
T Consensus       104 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620         104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            346778899999999996447999999999999998889999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1152|consensus

Probab=98.55  E-value=1.7e-07  Score=54.96  Aligned_cols=56  Identities=27%  Similarity=0.435  Sum_probs=48.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVL   59 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~   59 (68)
                      -++-++.|++-++.++|.+ +++||++|-+|.....++..++.|||.+....+...+
T Consensus       671 eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd  726 (772)
T KOG1152|consen  671 EAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFD  726 (772)
T ss_pred             HHHHHHHHHHhcccccccc-CceecccccccEEEecCCeEEEeeccchhhhcCCCcc
Confidence            3566889999999999996 9999999999999999999999999998877665433

>KOG1006|consensus

Probab=98.54  E-value=2.9e-08  Score=53.56  Aligned_cols=49  Identities=84%  Similarity=1.242  Sum_probs=42.2

Q ss_pred             HHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          8 TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         8 ~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ....+.++.|+...+.++||+++|.|++++..+.+|+-|||.+..+.++
T Consensus       173 tvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  173 TVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             eeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            3445679999987778999999999999999999999999998776553

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=98.54  E-value=1.7e-07  Score=50.95  Aligned_cols=45  Identities=29%  Similarity=0.589  Sum_probs=39.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCC
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI   49 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~   49 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.+|+.
T Consensus       103 ~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~  147 (328)
T cd08226         103 IGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSH  147 (328)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHH
Confidence            456889999999999986 999999999999999888888888764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=98.54  E-value=3.2e-07  Score=48.80  Aligned_cols=51  Identities=41%  Similarity=0.750  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. ++.|+++++.|+++.....+++.||+.+....
T Consensus       117 ~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614         117 QIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            3566889999999999986 99999999999999988899999999765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.53  E-value=2.3e-07  Score=53.68  Aligned_cols=49  Identities=22%  Similarity=0.365  Sum_probs=42.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ...++.+++.++.++|.. +++|+|+++.|+++ ....+++.|||+++...
T Consensus       430 ~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             HHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            356778999999999996 99999999999999 56778999999987654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.53  E-value=5.3e-07  Score=46.26  Aligned_cols=47  Identities=30%  Similarity=0.452  Sum_probs=41.3

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      ..++.+++.++.++|.. +++|+++++.|+++. ...+.+.|||.++..
T Consensus        98 ~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         98 LELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             HHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            47788999999999996 999999999999998 677889999987653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.52  E-value=5.4e-07  Score=45.93  Aligned_cols=47  Identities=23%  Similarity=0.373  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          6 QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.+++.++.++|.. +++|+++++.|+++. ...+++.|||.++...
T Consensus        94 ~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        94 ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            5788999999999996 999999999999998 7789999999876643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1151|consensus

Probab=98.50  E-value=7.1e-07  Score=51.41  Aligned_cols=56  Identities=41%  Similarity=0.586  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHhhC-CCceeeccCCCcEEEcC---CCcEEEEecCCcccccccccc
Q psy14632          4 TNQVTVATVKALNYLKEE-LKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVVEVVL   59 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~-~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~~~~~   59 (68)
                      +++|.-|++.++.|+... -+++|-+++|.|+++-.   .+.+++.|||+++.+.++.+.
T Consensus       570 ARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~  629 (775)
T KOG1151|consen  570 ARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYN  629 (775)
T ss_pred             HHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccC
Confidence            467788999999999764 37999999999999853   467899999999998877654

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=98.49  E-value=4e-07  Score=47.50  Aligned_cols=52  Identities=38%  Similarity=0.530  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++... ..+++.|||.+.....
T Consensus       102 ~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220         102 TILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            3566788999999999986 99999999999999754 4579999998876653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=98.48  E-value=7.7e-07  Score=46.69  Aligned_cols=49  Identities=31%  Similarity=0.617  Sum_probs=41.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.++|.. ++.|+++++.|+++.. ..+++.|||.++.+.
T Consensus       108 ~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222         108 VCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             HHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecC
Confidence            456788999999999986 9999999999999865 458999999887654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=98.44  E-value=6e-07  Score=46.89  Aligned_cols=52  Identities=38%  Similarity=0.537  Sum_probs=43.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC-cEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~-~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. ++.|+++++.|+++.... ..++.||+.+....+
T Consensus       102 ~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225         102 QILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            3567788999999999986 899999999999997664 468999998876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=98.43  E-value=1.2e-06  Score=43.88  Aligned_cols=52  Identities=44%  Similarity=0.745  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.+++.++.++|.. ++.|+++++.|+++.. ....++.||+.+.....
T Consensus        93 ~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~  145 (215)
T cd00180          93 EILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS  145 (215)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence            3567889999999999996 9999999999999998 78899999998776544

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290|consensus

Probab=98.42  E-value=3.8e-07  Score=52.48  Aligned_cols=38  Identities=34%  Similarity=0.562  Sum_probs=34.5

Q ss_pred             hHHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC
Q psy14632          2 FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR   39 (68)
Q Consensus         2 ~~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~   39 (68)
                      ..+++|+.|++.|+.|+|..++++|.++||+|+++...
T Consensus       187 ~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  187 SCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            36789999999999999988899999999999998765

>KOG0607|consensus

Probab=98.39  E-value=1.9e-06  Score=47.87  Aligned_cols=49  Identities=35%  Similarity=0.693  Sum_probs=38.9

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC---cEEEEecCCccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLV   54 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~---~~~~~~~g~~~~~~   54 (68)
                      ..+...++.++.++|.+ ++.||+++|+|++.....   .+|+-||.++..+.
T Consensus       179 s~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  179 SRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             HHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            34566788899999986 999999999999986544   36889987765543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=98.37  E-value=1.2e-06  Score=44.94  Aligned_cols=52  Identities=46%  Similarity=0.708  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.+++.++.++|.. +++|+++++.|+++......++.|||.+.....
T Consensus        88 ~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~  139 (244)
T smart00220       88 EARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDP  139 (244)
T ss_pred             HHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence            4567788999999999996 999999999999999888999999998877654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1167|consensus

Probab=98.36  E-value=7e-07  Score=50.19  Aligned_cols=49  Identities=37%  Similarity=0.516  Sum_probs=42.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~   52 (68)
                      .++.+.+.+..++.++|.. +++|||+|+.|++++. ...-.+.|||+|..
T Consensus       133 ~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  133 EIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             HHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHH
Confidence            4567788899999999996 9999999999999975 45567999999974

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=98.35  E-value=2.2e-06  Score=45.17  Aligned_cols=53  Identities=45%  Similarity=0.704  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC-cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~-~~~~~~~g~~~~~~~~   56 (68)
                      ....+..|++.++.++|.. +++|+++++.|++..... ..++.|||.++.+...
T Consensus       102 ~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515         102 EALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            3566788999999999986 899999999999998877 6999999998865543

>PRK10345 hypothetical protein; Provisional

Probab=98.31  E-value=2.8e-06  Score=44.27  Aligned_cols=45  Identities=33%  Similarity=0.488  Sum_probs=35.0

Q ss_pred             HHHHHHHHH-HHHhhCCCceeeccCCCcEEEcCC----CcEEEEe-cCCccc
Q psy14632          7 VTVATVKAL-NYLKEELKIIHRDVKPSNILLDRR----GAIKLCD-FGISGQ   52 (68)
Q Consensus         7 ~~~q~~~~~-~~~~~~~~~~h~~l~~~~~~~~~~----~~~~~~~-~g~~~~   52 (68)
                      ++.|++.++ .|+|.. +++|+++++.|+++...    ..+++.| ||....
T Consensus       109 ~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~~  159 (210)
T PRK10345        109 QLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNIGESTF  159 (210)
T ss_pred             HHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECCCCcce
Confidence            456777666 899996 99999999999999742    3689999 454443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=98.28  E-value=3.1e-06  Score=43.23  Aligned_cols=52  Identities=38%  Similarity=0.626  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.+++.++.++|.. ++.|+++++.|+++.....+++.|||.+......
T Consensus       100 ~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221      100 ARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            567788999999999986 9999999999999998899999999988776543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0590|consensus

Probab=98.27  E-value=4.6e-06  Score=49.23  Aligned_cols=48  Identities=27%  Similarity=0.542  Sum_probs=42.5

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      ..++.|+..|+.|+|.. ++.|++++++|+++...+.+++.|||.+...
T Consensus       423 ~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  423 DCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceee
Confidence            45678999999999995 9999999999999999999999999976543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=98.26  E-value=3.8e-06  Score=44.46  Aligned_cols=47  Identities=13%  Similarity=0.302  Sum_probs=40.2

Q ss_pred             HHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          6 QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ....++..++..+|.. +++|+|++|.|+++...+ +.+.|||......
T Consensus       139 ~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~  185 (232)
T PRK10359        139 DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA  185 (232)
T ss_pred             HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence            3456888999999996 999999999999998777 9999999776654

>KOG0670|consensus

Probab=98.24  E-value=3.6e-06  Score=49.28  Aligned_cols=56  Identities=30%  Similarity=0.509  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVVEVVL   59 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~~~~~   59 (68)
                      .+..++.|+..++.++-.+ +++|.+++|.|++.... ..+++.|||.|....+....
T Consensus       537 aVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit  593 (752)
T KOG0670|consen  537 AVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT  593 (752)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCcccccccccccc
Confidence            5778899999999999764 99999999999999854 66899999998877665533

>KOG0671|consensus

Probab=98.21  E-value=9.6e-06  Score=45.57  Aligned_cols=55  Identities=27%  Similarity=0.366  Sum_probs=43.5

Q ss_pred             hHHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC--------------------CcEEEEecCCcccccccc
Q psy14632          2 FITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR--------------------GAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         2 ~~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~--------------------~~~~~~~~g~~~~~~~~~   57 (68)
                      ..++.++.|++.++.++|.. ++.|.+++|+|+++-..                    ..+++.|||.|..-....
T Consensus       192 ~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h  266 (415)
T KOG0671|consen  192 DHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH  266 (415)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc
Confidence            36788999999999999985 99999999999987322                    136788888887654433

>KOG0695|consensus

Probab=98.17  E-value=1e-05  Score=45.46  Aligned_cols=46  Identities=43%  Similarity=0.653  Sum_probs=40.7

Q ss_pred             HHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          7 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         7 ~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      +...++-++.|+|++ +++.++++..|.+++..+.+++.|+|..+.-
T Consensus       356 ys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  356 YSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             hhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcC
Confidence            345677899999997 9999999999999999999999999987664

>KOG1024|consensus

Probab=98.14  E-value=5.2e-06  Score=47.23  Aligned_cols=55  Identities=22%  Similarity=0.284  Sum_probs=48.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVV   58 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~   58 (68)
                      ++..++.|++.++.|+|.. +++|+++...|.+++....+++.|-.++|.+-+..+
T Consensus       397 qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DY  451 (563)
T KOG1024|consen  397 QLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDY  451 (563)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhccccCcccc
Confidence            4567889999999999985 999999999999999999999999999998766543

>KOG4158|consensus

Probab=98.07  E-value=1.3e-05  Score=45.86  Aligned_cols=46  Identities=28%  Similarity=0.488  Sum_probs=37.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC----CcEEEEecCCc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGIS   50 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~----~~~~~~~~g~~   50 (68)
                      ..-+..|+++++.|+|.. ++.|+|+|+.|+++.-+    -.+-++|||++
T Consensus       343 ~~~~laQlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             HHHHHHHHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEccccee
Confidence            345678999999999985 99999999999988532    34678899865

>KOG0576|consensus

Probab=98.07  E-value=5.9e-06  Score=49.35  Aligned_cols=53  Identities=42%  Similarity=0.669  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ++..+++..+.++.|+|+. +-+||+++-.|+++...+..++.|||.+..+...
T Consensus       113 qiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen  113 QIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             HHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhh
Confidence            3556778888999999985 7799999999999999999999999988776543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.04  E-value=4.1e-05  Score=36.74  Aligned_cols=51  Identities=24%  Similarity=0.371  Sum_probs=42.1

Q ss_pred             HHHHHHHHHHHHHHHhhC--CCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEE--LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~--~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ...++.+++.++..+|..  .+++|+++++.|+++.....+++.||+.++...
T Consensus        88 ~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             HHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            345677888899999873  259999999999999887889999999887643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=97.87  E-value=7.7e-05  Score=37.18  Aligned_cols=43  Identities=30%  Similarity=0.312  Sum_probs=35.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +      ++.|+++..+..+++  ||.++...
T Consensus        18 ~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750       18 EIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             HHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeec
Confidence            4678899999999999986 4      899999988877777  88876544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=97.82  E-value=6.9e-05  Score=40.92  Aligned_cols=48  Identities=31%  Similarity=0.503  Sum_probs=36.1

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      ..+..|++..+.++|.. +++|.++++.|+++..++.+.+.||+.....
T Consensus       148 l~lT~Q~I~lvA~Lh~~-GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~  195 (288)
T PF14531_consen  148 LSLTVQMIRLVANLHSY-GLVHGDIKPENFLLDQDGGVFLGDFSSLVRA  195 (288)
T ss_dssp             HHHHHHHHHHHHHHHHT-TEEEST-SGGGEEE-TTS-EEE--GGGEEET
T ss_pred             HHHHHHHHHHHHHHhhc-ceEecccceeeEEEcCCCCEEEcChHHHeec
Confidence            34457888999999996 9999999999999999999999999765443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=97.79  E-value=0.00015  Score=35.93  Aligned_cols=45  Identities=31%  Similarity=0.434  Sum_probs=37.1

Q ss_pred             HHHHHHHHHHHHHhhCCC-----ceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          6 QVTVATVKALNYLKEELK-----IIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~-----~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      ..+.+++..+..+|.. .     ++|+|+++.|+++. ...+.+.||+.+..
T Consensus        87 ~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          87 ENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            4567888899999975 5     49999999999998 55688999998765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.78  E-value=0.00016  Score=41.52  Aligned_cols=50  Identities=32%  Similarity=0.527  Sum_probs=39.5

Q ss_pred             HHHHHHHH-HHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          6 QVTVATVK-ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         6 ~~~~q~~~-~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++..++. .+..+|.. +++|+|++|.|+++.....+.+.|||++..+.+.
T Consensus       260 ~ia~~~~~~~l~ql~~~-g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       260 ALAENLARSFLNQVLRD-GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             HHHHHHHHHHHHHHHhC-CceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            34444444 35667775 8999999999999988888999999999887654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1240|consensus

Probab=97.72  E-value=4e-05  Score=48.28  Aligned_cols=45  Identities=27%  Similarity=0.357  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          7 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         7 ~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      ++-|++.++.-+|.. +++|.|+|.+|+++....++.++||.-.++
T Consensus       125 iaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  125 IAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCC
Confidence            567999999999985 999999999999999999999999975444

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=97.70  E-value=0.00016  Score=37.56  Aligned_cols=48  Identities=21%  Similarity=0.304  Sum_probs=37.9

Q ss_pred             HHHHHHHHHHHHHH-hhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          5 NQVTVATVKALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         5 ~~~~~q~~~~~~~~-~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ..+..+++..+..+ |.. +++|+|+++.|+++.. ..+.+.||+.+-...
T Consensus       127 ~~i~~~i~~~l~~l~H~~-glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         127 KNAYYQVLSMMKQLYKEC-NLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            34567888888877 665 8999999999999964 568899999775543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1166|consensus

Probab=97.70  E-value=0.0002  Score=44.61  Aligned_cols=48  Identities=33%  Similarity=0.475  Sum_probs=38.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-------CCcEEEEecCCccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-------RGAIKLCDFGISGQ   52 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-------~~~~~~~~~g~~~~   52 (68)
                      +--+..|++.-+..+|.. +|+|.|+||.|+++..       ...++++|||.+=.
T Consensus       796 v~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  796 VMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             hhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            445667889999999985 9999999999998853       23489999998744

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.61  E-value=0.00036  Score=36.27  Aligned_cols=45  Identities=27%  Similarity=0.419  Sum_probs=36.6

Q ss_pred             HHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          6 QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++..+-.-+.-+|.. +++|.++-+.|+.+.... +.+.|||++..
T Consensus        96 ~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          96 DLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             HHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            3455666668889987 999999999999887655 77999999865

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.58  E-value=0.00032  Score=36.40  Aligned_cols=50  Identities=26%  Similarity=0.327  Sum_probs=41.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC---cEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~---~~~~~~~g~~~~~~   54 (68)
                      ...++.++...+.-+|.. ++.|.|+.+.|+++....   .+.++||..++...
T Consensus       120 ~~~ll~~l~~~i~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  120 RRELLRALARLIAKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHHHHHHHHHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            356677888889999996 999999999999998776   78899998766543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.50  E-value=0.0006  Score=36.96  Aligned_cols=47  Identities=15%  Similarity=0.139  Sum_probs=39.0

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-------CCcEEEEecCCccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-------RGAIKLCDFGISGQ   52 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-------~~~~~~~~~g~~~~   52 (68)
                      ..++.+++..+..+|.. ++.|+|+.+.|+++..       ...+.++||+.++.
T Consensus       141 ~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        141 RMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            45677888889999996 9999999999999974       35688999987743

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=97.49  E-value=0.00037  Score=43.02  Aligned_cols=42  Identities=19%  Similarity=0.432  Sum_probs=34.0

Q ss_pred             HHHHHHHHHHHHHHHHhhC--CCceeeccCCCcEEEcCCCcEEE
Q psy14632          3 ITNQVTVATVKALNYLKEE--LKIIHRDVKPSNILLDRRGAIKL   44 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~--~~~~h~~l~~~~~~~~~~~~~~~   44 (68)
                      .+..++.|++.|+.|+|..  .+++|+++++.|++++.....++
T Consensus       781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence            3567889999999999932  38999999999999987665544

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.17  E-value=0.0049  Score=31.88  Aligned_cols=48  Identities=21%  Similarity=0.366  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHHHHH-hhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          5 NQVTVATVKALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         5 ~~~~~q~~~~~~~~-~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ..++.+++..+..+ |.. +++|.++..-|+++... .+.++||+.+-...
T Consensus       109 ~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  109 KELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            34556666655554 464 99999999999999877 89999998775544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0590|consensus

Probab=96.96  E-value=0.00023  Score=42.37  Aligned_cols=51  Identities=39%  Similarity=0.656  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHh-hCCCceeeccCCCcEEEcCCC-cEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLK-EELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~-~~~~~~h~~l~~~~~~~~~~~-~~~~~~~g~~~~~~~   55 (68)
                      ...+..|+..++.|+| .. .+.|+++++++.++.... .++..||++|.....
T Consensus       125 ~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  125 ASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             hhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            3456788899999999 65 899999999999998877 899999999887766

>KOG3087|consensus

Probab=96.88  E-value=0.0075  Score=31.78  Aligned_cols=47  Identities=32%  Similarity=0.430  Sum_probs=37.0

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC---CcEEEEecCCccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQ   52 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~---~~~~~~~~g~~~~   52 (68)
                      ..++..+-..+.-+|.+ .++|.|+-+.|+++...   ....+.|||++..
T Consensus       116 ~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            45667777789999997 89999999999998543   3347899998643

>KOG1033|consensus

Probab=96.81  E-value=0.00031  Score=40.99  Aligned_cols=51  Identities=29%  Similarity=0.525  Sum_probs=41.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ...+++.|+..++.|   + +.+|+++++.|++......+++.|||+........
T Consensus       360 ~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~  410 (516)
T KOG1033|consen  360 LMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDE  410 (516)
T ss_pred             HHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhheeecccCC
Confidence            456677788888887   3 68999999999999888889999999876665444

>KOG0606|consensus

Probab=96.73  E-value=0.0011  Score=41.98  Aligned_cols=42  Identities=48%  Similarity=0.774  Sum_probs=37.1

Q ss_pred             HHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632         11 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus        11 ~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      ++-+++|+|.- +++|+++++.|.++..-+.+++.|||+.+..
T Consensus       152 mvla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  152 MVLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             hhHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhh
Confidence            35689999985 9999999999999999999999999987664

>KOG1023|consensus

Probab=96.45  E-value=0.0075  Score=35.45  Aligned_cols=50  Identities=34%  Similarity=0.418  Sum_probs=41.9

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ..+.+.++.++.|+|......|..++..|.+......++++|||+.....
T Consensus        51 ~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   51 LSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             HHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhccccc
Confidence            34567788899999976334999999999999999999999999877664

>PRK09902 hypothetical protein; Provisional

Probab=96.26  E-value=0.021  Score=30.30  Aligned_cols=48  Identities=15%  Similarity=0.108  Sum_probs=38.8

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc--EEEEecCCcccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQL   53 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~--~~~~~~g~~~~~   53 (68)
                      ..+..+++..+.-+|.. ++.|+++-+.++++...+.  +.++||..++..
T Consensus       131 ~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        131 QAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             HHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            35667788889999996 9999999999999974445  889998766554

>KOG0603|consensus

Probab=96.19  E-value=0.0033  Score=37.67  Aligned_cols=49  Identities=41%  Similarity=0.451  Sum_probs=40.9

Q ss_pred             HHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          8 TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         8 ~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      ...++-++.++|.- ++++++++.+|+++...+.+++.|||.++...+..
T Consensus       103 ~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen  103 LAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             HHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            34556678888874 89999999999999999999999999988876544

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=96.16  E-value=0.02  Score=34.14  Aligned_cols=34  Identities=35%  Similarity=0.543  Sum_probs=29.9

Q ss_pred             CceeeccCCCcEEEcCCC----cEEEEecCCccccccc
Q psy14632         23 KIIHRDVKPSNILLDRRG----AIKLCDFGISGQLVVE   56 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~----~~~~~~~g~~~~~~~~   56 (68)
                      ++.|+|++|.|+++....    .+.+.|||....+.+.
T Consensus       280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            899999999999998766    7899999998887654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=95.64  E-value=0.08  Score=28.45  Aligned_cols=44  Identities=23%  Similarity=0.351  Sum_probs=34.7

Q ss_pred             HHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          7 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         7 ~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      ++..+...+.-+|.. ++.|.|..|.|++... ..+.+.|++..+.
T Consensus       140 ~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~-~~i~iID~~~k~~  183 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSN-NGIRIIDTQGKRM  183 (229)
T ss_pred             HHHHHHHHHHHHHHc-CCccCCCCcCcEEEEC-CcEEEEECccccc
Confidence            345667788999986 9999999999988875 4488999875544

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG3741|consensus

Probab=95.46  E-value=0.074  Score=32.15  Aligned_cols=53  Identities=15%  Similarity=0.199  Sum_probs=42.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+|.++.|+..++.++|+. +..-+.+.+.+++......+++...|.-..+.++
T Consensus       394 ~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  394 VLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            4789999999999999997 8888999999999888777777776665544433

>KOG0601|consensus

Probab=94.58  E-value=0.023  Score=33.79  Aligned_cols=54  Identities=28%  Similarity=0.413  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHH----HHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVK----ALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~----~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~~~   57 (68)
                      .+++...+...    ++.++|.+ .+.|.++++.+++.... ..++..||+....+.+..
T Consensus       219 ~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~  277 (524)
T KOG0601|consen  219 LLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGN  277 (524)
T ss_pred             hhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeecCCcceeEEccCCc
Confidence            45566666666    99999997 89999999999999877 788999999887776654

>KOG1266|consensus

Probab=93.98  E-value=0.13  Score=29.59  Aligned_cols=41  Identities=27%  Similarity=0.422  Sum_probs=32.0

Q ss_pred             HHHHHHHHHHHHHHHhhC-CCceeeccCCCcEEEcCCCcEEE
Q psy14632          4 TNQVTVATVKALNYLKEE-LKIIHRDVKPSNILLDRRGAIKL   44 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~-~~~~h~~l~~~~~~~~~~~~~~~   44 (68)
                      .++++.|+++++.|+|+. -.+.|.++-...++...++.+++
T Consensus       178 wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIki  219 (458)
T KOG1266|consen  178 WKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKI  219 (458)
T ss_pred             HHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEe
Confidence            357889999999999986 36788888877787776665554

>KOG1243|consensus

Probab=93.53  E-value=0.22  Score=30.78  Aligned_cols=44  Identities=18%  Similarity=0.417  Sum_probs=37.0

Q ss_pred             HHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCc
Q psy14632          7 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS   50 (68)
Q Consensus         7 ~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~   50 (68)
                      -+.||+.++.++|.+.++.|.++....++....+..++.+|...
T Consensus       109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v  152 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV  152 (690)
T ss_pred             HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence            35789999999986668999999999999998888888877554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=91.92  E-value=0.3  Score=25.08  Aligned_cols=30  Identities=17%  Similarity=0.407  Sum_probs=25.0

Q ss_pred             CceeeccCCCcEEEcC--CCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDR--RGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~--~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|+++..  .....+.||+.+..
T Consensus       175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             EEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            6899999999999987  45578999987654

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=91.53  E-value=1.1  Score=24.82  Aligned_cols=48  Identities=21%  Similarity=0.267  Sum_probs=35.6

Q ss_pred             HHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          6 QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         6 ~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..+++..+.-+....+++|.+++.=|+++. ...+.++|++-+-...
T Consensus       170 ~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         170 GLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            34456666666666533899999999999998 7778899998765443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=91.25  E-value=1.1  Score=26.56  Aligned_cols=46  Identities=28%  Similarity=0.487  Sum_probs=33.0

Q ss_pred             HHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          7 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         7 ~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      ++++-+.-+.-+.......|+++.-.++++. .+.+.++||.++|.-
T Consensus       326 ff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         326 FFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             HHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            3333333333333345789999999999998 888999999998843

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=90.95  E-value=0.41  Score=25.31  Aligned_cols=30  Identities=30%  Similarity=0.502  Sum_probs=24.7

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|++........+.||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            479999999999998766667999987643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK05231 homoserine kinase; Provisional

Probab=90.83  E-value=0.32  Score=26.79  Aligned_cols=29  Identities=24%  Similarity=0.370  Sum_probs=24.6

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCcc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISG   51 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~   51 (68)
                      +++|.|+.+.|+++.......+.||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            68999999999999866666899998764

>KOG0601|consensus

Probab=90.81  E-value=0.14  Score=30.65  Aligned_cols=48  Identities=38%  Similarity=0.486  Sum_probs=38.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQ   52 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~   52 (68)
                      .+.+..|++.++.++|+. ..+|.++++.|+++... ...++.+++....
T Consensus       368 ~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  368 RLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             hhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccccc
Confidence            456678889999999984 89999999999999875 6667777776643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=90.67  E-value=0.96  Score=23.75  Aligned_cols=30  Identities=23%  Similarity=0.541  Sum_probs=25.2

Q ss_pred             CceeeccCCCcEEEcC-CCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDR-RGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|++... ...+.+.||..+..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            5899999999999987 46789999976654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=90.24  E-value=0.53  Score=25.77  Aligned_cols=31  Identities=29%  Similarity=0.409  Sum_probs=25.6

Q ss_pred             CCceeeccCCCcEEEcCC----CcEEEEecCCccc
Q psy14632         22 LKIIHRDVKPSNILLDRR----GAIKLCDFGISGQ   52 (68)
Q Consensus        22 ~~~~h~~l~~~~~~~~~~----~~~~~~~~g~~~~   52 (68)
                      ..++|.|+.+.|+++...    ..+.++||..+..
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            368999999999999864    6789999987654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2137|consensus

Probab=90.15  E-value=0.3  Score=30.32  Aligned_cols=43  Identities=23%  Similarity=0.543  Sum_probs=35.0

Q ss_pred             HHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         10 ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        10 q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      +++.|+.++|..-+++|.++.+.++........|+..|+++-.
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~  149 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVN  149 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhc
Confidence            3446789998655899999999999999999899988876533

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=89.91  E-value=2.3  Score=24.06  Aligned_cols=42  Identities=21%  Similarity=0.287  Sum_probs=30.7

Q ss_pred             HHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCc
Q psy14632          8 TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS   50 (68)
Q Consensus         8 ~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~   50 (68)
                      +..++.-+.-... .+++|.|++.=|++...++...+.||--+
T Consensus       208 l~~il~~~~~~~~-~GiVHGDlSefNIlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         208 LDKILEEVRKAYR-RGIVHGDLSEFNILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             HHHHHHHHHHHHH-cCccccCCchheEEEecCCCEEEEeCccc
Confidence            3444444443334 38999999999999999888999998544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=89.74  E-value=0.56  Score=24.82  Aligned_cols=30  Identities=27%  Similarity=0.330  Sum_probs=25.4

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|++........+.||+.+..
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            589999999999998877678999987653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=88.84  E-value=2.5  Score=23.30  Aligned_cols=30  Identities=33%  Similarity=0.618  Sum_probs=26.1

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|++......+.++||.-|..
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            589999999999998888999999976644

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=88.51  E-value=0.56  Score=25.53  Aligned_cols=29  Identities=28%  Similarity=0.393  Sum_probs=24.7

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCcc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISG   51 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~   51 (68)
                      .++|.|+.+.|+++.......+.||..+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            68999999999999887667899997654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=88.06  E-value=3  Score=25.35  Aligned_cols=34  Identities=44%  Similarity=0.699  Sum_probs=30.4

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ++.|.|..+-|++....+.+-..|||....+.+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            8999999999999999999999999988777654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=87.98  E-value=0.83  Score=24.30  Aligned_cols=29  Identities=24%  Similarity=0.402  Sum_probs=24.3

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|++..... ..+.||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            568999999999998766 88999987643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=87.77  E-value=0.63  Score=24.18  Aligned_cols=30  Identities=40%  Similarity=0.789  Sum_probs=20.7

Q ss_pred             CceeeccCCCcEEE-cCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILL-DRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~-~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|++. .....+.++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            68999999999999 7778899999987654

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=87.69  E-value=0.57  Score=24.11  Aligned_cols=30  Identities=43%  Similarity=0.730  Sum_probs=19.9

Q ss_pred             CceeeccCCCcEEEc-CCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLD-RRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|+++. ....+.+.||+.+..
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             EEEEeccccccceeeeccceeEEEecccceE
Confidence            689999999999998 445458999987654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=86.75  E-value=3.1  Score=21.66  Aligned_cols=48  Identities=21%  Similarity=0.257  Sum_probs=37.4

Q ss_pred             HHHHHHHHHHHHHHHHhhC--CCceeeccCCCcEEEcCCCcEEEEecCCc
Q psy14632          3 ITNQVTVATVKALNYLKEE--LKIIHRDVKPSNILLDRRGAIKLCDFGIS   50 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~--~~~~h~~l~~~~~~~~~~~~~~~~~~g~~   50 (68)
                      .+.++|.+++..+.++...  ..+.-.+.++.|+.+.....+++.|....
T Consensus        60 ~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v  109 (188)
T PF12260_consen   60 QRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDV  109 (188)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhc
Confidence            4567888998888888763  14556789999999988888999997643

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=86.73  E-value=0.92  Score=25.01  Aligned_cols=29  Identities=31%  Similarity=0.513  Sum_probs=24.9

Q ss_pred             CCceeeccCCCcEEEcCCCcEEEEecCCc
Q psy14632         22 LKIIHRDVKPSNILLDRRGAIKLCDFGIS   50 (68)
Q Consensus        22 ~~~~h~~l~~~~~~~~~~~~~~~~~~g~~   50 (68)
                      ..++|.|+.+.|+++.......+.||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccc
Confidence            37999999999999987776689999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10271 thiK thiamine kinase; Provisional

Probab=85.77  E-value=1.4  Score=23.09  Aligned_cols=29  Identities=28%  Similarity=0.577  Sum_probs=23.9

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      ..+|.++.+.|++....+ ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            469999999999887665 88999987754

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=85.45  E-value=1.5  Score=24.92  Aligned_cols=30  Identities=20%  Similarity=0.502  Sum_probs=26.4

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.++.+.|+++.......+.||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            589999999999999888899999987754

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=84.95  E-value=1.3  Score=24.38  Aligned_cols=30  Identities=27%  Similarity=0.491  Sum_probs=24.0

Q ss_pred             CceeeccCCCcEEEcC-CCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDR-RGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~   52 (68)
                      .++|.++.+.|++... .....+.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5799999999999986 34467999987644

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02721 ycfN_thiK thiamine kinase

Probab=84.71  E-value=1.3  Score=23.66  Aligned_cols=29  Identities=28%  Similarity=0.538  Sum_probs=23.7

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|++..... ..+.||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            579999999999997655 67999976644

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=83.04  E-value=2  Score=23.50  Aligned_cols=27  Identities=30%  Similarity=0.439  Sum_probs=22.7

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGIS   50 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~   50 (68)
                      +++|+++.+.|+++.. ..+.+.||+.+
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            6799999999999876 55789999854

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=81.31  E-value=3  Score=21.63  Aligned_cols=32  Identities=25%  Similarity=0.325  Sum_probs=24.9

Q ss_pred             CceeeccCCCcEEEcCCC-----cEEEEecCCccccc
Q psy14632         23 KIIHRDVKPSNILLDRRG-----AIKLCDFGISGQLV   54 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~-----~~~~~~~g~~~~~~   54 (68)
                      .++|+++.+.|+++....     .+.+.||..++.-.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g~  157 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYGS  157 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCcCC
Confidence            579999999999997432     57899998776543

subfamily of choline kinases

>PLN02236 choline kinase

Probab=80.21  E-value=3  Score=23.68  Aligned_cols=30  Identities=27%  Similarity=0.490  Sum_probs=24.7

Q ss_pred             CceeeccCCCcEEEcC-CCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDR-RGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|++... ...+.+.||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999875 45689999977654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	68
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-19
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-17
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-05
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-05
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-04
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-04
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-04
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-04
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-04
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-04
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-04
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-04
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-04
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-04
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-04
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-04
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-04
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-04
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-04
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-04
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-04
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-04
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-04
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-04
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-04
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-04
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-04
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-04
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-04
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-04
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-04
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-04
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-04
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-04
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-04
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-04
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-04
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-04
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-04
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-04
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-04
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-04
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-04
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-04
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-04
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-04
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-04
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-04
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-04
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-04
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-04

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 42/52 (80%), Positives = 47/52 (90%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 39/52 (75%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  ++TVA VKAL YLKE+  +IHRDVKPSNILLD RG IKLCDFGISG+LV
Sbjct: 125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 35/60 (58%), Positives = 48/60 (80%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFL 62
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+ E+   F+
Sbjct: 108 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV 167

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 167 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 218

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 33/52 (63%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 124 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 175

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 31/52 (59%), Positives = 44/52 (84%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           I  +V++A ++ L YL+E+ +I+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 115 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 166

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 30/55 (54%), Positives = 42/55 (76%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           I  ++ V+ VKAL +L  +L +IHRDVKPSN+L++  G +K+CDFGISG LV +V
Sbjct: 110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 30/55 (54%), Positives = 41/55 (74%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           I  ++ V+ VKAL +L  +L +IHRDVKPSN+L++  G +K+CDFGISG LV  V
Sbjct: 154 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV 208

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 30/55 (54%), Positives = 41/55 (74%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           I  ++ V+ VKAL +L  +L +IHRDVKPSN+L++  G +K CDFGISG LV +V
Sbjct: 137 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDV 191

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 23/42 (54%), Positives = 32/42 (76%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +K L+YL  E KI HRD+K +N+LL  +G +KL DFG++GQL
Sbjct: 126 LKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQL 166

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 25/54 (46%), Positives = 36/54 (66%), Gaps = 6/54 (11%)
Query: 5   NQVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++  +AT+     K L+YL  E KI HRD+K +N+LL   G +KL DFG++GQL
Sbjct: 117 DETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQL 169

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 25/54 (46%), Positives = 36/54 (66%), Gaps = 6/54 (11%)
Query: 5   NQVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++  +AT+     K L+YL  E KI HRD+K +N+LL   G +KL DFG++GQL
Sbjct: 102 DETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQL 154

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 25/54 (46%), Positives = 36/54 (66%), Gaps = 6/54 (11%)
Query: 5   NQVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++  +AT+     K L+YL  E KI HRD+K +N+LL   G +KL DFG++GQL
Sbjct: 102 DETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQL 154

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 23/42 (54%), Positives = 32/42 (76%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +K L+YL  E KI HRD+K +N+LL  +G +KL DFG++GQL
Sbjct: 130 LKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQL 170

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 25/54 (46%), Positives = 36/54 (66%), Gaps = 6/54 (11%)
Query: 5   NQVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++  +AT+     K L+YL  E KI HRD+K +N+LL   G +KL DFG++GQL
Sbjct: 122 DETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQL 174

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 27/57 (47%), Positives = 36/57 (63%), Gaps = 4/57 (7%)
Query: 2   FITNQVTVATVKAL----NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           FI  QV    +K++    +Y+  E  I HRDVKPSNIL+D+ G +KL DFG S  +V
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 23/44 (52%), Positives = 31/44 (70%), Gaps = 1/44 (2%)
Query: 10  ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +T+K L YL   ++ IHRD+K  NILL+  G  KL DFG++GQL
Sbjct: 133 STLKGLEYL-HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 23/45 (51%), Positives = 31/45 (68%), Gaps = 1/45 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           V AL+YL+ + +IIHRD+KP NILLD  G + + DF I+  L  E
Sbjct: 125 VMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 1/48 (2%)
Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +   +T  T++A+N+  +    IHRDVKP NIL+ +   IKLCDFG +
Sbjct: 103 LVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFA 149

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 24/42 (57%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           T+ ALNYL +  KIIHRD+K  NIL    G IKL DFG+S +
Sbjct: 144 TLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAK 184

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 24/42 (57%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           T+ ALNYL +  KIIHRD+K  NIL    G IKL DFG+S +
Sbjct: 144 TLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAK 184

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 24/42 (57%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           T+ ALNYL +  KIIHRD+K  NIL    G IKL DFG+S +
Sbjct: 144 TLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAK 184

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 21/42 (50%), Positives = 30/42 (71%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +K + YL  + KIIHRD+KPSN+L+   G IK+ DFG+S + 
Sbjct: 147 IKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 20/40 (50%), Positives = 30/40 (75%), Gaps = 1/40 (2%)
Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T++ L YL +   I+HRD+KP+N+LLD  G +KL DFG++
Sbjct: 121 TLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLA 159

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 9/61 (14%)
Query: 2   FITNQVTVA---TVKALNYLKE------ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           ++T +VT++   T K +  L E      +L I+HRD+KP NILLD    IKL DFG S Q
Sbjct: 114 YLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 53  L 53
           L
Sbjct: 174 L 174

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 9/61 (14%)
Query: 2   FITNQVTVA---TVKALNYLKE------ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           ++T +VT++   T K +  L E      +L I+HRD+KP NILLD    IKL DFG S Q
Sbjct: 114 YLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 53  L 53
           L
Sbjct: 174 L 174

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 23/41 (56%), Positives = 30/41 (73%), Gaps = 1/41 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           AL++L   L II+RD+KP NILLD  G IKL DFG+S + +
Sbjct: 138 ALDHL-HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 9/61 (14%)
Query: 2   FITNQVTVA---TVKALNYLKE------ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           ++T +VT++   T K +  L E      +L I+HRD+KP NILLD    IKL DFG S Q
Sbjct: 101 YLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 160
Query: 53  L 53
           L
Sbjct: 161 L 161

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 23/41 (56%), Positives = 30/41 (73%), Gaps = 1/41 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           AL++L   L II+RD+KP NILLD  G IKL DFG+S + +
Sbjct: 139 ALDHL-HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 178

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 23/41 (56%), Positives = 30/41 (73%), Gaps = 1/41 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           AL++L   L II+RD+KP NILLD  G IKL DFG+S + +
Sbjct: 138 ALDHL-HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 20/33 (60%), Positives = 25/33 (75%)
Query: 22  LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           L II+RD+KP NILLD  G IKL DFG+S + +
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI 181

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 18/30 (60%), Positives = 23/30 (76%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           IIHRD+KP NIL+ + G +KLCDFG +  L
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTL 174

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 23/51 (45%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V ++ ++AL+YL  +  +IHRD+K  +ILL   G IKL DFG   Q+  EV
Sbjct: 146 VCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 195

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 17/30 (56%), Positives = 26/30 (86%)
Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           E KI+HRD+KP N+L+++RG +KL DFG++
Sbjct: 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 118 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 155

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 295

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 261 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 298

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 119 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 156

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 120 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 157

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 21/37 (56%), Positives = 27/37 (72%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL YL  +  II+RD+KP NILLD+ G IK+ DFG +
Sbjct: 118 ALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFA 153

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 21/41 (51%), Positives = 28/41 (68%), Gaps = 1/41 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T   V AL+ +   + +IHRDVKP N+LLD+ G +KL DFG
Sbjct: 180 TAEVVLALDAI-HSMGLIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 19/42 (45%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++ L++L +  K+IHRD+K  N+LL     +KL DFG+S QL
Sbjct: 139 LRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 21/45 (46%), Positives = 30/45 (66%), Gaps = 1/45 (2%)
Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +V     +ALN+  +   IIHRDVKP+NIL+    A+K+ DFGI+
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANILISATNAVKVVDFGIA 163

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 18/39 (46%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 13  KALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K +NYL      I+HRD+K  N+L+D++  +K+CDFG+S
Sbjct: 148 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLS 186

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 29/39 (74%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y   + K++HRD+KP N+L++ RG +KL DFG++
Sbjct: 110 LRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLA 147

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 19/37 (51%), Positives = 27/37 (72%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y  E  K+IHRD+KP N+L+  +G +K+ DFG S
Sbjct: 126 ALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWS 161

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 19/37 (51%), Positives = 27/37 (72%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y  E  K+IHRD+KP N+L+  +G +K+ DFG S
Sbjct: 127 ALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWS 162

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/41 (46%), Positives = 30/41 (73%), Gaps = 1/41 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           ++ALN+L  + +IIHRD+K  N+L+   G I+L DFG+S +
Sbjct: 119 LEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAK 158

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/41 (46%), Positives = 30/41 (73%), Gaps = 1/41 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 52
           ++ALN+L  + +IIHRD+K  N+L+   G I+L DFG+S +
Sbjct: 127 LEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 21/41 (51%), Positives = 27/41 (65%), Gaps = 1/41 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T   V AL+ +   +  IHRDVKP N+LLD+ G +KL DFG
Sbjct: 179 TAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 21/41 (51%), Positives = 27/41 (65%), Gaps = 1/41 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T   V AL+ +   +  IHRDVKP N+LLD+ G +KL DFG
Sbjct: 174 TAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFG 213

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 21/41 (51%), Positives = 27/41 (65%), Gaps = 1/41 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T   V AL+ +   +  IHRDVKP N+LLD+ G +KL DFG
Sbjct: 179 TAEVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 21/36 (58%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL YL   L I++RD+KP NILLD +G I L DFG+
Sbjct: 151 ALGYL-HSLNIVYRDLKPENILLDSQGHIVLTDFGL 185

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 19/39 (48%), Positives = 29/39 (74%), Gaps = 1/39 (2%)
Query: 11  TVKALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T +A+ ++ +++  IIHRD+K  N+LL  +G IKLCDFG
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 18/27 (66%), Positives = 21/27 (77%)
Query: 22  LKIIHRDVKPSNILLDRRGAIKLCDFG 48
           L  +HRD+KP NILLDR G I+L DFG
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFG 207

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 138 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 179

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 161 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 202

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 171 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 212

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 169 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 210

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 152 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 193

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 167 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 167 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 212 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 253

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 141 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 182

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 145 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 186

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 145 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 186

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 137 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 178

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 146 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 187

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 134 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 175

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 2/43 (4%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLV 54
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 1/45 (2%)
Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +V     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIA 163

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 1/45 (2%)
Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +V     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIA 163

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 1/45 (2%)
Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +V     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIA 163

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 1/45 (2%)
Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +V     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+
Sbjct: 137 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIA 180

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/45 (44%), Positives = 30/45 (66%), Gaps = 1/45 (2%)
Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +V     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIA 163

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 26/67 (38%), Positives = 38/67 (56%), Gaps = 8/67 (11%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNIL-LDRRG---AIKLCDFGISGQLVVE---VVL 59
           V     K + YL  +  ++HRD+KPSNIL +D  G   +I++CDFG + QL  E   ++ 
Sbjct: 121 VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 60  PFLQINF 66
           P    NF
Sbjct: 180 PCYTANF 186

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 21/50 (42%), Positives = 31/50 (62%), Gaps = 1/50 (2%)
Query: 4   TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           T  +  + ++A+++L     I+HRD+KP NILLD    I+L DFG S  L
Sbjct: 202 TRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 159

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 161

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 164

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 160

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 164

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 161

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 157

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL +L    ++IHRD+K  NILL   G++KL DFG   Q+  E
Sbjct: 126 LQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL +L    ++IHRD+K  NILL   G++KL DFG   Q+  E
Sbjct: 126 LQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 26/35 (74%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           +++HRD+KP N+L++  GAIKL DFG++    V V
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 5/54 (9%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNIL-LDRRG---AIKLCDFGISGQLVVE 56
           V     K + YL  +  ++HRD+KPSNIL +D  G   +I++CDFG + QL  E
Sbjct: 121 VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL +L    ++IHRD+K  NILL   G++KL DFG   Q+  E
Sbjct: 127 LQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 170

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 1/51 (1%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V +A ++AL+ L  +  +IHRD+K  +ILL   G +KL DFG   Q+  EV
Sbjct: 252 VCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 1/51 (1%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V +A ++AL+ L  +  +IHRD+K  +ILL   G +KL DFG   Q+  EV
Sbjct: 175 VCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/36 (58%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ALNYL E   II+RD+K  N+LLD  G IKL D+G+
Sbjct: 118 ALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGM 152

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/36 (58%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ALNYL E   II+RD+K  N+LLD  G IKL D+G+
Sbjct: 133 ALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGM 167

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/36 (58%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ALNYL E   II+RD+K  N+LLD  G IKL D+G+
Sbjct: 165 ALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGM 199

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/36 (58%), Positives = 26/36 (72%), Gaps = 1/36 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ALNYL E   II+RD+K  N+LLD  G IKL D+G+
Sbjct: 122 ALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGM 156

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 13  KALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K +NYL      I+HR++K  N+L+D++  +K+CDFG+S
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL +L    ++IHRD+K  NILL   G++KL DFG   Q+  E
Sbjct: 126 LQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L++L    +++HRD+KP NIL+   G IKL DFG++
Sbjct: 130 LRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 1/51 (1%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V +A ++AL+ L  +  +IHRD+K  +ILL   G +KL DFG   Q+  EV
Sbjct: 132 VCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 181

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 16/28 (57%), Positives = 21/28 (75%)
Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +L  +HRD+KP NIL+D  G I+L DFG
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFG 220

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 16/33 (48%), Positives = 25/33 (75%)
Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +++I+HRD+KP NIL+D    +K+ DFGI+  L
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 1/51 (1%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V +A ++AL+ L  +  +IHRD+K  +ILL   G +KL DFG   Q+  EV
Sbjct: 125 VCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 174

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L++L    +++HRD+KP NIL+   G IKL DFG++
Sbjct: 130 LRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 136 LRGLKYIHSA-NVLHRDLKPSNLLLNTTSDLKICDFGLA 173

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 1/51 (1%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V +A ++AL+ L  +  +IHRD+K  +ILL   G +KL DFG   Q+  EV
Sbjct: 130 VCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 179

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 15/28 (53%), Positives = 24/28 (85%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +I+HRD+KP N+L++  GA+KL DFG++
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLA 166

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L++L    +++HRD+KP NIL+   G IKL DFG++
Sbjct: 130 LRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 22/51 (43%), Positives = 32/51 (62%), Gaps = 1/51 (1%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V +A ++AL+ L  +  +IHRD+K  +ILL   G +KL DFG   Q+  EV
Sbjct: 121 VCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 15/28 (53%), Positives = 24/28 (85%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +I+HRD+KP N+L++  GA+KL DFG++
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLA 166

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 16/28 (57%), Positives = 21/28 (75%)
Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +L  +HRD+KP N+LLD  G I+L DFG
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFG 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 16/28 (57%), Positives = 21/28 (75%)
Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           +L  +HRD+KP N+LLD  G I+L DFG
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFG 236

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 19/37 (51%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + K+IHRD+KP N+LL   G +K+ DFG S
Sbjct: 120 ALSYCHSK-KVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/45 (48%), Positives = 30/45 (66%), Gaps = 1/45 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           V AL +L  +L II+RD+K  NILLD  G + L DFG+S + V +
Sbjct: 169 VLALEHL-HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/35 (62%), Positives = 25/35 (71%), Gaps = 2/35 (5%)
Query: 21  ELKIIHRDVKPSNILL--DRRGAIKLCDFGISGQL 53
           EL IIH D+KP NILL   +R AIK+ DFG S QL
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 14/27 (51%), Positives = 23/27 (85%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KP N+L++R G +KL DFG++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLA 148

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/45 (46%), Positives = 27/45 (60%), Gaps = 1/45 (2%)
Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ +   + L+YL     IIHRDVK  NILLD     K+ DFGIS
Sbjct: 143 EICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGIS 186

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/45 (46%), Positives = 27/45 (60%), Gaps = 1/45 (2%)
Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ +   + L+YL     IIHRDVK  NILLD     K+ DFGIS
Sbjct: 143 EICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGIS 186

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/56 (39%), Positives = 35/56 (62%), Gaps = 6/56 (10%)
Query: 3   ITNQVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + ++ T+AT+     + L YL +  +I HRDVK  NILL   G++++ DFG+S  L
Sbjct: 112 VLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFL 166

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/56 (39%), Positives = 35/56 (62%), Gaps = 6/56 (10%)
Query: 3   ITNQVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + ++ T+AT+     + L YL +  +I HRDVK  NILL   G++++ DFG+S  L
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFL 171

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 27/37 (72%)
Query: 20  EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
            E  IIHRD+KP+N LL++  ++K+CDFG++  +  E
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 13  KALNYLKEELKIIHRDVKPSNIL-LDRRG---AIKLCDFGISGQLVVE---VVLPFLQIN 65
           K + YL  +  ++HRD+KPSNIL +D  G    +++CDFG + QL  E   ++ P    N
Sbjct: 132 KTVEYLHSQ-GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 66  F 66
           F
Sbjct: 191 F 191

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 13  KALNYLKEELKIIHRDVKPSNIL-LDRRG---AIKLCDFGISGQLVVE---VVLPFLQIN 65
           K + YL  +  ++HRD+KPSNIL +D  G    +++CDFG + QL  E   ++ P    N
Sbjct: 132 KTVEYLHSQ-GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 66  F 66
           F
Sbjct: 191 F 191

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 154 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLA 191

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLA 175

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 13/28 (46%), Positives = 24/28 (85%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +++HRD+KP N+L++R G +K+ DFG++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 13/28 (46%), Positives = 24/28 (85%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +++HRD+KP N+L++R G +K+ DFG++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLA 175

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 13/28 (46%), Positives = 24/28 (85%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +++HRD+KP N+L++R G +K+ DFG++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLA 147

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 134 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLA 171

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 134 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLA 171

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 124 ALSYCHSK-RVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 124 ALSYCHSK-RVIHRDIKPENLLLGSNGELKIADFGWS 159

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 154 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 191

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 136 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 173

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 142 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 179

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 134 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 171

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 139 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 176

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 136 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 173

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 140 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 177

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 131 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 168

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 132 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 169

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 132 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 169

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 139 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 176

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 134 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 171

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/51 (43%), Positives = 31/51 (60%), Gaps = 1/51 (1%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
           V  A ++AL YL  +  +IHRD+K  +ILL   G +KL DFG   Q+  +V
Sbjct: 146 VCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/39 (46%), Positives = 26/39 (66%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + A+ Y     KI+HRD+KP N+LLD    +K+ DFG+S
Sbjct: 123 ISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLS 160

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/39 (46%), Positives = 26/39 (66%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + A+ Y     KI+HRD+KP N+LLD    +K+ DFG+S
Sbjct: 122 ISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLS 159

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 16/30 (53%), Positives = 25/30 (83%)
Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           E  IIHRD+KP+N LL++  ++K+CDFG++
Sbjct: 149 ESGIIHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/39 (46%), Positives = 26/39 (66%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + A+ Y     KI+HRD+KP N+LLD    +K+ DFG+S
Sbjct: 113 ISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLS 150

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/39 (46%), Positives = 26/39 (66%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + A+ Y     KI+HRD+KP N+LLD    +K+ DFG+S
Sbjct: 117 ISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLS 154

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 115 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 162

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 141 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 188

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 143 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 190

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 139 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 139 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 116 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 163

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/42 (42%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G IK+ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV 192

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/42 (42%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G IK+ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV 191

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/42 (42%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G IK+ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV 191

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/42 (42%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G IK+ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV 191

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 146 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 122 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 157

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 124 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 159

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 137 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 172

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 121 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 121 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 119 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 154

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 117 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 152

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 121 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 156

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 158

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 125 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 160

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 146 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/37 (48%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 120 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWS 155

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLA 150

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 135 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLA 151

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/27 (55%), Positives = 21/27 (77%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA 152

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 113 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 160

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 120 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 167

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 114 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/49 (46%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 8   TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L  E
Sbjct: 135 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/36 (50%), Positives = 28/36 (77%), Gaps = 1/36 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL +L ++  II+RD+KP NI+L+ +G +KL DFG+
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGL 167

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 18/36 (50%), Positives = 28/36 (77%), Gaps = 1/36 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL +L ++  II+RD+KP NI+L+ +G +KL DFG+
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGL 167

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 17/40 (42%), Positives = 29/40 (72%), Gaps = 1/40 (2%)
Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T++A+  L     +IHRD+KPSN+L++    +K+CDFG++
Sbjct: 121 TLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLA 159

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 17/40 (42%), Positives = 29/40 (72%), Gaps = 1/40 (2%)
Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T++A+  L     +IHRD+KPSN+L++    +K+CDFG++
Sbjct: 121 TLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLA 159

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 17/40 (42%), Positives = 29/40 (72%), Gaps = 1/40 (2%)
Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T++A+  L     +IHRD+KPSN+L++    +K+CDFG++
Sbjct: 121 TLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLA 159

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 30/42 (71%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+++D++G IK+ DFG++ ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV 191

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/35 (62%), Positives = 25/35 (71%), Gaps = 2/35 (5%)
Query: 21  ELKIIHRDVKPSNILL--DRRGAIKLCDFGISGQL 53
           EL IIH D+KP NILL   +R AIK+ DFG S QL
Sbjct: 158 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 192

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/28 (53%), Positives = 23/28 (82%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           KI+HRD+K +N+L+ R G +KL DFG++
Sbjct: 145 KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/28 (53%), Positives = 23/28 (82%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           KI+HRD+K +N+L+ R G +KL DFG++
Sbjct: 144 KILHRDMKAANVLITRDGVLKLADFGLA 171

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 15/28 (53%), Positives = 23/28 (82%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           KI+HRD+K +N+L+ R G +KL DFG++
Sbjct: 145 KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 19/45 (42%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
           ++AL +L    ++IHR++K  NILL   G++KL DFG   Q+  E
Sbjct: 127 LQALEFLHSN-QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE 170

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L++L     I+HRD+KP NIL+   G +KL DFG++
Sbjct: 130 LRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLA 167

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L++L     I+HRD+KP NIL+   G +KL DFG++
Sbjct: 122 LRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L++L     I+HRD+KP NIL+   G +KL DFG++
Sbjct: 122 LRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L++L     I+HRD+KP NIL+   G +KL DFG++
Sbjct: 122 LRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 15/39 (38%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+L++    +K+CDFG++
Sbjct: 154 LRGLKYIHSA-NVLHRDLKPSNLLINTTCDLKICDFGLA 191

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/35 (62%), Positives = 25/35 (71%), Gaps = 2/35 (5%)
Query: 21  ELKIIHRDVKPSNILL--DRRGAIKLCDFGISGQL 53
           EL IIH D+KP NILL   +R AIK+ DFG S QL
Sbjct: 177 ELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL 211

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 21/42 (50%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           VT   ++ L YL     +IHRDVK  NILL   G +KL DFG
Sbjct: 159 VTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFG 199

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+++D++G IK+ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV 191

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+++D++G IK+ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV 191

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+++D++G IK+ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 16/28 (57%), Positives = 22/28 (78%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           KI+HRD+KP N+LLD    +K+ DFG+S
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLS 155

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+++D++G IK+ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+++D++G IK+ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+++D++G IK+ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 21/42 (50%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           VT   ++ L YL     +IHRDVK  NILL   G +KL DFG
Sbjct: 120 VTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFG 160

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 33/53 (62%), Gaps = 5/53 (9%)
Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +F T Q+    V  L +L +   II+RD+KP N+LLD  G +++ D G++ +L
Sbjct: 292 IFYTAQI----VSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 33/53 (62%), Gaps = 5/53 (9%)
Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +F T Q+    V  L +L +   II+RD+KP N+LLD  G +++ D G++ +L
Sbjct: 292 IFYTAQI----VSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 33/53 (62%), Gaps = 5/53 (9%)
Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +F T Q+    V  L +L +   II+RD+KP N+LLD  G +++ D G++ +L
Sbjct: 292 IFYTAQI----VSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 20/53 (37%), Positives = 33/53 (62%), Gaps = 5/53 (9%)
Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +F T Q+    V  L +L +   II+RD+KP N+LLD  G +++ D G++ +L
Sbjct: 292 IFYTAQI----VSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 13/27 (48%), Positives = 23/27 (85%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KP N+L++R G +KL +FG++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLA 148

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 21/45 (46%), Positives = 29/45 (64%), Gaps = 4/45 (8%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQL 53
           ++AL Y  +   IIHRDVKP N+LL   +    +KL DFG++ QL
Sbjct: 140 LEALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL 183

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 13/27 (48%), Positives = 24/27 (88%)
Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           I+HRD+KP+N L+++  ++K+CDFG++
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV 55
           V A+ Y  ++ +I+HRD+K  N+LLD    IK+ DFG S +  V
Sbjct: 121 VSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 163

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 144 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 19/44 (43%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV 55
           V A+ Y  ++ +I+HRD+K  N+LLD    IK+ DFG S +  V
Sbjct: 124 VSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 172 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 144 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 172 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 172 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 152 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 20/48 (41%), Positives = 29/48 (60%), Gaps = 1/48 (2%)
Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           V    +K + YL     ++HRD+KPSNILL+    +K+ DFG+S   V
Sbjct: 114 VVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 16/42 (38%), Positives = 30/42 (71%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+++D++G I++ DFG++ ++
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV 191

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 15/28 (53%), Positives = 23/28 (82%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           KI+HRD+K +N+L+ R G +KL DFG++
Sbjct: 145 KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 137 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 177

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D++G I++ DFG + ++
Sbjct: 146 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 186

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 118 VSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGL 154

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 115 VSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 115 VSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 115 VSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 115 VSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 120 VSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGL 156

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 1/38 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           V AL YL     +++RD+K  N++LD+ G IK+ DFG+
Sbjct: 115 VSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 2/47 (4%)
Query: 6   QVTVATVKALNYLKE--ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ + + + L YL +  + KIIHRDVK +NILLD      + DFG++
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 2/47 (4%)
Query: 6   QVTVATVKALNYLKE--ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ + + + L YL +  + KIIHRDVK +NILLD      + DFG++
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 189

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 17/37 (45%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ +FG S
Sbjct: 122 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIANFGWS 157

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 17/37 (45%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+Y   + ++IHRD+KP N+LL   G +K+ +FG S
Sbjct: 123 ALSYCHSK-RVIHRDIKPENLLLGSAGELKIANFGWS 158

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 16/42 (38%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + A++Y    + ++HRD+KP N+LLD     K+ DFG+S  +
Sbjct: 121 LSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++AL+Y+  +  IIHRD+KP NI +D    +K+ DFG++
Sbjct: 126 LEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLA 163

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/42 (38%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + A++Y    + ++HRD+KP N+LLD     K+ DFG+S  +
Sbjct: 121 LSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++AL+Y+  +  IIHRD+KP NI +D    +K+ DFG++
Sbjct: 126 LEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLA 163

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 159 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 209 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 196 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 232

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 211 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 247

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 202 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 238

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 161 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 197

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 150 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 186

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 204 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 240

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 159 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 150 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 186

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 159 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 150 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 186

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 150 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 186

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 159 KGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 155 KGMEFLASR-KXIHRDLAARNILLSEKNVVKICDFGLA 191

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)
Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 159 KGMEFLASR-KXIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 17/42 (40%), Positives = 28/42 (66%), Gaps = 1/42 (2%)
Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL   L +I+RD+KP N+L+D +G I++ DFG + ++
Sbjct: 138 VLTFEYL-HSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV 178

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 15/28 (53%), Positives = 21/28 (75%)
Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           KI+HRD+K  NI L + G ++L DFGI+
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIA 172

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	68
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-16
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-15
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-15
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-15
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-15
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-14
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-14
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-14
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-14
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-13
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-13
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-13
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-12
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-12
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-12
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-12
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-12
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-12
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-12
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-12
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-11
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-11
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-11
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-11
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-11
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-11
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-11
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-11
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-11
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-11
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-11
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-11
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-11
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-11
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-11
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-10
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-10
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-10
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-10
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-10
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-10
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-10
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-10
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-10
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-10
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-10
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-09
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-09
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-09
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-09
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-09
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-09
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-09
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-09
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-09
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-09
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-08
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-08
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-08
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-08
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-08
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-08
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-08
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-08
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-08
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-08
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-08
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-08
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-08
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-08
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-08
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-08
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-08
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-06
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-06
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-06
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-06
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-06
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-06
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-06
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-05
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-05
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-05
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-05
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-05
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-05
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-05
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-05
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-05
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-05
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-05
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-05
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-05
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-05
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-05
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-05
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-05
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-05
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-05
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-05
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-05
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-05
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-05
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-05
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-05
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-05
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-05
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-05
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-05
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-05
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-05
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-05
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-05
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-04
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-04
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-04
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-04
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-04
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-04

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  103 bits (258), Expect = 7e-29
 Identities = 41/48 (85%), Positives = 45/48 (93%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           +T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLV
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (253), Expect = 3e-28
 Identities = 28/48 (58%), Positives = 38/48 (79%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           + V+ VKAL +L  +L +IHRDVKPSN+L++  G +K+CDFGISG LV
Sbjct: 114 IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.4 bits (248), Expect = 2e-27
 Identities = 38/48 (79%), Positives = 42/48 (87%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           +TVA VKAL YLKE+  +IHRDVKPSNILLD RG IKLCDFGISG+LV
Sbjct: 129 MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.8 bits (246), Expect = 6e-27
 Identities = 32/48 (66%), Positives = 42/48 (87%)

Query: 7   VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 68.9 bits (169), Expect = 3e-16
 Identities = 23/43 (53%), Positives = 31/43 (72%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            +K L+YL  E K IHRD+K +N+LL   G +KL DFG++GQL
Sbjct: 128 ILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 68.9 bits (169), Expect = 4e-16
 Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            ++ L++L +  K+IHRD+K  N+LL     +KL DFG+S QL
Sbjct: 138 ILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 68.5 bits (168), Expect = 5e-16
 Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            ++ L YL +    IHRDVK  NILL   G++++ DFG+S  L
Sbjct: 130 VLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 67.7 bits (166), Expect = 1e-15
 Identities = 19/42 (45%), Positives = 26/42 (61%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + AL +L     ++H DVKP+NI L  RG  KL DFG+  +L
Sbjct: 167 LLALAHL-HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 67.8 bits (166), Expect = 1e-15
 Identities = 23/43 (53%), Positives = 29/43 (67%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           T+K L YL    + IHRD+K  NILL+  G  KL DFG++GQL
Sbjct: 134 TLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 67.3 bits (165), Expect = 1e-15
 Identities = 17/43 (39%), Positives = 27/43 (62%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
             K ++Y+  + K+I+RD+KPSNI L     +K+ DFG+   L
Sbjct: 131 ITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 67.3 bits (165), Expect = 2e-15
 Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            ++ALN+L  + +IIHRD+K  N+L+   G I+L DFG+S + 
Sbjct: 126 MLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 67.6 bits (165), Expect = 2e-15
 Identities = 13/44 (29%), Positives = 23/44 (52%), Gaps = 1/44 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
            +KAL+Y+      +HR VK S+IL+   G + L     +  ++
Sbjct: 137 VLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 67.1 bits (164), Expect = 2e-15
 Identities = 19/43 (44%), Positives = 25/43 (58%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            ++ L YL     +IHRDVK  NILL   G +KL DFG +  +
Sbjct: 163 ALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 66.6 bits (163), Expect = 3e-15
 Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            ++AL YL  +  +IHRD+K  +ILL   G +KL DFG   Q+
Sbjct: 150 VLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 66.2 bits (162), Expect = 4e-15
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            ++AL +L    ++IHRD+K  NILL   G++KL DFG   Q+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 65.8 bits (161), Expect = 5e-15
 Identities = 13/42 (30%), Positives = 24/42 (57%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
             AL ++    +++HRD+KP+N+ +   G +KL D G+    
Sbjct: 146 CSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 66.3 bits (162), Expect = 5e-15
 Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
             AL ++ +  KI+HRD+K  NI L + G ++L DFGI+  L
Sbjct: 135 CLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 64.7 bits (157), Expect = 2e-14
 Identities = 14/50 (28%), Positives = 26/50 (52%), Gaps = 5/50 (10%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + +T QV    ++ L  L     ++H  ++P +I+LD+RG + L  F   
Sbjct: 214 LQLTLQV----IRLLASL-HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 64.0 bits (156), Expect = 3e-14
 Identities = 19/54 (35%), Positives = 28/54 (51%), Gaps = 6/54 (11%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-IKLCDFGISGQL 53
           ++   Q     ++ L YL    +I+H DVK  N+LL   G+   LCDFG +  L
Sbjct: 153 LYYLGQA----LEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 62.7 bits (153), Expect = 5e-14
 Identities = 16/46 (34%), Positives = 25/46 (54%), Gaps = 4/46 (8%)

Query: 12  VKALNYL----KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
             AL            ++HRD+KP+N+ LD +  +KL DFG++  L
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 63.1 bits (153), Expect = 6e-14
 Identities = 9/50 (18%), Positives = 19/50 (38%), Gaps = 5/50 (10%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             +T Q+    ++    L +   ++H    P N+ +   G + L D    
Sbjct: 197 HILTAQL----IRLAANL-QSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 63.1 bits (154), Expect = 7e-14
 Identities = 20/37 (54%), Positives = 27/37 (72%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL+YL +  +IIHRD+KP NILLD  G + + DF I+
Sbjct: 127 ALDYL-QNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 62.8 bits (153), Expect = 7e-14
 Identities = 21/39 (53%), Positives = 28/39 (71%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + +Y+  E  I HRDVKPSNIL+D+ G +KL DFG S
Sbjct: 161 LNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 62.0 bits (151), Expect = 1e-13
 Identities = 17/42 (40%), Positives = 29/42 (69%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++AL+Y+  +  IIHRD+KP NI +D    +K+ DFG++  +
Sbjct: 126 LEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 61.6 bits (150), Expect = 2e-13
 Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            +A+ +L  +  ++HRD+KPSNI       +K+ DFG+   +
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 61.9 bits (150), Expect = 2e-13
 Identities = 14/50 (28%), Positives = 26/50 (52%), Gaps = 5/50 (10%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + +T QV    ++ L  L     ++H  ++P +I+LD+RG + L  F   
Sbjct: 209 LQLTLQV----IRLLASL-HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 61.2 bits (149), Expect = 2e-13
 Identities = 16/47 (34%), Positives = 22/47 (46%), Gaps = 1/47 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV 57
             + L  +  +    HRD+KP+NILL   G   L D G   Q  + V
Sbjct: 143 ICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 60.9 bits (148), Expect = 4e-13
 Identities = 18/39 (46%), Positives = 26/39 (66%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V A++ +  +L  +HRD+KP NIL+D  G I+L DFG  
Sbjct: 185 VIAIDSV-HQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 60.9 bits (148), Expect = 4e-13
 Identities = 21/46 (45%), Positives = 29/46 (63%), Gaps = 1/46 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
            V A++ +   L  +HRD+KP NILLDR G I+L DFG   +L  +
Sbjct: 171 IVMAIDSV-HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 60.5 bits (147), Expect = 5e-13
 Identities = 20/42 (47%), Positives = 28/42 (66%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V AL+ +   +  IHRDVKP N+LLD+ G +KL DFG   ++
Sbjct: 178 VLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 60.0 bits (146), Expect = 6e-13
 Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 1/39 (2%)

Query: 13  KALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K +NYL      I+HR++K  N+L+D++  +K+CDFG+S
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 59.6 bits (145), Expect = 9e-13
 Identities = 14/26 (53%), Positives = 15/26 (57%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGI 49
             HRDVKP NIL+       L DFGI
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGI 180

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 59.7 bits (145), Expect = 1e-12
 Identities = 18/39 (46%), Positives = 28/39 (71%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+ 
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 59.1 bits (144), Expect = 1e-12
 Identities = 20/38 (52%), Positives = 27/38 (71%), Gaps = 1/38 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T++A+N+  +    IHRDVKP NIL+ +   IKLCDFG
Sbjct: 111 TLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFG 147

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 58.9 bits (143), Expect = 2e-12
 Identities = 20/54 (37%), Positives = 33/54 (61%), Gaps = 6/54 (11%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQL 53
            F T Q+    ++ L YL +  +I+HRD+K  N+L++   G +K+ DFG S +L
Sbjct: 125 GFYTKQI----LEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 59.1 bits (143), Expect = 2e-12
 Identities = 14/39 (35%), Positives = 24/39 (61%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            +A+ +L  +  ++HRD+KPSNI       +K+ DFG+ 
Sbjct: 174 AEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLV 211

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 58.9 bits (142), Expect = 2e-12
 Identities = 16/37 (43%), Positives = 24/37 (64%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L +L +   II+RD+K  N++LD  G IK+ DFG+ 
Sbjct: 454 GLFFL-QSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 58.6 bits (142), Expect = 2e-12
 Identities = 19/41 (46%), Positives = 30/41 (73%), Gaps = 1/41 (2%)

Query: 11  TVKALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T +A+ ++ +++  IIHRD+K  N+LL  +G IKLCDFG +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 58.7 bits (142), Expect = 2e-12
 Identities = 17/57 (29%), Positives = 31/57 (54%), Gaps = 2/57 (3%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT 68
           ++A++ + +   I+H D+KP+N L+   G +KL DFGI+ Q+  +          G 
Sbjct: 165 LEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 58.7 bits (143), Expect = 2e-12
 Identities = 18/37 (48%), Positives = 27/37 (72%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL +L  +  II+RD+KP NI+L+ +G +KL DFG+ 
Sbjct: 133 ALGHL-HQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 58.4 bits (142), Expect = 2e-12
 Identities = 17/38 (44%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
            +  + +      IIHRD+KP NIL+ + G +KLCDFG
Sbjct: 133 IINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFG 169

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 58.4 bits (142), Expect = 2e-12
 Identities = 20/39 (51%), Positives = 25/39 (64%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V AL YL     IIHRD+KP NILL+    I++ DFG +
Sbjct: 140 VSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTA 177

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 58.5 bits (142), Expect = 3e-12
 Identities = 21/37 (56%), Positives = 26/37 (70%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ALNYL  E  II+RD+K  N+LLD  G IKL D+G+ 
Sbjct: 165 ALNYL-HERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 58.4 bits (142), Expect = 3e-12
 Identities = 17/36 (47%), Positives = 25/36 (69%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + L++L    +++HRD+KP NIL+   G IKL DFG
Sbjct: 131 RGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFG 165

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 58.4 bits (142), Expect = 3e-12
 Identities = 21/37 (56%), Positives = 26/37 (70%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL YL   L I++RD+KP NILLD +G I L DFG+ 
Sbjct: 151 ALGYL-HSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 57.6 bits (140), Expect = 4e-12
 Identities = 18/39 (46%), Positives = 25/39 (64%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             AL+Y     ++IHRD+KP N+LL   G +K+ DFG S
Sbjct: 119 ANALSYC-HSKRVIHRDIKPENLLLGSAGELKIADFGWS 156

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 58.0 bits (141), Expect = 4e-12
 Identities = 17/36 (47%), Positives = 24/36 (66%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
             L Y+    KI+HRD+K +N+L+ R G +KL DFG
Sbjct: 135 NGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFG 169

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 58.1 bits (141), Expect = 4e-12
 Identities = 18/57 (31%), Positives = 32/57 (56%), Gaps = 2/57 (3%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT 68
           ++A++ + +   I+H D+KP+N L+   G +KL DFGI+ Q+  +          GT
Sbjct: 137 LEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 57.8 bits (140), Expect = 4e-12
 Identities = 18/57 (31%), Positives = 32/57 (56%), Gaps = 2/57 (3%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT 68
           ++A++ + +   I+H D+KP+N L+   G +KL DFGI+ Q+  +          GT
Sbjct: 118 LEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 57.6 bits (140), Expect = 4e-12
 Identities = 17/36 (47%), Positives = 24/36 (66%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + L++L     I+HRD+KP NIL+   G +KL DFG
Sbjct: 131 RGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFG 165

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 58.1 bits (141), Expect = 4e-12
 Identities = 20/37 (54%), Positives = 26/37 (70%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL +L  +L II+RD+K  NILLD  G + L DFG+S
Sbjct: 171 ALEHL-HKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 58.0 bits (141), Expect = 4e-12
 Identities = 16/37 (43%), Positives = 24/37 (64%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L +L +   II+RD+K  N++LD  G IK+ DFG+ 
Sbjct: 133 GLFFL-QSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 57.6 bits (140), Expect = 5e-12
 Identities = 23/37 (62%), Positives = 28/37 (75%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL++L   L II+RD+KP NILLD  G IKL DFG+S
Sbjct: 138 ALDHL-HSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 57.6 bits (140), Expect = 5e-12
 Identities = 21/37 (56%), Positives = 26/37 (70%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ALNYL  E  II+RD+K  N+LLD  G IKL D+G+ 
Sbjct: 122 ALNYL-HERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 57.6 bits (140), Expect = 5e-12
 Identities = 17/36 (47%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + L Y   + K++HRD+KP N+L++ RG +KL DFG
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFG 145

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 57.2 bits (139), Expect = 6e-12
 Identities = 15/36 (41%), Positives = 26/36 (72%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + + +  +  +I+HRD+KP N+L++  GA+KL DFG
Sbjct: 130 RGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFG 164

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 57.2 bits (139), Expect = 7e-12
 Identities = 21/37 (56%), Positives = 26/37 (70%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL YL     II+RD+KP NILLD+ G IK+ DFG +
Sbjct: 118 ALEYL-HSKDIIYRDLKPENILLDKNGHIKITDFGFA 153

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 57.2 bits (139), Expect = 7e-12
 Identities = 18/36 (50%), Positives = 27/36 (75%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + L +  E  KI+HRD+KP N+L+++RG +KL DFG
Sbjct: 119 QGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFG 153

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 57.1 bits (139), Expect = 7e-12
 Identities = 15/36 (41%), Positives = 24/36 (66%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           K L +      ++HRD+KP N+L++R G +KL +FG
Sbjct: 112 KGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFG 146

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 57.2 bits (139), Expect = 7e-12
 Identities = 17/37 (45%), Positives = 24/37 (64%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L +L     I++RD+K  NILLD+ G IK+ DFG+ 
Sbjct: 130 GLQFL-HSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 57.2 bits (139), Expect = 7e-12
 Identities = 18/37 (48%), Positives = 24/37 (64%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL +L  +  II+RD+K  N+LLD  G  KL DFG+ 
Sbjct: 136 ALMFL-HDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 57.3 bits (139), Expect = 8e-12
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V    YL   L +I+RD+KP N+L+D++G I++ DFG +
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 56.8 bits (138), Expect = 8e-12
 Identities = 19/39 (48%), Positives = 27/39 (69%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             AL+Y   E K+IHRD+KP N+L+  +G +K+ DFG S
Sbjct: 124 ADALHYC-HERKVIHRDIKPENLLMGYKGELKIADFGWS 161

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 57.0 bits (138), Expect = 8e-12
 Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 3/41 (7%)

Query: 13  KALNYL--KEELKIIHRDVKPSNILLDRRG-AIKLCDFGIS 50
           + + YL   +   +IHRD+KP N+LL   G  +K+CDFG +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 57.2 bits (139), Expect = 8e-12
 Identities = 20/38 (52%), Positives = 28/38 (73%), Gaps = 1/38 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           T++ L YL +   I+HRD+KP+N+LLD  G +KL DFG
Sbjct: 121 TLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFG 157

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 56.8 bits (138), Expect = 9e-12
 Identities = 16/36 (44%), Positives = 25/36 (69%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + L +     +++HRD+KP N+L++  GAIKL DFG
Sbjct: 114 QGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFG 148

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 56.8 bits (138), Expect = 9e-12
 Identities = 21/38 (55%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + L+YL     IIHRDVK  NILLD     K+ DFGIS
Sbjct: 150 RGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGIS 186

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 56.8 bits (138), Expect = 1e-11
 Identities = 14/36 (38%), Positives = 25/36 (69%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
             + Y  +  +++HRD+KP N+L++R G +K+ DFG
Sbjct: 111 NGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFG 145

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 56.6 bits (137), Expect = 1e-11
 Identities = 14/45 (31%), Positives = 22/45 (48%), Gaps = 7/45 (15%)

Query: 13  KALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             L +L  E+        I HRD+K  NIL+ + G   + D G++
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 56.5 bits (137), Expect = 1e-11
 Identities = 15/38 (39%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + ++YL     IIHRD+K +NI L     +K+ DFG++
Sbjct: 131 RGMDYL-HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 56.5 bits (137), Expect = 1e-11
 Identities = 16/37 (43%), Positives = 25/37 (67%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           AL YL     +++RD+K  N++LD+ G IK+ DFG+ 
Sbjct: 117 ALEYL-HSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 56.4 bits (136), Expect = 2e-11
 Identities = 13/37 (35%), Positives = 25/37 (67%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L ++     +++RD+KP+NILLD  G +++ D G++
Sbjct: 304 GLEHM-HNRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 56.1 bits (136), Expect = 2e-11
 Identities = 16/26 (61%), Positives = 21/26 (80%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGI 49
           IIHRDVKP+NI++    A+K+ DFGI
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGI 162

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 55.7 bits (135), Expect = 2e-11
 Identities = 15/26 (57%), Positives = 20/26 (76%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGI 49
           I+HRD+KP NIL+D    +K+ DFGI
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGI 157

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 55.5 bits (134), Expect = 3e-11
 Identities = 15/46 (32%), Positives = 23/46 (50%), Gaps = 7/46 (15%)

Query: 12  VKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V  L +L  E+        I HRD+K  NIL+ + G   + D G++
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 55.2 bits (133), Expect = 4e-11
 Identities = 15/37 (40%), Positives = 25/37 (67%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L +L  +  II+RD+KP N+LLD  G +++ D G++
Sbjct: 301 GLEHL-HQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 55.1 bits (133), Expect = 4e-11
 Identities = 15/47 (31%), Positives = 23/47 (48%), Gaps = 9/47 (19%)

Query: 13  KALNYLKEEL---------KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + L YL E++          I HRD+K  N+LL       + DFG++
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 55.0 bits (133), Expect = 4e-11
 Identities = 12/38 (31%), Positives = 20/38 (52%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL   + IIHRD+   N L+     + + DFG++
Sbjct: 119 SGMAYL-HSMNIIHRDLNSHNCLVRENKNVVVADFGLA 155

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 55.2 bits (133), Expect = 5e-11
 Identities = 16/37 (43%), Positives = 24/37 (64%), Gaps = 1/37 (2%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            L  L    +I++RD+KP NILLD  G I++ D G++
Sbjct: 298 GLEDL-HRERIVYRDLKPENILLDDHGHIRISDLGLA 333

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 55.0 bits (133), Expect = 5e-11
 Identities = 15/38 (39%), Positives = 25/38 (65%), Gaps = 2/38 (5%)

Query: 13  KALNYL-KEELKIIHRDVKPSNILLDRR-GAIKLCDFG 48
           +++  L    + + HRD+KP N+L++   G +KLCDFG
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 54.6 bits (132), Expect = 5e-11
 Identities = 13/44 (29%), Positives = 21/44 (47%), Gaps = 6/44 (13%)

Query: 13  KALNYL-KEELKIIHRDVKPSNILLDRRGA-----IKLCDFGIS 50
             + Y+  +   I+HRD++  NI L           K+ DFG+S
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 54.8 bits (132), Expect = 5e-11
 Identities = 16/48 (33%), Positives = 22/48 (45%), Gaps = 8/48 (16%)

Query: 11  TVKALNYLKEEL--------KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + L YL  EL         I HRD+   N+L+   G   + DFG+S
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 54.9 bits (132), Expect = 5e-11
 Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 2/36 (5%)

Query: 14  ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           AL+YL   + +++ D+KP NI+L     +KL D G 
Sbjct: 194 ALSYL-HSIGLVYNDLKPENIMLTEEQ-LKLIDLGA 227

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 54.5 bits (132), Expect = 5e-11
 Identities = 4/39 (10%), Positives = 15/39 (38%), Gaps = 1/39 (2%)

Query: 13  KALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + +L   E  I    +   ++++D     ++    + 
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 54.4 bits (131), Expect = 7e-11
 Identities = 13/25 (52%), Positives = 22/25 (88%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFG 48
           I+HRD+KP+N L+++  ++K+CDFG
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFG 201

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 54.5 bits (132), Expect = 7e-11
 Identities = 19/38 (50%), Positives = 23/38 (60%), Gaps = 2/38 (5%)

Query: 13  KALNYLKEE--LKIIHRDVKPSNILLDRRGAIKLCDFG 48
           + L YL +    KIIHRDVK +NILLD      + DFG
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 54.1 bits (131), Expect = 8e-11
 Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +  + YL     I+HRD+  SN+LL R   IK+ DFG++ QL
Sbjct: 122 ITGMLYLHS-HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 54.3 bits (131), Expect = 8e-11
 Identities = 13/38 (34%), Positives = 21/38 (55%), Gaps = 2/38 (5%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL     I+H+D+K  N+  D  G + + DFG+ 
Sbjct: 141 KGMGYL-HAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 54.2 bits (131), Expect = 8e-11
 Identities = 20/39 (51%), Positives = 26/39 (66%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ +  L  +L I+HRD+KP NILLD    IKL DFG S
Sbjct: 134 LEVICAL-HKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 54.2 bits (131), Expect = 1e-10
 Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL    ++IHRD+K  N+ L+    +K+ DFG++ ++
Sbjct: 151 VLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 53.9 bits (130), Expect = 1e-10
 Identities = 18/37 (48%), Positives = 24/37 (64%), Gaps = 2/37 (5%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFG 48
           ++L Y+     I HRD+KP N+LLD     +KLCDFG
Sbjct: 167 RSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFG 202

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 53.9 bits (130), Expect = 1e-10
 Identities = 19/39 (48%), Positives = 27/39 (69%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++A+++L     I+HRD+KP NILLD    I+L DFG S
Sbjct: 210 LEAVSFL-HANNIVHRDLKPENILLDDNMQIRLSDFGFS 247

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 53.6 bits (129), Expect = 1e-10
 Identities = 15/47 (31%), Positives = 23/47 (48%), Gaps = 7/47 (14%)

Query: 11  TVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           T   L +L  E+        I HRD+K  NIL+ + G   + D G++
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 53.4 bits (129), Expect = 2e-10
 Identities = 21/39 (53%), Positives = 28/39 (71%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +K + YL    KIIHRD+KPSN+L+   G IK+ DFG+S
Sbjct: 147 IKGIEYL-HYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 53.5 bits (129), Expect = 2e-10
 Identities = 18/37 (48%), Positives = 25/37 (67%), Gaps = 2/37 (5%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFG 48
           ++L Y+   + I HRD+KP N+LLD   G +KL DFG
Sbjct: 152 RSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFG 187

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 53.0 bits (128), Expect = 2e-10
 Identities = 14/42 (33%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           V    YL    ++IHRD+K  N+ L+    +K+ DFG++ ++
Sbjct: 125 VLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 52.5 bits (126), Expect = 3e-10
 Identities = 17/43 (39%), Positives = 26/43 (60%), Gaps = 5/43 (11%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGIS 50
           V  +N+L+E   I+HR++KP NI+     D +   KL DFG +
Sbjct: 122 VGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 52.4 bits (126), Expect = 3e-10
 Identities = 18/39 (46%), Positives = 23/39 (58%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V A+ YL     IIHRD+K  NI++     IKL DFG +
Sbjct: 140 VSAVGYL-RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.4 bits (126), Expect = 4e-10
 Identities = 17/43 (39%), Positives = 30/43 (69%), Gaps = 2/43 (4%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLV 54
           +A+ ++   L I HRD+KP N+L++ +   +KLCDFG + +L+
Sbjct: 152 RAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 52.5 bits (126), Expect = 4e-10
 Identities = 17/43 (39%), Positives = 26/43 (60%), Gaps = 5/43 (11%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGIS 50
           V  +N+L+E   I+HR++KP NI+     D +   KL DFG +
Sbjct: 122 VGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 51.7 bits (124), Expect = 7e-10
 Identities = 19/51 (37%), Positives = 26/51 (50%), Gaps = 6/51 (11%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGA-----IKLCDFGISGQLVVE 56
           T   L +L   L I+HRD+KP NIL+    A       + DFG+  +L V 
Sbjct: 127 TTSGLAHL-HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 51.5 bits (124), Expect = 7e-10
 Identities = 13/41 (31%), Positives = 21/41 (51%), Gaps = 6/41 (14%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLD-----RRGAIKLCDFG 48
             +N+     + +HRD+KP N+LL          +K+ DFG
Sbjct: 143 NGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 51.7 bits (124), Expect = 8e-10
 Identities = 15/27 (55%), Positives = 24/27 (88%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           IIHRD+KP+N LL++  ++K+CDFG++
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 51.7 bits (124), Expect = 8e-10
 Identities = 15/40 (37%), Positives = 24/40 (60%), Gaps = 5/40 (12%)

Query: 13  KALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFG 48
             ++YL     ++HRD+KP+NIL+      RG +K+ D G
Sbjct: 139 DGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMG 177

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 51.6 bits (124), Expect = 8e-10
 Identities = 13/60 (21%), Positives = 22/60 (36%), Gaps = 20/60 (33%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAI-------------------KLCDFGISGQL 53
           + L Y+     ++H D+KPSNI + R                       K+ D G   ++
Sbjct: 126 RGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 51.1 bits (123), Expect = 9e-10
 Identities = 17/48 (35%), Positives = 29/48 (60%), Gaps = 10/48 (20%)

Query: 13  KALNYL--KEELKIIHRDVKPSNILLDRRGA--------IKLCDFGIS 50
           + +NYL  +  + IIHRD+K SNIL+ ++          +K+ DFG++
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 51.1 bits (123), Expect = 9e-10
 Identities = 18/39 (46%), Positives = 25/39 (64%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V A+ Y   + +I+HRD+K  N+LLD    IK+ DFG S
Sbjct: 124 VSAVQYC-HQKRIVHRDLKAENLLLDADMNIKIADFGFS 161

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 51.4 bits (124), Expect = 9e-10
 Identities = 17/36 (47%), Positives = 22/36 (61%), Gaps = 1/36 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
             +N+L E    IHRD+K +NILLD     K+ DFG
Sbjct: 144 NGINFLHEN-HHIHRDIKSANILLDEAFTAKISDFG 178

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 51.2 bits (123), Expect = 1e-09
 Identities = 14/25 (56%), Positives = 20/25 (80%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFG 48
           ++HRD+KPSNILL+    +K+ DFG
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFG 154

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 50.8 bits (121), Expect = 1e-09
 Identities = 18/42 (42%), Positives = 23/42 (54%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
             AL YL E  +IIHRD+KP NI+L         K+ D G +
Sbjct: 131 SSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 50.8 bits (122), Expect = 1e-09
 Identities = 15/43 (34%), Positives = 23/43 (53%), Gaps = 2/43 (4%)

Query: 13  KALNYL-KEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQL 53
           K L +L      IIHRD+K  NI +    G++K+ D G++   
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 50.6 bits (121), Expect = 2e-09
 Identities = 15/38 (39%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + +L     IIHRD+KPSNI++     +K+ DFG++
Sbjct: 175 CGIKHL-HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 50.5 bits (121), Expect = 2e-09
 Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 4/51 (7%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVVEVVL 59
            +A+ YL   + I HRDVKP N+L         +KL DFG + +      L
Sbjct: 171 GEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 50.4 bits (121), Expect = 2e-09
 Identities = 15/29 (51%), Positives = 22/29 (75%)

Query: 22  LKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA 152

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 50.3 bits (121), Expect = 2e-09
 Identities = 14/39 (35%), Positives = 23/39 (58%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +  L YL     I+H+D+KP N+LL   G +K+   G++
Sbjct: 119 IDGLEYL-HSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.5 bits (121), Expect = 2e-09
 Identities = 18/48 (37%), Positives = 27/48 (56%), Gaps = 7/48 (14%)

Query: 3   ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL--DRRGAIKLCDFG 48
             + +    ++ L+ L +  +IIH D+KP NILL    R  IK+ DFG
Sbjct: 205 FAHSI----LQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFG 247

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 50.3 bits (121), Expect = 2e-09
 Identities = 14/27 (51%), Positives = 23/27 (85%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +IHRD+KPSN+L++    +K+CDFG++
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLA 159

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 50.2 bits (120), Expect = 2e-09
 Identities = 19/41 (46%), Positives = 22/41 (53%), Gaps = 3/41 (7%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG--AIKLCDFGIS 50
             AL+YL     I HRD+KP N L        IKL DFG+S
Sbjct: 178 FSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLS 217

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 50.4 bits (121), Expect = 2e-09
 Identities = 16/40 (40%), Positives = 25/40 (62%), Gaps = 2/40 (5%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGIS 50
           ++A+ +      ++HRD+K  NIL+D  RG +KL DFG  
Sbjct: 159 LEAVRHC-HNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 50.4 bits (121), Expect = 2e-09
 Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGIS 50
             AL++L     I HRD+KP NIL    ++   +K+CDF + 
Sbjct: 121 ASALDFL-HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 50.0 bits (120), Expect = 2e-09
 Identities = 12/27 (44%), Positives = 18/27 (66%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+ P NILL     I +CDF ++
Sbjct: 155 VVHRDLHPGNILLADNNDITICDFNLA 181

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 49.9 bits (120), Expect = 3e-09
 Identities = 15/29 (51%), Positives = 22/29 (75%)

Query: 22  LKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + I HRD+KP N+LLD R  +K+ DFG++
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLA 152

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 50.0 bits (120), Expect = 3e-09
 Identities = 20/49 (40%), Positives = 28/49 (57%), Gaps = 5/49 (10%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISGQLVVE 56
            K + YL     ++HRD+KPSNIL         +I++CDFG + QL  E
Sbjct: 126 TKTVEYL-HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 50.0 bits (120), Expect = 3e-09
 Identities = 13/27 (48%), Positives = 21/27 (77%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           IIHRD+KPSN+ ++    +K+ DFG++
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLA 179

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.0 bits (120), Expect = 3e-09
 Identities = 12/26 (46%), Positives = 19/26 (73%), Gaps = 1/26 (3%)

Query: 24  IIHRDVKPSNILLDR-RGAIKLCDFG 48
           I+HRDVKP N+++D     ++L D+G
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWG 176

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 49.6 bits (119), Expect = 3e-09
 Identities = 12/27 (44%), Positives = 20/27 (74%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           IIHRD+KP N+ ++    +K+ DFG++
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLA 175

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 49.6 bits (119), Expect = 4e-09
 Identities = 16/42 (38%), Positives = 23/42 (54%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGIS 50
             A+ +L     I HRDVKP N+L    ++   +KL DFG +
Sbjct: 138 GTAIQFL-HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 49.3 bits (118), Expect = 4e-09
 Identities = 14/44 (31%), Positives = 22/44 (50%), Gaps = 6/44 (13%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDR------RGAIKLCDFGIS 50
             L+Y+     IIH D+KP N+L++          IK+ D G +
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 49.2 bits (118), Expect = 4e-09
 Identities = 18/40 (45%), Positives = 24/40 (60%), Gaps = 2/40 (5%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGIS 50
           V A+ +      ++HRD+K  NIL+D RRG  KL DFG  
Sbjct: 149 VAAIQHC-HSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 49.2 bits (118), Expect = 5e-09
 Identities = 10/27 (37%), Positives = 20/27 (74%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KP N+ ++    +K+ DFG++
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLA 173

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.3 bits (118), Expect = 5e-09
 Identities = 23/49 (46%), Positives = 28/49 (57%), Gaps = 7/49 (14%)

Query: 3   ITNQVTVATVKALNYLK-EELKIIHRDVKPSNILL--DRRGAIKLCDFG 48
              Q+      AL +L   EL IIH D+KP NILL   +R AIK+ DFG
Sbjct: 162 FAQQM----CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 49.2 bits (118), Expect = 5e-09
 Identities = 14/27 (51%), Positives = 23/27 (85%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLA 175

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 49.2 bits (118), Expect = 5e-09
 Identities = 14/42 (33%), Positives = 27/42 (64%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGIS 50
           V A++++  ++ ++HRD+KP N+L    +    IK+ DFG +
Sbjct: 116 VSAVSHM-HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 48.9 bits (117), Expect = 6e-09
 Identities = 19/59 (32%), Positives = 33/59 (55%), Gaps = 6/59 (10%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVVEVVLPFLQINFGT 68
            + + ++ + + I+H D+KP NIL   R    IK+ DFG++ +         L++NFGT
Sbjct: 197 CEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGT 251

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 49.0 bits (117), Expect = 7e-09
 Identities = 4/26 (15%), Positives = 8/26 (30%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGI 49
           +      PS + +   G + L     
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPAT 175

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 48.6 bits (116), Expect = 7e-09
 Identities = 14/28 (50%), Positives = 20/28 (71%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            ++HRD+KP N+LLD     K+ DFG+S
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLS 163

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 48.5 bits (116), Expect = 9e-09
 Identities = 14/27 (51%), Positives = 21/27 (77%)

Query: 24  IIHRDVKPSNILLDRRGAIKLCDFGIS 50
           IIHRD+KPSNI++     +K+ DFG++
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLA 174

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 48.5 bits (116), Expect = 1e-08
 Identities = 17/42 (40%), Positives = 26/42 (61%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
              + Y+  +  I+HRD+KP NILL+ +     IK+ DFG+S
Sbjct: 131 FSGITYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 48.4 bits (116), Expect = 1e-08
 Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 4/45 (8%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQL 53
           ++AL Y   +  IIHRDVKP  +LL  +     +KL  FG++ QL
Sbjct: 140 LEALRYC-HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 48.4 bits (116), Expect = 1e-08
 Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGIS 50
           ++ + YL +   I+H D+KP NILL      G IK+ DFG+S
Sbjct: 141 LEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 48.2 bits (115), Expect = 1e-08
 Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           +  + YL  +  I+HRD+KP NILL+ +     IK+ DFG+S
Sbjct: 156 LSGICYL-HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 48.0 bits (115), Expect = 1e-08
 Identities = 16/29 (55%), Positives = 22/29 (75%)

Query: 22  LKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            KI+HRD+KP N+LLD    +K+ DFG+S
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLS 155

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 48.0 bits (115), Expect = 1e-08
 Identities = 14/28 (50%), Positives = 20/28 (71%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            ++HRD+KP N+LLD     K+ DFG+S
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLS 158

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 47.8 bits (114), Expect = 1e-08
 Identities = 15/59 (25%), Positives = 34/59 (57%), Gaps = 6/59 (10%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVVEVVLPFLQINFGT 68
            + L ++ E   I+H D+KP NI+ + +   ++K+ DFG++ +L  + +   +++   T
Sbjct: 159 CEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTAT 213

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 47.8 bits (114), Expect = 1e-08
 Identities = 17/42 (40%), Positives = 27/42 (64%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           +  + YL  +  I+HRD+KP N+LL+ +     IK+ DFG+S
Sbjct: 146 LSGVTYL-HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 47.9 bits (115), Expect = 1e-08
 Identities = 15/42 (35%), Positives = 27/42 (64%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           ++++ Y      I+HR++KP N+LL  +    A+KL DFG++
Sbjct: 115 LESIAYC-HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 47.7 bits (114), Expect = 2e-08
 Identities = 17/42 (40%), Positives = 26/42 (61%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           ++A+ YL  E  I+HRD+KP N+L         +K+ DFG+S
Sbjct: 158 LEAVAYL-HENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 47.7 bits (114), Expect = 2e-08
 Identities = 15/42 (35%), Positives = 27/42 (64%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           ++++ Y      I+HR++KP N+LL  +    A+KL DFG++
Sbjct: 138 LESIAYC-HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 47.8 bits (114), Expect = 2e-08
 Identities = 16/42 (38%), Positives = 28/42 (66%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           +  + Y+  + KI+HRD+KP N+LL+ +     I++ DFG+S
Sbjct: 136 LSGITYM-HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 47.6 bits (114), Expect = 2e-08
 Identities = 17/42 (40%), Positives = 24/42 (57%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           + A+ YL  E  I+HRD+KP N+L         I + DFG+S
Sbjct: 116 LSAVKYL-HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 47.7 bits (114), Expect = 2e-08
 Identities = 14/42 (33%), Positives = 29/42 (69%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           ++A+ +   ++ ++HR++KP N+LL  +    A+KL DFG++
Sbjct: 120 LEAVLHC-HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 47.3 bits (113), Expect = 2e-08
 Identities = 20/42 (47%), Positives = 26/42 (61%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           + A+ YL  E  IIHRD+KP N+LL  +     IK+ DFG S
Sbjct: 124 LLAVQYL-HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 47.3 bits (112), Expect = 3e-08
 Identities = 13/61 (21%), Positives = 24/61 (39%), Gaps = 16/61 (26%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILL-----------DRRGAIKLCDFGI 49
           +    ++    +  +  + +  +IIH D+KP N +L           D    + L D G 
Sbjct: 175 ISFAMRM----LYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 50  S 50
           S
Sbjct: 230 S 230

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 47.1 bits (112), Expect = 3e-08
 Identities = 17/59 (28%), Positives = 30/59 (50%), Gaps = 6/59 (10%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVVEVVLPFLQINFGT 68
            K L ++ E    +H D+KP NI+   +    +KL DFG++  L  +     +++  GT
Sbjct: 265 CKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGT 319

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 46.9 bits (112), Expect = 3e-08
 Identities = 17/41 (41%), Positives = 23/41 (56%), Gaps = 4/41 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGI 49
            +A+ YL   + I HRDVKP N+L   +     +KL DFG 
Sbjct: 127 GEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 47.0 bits (112), Expect = 3e-08
 Identities = 15/31 (48%), Positives = 20/31 (64%), Gaps = 2/31 (6%)

Query: 22  LKIIHRDVKPSNILLD--RRGAIKLCDFGIS 50
           ++I HRD+K  N LLD      +K+CDFG S
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYS 165

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 46.5 bits (111), Expect = 4e-08
 Identities = 10/28 (35%), Positives = 21/28 (75%), Gaps = 1/28 (3%)

Query: 24  IIHRDVKPSNILLDRRG-AIKLCDFGIS 50
           ++HRD+KP+N+ ++     +K+ DFG++
Sbjct: 141 VLHRDLKPANLFINTEDLVLKIGDFGLA 168

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 46.4 bits (111), Expect = 4e-08
 Identities = 17/43 (39%), Positives = 25/43 (58%), Gaps = 5/43 (11%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGA----IKLCDFGIS 50
           +  ++YL    +I H D+KP NI+L  +      IKL DFGI+
Sbjct: 118 LDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 46.6 bits (111), Expect = 4e-08
 Identities = 20/42 (47%), Positives = 26/42 (61%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGIS 50
           + A+ YL  E  IIHRD+KP N+LL   +    IK+ DFG S
Sbjct: 249 LLAVQYL-HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 46.6 bits (111), Expect = 4e-08
 Identities = 18/43 (41%), Positives = 25/43 (58%), Gaps = 5/43 (11%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGIS 50
           +  +NYL    KI H D+KP NI+L  +      IKL DFG++
Sbjct: 125 LDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 46.4 bits (111), Expect = 5e-08
 Identities = 15/42 (35%), Positives = 23/42 (54%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           + A+ Y   +L + HRD+KP N L         +KL DFG++
Sbjct: 116 LSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 46.3 bits (110), Expect = 5e-08
 Identities = 18/55 (32%), Positives = 25/55 (45%), Gaps = 14/55 (25%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGA-------------IKLCDFGISGQL 53
              + +L   LKIIHRD+KP NIL+                  I + DFG+  +L
Sbjct: 125 ASGVAHL-HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 46.1 bits (110), Expect = 5e-08
 Identities = 17/42 (40%), Positives = 26/42 (61%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
              + Y+  +  I+HRD+KP NILL+ +     IK+ DFG+S
Sbjct: 131 FSGITYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 46.1 bits (110), Expect = 7e-08
 Identities = 15/42 (35%), Positives = 23/42 (54%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGIS 50
           + AL Y      ++H+D+KP NIL         IK+ DFG++
Sbjct: 134 MNALAYF-HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 46.1 bits (110), Expect = 7e-08
 Identities = 17/43 (39%), Positives = 25/43 (58%), Gaps = 5/43 (11%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGA----IKLCDFGIS 50
           +  + YL   L+I H D+KP NI+L  R      IK+ DFG++
Sbjct: 124 LNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 45.7 bits (109), Expect = 8e-08
 Identities = 18/43 (41%), Positives = 25/43 (58%), Gaps = 5/43 (11%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGIS 50
           +  +NYL    KI H D+KP NI+L  +      IKL DFG++
Sbjct: 125 LDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 45.3 bits (108), Expect = 1e-07
 Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 6/59 (10%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRR--GAIKLCDFGISGQLVVEVVLPFLQINFGT 68
            +AL +L     I H D++P NI+   R    IK+ +FG + QL         ++ F  
Sbjct: 112 CEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTA 166

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 3e-07
 Identities = 15/55 (27%), Positives = 23/55 (41%), Gaps = 20/55 (36%)

Query: 13  KALNYLKEELKIIHRDVKPSNILL-------------------DRRGAIKLCDFG 48
            AL +L E  ++ H D+KP NIL                     +  +I++ DFG
Sbjct: 134 HALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.8 bits (104), Expect = 4e-07
 Identities = 16/55 (29%), Positives = 22/55 (40%), Gaps = 20/55 (36%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLD-------------------RRGAIKLCDFG 48
           K++N+L    K+ H D+KP NIL                         IK+ DFG
Sbjct: 129 KSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.9 bits (99), Expect = 2e-06
 Identities = 20/61 (32%), Positives = 26/61 (42%), Gaps = 26/61 (42%)

Query: 13  KALNYLKEELKIIHRDVKPSNILL-------------------------DRRGAIKLCDF 47
           KALNYL++ + + H D+KP NILL                          +   IKL DF
Sbjct: 148 KALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 48  G 48
           G
Sbjct: 207 G 207

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 41.5 bits (98), Expect = 3e-06
 Identities = 14/38 (36%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K +NYL E+ +++HRD+   N+L+     +K+ DFG++
Sbjct: 128 KGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 41.3 bits (97), Expect = 3e-06
 Identities = 10/29 (34%), Positives = 18/29 (62%), Gaps = 2/29 (6%)

Query: 24  IIHRDVKPSNILLDRRGA--IKLCDFGIS 50
            +H D+K +N+LL  +    + L D+G+S
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLS 200

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 41.1 bits (96), Expect = 4e-06
 Identities = 15/38 (39%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL EE   +HR++   N+LL  R   K+ DFG+S
Sbjct: 447 MGMKYL-EEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.7 bits (95), Expect = 6e-06
 Identities = 16/38 (42%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 204 KGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 40.3 bits (95), Expect = 6e-06
 Identities = 14/34 (41%), Positives = 19/34 (55%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +L      IHRD+   NILL      K+CDFG++
Sbjct: 160 FL-ASKNCIHRDLAARNILLTHGRITKICDFGLA 192

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 40.4 bits (95), Expect = 7e-06
 Identities = 13/38 (34%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL EE  ++HR++   N+LL     +++ DFG++
Sbjct: 126 KGMYYL-EEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 40.3 bits (95), Expect = 7e-06
 Identities = 14/38 (36%), Positives = 21/38 (55%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL E    IHRD+   N L+  +  +K+ DFG+S
Sbjct: 224 AGMEYL-ESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 40.4 bits (95), Expect = 7e-06
 Identities = 14/38 (36%), Positives = 26/38 (68%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K +NYL E+ +++HRD+   N+L+     +K+ DFG++
Sbjct: 128 KGMNYL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 40.3 bits (95), Expect = 7e-06
 Identities = 15/38 (39%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + YL E  + IHRD+   N+LL  R  +K+ DFG+ 
Sbjct: 132 EGMGYL-ESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 40.1 bits (94), Expect = 7e-06
 Identities = 14/38 (36%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            A+ YL E+   IHR++   N L+     +K+ DFG+S
Sbjct: 329 SAMEYL-EKKNFIHRNLAARNCLVGENHLVKVADFGLS 365

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 40.0 bits (94), Expect = 9e-06
 Identities = 12/34 (35%), Positives = 21/34 (61%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +L E    +HRD+   N+L+     +K+CDFG++
Sbjct: 187 FL-EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 39.9 bits (94), Expect = 9e-06
 Identities = 13/34 (38%), Positives = 18/34 (52%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +L      IHRDV   N+LL      K+ DFG++
Sbjct: 179 FL-ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 40.1 bits (94), Expect = 1e-05
 Identities = 10/29 (34%), Positives = 19/29 (65%), Gaps = 2/29 (6%)

Query: 24  IIHRDVKPSNILLDRRGA--IKLCDFGIS 50
            +H D+K SN+LL+ +    + L D+G++
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 39.9 bits (93), Expect = 1e-05
 Identities = 13/26 (50%), Positives = 19/26 (73%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILL 36
            ++ L+YL  + +IIH D+KP NILL
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILL 180

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 39.5 bits (93), Expect = 1e-05
 Identities = 15/38 (39%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL EE   +HRD+   N+LL  +   K+ DFG+S
Sbjct: 128 MGMKYL-EESNFVHRDLAARNVLLVTQHYAKISDFGLS 164

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 39.9 bits (93), Expect = 1e-05
 Identities = 12/38 (31%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + Y+ E +  +HRD++ +NIL+      K+ DFG++
Sbjct: 374 SGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLA 410

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 39.5 bits (91), Expect = 1e-05
 Identities = 10/38 (26%), Positives = 16/38 (42%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 48
              +L   +  L+  HRD+   N+LL +    KL    
Sbjct: 170 LTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL 207

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 39.7 bits (93), Expect = 1e-05
 Identities = 12/34 (35%), Positives = 22/34 (64%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ E+   IHRD++ +NIL+      K+ DFG++
Sbjct: 299 FI-EQRNYIHRDLRAANILVSASLVCKIADFGLA 331

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 39.5 bits (93), Expect = 1e-05
 Identities = 16/38 (42%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL EE   +HRD+   N+LL  R   K+ DFG+S
Sbjct: 121 MGMKYL-EEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 39.2 bits (92), Expect = 2e-05
 Identities = 14/38 (36%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL  +L  +HRD+   N+L+D     K+ DFG+S
Sbjct: 162 AGMRYL-SDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 39.3 bits (92), Expect = 2e-05
 Identities = 14/38 (36%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL    + IHRD+   NIL++    +K+ DFG++
Sbjct: 156 KGMEYL-GTKRYIHRDLATRNILVENENRVKIGDFGLT 192

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 39.2 bits (92), Expect = 2e-05
 Identities = 14/38 (36%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL    + IHRD+   NIL++    +K+ DFG++
Sbjct: 125 KGMEYL-GTKRYIHRDLATRNILVENENRVKIGDFGLT 161

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 38.7 bits (91), Expect = 2e-05
 Identities = 15/38 (39%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + YL EE  +IHRD+   N L+     IK+ DFG++
Sbjct: 115 EGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMT 151

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 39.0 bits (91), Expect = 2e-05
 Identities = 12/38 (31%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + Y+ E +  +HRD++ +NIL+      K+ DFG++
Sbjct: 291 SGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLA 327

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 38.9 bits (91), Expect = 2e-05
 Identities = 13/38 (34%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +A+ YL E    +HRD+   N+L+      K+ DFG++
Sbjct: 300 EAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 38.7 bits (91), Expect = 2e-05
 Identities = 17/38 (44%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           KA+ YL E +  +HRD+   NIL+     +KL DFG+S
Sbjct: 124 KAMAYL-ESINCVHRDIAVRNILVASPECVKLGDFGLS 160

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 38.9 bits (91), Expect = 3e-05
 Identities = 14/38 (36%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + YL      IHRD+   N+LLD    +K+ DFG++
Sbjct: 145 EGMAYL-HAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 38.8 bits (91), Expect = 3e-05
 Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL    K IHRD+   N+L+     +K+ DFG++
Sbjct: 172 YL-ASQKCIHRDLAARNVLVTENNVMKIADFGLA 204

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 38.7 bits (91), Expect = 3e-05
 Identities = 14/38 (36%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + +L E  + IHRD+   N L+DR   +K+ DFG++
Sbjct: 115 EGMAFL-ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 38.4 bits (90), Expect = 3e-05
 Identities = 12/38 (31%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K ++YL    + +HRD+   N+L++    +K+ DFG++
Sbjct: 137 KGMDYL-GSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 38.7 bits (90), Expect = 3e-05
 Identities = 16/38 (42%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            AL YL E  + +HRD+   N+L+     +KL DFG+S
Sbjct: 502 TALAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 38.5 bits (90), Expect = 3e-05
 Identities = 13/38 (34%), Positives = 21/38 (55%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL   +  +HRD+   NIL++     K+ DFG+S
Sbjct: 158 AGMKYL-ANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 38.5 bits (90), Expect = 3e-05
 Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL    K IHRD+   N+L+     +K+ DFG++
Sbjct: 218 YL-ASQKCIHRDLAARNVLVTENNVMKIADFGLA 250

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 38.4 bits (90), Expect = 3e-05
 Identities = 15/34 (44%), Positives = 22/34 (64%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +L    K IHRD+   NILL  +  +K+CDFG++
Sbjct: 163 FL-ASRKCIHRDLAARNILLSEKNVVKICDFGLA 195

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 38.4 bits (90), Expect = 3e-05
 Identities = 15/38 (39%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            A+ YL E+   IHRD+   N L+     +K+ DFG+S
Sbjct: 122 SAMEYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 38.6 bits (90), Expect = 3e-05
 Identities = 7/29 (24%), Positives = 14/29 (48%), Gaps = 2/29 (6%)

Query: 24  IIHRDVKPSNILLDR--RGAIKLCDFGIS 50
            +H +V   NI +D   +  + L  +G +
Sbjct: 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 38.3 bits (90), Expect = 4e-05
 Identities = 13/38 (34%), Positives = 22/38 (57%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +A+ YL E    +HRD+   N+L+      K+ DFG++
Sbjct: 128 EAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 38.4 bits (90), Expect = 4e-05
 Identities = 14/34 (41%), Positives = 23/34 (67%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL E  + +HRD+   N L++ +G +K+ DFG+S
Sbjct: 135 YL-ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 38.1 bits (89), Expect = 4e-05
 Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL    K IHRD+   N+L+     +K+ DFG++
Sbjct: 206 YL-ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 38.1 bits (89), Expect = 4e-05
 Identities = 12/38 (31%), Positives = 18/38 (47%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL      IHRD+   N +L     + + DFG+S
Sbjct: 148 CGMEYL-SSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 38.0 bits (89), Expect = 5e-05
 Identities = 16/38 (42%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            AL YL E  + +HRD+   N+L+     +KL DFG+S
Sbjct: 127 TALAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 38.0 bits (89), Expect = 5e-05
 Identities = 15/34 (44%), Positives = 23/34 (67%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL  E+K++HRD+   NIL+     +K+ DFG+S
Sbjct: 165 YL-AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 37.7 bits (88), Expect = 5e-05
 Identities = 13/32 (40%), Positives = 19/32 (59%), Gaps = 5/32 (15%)

Query: 24  IIHRDVKPSNILLDRRGA-----IKLCDFGIS 50
           +I+RDVKP N L+ R G      I + DF ++
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 37.7 bits (88), Expect = 5e-05
 Identities = 12/38 (31%), Positives = 21/38 (55%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL  ++  +HRD+   NIL++     K+ DFG+ 
Sbjct: 158 SGMKYL-SDMGYVHRDLAARNILINSNLVCKVSDFGLG 194

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 38.0 bits (89), Expect = 5e-05
 Identities = 13/38 (34%), Positives = 25/38 (65%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + ++ EE   IHRD++ +NIL+    + K+ DFG++
Sbjct: 120 EGMAFI-EERNYIHRDLRAANILVSDTLSCKIADFGLA 156

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 37.7 bits (88), Expect = 6e-05
 Identities = 13/38 (34%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL    + +HRD+   NIL++    +K+ DFG++
Sbjct: 138 KGMEYL-GSRRCVHRDLAARNILVESEAHVKIADFGLA 174

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 37.7 bits (88), Expect = 7e-05
 Identities = 11/34 (32%), Positives = 19/34 (55%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL    K +HRD+   N ++     +K+ DFG++
Sbjct: 153 YL-NANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 37.3 bits (87), Expect = 7e-05
 Identities = 19/46 (41%), Positives = 24/46 (52%), Gaps = 9/46 (19%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGA--------IKLCDFGIS 50
            A+++L EE  +IH +V   NILL R           IKL D GIS
Sbjct: 124 AAMHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 37.3 bits (87), Expect = 8e-05
 Identities = 11/32 (34%), Positives = 19/32 (59%), Gaps = 5/32 (15%)

Query: 24  IIHRDVKPSNILLDRRGA-----IKLCDFGIS 50
           +++RD+KP N L+ R  +     I + DFG+ 
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 37.3 bits (87), Expect = 8e-05
 Identities = 11/38 (28%), Positives = 18/38 (47%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
             + YL      +HRD+   N +L     + + DFG+S
Sbjct: 158 LGMEYL-SNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 37.4 bits (87), Expect = 8e-05
 Identities = 13/38 (34%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + +L    K +HRD+   N +LD +  +K+ DFG++
Sbjct: 203 KGMKFL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 37.2 bits (87), Expect = 8e-05
 Identities = 14/38 (36%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + + YL  E K +HRD+   N +LD    +K+ DFG++
Sbjct: 135 RGMEYL-AEQKFVHRDLAARNCMLDESFTVKVADFGLA 171

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 37.2 bits (87), Expect = 9e-05
 Identities = 14/38 (36%), Positives = 23/38 (60%), Gaps = 1/38 (2%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           K + YL    K +HRD+   N +LD +  +K+ DFG++
Sbjct: 139 KGMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 37.3 bits (87), Expect = 9e-05
 Identities = 14/34 (41%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL  + + IHRD+   NIL+      K+ DFG+S
Sbjct: 157 YL-SQKQFIHRDLAARNILVGENYVAKIADFGLS 189

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 36.9 bits (86), Expect = 1e-04
 Identities = 14/34 (41%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL  E K +HRD+   N L+     +K+ DFG+S
Sbjct: 189 YL-SERKFVHRDLATRNCLVGENMVVKIADFGLS 221

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 36.9 bits (85), Expect = 1e-04
 Identities = 10/30 (33%), Positives = 17/30 (56%), Gaps = 3/30 (10%)

Query: 24  IIHRDVKPSNILLDRRG---AIKLCDFGIS 50
            +HRD+KP N L+        + + DFG++
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 36.4 bits (85), Expect = 2e-04
 Identities = 12/34 (35%), Positives = 18/34 (52%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL      +HRD+   N L+     +K+ DFG+S
Sbjct: 148 YL-ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 36.5 bits (85), Expect = 2e-04
 Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL   L  +HRD+   N L+ +   +K+ DFG+S
Sbjct: 173 YL-AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 35.8 bits (83), Expect = 3e-04
 Identities = 16/37 (43%), Positives = 20/37 (54%), Gaps = 4/37 (10%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 50
           YL EE   IHRD+   N LL   G     K+ DFG++
Sbjct: 196 YL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 35.4 bits (82), Expect = 4e-04
 Identities = 16/37 (43%), Positives = 20/37 (54%), Gaps = 4/37 (10%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGIS 50
           YL EE   IHRD+   N LL   G     K+ DFG++
Sbjct: 155 YL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 35.3 bits (82), Expect = 4e-04
 Identities = 9/34 (26%), Positives = 19/34 (55%), Gaps = 1/34 (2%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           YL     ++H+D+   N+L+  +  +K+ D G+ 
Sbjct: 143 YL-SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 35.0 bits (81), Expect = 6e-04
 Identities = 12/30 (40%), Positives = 17/30 (56%), Gaps = 3/30 (10%)

Query: 24  IIHRDVKPSNILLDRRG---AIKLCDFGIS 50
            IHRDVKP N L+        + + DFG++
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	68
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.7
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.66
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.66
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.65
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.63
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.62
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.62
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.62
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.61
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.6
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.6
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.59
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.57
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.56
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.55
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.55
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.51
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.51
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.5
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.44
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.35
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.33
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.32
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.32
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.32
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.32
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.31
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.3
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.3
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.3
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.3
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.3
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.3
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.3
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.29
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.29
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.29
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.28
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.28
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.28
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.28
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.28
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.27
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.27
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.27
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.26
3niz_A	311	Rhodanese family protein; structural genomics, str	99.26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.25
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.24
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.24
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.24
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.23
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.23
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.23
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.21
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.21
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.21
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.2
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.2
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.2
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.2
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.2
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.2
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.2
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.2
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.2
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.2
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.19
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.18
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.17
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.17
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.15
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.15
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.14
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.14
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.14
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.14
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.13
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.12
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.12
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.12
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.11
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.11
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.11
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.11
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.11
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.1
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.1
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.1
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.1
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.1
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.1
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.1
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.1
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.1
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.09
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.09
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.09
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.09
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.09
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.09
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.09
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.09
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.09
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.08
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.08
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.08
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.08
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.08
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.08
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.08
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.07
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.07
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.07
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.07
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.07
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.07
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.07
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.06
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.06
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.06
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.06
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.06
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.06
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.06
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.05
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.05
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.05
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.05
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.05
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.05
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.05
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.05
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.04
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.04
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.04
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.04
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.04
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.04
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.03
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.03
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.03
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.03
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.03
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.02
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.02
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.02
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.01
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.01
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	98.99
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	98.99
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	98.99
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	98.99
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	98.98
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	98.97
3bhy_A	283	Death-associated protein kinase 3; death associate	98.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	98.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	98.96
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	98.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	98.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	98.96
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	98.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	98.95
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	98.94
2dyl_A	318	Dual specificity mitogen-activated protein kinase	98.92
3aln_A	327	Dual specificity mitogen-activated protein kinase;	98.91
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	98.89
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	98.87
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	98.83
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	98.8
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	98.72
3uqc_A	286	Probable conserved transmembrane protein; structur	98.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	96.39
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	96.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	95.36
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	93.84
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	87.56
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	87.18
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	87.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	85.78
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	84.85
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	83.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	82.76
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	81.56
3ats_A	357	Putative uncharacterized protein; hypothetical pro	80.91

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.70  E-value=4.7e-17  Score=87.11  Aligned_cols=65  Identities=40%  Similarity=0.503  Sum_probs=55.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .++.++.|++.|+.|+|+. +++|||+|++|++++....+++.|||+++.+..........+.+||
T Consensus       133 ~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GT  197 (311)
T 4aw0_A          133 CTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT  197 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccC
Confidence            4677899999999999996 9999999999999999999999999999988765544555566776

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.66  E-value=2.3e-16  Score=85.42  Aligned_cols=63  Identities=40%  Similarity=0.608  Sum_probs=53.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .++.++.|++.|+.|+|+. +++|||+|++|++++..+.+|+.|||+++.+..+.  ......+||
T Consensus       171 ~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT  233 (346)
T 4fih_A          171 QIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGT  233 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccC
Confidence            4678899999999999996 99999999999999999999999999998876543  233445565

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.66  E-value=1.8e-16  Score=84.69  Aligned_cols=65  Identities=26%  Similarity=0.383  Sum_probs=47.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .+..++.|++.|+.|+|+. +++|||+|+.|++++.+..+|++|||+|+..............+||
T Consensus       133 ~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT  197 (307)
T 3omv_A          133 QLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS  197 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccC
Confidence            4677899999999999996 9999999999999999999999999999876544333333344454

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.65  E-value=5e-16  Score=85.88  Aligned_cols=63  Identities=40%  Similarity=0.608  Sum_probs=52.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .++.++.|++.|+.|+|+. +++|||+|++|++++..+.+|+.|||+++.+....  ......+||
T Consensus       248 ~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT  310 (423)
T 4fie_A          248 QIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGT  310 (423)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEEC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccC
Confidence            4678899999999999996 99999999999999999999999999998876543  233344554

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.63  E-value=5.4e-16  Score=82.81  Aligned_cols=63  Identities=38%  Similarity=0.419  Sum_probs=49.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .++.++.|++.|+.|+|+. +++|||+|++|++++....+++.|||+|+...+..  ....+.+||
T Consensus       127 ~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT  189 (304)
T 3ubd_A          127 DVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT  189 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccC
Confidence            4677899999999999996 99999999999999999999999999998765543  233344555

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.62  E-value=6.9e-16  Score=82.14  Aligned_cols=53  Identities=26%  Similarity=0.539  Sum_probs=43.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      +..++.|++.|+.|+|+. +++|||+||.|+++.....+++.|||+++.+....
T Consensus       120 ~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~  172 (299)
T 4g31_A          120 CLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE  172 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCCCC-------
T ss_pred             HHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCCcEEEccCccceecCCCc
Confidence            567899999999999996 99999999999999999999999999998876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.62  E-value=1.1e-15  Score=81.69  Aligned_cols=65  Identities=15%  Similarity=0.308  Sum_probs=53.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .+..++.|++.|+.|+|+. +++|||+++.|++++....+|++|||+++.+.........+..+||
T Consensus       146 ~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt  210 (308)
T 4gt4_A          146 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP  210 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccC
Confidence            3567899999999999996 8999999999999999999999999999987655433333444444

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.62  E-value=2.7e-16  Score=85.28  Aligned_cols=53  Identities=36%  Similarity=0.538  Sum_probs=48.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|||+|++|++++..+.+|+.|||+++.+.+.
T Consensus       126 ~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          126 QILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            3567899999999999996 9999999999999999999999999999887653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.61  E-value=1.1e-15  Score=80.67  Aligned_cols=53  Identities=34%  Similarity=0.604  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|||+||+|++++....+++.|||+|+...+.
T Consensus       113 ~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A          113 EARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            4678899999999999996 9999999999999999999999999999876554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.60  E-value=1.3e-15  Score=82.01  Aligned_cols=54  Identities=24%  Similarity=0.365  Sum_probs=42.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|||+|+.|++++....+|+.|||+++.+....
T Consensus       159 ~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~  212 (329)
T 4aoj_A          159 QLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD  212 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECCCCcEEEcccccceeccCCC
Confidence            3567899999999999996 99999999999999999999999999998875544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.60  E-value=8.1e-16  Score=81.91  Aligned_cols=54  Identities=22%  Similarity=0.390  Sum_probs=48.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|||+++.|++++.+..+|+.|||+++......
T Consensus       129 ~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  182 (299)
T 4asz_A          129 QMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD  182 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCCcEEECCcccceecCCCC
Confidence            3567899999999999996 99999999999999999999999999998776544

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.59  E-value=9.8e-16  Score=83.12  Aligned_cols=53  Identities=30%  Similarity=0.611  Sum_probs=47.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      +..++.|++.|+.|+|+. +++|||+++.|++++....+|+.|||+|+.+..+.
T Consensus       187 ~~~~~~qia~gl~yLH~~-~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~  239 (353)
T 4ase_A          187 LICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  239 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred             HHHHHHHHHHHHHhHhhC-CeecCccCccceeeCCCCCEEECcchhhhhcccCC
Confidence            457889999999999996 89999999999999999999999999999876544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.57  E-value=6.9e-15  Score=80.82  Aligned_cols=65  Identities=28%  Similarity=0.503  Sum_probs=50.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccc--cccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVL--PFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~~gt   68 (68)
                      .++.++.|++.|+.|+|+. +++|||+|+.|++++....+++.|||+++.+......  ....+.+||
T Consensus       159 ~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT  225 (398)
T 4b99_A          159 HVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT  225 (398)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeC
Confidence            4678899999999999996 9999999999999999999999999999887543221  233344555

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.56  E-value=5.8e-15  Score=79.75  Aligned_cols=53  Identities=34%  Similarity=0.535  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC-cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~-~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|||+|+.|++++..+ .+++.|||+++.+.++
T Consensus       151 ~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          151 RALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            4677899999999999996 999999999999998776 5999999999887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.55  E-value=1e-14  Score=77.45  Aligned_cols=52  Identities=29%  Similarity=0.509  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC--ceeeccCCCcEEEcC-CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK--IIHRDVKPSNILLDR-RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~--~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.|+.|+|+. +  ++|||+||.|+++.. ...+|+.|||+|+....
T Consensus       130 ~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          130 VLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            4567899999999999986 6  999999999999974 67899999999976443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.55  E-value=3e-15  Score=85.01  Aligned_cols=52  Identities=25%  Similarity=0.433  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ...++.|++.++.|+|+. +++|||+||.|+++..++.+|+.|||+++.+...
T Consensus       341 ~~~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          341 REKILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             HHHHHHHHHHHHHHHHHC-CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            356889999999999996 9999999999999999999999999999877554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.51  E-value=3.2e-14  Score=82.32  Aligned_cols=54  Identities=24%  Similarity=0.469  Sum_probs=48.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|+. +++|||+||+|++++..+.++++|||+|+.+....
T Consensus       293 ~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          293 DMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            4677899999999999996 99999999999999999999999999998876543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.51  E-value=3.6e-14  Score=77.16  Aligned_cols=52  Identities=37%  Similarity=0.522  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.|+.|+|+. +++|||+||+|++++.. ..+++.|||+|+...+
T Consensus       118 ~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          118 EVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            4678899999999999996 99999999999999765 6899999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.50  E-value=4.3e-14  Score=75.27  Aligned_cols=55  Identities=27%  Similarity=0.392  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHHhhC-------CCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEE-------LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~-------~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+.       .+++|||+|+.|++++.+..+|++|||+++......
T Consensus       101 ~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  162 (303)
T 3hmm_A          101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT  162 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence            3567889999999999963       279999999999999999999999999998776543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.44  E-value=3.5e-13  Score=72.70  Aligned_cols=51  Identities=24%  Similarity=0.438  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-----------CCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-----------RGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-----------~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+|+++.|+++..           ...+++.|||+++.+.
T Consensus       173 ~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~  234 (365)
T 3e7e_A          173 LVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK  234 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGG
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhh
Confidence            3678899999999999996 9999999999999987           7889999999997654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.41  E-value=4.3e-13  Score=76.39  Aligned_cols=54  Identities=28%  Similarity=0.478  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC--CcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR--GAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~--~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|+. +++|||+++.|+++...  ..+++.|||+++.+.+..
T Consensus       256 ~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          256 EAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            4677899999999999996 99999999999999754  679999999999876543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.35  E-value=3.4e-12  Score=67.99  Aligned_cols=54  Identities=26%  Similarity=0.506  Sum_probs=48.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+....
T Consensus       116 ~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A          116 LLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            4677889999999999996 99999999999999999999999999998875443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.34  E-value=4.5e-12  Score=67.70  Aligned_cols=53  Identities=32%  Similarity=0.553  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       106 ~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A          106 DAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            4678899999999999996 9999999999999999999999999999876543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.33  E-value=5.1e-12  Score=68.60  Aligned_cols=52  Identities=27%  Similarity=0.517  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       205 ~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  256 (370)
T 2psq_A          205 LVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNI  256 (370)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCSSCEETTCC
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeccccchhhEEECCCCCEEEccccCCcccCcc
Confidence            566889999999999996 9999999999999999999999999999876543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.32  E-value=3.3e-12  Score=69.10  Aligned_cols=51  Identities=35%  Similarity=0.565  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++...
T Consensus       125 ~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          125 RARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            3567889999999999996 99999999999999999999999999987643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.32  E-value=5.4e-12  Score=69.33  Aligned_cols=50  Identities=42%  Similarity=0.589  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++..
T Consensus       154 ~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          154 HARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            4567889999999999996 9999999999999999999999999999763

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.32  E-value=4.1e-12  Score=70.33  Aligned_cols=52  Identities=27%  Similarity=0.602  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       157 ~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          157 HIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            4677899999999999996 999999999999999999999999999987653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.32  E-value=7.3e-12  Score=72.43  Aligned_cols=51  Identities=31%  Similarity=0.509  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++...
T Consensus       443 ~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          443 HAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            3567889999999999996 99999999999999999999999999998643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.31  E-value=4.8e-12  Score=69.82  Aligned_cols=53  Identities=34%  Similarity=0.653  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.....
T Consensus       130 ~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          130 HIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            4677899999999999997 9999999999999999999999999999876543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.31  E-value=7.7e-12  Score=67.56  Aligned_cols=51  Identities=33%  Similarity=0.576  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++...
T Consensus       119 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A          119 RATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            3567889999999999996 99999999999999999999999999987653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.30  E-value=7.8e-12  Score=69.41  Aligned_cols=53  Identities=34%  Similarity=0.590  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++.+...
T Consensus       176 ~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          176 MARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            3567889999999999996 9999999999999999999999999999776543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.30  E-value=1e-11  Score=65.24  Aligned_cols=51  Identities=31%  Similarity=0.699  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||.++...
T Consensus       102 ~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A          102 IVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            4677899999999999996 99999999999999999999999999997764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.30  E-value=8.4e-12  Score=67.59  Aligned_cols=51  Identities=31%  Similarity=0.509  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++...
T Consensus       122 ~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          122 HAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            3567889999999999996 99999999999999999999999999987643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.30  E-value=1.1e-11  Score=65.52  Aligned_cols=53  Identities=40%  Similarity=0.683  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++......
T Consensus       117 ~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A          117 QIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             HHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            4567889999999999996 9999999999999999999999999998776543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.30  E-value=9.7e-12  Score=67.79  Aligned_cols=51  Identities=39%  Similarity=0.621  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++...+.+++.|||+++...
T Consensus       140 ~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          140 RARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            3566889999999999996 99999999999999999999999999998644

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.30  E-value=1e-11  Score=67.09  Aligned_cols=53  Identities=28%  Similarity=0.550  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc--CCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD--RRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~--~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.  ....+++.|||+++.+...
T Consensus       153 ~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          153 TVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGG
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCCCCeEEEEECCcceecccC
Confidence            4677899999999999996 999999999999998  7788999999999876544

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.29  E-value=5.6e-12  Score=68.54  Aligned_cols=50  Identities=40%  Similarity=0.718  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      ++.++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++.+.
T Consensus       111 ~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A          111 KQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             HHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            466788999999999996 99999999999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.29  E-value=9.3e-12  Score=66.76  Aligned_cols=53  Identities=36%  Similarity=0.591  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++.....
T Consensus       115 ~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A          115 EARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            3567889999999999996 9999999999999999999999999999876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.29  E-value=7.8e-12  Score=67.32  Aligned_cols=51  Identities=33%  Similarity=0.598  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       106 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A          106 RARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            3567889999999999996 99999999999999999999999999987643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.29  E-value=7.6e-12  Score=68.35  Aligned_cols=53  Identities=30%  Similarity=0.535  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++. ...+++.|||+++.+....
T Consensus       156 ~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          156 ERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            4567889999999999996 999999999999995 4679999999998775543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.29  E-value=3.1e-12  Score=68.39  Aligned_cols=52  Identities=17%  Similarity=0.262  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHh-hCCCceeeccCCCcEEEcCCC--------------------cEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLK-EELKIIHRDVKPSNILLDRRG--------------------AIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~-~~~~~~h~~l~~~~~~~~~~~--------------------~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+| .. +++|+|+++.|+++....                    .+++.|||+++...+
T Consensus       162 ~~~~i~~qi~~aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          162 TAKSILHQLTASLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            46788999999999999 75 899999999999998765                    799999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.29  E-value=1.2e-11  Score=65.07  Aligned_cols=52  Identities=40%  Similarity=0.681  Sum_probs=46.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       138 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  189 (298)
T 2zv2_A          138 QARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG  189 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            4567889999999999996 999999999999999999999999999877654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.28  E-value=7e-12  Score=69.87  Aligned_cols=53  Identities=28%  Similarity=0.453  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.....
T Consensus       165 ~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          165 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  217 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence            3567889999999999996 9999999999999999999999999999876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.28  E-value=3.1e-12  Score=68.28  Aligned_cols=53  Identities=30%  Similarity=0.567  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       118 ~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A          118 YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            3567889999999999996 9999999999999999999999999999876543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.28  E-value=1.2e-11  Score=68.24  Aligned_cols=53  Identities=42%  Similarity=0.613  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++.+...
T Consensus       169 ~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          169 WARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            3567889999999999996 9999999999999999999999999999876543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.28  E-value=8.6e-12  Score=66.44  Aligned_cols=54  Identities=28%  Similarity=0.428  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCC----------CceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEEL----------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~----------~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.++.|+|+ .          +++|+++++.|+++.....+++.|||+++.+....
T Consensus       122 ~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~  185 (322)
T 3soc_A          122 ELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK  185 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTS
T ss_pred             HHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccccc
Confidence            456789999999999997 4          79999999999999999999999999998766543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.28  E-value=1.2e-11  Score=66.67  Aligned_cols=50  Identities=42%  Similarity=0.589  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++..
T Consensus       111 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A          111 HARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            3567889999999999996 9999999999999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.28  E-value=1.3e-11  Score=67.57  Aligned_cols=52  Identities=42%  Similarity=0.721  Sum_probs=46.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       116 ~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A          116 TVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            3567889999999999996 999999999999999999999999999987654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.27  E-value=1.1e-11  Score=68.57  Aligned_cols=51  Identities=33%  Similarity=0.605  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhh-CCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~-~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|+ . +++|+++++.|++++....+++.|||+++...
T Consensus       249 ~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          249 RARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             HHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            356788999999999997 6 89999999999999999999999999987643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.27  E-value=1.5e-11  Score=67.89  Aligned_cols=53  Identities=38%  Similarity=0.598  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++.+...
T Consensus       163 ~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          163 MARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            3567889999999999996 9999999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.27  E-value=1.9e-11  Score=64.59  Aligned_cols=52  Identities=33%  Similarity=0.636  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++....
T Consensus       121 ~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  172 (308)
T 3g33_A          121 TIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSY  172 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEeeCccccccCC
Confidence            4677899999999999996 899999999999999999999999999976654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.27  E-value=7.4e-12  Score=67.16  Aligned_cols=53  Identities=30%  Similarity=0.535  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++. ...+++.|||+++.+....
T Consensus       109 ~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A          109 ERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            4567889999999999996 999999999999996 4669999999998775443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.27  E-value=1.7e-11  Score=64.98  Aligned_cols=52  Identities=27%  Similarity=0.570  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.....
T Consensus       166 ~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            577899999999999996 9999999999999999999999999999877654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.27  E-value=1.6e-11  Score=66.09  Aligned_cols=53  Identities=34%  Similarity=0.575  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...+.
T Consensus       109 ~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B          109 EGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            4567889999999999996 9999999999999999999999999998776543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.27  E-value=1.3e-11  Score=67.09  Aligned_cols=52  Identities=25%  Similarity=0.502  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++....
T Consensus       192 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  243 (382)
T 3tt0_A          192 DLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHH  243 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCcceEEEcCCCcEEEcccCccccccc
Confidence            4677899999999999996 999999999999999999999999999987654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.26  E-value=4.9e-12  Score=67.86  Aligned_cols=52  Identities=31%  Similarity=0.603  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       194 ~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          194 HLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence            3567889999999999996 999999999999999889999999999986643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.26  E-value=1.9e-11  Score=64.94  Aligned_cols=51  Identities=29%  Similarity=0.582  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       120 ~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A          120 QIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            4567889999999999996 99999999999999999999999999997764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.26  E-value=1.9e-11  Score=69.47  Aligned_cols=53  Identities=34%  Similarity=0.547  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++...+.+++.|||+++.+...
T Consensus       290 ~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          290 RAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            3566789999999999996 9999999999999999999999999999876554

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.26  E-value=2.5e-11  Score=64.58  Aligned_cols=51  Identities=35%  Similarity=0.715  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       109 ~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A          109 LVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            3567788999999999996 99999999999999999999999999987764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.26  E-value=1.1e-11  Score=65.75  Aligned_cols=53  Identities=25%  Similarity=0.434  Sum_probs=42.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||.++.....
T Consensus       138 ~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~  190 (323)
T 3qup_A          138 TLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG  190 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             HHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCCCEEEeecccccccccc
Confidence            3567889999999999996 9999999999999999999999999999876543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.25  E-value=7.7e-12  Score=66.83  Aligned_cols=53  Identities=30%  Similarity=0.567  Sum_probs=42.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+...
T Consensus       118 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A          118 YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             HHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            3567889999999999996 9999999999999998899999999999876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.25  E-value=2e-11  Score=64.38  Aligned_cols=52  Identities=29%  Similarity=0.482  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       151 ~~~~i~~qi~~~l~~lH~~-~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~  202 (314)
T 2ivs_A          151 DLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYE  202 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTEEEECCCTTCEECTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcccccchheEEEcCCCCEEEccccccccccc
Confidence            3567889999999999996 999999999999999999999999999887654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.25  E-value=1.3e-11  Score=65.96  Aligned_cols=52  Identities=23%  Similarity=0.558  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       174 ~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~  225 (344)
T 1rjb_A          174 LLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD  225 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred             HHHHHHHHHHHHHHHHhC-CcccCCCChhhEEEcCCCcEEeCCCccCcccccC
Confidence            567889999999999996 9999999999999999999999999999876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.24  E-value=2.9e-11  Score=64.62  Aligned_cols=51  Identities=35%  Similarity=0.567  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       122 ~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A          122 TACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            3566789999999999996 99999999999999999999999999987644

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.24  E-value=4e-11  Score=66.64  Aligned_cols=53  Identities=28%  Similarity=0.466  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..   ...+++.|||+++.....
T Consensus       111 ~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A          111 DASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            3567889999999999996 9999999999999973   467999999999776544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.24  E-value=1.5e-11  Score=65.23  Aligned_cols=52  Identities=38%  Similarity=0.487  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|++++....+++.|||++.....
T Consensus       158 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          158 QVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            4567899999999999996 999999999999999999999999999876644

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.24  E-value=3.2e-11  Score=64.72  Aligned_cols=51  Identities=35%  Similarity=0.689  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.
T Consensus       125 ~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A          125 EIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            4678899999999999996 99999999999999999999999999987764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.24  E-value=2.2e-11  Score=63.92  Aligned_cols=53  Identities=25%  Similarity=0.406  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHh--------hCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLK--------EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~--------~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|        .. +++|+++++.|+++.....+++.|||+++.....
T Consensus       106 ~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  166 (301)
T 3q4u_A          106 SCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS  166 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCCCEEEeeCCCeeecccc
Confidence            35678899999999999        75 8999999999999999999999999998766543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.24  E-value=2.3e-11  Score=64.48  Aligned_cols=53  Identities=23%  Similarity=0.431  Sum_probs=46.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.....
T Consensus       139 ~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          139 KMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  191 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCCeEEECcCccccccccc
Confidence            3566889999999999996 9999999999999999999999999998876543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.24  E-value=2.7e-11  Score=64.34  Aligned_cols=51  Identities=41%  Similarity=0.604  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       140 ~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          140 QRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGT  190 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred             HHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            4567889999999999996 99999999999999999999999999987654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.24  E-value=2.4e-11  Score=65.29  Aligned_cols=52  Identities=38%  Similarity=0.714  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       113 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A          113 HIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            4677899999999999996 999999999999999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.23  E-value=3.9e-11  Score=64.01  Aligned_cols=53  Identities=40%  Similarity=0.660  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       142 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          142 QIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence            4567889999999999996 9999999999999999999999999998776543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.23  E-value=1.8e-11  Score=66.95  Aligned_cols=52  Identities=29%  Similarity=0.632  Sum_probs=43.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE----cCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~----~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++    .....+++.|||+++.+..
T Consensus       129 ~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  184 (405)
T 3rgf_A          129 MVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  184 (405)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCC
Confidence            3677899999999999996 99999999999999    5667899999999987654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.23  E-value=3.6e-11  Score=64.84  Aligned_cols=53  Identities=36%  Similarity=0.592  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC---cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~---~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++....   .+++.|||+++.....
T Consensus       131 ~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~  186 (351)
T 3c0i_A          131 VASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES  186 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCcceeEecCC
Confidence            3567889999999999996 999999999999997544   3999999999876553

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.23  E-value=1.5e-11  Score=67.63  Aligned_cols=53  Identities=25%  Similarity=0.370  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|+. +++|+|+|+.|+++.....+++.|||+++.....
T Consensus       212 ~~~~i~~qi~~aL~~LH~~-~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~  264 (413)
T 3dzo_A          212 ARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS  264 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCcccceEEEecCCeEEEEeccceeecCCc
Confidence            3456778999999999996 9999999999999999999999999998765443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.23  E-value=2.6e-11  Score=64.70  Aligned_cols=53  Identities=26%  Similarity=0.581  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc-----EEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-----IKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~-----~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....     +++.|||+++.+...
T Consensus       106 ~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A          106 TVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            4567899999999999996 9999999999999987665     999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.23  E-value=1.2e-11  Score=65.94  Aligned_cols=52  Identities=27%  Similarity=0.500  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.....
T Consensus       176 ~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  227 (343)
T 1luf_A          176 QLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA  227 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCcceEEECCCCeEEEeecCCCcccccC
Confidence            456889999999999996 9999999999999998889999999998776443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.23  E-value=2.3e-11  Score=65.82  Aligned_cols=51  Identities=16%  Similarity=0.293  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ..++.|++.++.|+|.. +++|+|+++.|++++....+++.|||+++.....
T Consensus       197 ~~i~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~  247 (371)
T 3q60_A          197 HILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR  247 (371)
T ss_dssp             HHHHHHHHHHHHHHHHT-TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE
T ss_pred             HHHHHHHHHHHHHHHHC-CCccCcCCHHHEEECCCCCEEEEecceeeecCCC
Confidence            45669999999999996 9999999999999999999999999999876543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.23  E-value=1.9e-11  Score=66.98  Aligned_cols=52  Identities=33%  Similarity=0.564  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..   ...+++.|||+++....
T Consensus       162 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          162 EASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            4577899999999999996 9999999999999986   67899999999987653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.23  E-value=4.4e-11  Score=64.62  Aligned_cols=53  Identities=30%  Similarity=0.627  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.....
T Consensus       129 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          129 HICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            3567889999999999996 9999999999999999999999999999876543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.22  E-value=2e-11  Score=66.23  Aligned_cols=50  Identities=26%  Similarity=0.396  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++...
T Consensus       208 ~~~i~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~  257 (377)
T 3byv_A          208 RLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  257 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             HHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence            456889999999999996 99999999999999999999999999988644

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.22  E-value=3.7e-11  Score=67.34  Aligned_cols=53  Identities=28%  Similarity=0.550  Sum_probs=47.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++...+.
T Consensus       117 ~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A          117 ESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            4567899999999999996 9999999999999999999999999999876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.22  E-value=3.2e-11  Score=68.99  Aligned_cols=53  Identities=32%  Similarity=0.499  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++.+...
T Consensus       287 ~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          287 RAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            3567889999999999996 9999999999999999999999999999877543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.21  E-value=3.1e-11  Score=65.17  Aligned_cols=52  Identities=40%  Similarity=0.510  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       160 ~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          160 EVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            3567788999999999996 999999999999999999999999999887643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.21  E-value=1.1e-11  Score=67.25  Aligned_cols=52  Identities=29%  Similarity=0.410  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..   ...+++.|||+++.+..
T Consensus       182 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~  236 (367)
T 3l9p_A          182 DLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR  236 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCceEEECCCcccccccc
Confidence            3567899999999999996 9999999999999984   34599999999976543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.21  E-value=1.9e-11  Score=64.15  Aligned_cols=51  Identities=31%  Similarity=0.605  Sum_probs=41.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       121 ~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A          121 KLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEccceeccccc
Confidence            3567889999999999996 99999999999999999999999999987654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.21  E-value=6.1e-11  Score=62.18  Aligned_cols=53  Identities=23%  Similarity=0.409  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc-----EEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-----IKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~-----~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....     +++.|||+++.....
T Consensus       107 ~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A          107 TVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            4677899999999999986 9999999999999976554     999999999876654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.21  E-value=5.4e-11  Score=62.71  Aligned_cols=52  Identities=33%  Similarity=0.574  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       134 ~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          134 MRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             HHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence            3567889999999999996 999999999999999999999999999876544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.21  E-value=5.9e-11  Score=61.66  Aligned_cols=52  Identities=33%  Similarity=0.558  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       106 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A          106 DAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            4577889999999999996 999999999999999989999999999876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.21  E-value=3.8e-11  Score=65.62  Aligned_cols=53  Identities=36%  Similarity=0.637  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-CCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|++++ ....+++.|||+++.+...
T Consensus       142 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          142 LIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            3567889999999999996 999999999999998 6788999999999876443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.21  E-value=4.9e-11  Score=63.69  Aligned_cols=53  Identities=26%  Similarity=0.484  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.....
T Consensus       158 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  210 (334)
T 2pvf_A          158 DLVSCTYQLARGMEYLASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNI  210 (334)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECTTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            3567889999999999996 9999999999999999999999999998776543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.21  E-value=4.7e-11  Score=64.08  Aligned_cols=53  Identities=36%  Similarity=0.530  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+...
T Consensus       131 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  183 (335)
T 3dls_A          131 LASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG  183 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence            4567899999999999996 9999999999999999999999999999876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.21  E-value=1.9e-11  Score=64.10  Aligned_cols=51  Identities=27%  Similarity=0.711  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++...
T Consensus       101 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A          101 TAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            3567889999999999996 99999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.20  E-value=2.6e-11  Score=63.97  Aligned_cols=53  Identities=28%  Similarity=0.527  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.....
T Consensus       146 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  198 (313)
T 1t46_A          146 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKND  198 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEcCCCCEEEcccccccccccc
Confidence            3567889999999999996 9999999999999999999999999998876544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.20  E-value=5.6e-11  Score=64.56  Aligned_cols=53  Identities=34%  Similarity=0.545  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC----cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~----~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++....    .+++.|||+++.+.+.
T Consensus       116 ~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~  172 (361)
T 2yab_A          116 EATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG  172 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence            4577899999999999996 999999999999997655    6999999999876553

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.20  E-value=2.7e-11  Score=64.16  Aligned_cols=52  Identities=38%  Similarity=0.648  Sum_probs=43.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       117 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A          117 RAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            3567889999999999996 999999999999999999999999999977654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.20  E-value=7e-11  Score=62.48  Aligned_cols=52  Identities=25%  Similarity=0.443  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||.++....
T Consensus       109 ~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A          109 QRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            4567889999999999996 999999999999999999999999999987644

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.20  E-value=4.7e-11  Score=64.53  Aligned_cols=53  Identities=30%  Similarity=0.548  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.....
T Consensus       142 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          142 HARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            3567889999999999996 9999999999999999999999999999876543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.20  E-value=2.6e-11  Score=65.86  Aligned_cols=52  Identities=27%  Similarity=0.455  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++...+
T Consensus       214 ~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          214 TLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            3567889999999999996 999999999999999999999999999876544

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.20  E-value=6.1e-11  Score=63.39  Aligned_cols=52  Identities=40%  Similarity=0.657  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++....
T Consensus       107 ~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A          107 VAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            3567889999999999986 999999999999999999999999999987654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.20  E-value=5.8e-11  Score=63.75  Aligned_cols=52  Identities=27%  Similarity=0.540  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC--cEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~--~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++....  .+++.|||+++.+..
T Consensus       152 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~  205 (345)
T 2v62_A          152 TVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP  205 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCcEEEEeCCCceeccc
Confidence            4677899999999999996 999999999999998766  899999999987654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.20  E-value=3.6e-11  Score=63.60  Aligned_cols=52  Identities=23%  Similarity=0.438  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       148 ~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~  199 (313)
T 3brb_A          148 TLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS  199 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTSCEEECSCSCC-----
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            4577889999999999996 999999999999999999999999999877644

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.20  E-value=4.6e-11  Score=65.78  Aligned_cols=51  Identities=41%  Similarity=0.694  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~   55 (68)
                      ++.++.|++.++.|+|.. +++|+++++.|+++... ..+++.|||+++.+..
T Consensus       158 ~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          158 VKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             HHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            567889999999999996 99999999999999854 5689999999987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.19  E-value=8.1e-11  Score=61.93  Aligned_cols=51  Identities=29%  Similarity=0.615  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       110 ~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C          110 QAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            4567889999999999996 99999999999999999999999999987764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.19  E-value=7.5e-11  Score=66.21  Aligned_cols=54  Identities=20%  Similarity=0.480  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE---cCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~---~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++   .....+++.|||+++.+....
T Consensus       104 ~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A          104 TVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            4677899999999999996 99999999999999   467889999999998776543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.19  E-value=8.9e-11  Score=61.44  Aligned_cols=53  Identities=25%  Similarity=0.515  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE---cCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~---~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++   .....+++.|||.++.....
T Consensus       106 ~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A          106 TVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            4577889999999999996 99999999999999   67788999999999876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.18  E-value=1.7e-11  Score=65.24  Aligned_cols=52  Identities=25%  Similarity=0.496  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.....
T Consensus       166 ~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  217 (333)
T 2i1m_A          166 LLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND  217 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGC
T ss_pred             HHHHHHHHHHHHHHHhcC-CcccCCcccceEEECCCCeEEECccccccccccc
Confidence            567889999999999996 9999999999999998889999999999876543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.18  E-value=4.7e-11  Score=63.65  Aligned_cols=51  Identities=33%  Similarity=0.683  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       101 ~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A          101 NVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            3567889999999999996 99999999999999999999999999987654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.18  E-value=7.3e-11  Score=62.87  Aligned_cols=53  Identities=32%  Similarity=0.568  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCC--------CceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEEL--------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~--------~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|...        +++|+++++.|+++.....+++.|||+++.+..
T Consensus       112 ~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~  172 (336)
T 3g2f_A          112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG  172 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             HHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence            35678899999999999731        899999999999999999999999999987653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.18  E-value=4.8e-11  Score=62.90  Aligned_cols=52  Identities=33%  Similarity=0.585  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       112 ~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A          112 TAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            4567889999999999996 999999999999999999999999999877654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.18  E-value=2.6e-11  Score=64.04  Aligned_cols=52  Identities=31%  Similarity=0.603  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       149 ~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  200 (316)
T 2xir_A          149 HLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  200 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEECCCcccccccc
Confidence            3567889999999999996 999999999999999888999999999876643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.17  E-value=8.2e-11  Score=63.83  Aligned_cols=52  Identities=31%  Similarity=0.545  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++....
T Consensus       129 ~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          129 RIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            3567889999999999996 999999999999999999999999999987544

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.17  E-value=7.5e-11  Score=62.99  Aligned_cols=53  Identities=26%  Similarity=0.392  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++.+...
T Consensus       152 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          152 QLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            4567889999999999996 9999999999999999999999999999876543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.17  E-value=6.2e-11  Score=62.57  Aligned_cols=51  Identities=43%  Similarity=0.801  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       103 ~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A          103 LVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            4567889999999999996 99999999999999999999999999987755

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.17  E-value=7.6e-11  Score=62.59  Aligned_cols=53  Identities=36%  Similarity=0.522  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE----cCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~----~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++    .....+++.|||+++.+...
T Consensus       113 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A          113 EFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            4567889999999999996 99999999999988    55667899999999876544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.17  E-value=7.6e-11  Score=62.96  Aligned_cols=53  Identities=28%  Similarity=0.437  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC--CCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~--~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..  ...+++.|||+++.+.+.
T Consensus       103 ~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A          103 EIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            4577899999999999996 9999999999999986  678999999999876543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.16  E-value=5.2e-11  Score=63.27  Aligned_cols=52  Identities=33%  Similarity=0.657  Sum_probs=41.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC--ceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~--~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +  ++|+++++.|+++.....+++.|||+++....
T Consensus       138 ~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          138 RRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             HHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            3567889999999999986 8  99999999999999999999999999875443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.16  E-value=1.1e-10  Score=63.29  Aligned_cols=53  Identities=28%  Similarity=0.561  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC---CcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~---~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++...   ..+++.|||+++...+.
T Consensus       129 ~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          129 DASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            3567889999999999996 99999999999999754   35999999999876543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.16  E-value=5e-11  Score=64.60  Aligned_cols=52  Identities=29%  Similarity=0.460  Sum_probs=42.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       128 ~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          128 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            3567889999999999996 999999999999999999999999999877654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.16  E-value=1e-10  Score=61.32  Aligned_cols=52  Identities=27%  Similarity=0.533  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+.+
T Consensus       125 ~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          125 DLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            3567889999999999996 999999999999999999999999999976644

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.15  E-value=9.4e-11  Score=61.62  Aligned_cols=53  Identities=25%  Similarity=0.538  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.....
T Consensus       127 ~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          127 QQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            3567889999999999996 9999999999999998899999999999876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.15  E-value=1.2e-10  Score=61.94  Aligned_cols=53  Identities=30%  Similarity=0.498  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC-cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~-~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.... .+++.|||+++.....
T Consensus       131 ~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          131 DIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            3567889999999999996 999999999999998665 7999999999766543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.15  E-value=1.4e-10  Score=61.99  Aligned_cols=52  Identities=31%  Similarity=0.518  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC----cEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~----~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++....    .+++.|||+++.+..
T Consensus       115 ~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A          115 EATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            4567899999999999996 999999999999997665    799999999987653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.15  E-value=6.7e-11  Score=63.23  Aligned_cols=52  Identities=27%  Similarity=0.475  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC---cEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~---~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++....   .+++.|||+++....
T Consensus       107 ~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A          107 EASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            4567899999999999996 999999999999997544   789999999976543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.15  E-value=7.6e-11  Score=65.43  Aligned_cols=52  Identities=21%  Similarity=0.441  Sum_probs=46.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++....
T Consensus       285 ~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          285 KLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            3567889999999999996 999999999999999999999999999987654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.15  E-value=9.7e-11  Score=62.50  Aligned_cols=52  Identities=35%  Similarity=0.772  Sum_probs=43.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.+..
T Consensus       125 ~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          125 VVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            4667899999999999996 999999999999999999999999999876543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.15  E-value=1.1e-10  Score=61.74  Aligned_cols=51  Identities=22%  Similarity=0.296  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ...++.|++.++.++|.. +++|+++++.|+++. ...+++.|||+++.....
T Consensus       195 ~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~~~vkl~DFG~a~~~~~~  245 (282)
T 1zar_A          195 PDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEE  245 (282)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-TTEEEECCCTTCEETTST
T ss_pred             HHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-CCcEEEEECCCCeECCCC
Confidence            456889999999999996 999999999999999 888999999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.14  E-value=1.6e-10  Score=62.30  Aligned_cols=53  Identities=40%  Similarity=0.721  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC----CcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~----~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++...    ..+++.|||+++.+...
T Consensus       117 ~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A          117 EASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            3567889999999999996 99999999999998433    34899999999876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.14  E-value=9.8e-11  Score=64.68  Aligned_cols=52  Identities=37%  Similarity=0.592  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc--EEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~--~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....  +++.|||+++....
T Consensus       201 ~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          201 LVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            4677899999999999996 9999999999999988766  99999999876543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.14  E-value=1.3e-10  Score=63.22  Aligned_cols=53  Identities=30%  Similarity=0.658  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-CCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++. ....+++.|||.++.+...
T Consensus       142 ~~~~i~~qi~~aL~~LH~~-gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  195 (383)
T 3eb0_A          142 LISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS  195 (383)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence            4567889999999999986 999999999999997 5778999999999876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.14  E-value=1.7e-10  Score=62.53  Aligned_cols=53  Identities=40%  Similarity=0.649  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+...
T Consensus       201 ~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          201 ETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            4567889999999999996 9999999999999999999999999998876543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.14  E-value=1.9e-10  Score=61.53  Aligned_cols=51  Identities=27%  Similarity=0.487  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...
T Consensus       142 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          142 EARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            4567889999999999996 99999999999999999999999999987764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.14  E-value=1.6e-10  Score=62.18  Aligned_cols=52  Identities=40%  Similarity=0.567  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-------------------------CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-------------------------RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-------------------------~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++..                         ...+++.|||+++....
T Consensus       138 ~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~  214 (360)
T 3llt_A          138 DIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD  214 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence            4567889999999999996 9999999999999964                         67799999999876543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.13  E-value=1.6e-10  Score=61.43  Aligned_cols=54  Identities=28%  Similarity=0.522  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCC-------CceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~-------~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|...       +++|+++++.|+++.....+++.|||+++.+...
T Consensus       135 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~  195 (337)
T 3mdy_A          135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD  195 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccc
Confidence            35678899999999999731       7999999999999999999999999999766443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.13  E-value=9.4e-11  Score=63.69  Aligned_cols=52  Identities=29%  Similarity=0.566  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++....
T Consensus       133 ~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          133 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            3567889999999999996 999999999999999999999999999877543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.13  E-value=1.9e-10  Score=62.57  Aligned_cols=53  Identities=26%  Similarity=0.374  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE--cCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL--DRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~--~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++  .....+++.|||+++.+.+.
T Consensus       188 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          188 DTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            3566788999999999996 99999999999998  45567999999999876544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.13  E-value=1.3e-10  Score=61.09  Aligned_cols=52  Identities=27%  Similarity=0.503  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++...+
T Consensus       129 ~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          129 DLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            3567889999999999996 999999999999999999999999999976654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.13  E-value=8.4e-11  Score=61.75  Aligned_cols=52  Identities=33%  Similarity=0.529  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++....
T Consensus       115 ~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A          115 KLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             HHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            3567889999999999996 999999999999999999999999999987654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.12  E-value=1.2e-10  Score=62.59  Aligned_cols=53  Identities=25%  Similarity=0.445  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC--cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~--~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++....  .+++.|||+++.+...
T Consensus       160 ~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          160 SVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCC
Confidence            4577899999999999996 999999999999999877  8999999999876543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.12  E-value=1.3e-10  Score=63.50  Aligned_cols=53  Identities=36%  Similarity=0.522  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE----cCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~----~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++    .....+++.|||.++.+...
T Consensus       113 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A          113 EFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            4567889999999999996 99999999999998    55566899999999876544

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.12  E-value=1.4e-10  Score=64.27  Aligned_cols=51  Identities=33%  Similarity=0.520  Sum_probs=42.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-----CCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-----RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-----~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|+. +++|+++++.|+++..     ...+++.|||+++.+..
T Consensus       120 ~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          120 PITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             HHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            457889999999999996 9999999999999942     23578999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.12  E-value=2.4e-10  Score=59.29  Aligned_cols=53  Identities=25%  Similarity=0.495  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++...+.
T Consensus       105 ~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A          105 QLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            4567889999999999996 9999999999999999999999999998876544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.12  E-value=2.7e-10  Score=59.66  Aligned_cols=53  Identities=25%  Similarity=0.512  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc---CCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~---~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.   ....+++.|||.++.....
T Consensus       106 ~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A          106 TVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            4567899999999999996 999999999999994   6778999999999876554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.12  E-value=2.4e-10  Score=61.03  Aligned_cols=51  Identities=37%  Similarity=0.650  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC--cEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~--~~~~~~~g~~~~~~~   55 (68)
                      ++.++.|++.++.|+|.. +++|+++++.|+++....  .+++.|||.++.+..
T Consensus       170 ~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          170 ISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            567889999999999996 999999999999997655  799999999986543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.12  E-value=3.2e-10  Score=59.53  Aligned_cols=51  Identities=27%  Similarity=0.487  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       116 ~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A          116 EARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            3567889999999999996 99999999999999999999999999987764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.11  E-value=3e-10  Score=60.33  Aligned_cols=53  Identities=36%  Similarity=0.596  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCC--CceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEEL--KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~--~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|...  +++|+++++.|+++.....+++.|||.++....
T Consensus       132 ~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY  186 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence            45778999999999999832  799999999999999999999999999987643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.11  E-value=1.3e-10  Score=65.19  Aligned_cols=53  Identities=25%  Similarity=0.488  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|++++....+++.|||+++.....
T Consensus       319 ~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          319 VLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            3567889999999999996 9999999999999998899999999999876543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.11  E-value=3.3e-10  Score=59.01  Aligned_cols=53  Identities=26%  Similarity=0.520  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE---cCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~---~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++   .....+++.|||.+....+.
T Consensus       107 ~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A          107 DAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            4567899999999999996 99999999999999   66788999999998776543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.11  E-value=1.6e-10  Score=61.56  Aligned_cols=53  Identities=26%  Similarity=0.520  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.....
T Consensus       128 ~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          128 RLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            4567889999999999996 9999999999999999999999999999876543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.11  E-value=2.1e-10  Score=61.62  Aligned_cols=53  Identities=30%  Similarity=0.669  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHh--hCCCceeeccCCCcEEEcC-CCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLK--EELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~--~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|  .. +++|+++++.|+++.. ...+++.|||+++.+...
T Consensus       130 ~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~  185 (360)
T 3e3p_A          130 LIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS  185 (360)
T ss_dssp             HHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT
T ss_pred             HHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC
Confidence            35678899999999999  75 9999999999999986 788999999999876543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.11  E-value=2.7e-10  Score=60.84  Aligned_cols=52  Identities=29%  Similarity=0.490  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE-------------------cCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL-------------------DRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~-------------------~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++                   .....+++.|||.++....
T Consensus       124 ~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          124 HVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc
Confidence            4677899999999999996 99999999999999                   4567899999999876443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.11  E-value=1.4e-10  Score=63.89  Aligned_cols=52  Identities=40%  Similarity=0.556  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC---CcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~---~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++...   ..+++.|||+++.+..
T Consensus       240 ~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  294 (419)
T 3i6u_A          240 TCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE  294 (419)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence            4567889999999999996 99999999999999654   3499999999987654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.11  E-value=2.6e-10  Score=60.45  Aligned_cols=52  Identities=33%  Similarity=0.695  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       121 ~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  172 (326)
T 1blx_A          121 TIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF  172 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccccccC
Confidence            3567889999999999996 999999999999999999999999999876653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.10  E-value=1.5e-10  Score=61.31  Aligned_cols=52  Identities=31%  Similarity=0.546  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.. ..+++.|||+++.+...
T Consensus       128 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          128 ERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            4567889999999999996 9999999999999964 77999999998876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.10  E-value=1.1e-10  Score=63.55  Aligned_cols=51  Identities=25%  Similarity=0.520  Sum_probs=40.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|+. +++|+++++.|++++....+++.|||+++.+.+
T Consensus       194 ~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          194 LIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             HHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeeccccccccc
Confidence            567889999999999996 999999999999999999999999999986644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.10  E-value=2.1e-10  Score=63.67  Aligned_cols=51  Identities=24%  Similarity=0.527  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++...
T Consensus       290 ~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          290 CLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            3567889999999999996 99999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.10  E-value=1.2e-10  Score=63.29  Aligned_cols=53  Identities=25%  Similarity=0.406  Sum_probs=40.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       148 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          148 QLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            3567889999999999996 9999999999999999999999999999876543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.10  E-value=2.2e-10  Score=62.71  Aligned_cols=53  Identities=26%  Similarity=0.499  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC--CCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~--~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..  ...+++.|||+++.+...
T Consensus       150 ~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          150 EVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            4677899999999999996 9999999999999974  466999999999876543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.10  E-value=2.9e-10  Score=59.96  Aligned_cols=54  Identities=33%  Similarity=0.541  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++..   ...+++.|||+++......
T Consensus       118 ~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (299)
T 3m2w_A          118 EASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK  174 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEecccccccccccc
Confidence            4677899999999999996 9999999999999987   6789999999998766543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.10  E-value=1.7e-10  Score=62.03  Aligned_cols=51  Identities=29%  Similarity=0.545  Sum_probs=42.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       135 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (362)
T 3pg1_A          135 HIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDT  185 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCTTC-----
T ss_pred             HHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCCCEEEEecCcccccc
Confidence            4567899999999999996 99999999999999999999999999987544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.10  E-value=1.8e-10  Score=61.71  Aligned_cols=52  Identities=33%  Similarity=0.625  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       113 ~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A          113 HIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            3567889999999999996 999999999999999999999999999887653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.10  E-value=8.7e-11  Score=62.74  Aligned_cols=51  Identities=25%  Similarity=0.572  Sum_probs=43.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-----CCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-----RRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-----~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|+. +++|+++++.|+++.     ....+++.|||+++.+.
T Consensus       133 ~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          133 VIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            4577899999999999996 999999999999995     34458999999987654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.09  E-value=3.4e-10  Score=63.32  Aligned_cols=53  Identities=32%  Similarity=0.638  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC---CcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~---~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++...   ..+++.|||+++.....
T Consensus       137 ~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          137 DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            3567889999999999996 99999999999999653   45999999998776543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.09  E-value=9e-11  Score=61.34  Aligned_cols=52  Identities=29%  Similarity=0.480  Sum_probs=39.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       117 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A          117 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECccccccccCc
Confidence            3567889999999999996 999999999999999889999999999877654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.09  E-value=2.3e-10  Score=62.02  Aligned_cols=52  Identities=25%  Similarity=0.543  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       145 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          145 KIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            4567889999999999996 999999999999999999999999999876544

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.09  E-value=2.9e-10  Score=60.44  Aligned_cols=53  Identities=26%  Similarity=0.456  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.....
T Consensus       135 ~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          135 QLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            4567889999999999996 9999999999999999999999999999876543

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.09  E-value=2.2e-10  Score=60.16  Aligned_cols=51  Identities=31%  Similarity=0.684  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       104 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  154 (299)
T 2r3i_A          104 LIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  154 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence            3567889999999999996 99999999999999999999999999887654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.09  E-value=2.5e-10  Score=59.46  Aligned_cols=51  Identities=35%  Similarity=0.575  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       113 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A          113 EARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            4567889999999999996 99999999999999999999999999987654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.09  E-value=2.8e-10  Score=60.71  Aligned_cols=53  Identities=26%  Similarity=0.416  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHh--------hCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLK--------EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~--------~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|        .. +++|+++++.|+++.....+++.|||+++.....
T Consensus       140 ~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  200 (342)
T 1b6c_B          140 GMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  200 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCCCEEEEECCCceecccc
Confidence            35678899999999999        64 8999999999999999999999999998776543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.09  E-value=5.2e-10  Score=58.91  Aligned_cols=53  Identities=43%  Similarity=0.749  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....+.
T Consensus       120 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          120 QIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            4567889999999999996 9999999999999999899999999998776543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.09  E-value=1.7e-10  Score=62.50  Aligned_cols=50  Identities=34%  Similarity=0.507  Sum_probs=42.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc--EEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~--~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....  +++.|||+++..
T Consensus       117 ~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A          117 EARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            4577889999999999996 9999999999999976554  999999998743

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.09  E-value=5.4e-10  Score=59.06  Aligned_cols=52  Identities=44%  Similarity=0.692  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+....+
T Consensus       126 ~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          126 EIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            3567889999999999996 999999999999999989999999999877654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.09  E-value=2.5e-10  Score=59.60  Aligned_cols=52  Identities=27%  Similarity=0.556  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       121 ~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A          121 QLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            4677899999999999996 999999999999999999999999999876643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.08  E-value=3.6e-10  Score=60.15  Aligned_cols=53  Identities=32%  Similarity=0.518  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-CCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++. ....+++.|||+++...+.
T Consensus       150 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~  203 (320)
T 3a99_A          150 LARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT  203 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc
Confidence            4567889999999999996 999999999999998 6788999999998876543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.08  E-value=1.4e-10  Score=64.08  Aligned_cols=52  Identities=33%  Similarity=0.456  Sum_probs=44.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-------------CcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-------------GAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-------------~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.|+.|+|+. +++|+++++.|+++...             ..+++.|||+++.+...
T Consensus       117 ~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~  181 (434)
T 2rio_A          117 PISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG  181 (434)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-
T ss_pred             HHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCC
Confidence            356899999999999996 99999999999999643             46899999999877553

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.08  E-value=4.9e-10  Score=59.60  Aligned_cols=53  Identities=34%  Similarity=0.545  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC----cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~----~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++....    .+++.|||.++...+.
T Consensus       116 ~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~  172 (321)
T 2a2a_A          116 EATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG  172 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc
Confidence            4567889999999999996 999999999999998766    7999999998776543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.08  E-value=2.7e-10  Score=63.61  Aligned_cols=52  Identities=33%  Similarity=0.627  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc---CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~---~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.   ....+++.|||+++....
T Consensus       122 ~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          122 DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            4677899999999999996 999999999999995   345699999999876644

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.08  E-value=3.9e-10  Score=58.80  Aligned_cols=50  Identities=20%  Similarity=0.281  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHh-hCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLK-EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~-~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.++| .. +++|+|++|.|+++..  .+++.|||++.....+
T Consensus       172 ~~~i~~qi~~~l~~lH~~~-givHrDlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          172 VEGIFNDVVENVKRLYQEA-ELVHADLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-CEECSSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            4678899999999999 75 9999999999999987  8999999999776443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.08  E-value=8.7e-11  Score=67.66  Aligned_cols=53  Identities=28%  Similarity=0.486  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+|+++.|+++.....+++.|||+++.+...
T Consensus       470 ~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          470 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            3567899999999999996 9999999999999999999999999999876543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.08  E-value=2.8e-10  Score=60.38  Aligned_cols=52  Identities=37%  Similarity=0.596  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..+..
T Consensus       130 ~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          130 WIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  181 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence            3567889999999999996 999999999999999999999999999876543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.08  E-value=3.5e-10  Score=58.92  Aligned_cols=53  Identities=32%  Similarity=0.585  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++.+...
T Consensus       123 ~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  175 (284)
T 2a19_B          123 LALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND  175 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEESSCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCEEECcchhheecccc
Confidence            3567889999999999996 9999999999999998899999999998776543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.08  E-value=2.3e-10  Score=61.76  Aligned_cols=52  Identities=40%  Similarity=0.631  Sum_probs=46.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++....
T Consensus       155 ~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          155 EIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            3567889999999999996 999999999999999999999999999876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.08  E-value=4.9e-10  Score=59.44  Aligned_cols=52  Identities=31%  Similarity=0.478  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-------------------CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-------------------RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-------------------~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..                   ...+++.|||.++....
T Consensus       119 ~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          119 HIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc
Confidence            4567899999999999996 9999999999999976                   55689999999876543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.07  E-value=2.8e-10  Score=61.18  Aligned_cols=52  Identities=25%  Similarity=0.543  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       127 ~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          127 KIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            4567889999999999996 999999999999999999999999999876543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.07  E-value=1.5e-10  Score=66.40  Aligned_cols=52  Identities=29%  Similarity=0.496  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+..
T Consensus       437 ~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          437 NVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            4567899999999999996 999999999999999999999999999987653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.07  E-value=3.4e-10  Score=59.02  Aligned_cols=53  Identities=23%  Similarity=0.460  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|+. +++|+++++.|+++.....+++.|||.++.....
T Consensus       110 ~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A          110 KLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            3567889999999999996 9999999999999999899999999998876543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.07  E-value=4.3e-10  Score=58.90  Aligned_cols=52  Identities=31%  Similarity=0.512  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       111 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A          111 NVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            4567889999999999996 999999999999999889999999999887653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.07  E-value=1.4e-10  Score=64.38  Aligned_cols=52  Identities=21%  Similarity=0.424  Sum_probs=44.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++.....+++.|||+++...+
T Consensus       281 ~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          281 QLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            4567889999999999996 999999999999999888999999999987654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.07  E-value=1.6e-10  Score=65.30  Aligned_cols=52  Identities=21%  Similarity=0.424  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++.+.+
T Consensus       364 ~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          364 QLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            4567889999999999996 999999999999999888999999999987654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.07  E-value=2.6e-10  Score=64.75  Aligned_cols=49  Identities=20%  Similarity=0.436  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          5 NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         5 ~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      ..++.|++.++.|+|+. +++|+|+++.|+++..  .+++.|||+++...+.
T Consensus       434 ~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          434 LDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             THHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             HHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            36789999999999996 9999999999999988  8999999999887653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.07  E-value=4e-10  Score=58.79  Aligned_cols=52  Identities=37%  Similarity=0.609  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++.....
T Consensus       110 ~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A          110 RTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            3567889999999999986 999999999999999999999999998765543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.06  E-value=5.1e-10  Score=62.76  Aligned_cols=53  Identities=34%  Similarity=0.671  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC---cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~---~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++....   .+++.|||+++.....
T Consensus       147 ~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          147 DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD  202 (504)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence            4577899999999999996 999999999999997654   6899999999876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.06  E-value=3.2e-10  Score=61.67  Aligned_cols=51  Identities=25%  Similarity=0.430  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+....
T Consensus       129 ~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          129 AIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            4567889999999999996 99999999999999999999999999876543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.06  E-value=5.7e-10  Score=58.44  Aligned_cols=51  Identities=35%  Similarity=0.666  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.. ...+++.|||.++....
T Consensus       124 ~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          124 IGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             HHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            456788999999999996 9999999999999986 78899999999876643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.06  E-value=2e-10  Score=59.64  Aligned_cols=52  Identities=27%  Similarity=0.486  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       107 ~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A          107 TLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            3567889999999999996 999999999999999888999999999876644

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.06  E-value=2.1e-10  Score=60.87  Aligned_cols=52  Identities=38%  Similarity=0.667  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC--ceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~--~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +  ++|+++++.|+++.....+++.|||+++....
T Consensus       137 ~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  190 (337)
T 3ll6_A          137 TVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH  190 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccceeccc
Confidence            4677899999999999986 7  99999999999999999999999999877654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.06  E-value=3.2e-10  Score=61.12  Aligned_cols=52  Identities=33%  Similarity=0.585  Sum_probs=40.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++..   ...+++.|||+++....
T Consensus       149 ~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          149 DAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            4567889999999999996 9999999999999975   67899999999876644

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.06  E-value=4e-10  Score=60.99  Aligned_cols=38  Identities=34%  Similarity=0.642  Sum_probs=32.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG   40 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~   40 (68)
                      .++.++.|++.++.|+|...+++|+++++.|+++....
T Consensus       147 ~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            46788999999999999833799999999999997553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.06  E-value=3.4e-10  Score=60.40  Aligned_cols=52  Identities=35%  Similarity=0.596  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++..   ...+++.|||+++....
T Consensus       132 ~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          132 DVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            4677899999999999996 9999999999999986   67899999999987654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.06  E-value=4.5e-10  Score=58.89  Aligned_cols=52  Identities=29%  Similarity=0.618  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc---CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~---~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.   ....+++.|||.++.+..
T Consensus       125 ~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          125 YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            3567889999999999996 999999999999994   456799999999976554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.05  E-value=5.2e-10  Score=59.01  Aligned_cols=51  Identities=24%  Similarity=0.565  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-CCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++. ....+++.|||.++...
T Consensus       121 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~  172 (320)
T 2i6l_A          121 HARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD  172 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccCccccccC
Confidence            3567889999999999996 999999999999997 45689999999988764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.05  E-value=3.7e-10  Score=59.03  Aligned_cols=52  Identities=31%  Similarity=0.585  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       122 ~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A          122 TLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            3567889999999999996 999999999999999889999999999877654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.05  E-value=1.5e-10  Score=64.51  Aligned_cols=53  Identities=30%  Similarity=0.679  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc---CCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~---~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.   ....+++.|||+++.+...
T Consensus       127 ~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          127 DAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            4567899999999999996 999999999999994   5678999999998776543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.05  E-value=5.4e-10  Score=64.62  Aligned_cols=52  Identities=27%  Similarity=0.422  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|+. +++|+++++.|+++... .+++.|||+++.....
T Consensus       183 ~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          183 EAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            4577899999999999996 99999999999999875 7899999999876543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.05  E-value=1.9e-10  Score=60.10  Aligned_cols=54  Identities=54%  Similarity=0.923  Sum_probs=40.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|...+++|+++++.|+++.....+++.|||.++.....
T Consensus       110 ~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A          110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             HHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            356789999999999998338999999999999999999999999998776543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.05  E-value=6.8e-10  Score=58.05  Aligned_cols=52  Identities=29%  Similarity=0.582  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC--ceeeccCCCcEEEcCCCc-----EEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGA-----IKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~--~~h~~l~~~~~~~~~~~~-----~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +  ++|+++++.|+++.....     +++.|||.++....
T Consensus       123 ~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~  181 (287)
T 4f0f_A          123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH  181 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc
Confidence            3567889999999999986 8  999999999999976654     89999999875543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.05  E-value=8.6e-10  Score=57.54  Aligned_cols=53  Identities=26%  Similarity=0.543  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc---EEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~---~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....   +++.|||.+......
T Consensus       106 ~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A          106 DASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            4567889999999999996 9999999999999975544   999999998766543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.05  E-value=8.7e-10  Score=57.85  Aligned_cols=52  Identities=44%  Similarity=0.593  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       125 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  176 (298)
T 1phk_A          125 ETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP  176 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence            4567889999999999996 999999999999999999999999999877654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.04  E-value=3.8e-10  Score=60.42  Aligned_cols=52  Identities=27%  Similarity=0.396  Sum_probs=42.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       148 ~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          148 QLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            4567889999999999996 999999999999999999999999999887654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.04  E-value=5.6e-10  Score=59.46  Aligned_cols=53  Identities=32%  Similarity=0.536  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.....
T Consensus       146 ~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          146 KLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            3567889999999999996 9999999999999998899999999999876543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.04  E-value=2.1e-10  Score=61.04  Aligned_cols=52  Identities=29%  Similarity=0.418  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc---CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~---~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.   ....+++.|||+++....
T Consensus       141 ~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~  195 (327)
T 2yfx_A          141 DLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR  195 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcceEEECcccccccccc
Confidence            3567889999999999996 999999999999998   345699999998876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.04  E-value=4.7e-10  Score=59.35  Aligned_cols=51  Identities=33%  Similarity=0.646  Sum_probs=42.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc---EEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~---~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....   +++.|||+++...
T Consensus       112 ~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A          112 EASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             HHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            3567889999999999996 9999999999999986554   8999999987654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.04  E-value=4e-10  Score=59.13  Aligned_cols=53  Identities=28%  Similarity=0.486  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||+++.....
T Consensus       118 ~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A          118 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            3567899999999999996 9999999999999998899999999998776543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.04  E-value=9.1e-10  Score=58.89  Aligned_cols=52  Identities=40%  Similarity=0.740  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHHHHhh-CCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~-~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|. . +++|+++++.|+++.....+++.|||.++....
T Consensus       152 ~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  204 (348)
T 2pml_X          152 VIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD  204 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             HHHHHHHHHHHHHHHHhccC-CEeecCCChHhEEEcCCCcEEEecccccccccc
Confidence            466789999999999998 6 899999999999999999999999999877543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.03  E-value=4.3e-10  Score=59.89  Aligned_cols=50  Identities=28%  Similarity=0.520  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++..
T Consensus       143 ~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~  192 (327)
T 1fvr_A          143 QLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQ  192 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEESS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcCCCeEEEcccCcCccc
Confidence            3567899999999999996 9999999999999998889999999998743

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.03  E-value=5e-10  Score=58.63  Aligned_cols=51  Identities=33%  Similarity=0.601  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++...
T Consensus       117 ~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  167 (303)
T 1zy4_A          117 EYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH  167 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCCCSCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeCcchhhcc
Confidence            3567889999999999996 99999999999999999999999999987654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.03  E-value=6.1e-10  Score=58.07  Aligned_cols=51  Identities=24%  Similarity=0.528  Sum_probs=42.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       119 ~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A          119 LLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             HHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            567889999999999996 999999999999999989999999999876543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.03  E-value=6.9e-10  Score=57.71  Aligned_cols=52  Identities=23%  Similarity=0.468  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-------------------CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-------------------RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-------------------~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++.                   ....+++.|||.+.....
T Consensus       116 ~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  186 (289)
T 1x8b_A          116 ELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS  186 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence            4577899999999999996 999999999999997                   334689999999877654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.03  E-value=4.6e-10  Score=58.68  Aligned_cols=51  Identities=37%  Similarity=0.484  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCc--------EEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--------IKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~--------~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....        +++.|||.+....
T Consensus       114 ~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~  172 (289)
T 4fvq_A          114 WKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL  172 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCcccccccceeeeccCccccccc
Confidence            3567889999999999996 9999999999999987665        9999999986654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.02  E-value=1.1e-09  Score=57.26  Aligned_cols=52  Identities=37%  Similarity=0.622  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||++.....
T Consensus       115 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A          115 RSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            3567889999999999986 999999999999999889999999998865543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.02  E-value=4e-10  Score=58.84  Aligned_cols=52  Identities=31%  Similarity=0.462  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       114 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A          114 TLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            3567889999999999996 999999999999999889999999999877654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.02  E-value=5.2e-10  Score=59.08  Aligned_cols=52  Identities=27%  Similarity=0.530  Sum_probs=40.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       137 ~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          137 TVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             HHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            3567889999999999996 999999999999999999999999999876544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.01  E-value=8.1e-10  Score=58.40  Aligned_cols=53  Identities=38%  Similarity=0.526  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc-CCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++. ....+++.|||.++.....
T Consensus       140 ~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~  193 (312)
T 2iwi_A          140 PSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE  193 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC
Confidence            4567889999999999996 999999999999998 7788999999998876543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.01  E-value=1.2e-09  Score=59.43  Aligned_cols=53  Identities=49%  Similarity=0.667  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHHhh-CCCceeeccCCCcEEEc--CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKE-ELKIIHRDVKPSNILLD--RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~-~~~~~h~~l~~~~~~~~--~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|. ..+++|+++++.|+++.  ....+++.|||+++....
T Consensus       158 ~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             HHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             HHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence            456789999999999994 24899999999999995  366799999999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.00  E-value=1.1e-09  Score=58.23  Aligned_cols=52  Identities=40%  Similarity=0.563  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC---cEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~---~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++....   .+++.|||+++....
T Consensus       115 ~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  169 (322)
T 2ycf_A          115 TCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE  169 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence            3567889999999999996 999999999999997654   499999999877644

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.00  E-value=9.9e-10  Score=58.12  Aligned_cols=50  Identities=30%  Similarity=0.432  Sum_probs=45.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.++..
T Consensus       135 ~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          135 QILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            3567889999999999996 9999999999999999899999999987654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.00  E-value=1.3e-09  Score=57.09  Aligned_cols=52  Identities=29%  Similarity=0.509  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC--ceeeccCCCcEEEc-CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK--IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~--~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +  ++|+++++.|+++. ....+++.|||.+.....
T Consensus       130 ~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          130 VLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             HHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            4567889999999999986 7  99999999999997 678899999999865443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=98.99  E-value=4.5e-10  Score=58.71  Aligned_cols=53  Identities=26%  Similarity=0.504  Sum_probs=46.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++.....
T Consensus       112 ~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A          112 VLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            3567889999999999996 9999999999999998889999999998776543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=98.99  E-value=6.7e-10  Score=57.46  Aligned_cols=52  Identities=27%  Similarity=0.486  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.++....
T Consensus       105 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A          105 TLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            3567889999999999996 999999999999999888999999999876643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=98.99  E-value=5e-10  Score=64.76  Aligned_cols=52  Identities=29%  Similarity=0.493  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||+++...+.
T Consensus       493 ~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          493 LILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             HHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            457889999999999996 9999999999999998899999999999876543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=98.99  E-value=9.4e-10  Score=59.24  Aligned_cols=53  Identities=28%  Similarity=0.473  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc------CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD------RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~------~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|...+++|+++++.|+++.      ....+++.|||+++....
T Consensus       132 ~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~  190 (373)
T 1q8y_A          132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE  190 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC
Confidence            35678899999999999833899999999999994      233689999999877654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=98.97  E-value=1.4e-09  Score=56.42  Aligned_cols=53  Identities=38%  Similarity=0.616  Sum_probs=40.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC---ceeeccCCCcEEEcC--------CCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK---IIHRDVKPSNILLDR--------RGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~---~~h~~l~~~~~~~~~--------~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|.. +   ++|+++++.|+++..        ...+++.|||.++.....
T Consensus       106 ~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~  169 (271)
T 3dtc_A          106 ILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT  169 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc
Confidence            4677899999999999996 6   889999999999975        567999999998765543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=98.97  E-value=1.9e-09  Score=56.25  Aligned_cols=52  Identities=35%  Similarity=0.581  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC----cEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~----~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++....    .+++.|||.+.....
T Consensus       109 ~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A          109 EATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            4567889999999999996 999999999999997655    799999999877643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=98.96  E-value=3.9e-10  Score=59.26  Aligned_cols=49  Identities=41%  Similarity=0.734  Sum_probs=44.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||++..
T Consensus       118 ~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A          118 QIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            3567889999999999996 999999999999999889999999998654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=98.96  E-value=3.3e-10  Score=58.97  Aligned_cols=52  Identities=33%  Similarity=0.537  Sum_probs=44.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC-----ceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK-----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~-----~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +     ++|+++++.|+++.....+++.|||.++....
T Consensus       112 ~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~  168 (279)
T 2w5a_A          112 FVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  168 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred             HHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence            3577889999999999986 7     99999999999999999999999999876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=98.96  E-value=1.2e-09  Score=57.84  Aligned_cols=52  Identities=31%  Similarity=0.370  Sum_probs=42.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       135 ~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          135 RAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             HHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            3567889999999999996 999999999999999989999999998876544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=98.96  E-value=6.7e-10  Score=58.29  Aligned_cols=51  Identities=37%  Similarity=0.668  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++.....+++.|||.+..+.
T Consensus       122 ~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A          122 TIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            4567889999999999996 99999999999999999999999999887654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=98.96  E-value=1.6e-09  Score=58.15  Aligned_cols=52  Identities=31%  Similarity=0.540  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++..   ...+++.|||+++....
T Consensus       129 ~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          129 EAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            4678899999999999996 9999999999999975   34599999999876553

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=98.95  E-value=1.1e-09  Score=56.91  Aligned_cols=52  Identities=31%  Similarity=0.572  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++.....+++.|||.+.....
T Consensus       112 ~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A          112 EARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            3567889999999999996 999999999999999999999999999877644

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=98.95  E-value=6e-10  Score=59.97  Aligned_cols=53  Identities=62%  Similarity=1.080  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|...+++|+++++.|+++.....+++.|||+++.+..
T Consensus       132 ~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            35678899999999999733799999999999999999999999999876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=98.94  E-value=2e-09  Score=57.00  Aligned_cols=51  Identities=33%  Similarity=0.682  Sum_probs=39.9

Q ss_pred             HHHHHHHHHHHHHHHhh---CCCceeeccCCCcEEEcCCCc-EEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKE---ELKIIHRDVKPSNILLDRRGA-IKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~---~~~~~h~~l~~~~~~~~~~~~-~~~~~~g~~~~~~~   55 (68)
                      +..++.|++.++.|+|.   . +++|+++++.|+++..... +++.|||++.....
T Consensus       104 ~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A          104 AMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             HHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             HHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            45678899999999998   5 7999999999999987665 79999999876543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=98.92  E-value=1.2e-09  Score=57.75  Aligned_cols=53  Identities=74%  Similarity=1.087  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.|+|...+++|+++++.|+++.....+++.|||+++.+..
T Consensus       125 ~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             HHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            35678899999999999732799999999999999999999999999876543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=98.91  E-value=1.1e-09  Score=58.21  Aligned_cols=53  Identities=79%  Similarity=1.145  Sum_probs=44.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|...+++|+++++.|+++.....+++.|||+++.+..
T Consensus       126 ~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             HHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            35678899999999999833799999999999999999999999999877654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=98.89  E-value=3.3e-09  Score=56.12  Aligned_cols=49  Identities=33%  Similarity=0.626  Sum_probs=41.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++. ...+++.|||+++..
T Consensus       131 ~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          131 KTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            4678899999999999996 999999999999997 567899999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=98.87  E-value=3.2e-09  Score=56.02  Aligned_cols=51  Identities=35%  Similarity=0.595  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEE---cCCCcEEEEecCCccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLV   54 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~---~~~~~~~~~~~g~~~~~~   54 (68)
                      .+..++.|++.++.|+|.. +++|+++++.|+++   .....+++.|||.++...
T Consensus       107 ~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A          107 DASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            3567889999999999996 99999999999999   567789999999886544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=98.83  E-value=1.6e-08  Score=59.07  Aligned_cols=53  Identities=36%  Similarity=0.525  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC---cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~---~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+++++.|+++....   .+++.|||.++.....
T Consensus       122 ~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~  177 (676)
T 3qa8_A          122 PIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG  177 (676)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEcccccccccccc
Confidence            4577899999999999996 999999999999998554   3899999999876543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=98.80  E-value=1.4e-08  Score=53.15  Aligned_cols=52  Identities=33%  Similarity=0.628  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC---CcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~---~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.++.++|.. +++|+++++.|+++...   ..+++.|||.+.....
T Consensus       122 ~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          122 DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            4567889999999999996 99999999999999643   4699999998876543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=98.72  E-value=2.6e-08  Score=51.46  Aligned_cols=49  Identities=6%  Similarity=0.191  Sum_probs=42.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC--ceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~--~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .+..++.|++.++.|+|.. +  ++|+++++.|+++......++.+++++..
T Consensus       112 ~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A          112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             HHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             HHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            4677899999999999985 7  99999999999999888889988876644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=98.65  E-value=5.1e-08  Score=51.41  Aligned_cols=46  Identities=11%  Similarity=0.042  Sum_probs=40.1

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS   50 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~   50 (68)
                      +..++.|++.++.|+|.. +++|+++++.|+++...+.+++.+.+..
T Consensus       131 ~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          131 AIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             HHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEecccc
Confidence            456889999999999996 9999999999999998888888765543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.23  E-value=1.8e-06  Score=47.96  Aligned_cols=46  Identities=17%  Similarity=0.221  Sum_probs=37.9

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC----------cEEEEecCCc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----------AIKLCDFGIS   50 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~----------~~~~~~~g~~   50 (68)
                      ...++.|++.++.++|.. +++|+++++.|+++....          .+.++||+-+
T Consensus       207 ~~~l~~qll~~l~~lH~~-gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          207 PASLYADLIALILRLAKH-GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTC
T ss_pred             HHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCc
Confidence            356788999999999996 999999999999997544          2678888644

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=96.39  E-value=0.0058  Score=31.22  Aligned_cols=30  Identities=23%  Similarity=0.297  Sum_probs=24.9

Q ss_pred             ceeeccCCCcEEEcCCCcEEEEecCCcccc
Q psy14632         24 IIHRDVKPSNILLDRRGAIKLCDFGISGQL   53 (68)
Q Consensus        24 ~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~   53 (68)
                      ++|+|+++.|+++.......+.||+.+..-
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence            899999999999977655679999987553

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=96.29  E-value=0.007  Score=31.23  Aligned_cols=30  Identities=30%  Similarity=0.428  Sum_probs=24.3

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|+|+.+.|+++.......+.||+.+..
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            478999999999997665567999987644

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=95.36  E-value=0.046  Score=29.57  Aligned_cols=30  Identities=20%  Similarity=0.437  Sum_probs=24.5

Q ss_pred             CceeeccCCCcEEEcCCC--cEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRG--AIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~--~~~~~~~g~~~~   52 (68)
                      .++|+|+++.|+++....  ...+.||+.+..
T Consensus       217 ~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          217 SIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             EEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             eEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            589999999999998653  368999987754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=93.84  E-value=0.23  Score=26.36  Aligned_cols=31  Identities=23%  Similarity=0.280  Sum_probs=26.0

Q ss_pred             CCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         22 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        22 ~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      ..++|+|+.+.|+++.....+.+.||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4799999999999997667789999987643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=87.56  E-value=0.34  Score=24.97  Aligned_cols=30  Identities=27%  Similarity=0.391  Sum_probs=24.7

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|+++.......+.||+.+..
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            378999999999998776677999987654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=87.18  E-value=0.25  Score=26.11  Aligned_cols=30  Identities=30%  Similarity=0.489  Sum_probs=25.1

Q ss_pred             CceeeccCCCcEEEcC--CCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDR--RGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~--~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|+++..  .....+.||+.+..
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence            5799999999999987  55678999987754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=87.06  E-value=1.2  Score=24.79  Aligned_cols=30  Identities=17%  Similarity=0.286  Sum_probs=25.1

Q ss_pred             CCceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         22 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        22 ~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      ..++|.|+.+.|+++.... ..+.||+.+..
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            3789999999999997665 88999977654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=84.85  E-value=0.39  Score=25.48  Aligned_cols=30  Identities=23%  Similarity=0.302  Sum_probs=24.4

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|+++.......+.||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            589999999999998765567999976643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=83.61  E-value=0.7  Score=24.62  Aligned_cols=30  Identities=27%  Similarity=0.504  Sum_probs=24.1

Q ss_pred             CceeeccCCCcEEEcC----CCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDR----RGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~----~~~~~~~~~g~~~~   52 (68)
                      .++|.++.+.|+++..    .....+.||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            5799999999999986    34457999987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=81.56  E-value=0.82  Score=24.45  Aligned_cols=30  Identities=23%  Similarity=0.360  Sum_probs=24.7

Q ss_pred             CceeeccCCCcEEEcCC----CcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRR----GAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~----~~~~~~~~g~~~~   52 (68)
                      .++|+|+.+.|+++...    ....+.||..+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            68999999999999763    5688999987644

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=80.91  E-value=0.58  Score=25.20  Aligned_cols=30  Identities=13%  Similarity=0.285  Sum_probs=24.0

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|+++.......+.||..+..
T Consensus       223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          223 VLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             eEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            689999999999998544568999876643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	68
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-15
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-13
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-12
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-12
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-11
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-11
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-11
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-11
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-11
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-10
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-10
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-10
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-10
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-10
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-10
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-10
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-10
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-10
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-09
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-09
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-09
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-09
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-09
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-09
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-09
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-09
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-09
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-09
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-08
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-08
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-08
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-08
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-08
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-08
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-08
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-08
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-08
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-08
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-08
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-08
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-07
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-07
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-07
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-07
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-07
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-07
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-07
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-07
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-07
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-07
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-06
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-06
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-06
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-06
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-06
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-05
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-04
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-04
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-04
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-04
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-04
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	0.001

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.6 bits (162), Expect = 1e-15
 Identities = 32/48 (66%), Positives = 42/48 (87%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.0 bits (145), Expect = 2e-13
 Identities = 23/42 (54%), Positives = 28/42 (66%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + ALNYL  + KIIHRD+K  NIL    G IKL DFG+S + 
Sbjct: 120 LDALNYL-HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.7 bits (139), Expect = 1e-12
 Identities = 18/42 (42%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
             AL+Y     ++IHRD+KP N+LL   G +K+ DFG S   
Sbjct: 116 ANALSYC-HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (134), Expect = 9e-12
 Identities = 16/45 (35%), Positives = 27/45 (60%), Gaps = 1/45 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            +   T + ++YL  +  IIHRD+K +NI L     +K+ DFG++
Sbjct: 108 DIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (133), Expect = 1e-11
 Identities = 17/53 (32%), Positives = 31/53 (58%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + +  Q+T+A  +          ++HRD+KP+N+ LD +  +KL DFG++  L
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.0 bits (132), Expect = 2e-11
 Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 1/45 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            VT   ++ L YL     +IHRDVK  NILL   G +KL DFG +
Sbjct: 119 AVTHGALQGLAYL-HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.7 bits (131), Expect = 2e-11
 Identities = 13/39 (33%), Positives = 26/39 (66%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +  L ++     +++RD+KP+NILLD  G +++ D G++
Sbjct: 117 ILGLEHM-HNRFVVYRDLKPANILLDEHGHVRISDLGLA 154

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 53.9 bits (129), Expect = 4e-11
 Identities = 17/37 (45%), Positives = 23/37 (62%)

Query: 17  YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
                  II+RD+KP NILLD+ G IK+ DFG +  +
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (128), Expect = 6e-11
 Identities = 13/39 (33%), Positives = 23/39 (58%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            K + +L E    +HRD+   N+L+     +K+CDFG++
Sbjct: 174 AKGMEFL-EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (124), Expect = 2e-10
 Identities = 20/57 (35%), Positives = 29/57 (50%), Gaps = 1/57 (1%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT 68
           +  + YL   + I HRD+KP N+LLD R  +K+ DFG++           L    GT
Sbjct: 113 MAGVVYL-HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 51.6 bits (123), Expect = 3e-10
 Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++  A ++ +  L  +L I+HRD+KP NILLD    IKL DFG S QL
Sbjct: 114 KIMRALLEVICAL-HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (121), Expect = 5e-10
 Identities = 15/48 (31%), Positives = 28/48 (58%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
              V   K +NYL++  +++HRD+   N+L+     +K+ DFG++  L
Sbjct: 115 NWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.8 bits (121), Expect = 6e-10
 Identities = 20/48 (41%), Positives = 29/48 (60%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            V    ++AL +L    ++IHRD+K  NILL   G++KL DFG   Q+
Sbjct: 120 AVCRECLQALEFL-HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (120), Expect = 7e-10
 Identities = 15/41 (36%), Positives = 24/41 (58%), Gaps = 2/41 (4%)

Query: 12  VKALNYLKEE-LKIIHRDVKPSNILLDRR-GAIKLCDFGIS 50
           +K L +L      IIHRD+K  NI +    G++K+ D G++
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (120), Expect = 7e-10
 Identities = 12/36 (33%), Positives = 23/36 (63%), Gaps = 1/36 (2%)

Query: 15  LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           + Y+ E +  +HRD++ +NIL+      K+ DFG++
Sbjct: 126 MAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLA 160

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 50.1 bits (119), Expect = 8e-10
 Identities = 16/44 (36%), Positives = 24/44 (54%), Gaps = 3/44 (6%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL--DRRGAIKLCDFGISGQL 53
            K L ++  E   +H D+KP NI+    R   +KL DFG++  L
Sbjct: 134 CKGLCHM-HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.2 bits (119), Expect = 9e-10
 Identities = 14/51 (27%), Positives = 26/51 (50%), Gaps = 7/51 (13%)

Query: 6   QVTVATVKALNYL-------KEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
           ++ ++T   L +L       + +  I HRD+K  NIL+ + G   + D G+
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.2 bits (119), Expect = 9e-10
 Identities = 14/48 (29%), Positives = 23/48 (47%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            +       + YL E  K +HRD+   N L+     +K+ DFG+S  +
Sbjct: 144 CIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.8 bits (118), Expect = 1e-09
 Identities = 12/33 (36%), Positives = 22/33 (66%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
              +++RD+K  N++LD+ G IK+ DFG+  + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 49.8 bits (118), Expect = 1e-09
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V    YL   L +I+RD+KP N+L+D++G I++ DFG +
Sbjct: 151 VLTFEYL-HSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (116), Expect = 2e-09
 Identities = 13/42 (30%), Positives = 26/42 (61%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            + + ++ EE   IHRD++ +NIL+    + K+ DFG++  +
Sbjct: 119 AEGMAFI-EERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (115), Expect = 3e-09
 Identities = 17/42 (40%), Positives = 27/42 (64%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +  L Y+    KI+HRD+K +N+L+ R G +KL DFG++   
Sbjct: 127 LNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAF 167

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 48.6 bits (115), Expect = 3e-09
 Identities = 14/48 (29%), Positives = 24/48 (50%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            +       + YL  ++  +HRD+   NIL++     K+ DFG+S  L
Sbjct: 132 GMLRGIAAGMKYL-ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (114), Expect = 4e-09
 Identities = 14/39 (35%), Positives = 23/39 (58%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            + ++YL +  + IHRD+   NIL+      K+ DFG+S
Sbjct: 137 ARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLS 174

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (114), Expect = 5e-09
 Identities = 13/42 (30%), Positives = 21/42 (50%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + A       +  +HRD+   NIL++     K+ DFG+S  L
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (113), Expect = 5e-09
 Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            K + +L    K IHRD+   NILL  +  +K+CDFG++  +
Sbjct: 144 AKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 47.8 bits (113), Expect = 5e-09
 Identities = 11/33 (33%), Positives = 18/33 (54%)

Query: 21  ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +   IHRD+   N L+     +K+ DFG+S  +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (112), Expect = 9e-09
 Identities = 20/39 (51%), Positives = 25/39 (64%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           V AL YL     IIHRD+KP NILL+    I++ DFG +
Sbjct: 118 VSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTA 155

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (110), Expect = 1e-08
 Identities = 17/48 (35%), Positives = 25/48 (52%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++       + YL EE   +HRD+   N+LL  R   K+ DFG+S  L
Sbjct: 113 ELLHQVSMGMKYL-EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.7 bits (110), Expect = 1e-08
 Identities = 18/56 (32%), Positives = 31/56 (55%), Gaps = 5/56 (8%)

Query: 1   MFITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE 56
            F   ++    +  L +L     I++RD+K  NILLD+ G IK+ DFG+  + ++ 
Sbjct: 106 TFYAAEI----ILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (110), Expect = 2e-08
 Identities = 13/48 (27%), Positives = 26/48 (54%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           + ++   +A+ YL E    +HRD+   N+L+      K+ DFG++ + 
Sbjct: 107 KFSLDVCEAMEYL-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.4 bits (109), Expect = 2e-08
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG++
Sbjct: 119 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLA 156

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.4 bits (109), Expect = 2e-08
 Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L++L    +++HRD+KP NIL+   G IKL DFG++
Sbjct: 126 LRGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (109), Expect = 2e-08
 Identities = 15/42 (35%), Positives = 22/42 (52%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            K + +L      IHRD+   NILL      K+CDFG++  +
Sbjct: 155 AKGMAFL-ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (109), Expect = 2e-08
 Identities = 14/42 (33%), Positives = 24/42 (57%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
            + + YL+E   +IHRD+   N L+     IK+ DFG++  +
Sbjct: 111 CEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (108), Expect = 2e-08
 Identities = 15/42 (35%), Positives = 27/42 (64%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +K L +      ++HRD+KP N+L++R G +KL +FG++   
Sbjct: 111 LKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAF 151

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (106), Expect = 5e-08
 Identities = 16/39 (41%), Positives = 28/39 (71%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           ++ L +     +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 112 LQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLA 149

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (106), Expect = 5e-08
 Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
             AL YL E  + +HRD+   N+L+     +KL DFG+S  +
Sbjct: 118 STALAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 45.1 bits (106), Expect = 6e-08
 Identities = 14/44 (31%), Positives = 28/44 (63%), Gaps = 3/44 (6%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLD--RRGAIKLCDFGISGQL 53
            + L ++  E  I+H D+KP NI+ +  +  ++K+ DFG++ +L
Sbjct: 137 CEGLKHM-HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.8 bits (105), Expect = 7e-08
 Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           T++ L YL +   I+HRD+KP+N+LLD  G +KL DFG++   
Sbjct: 109 TLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSF 150

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 44.5 bits (104), Expect = 1e-07
 Identities = 14/42 (33%), Positives = 28/42 (66%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +  + Y   + +++HRD+KP N+L++R G +K+ DFG++   
Sbjct: 110 LNGIAYC-HDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (104), Expect = 1e-07
 Identities = 17/43 (39%), Positives = 26/43 (60%), Gaps = 2/43 (4%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQL 53
           ++A+ +      ++HRD+K  NIL+D  RG +KL DFG    L
Sbjct: 120 LEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 1e-07
 Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 2/44 (4%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGA-IKLCDFGISGQLV 54
            ++L Y+     I HRD+KP N+LLD   A +KLCDFG + QLV
Sbjct: 132 FRSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (103), Expect = 1e-07
 Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 1/43 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 54
           V AL +L  +L II+RD+K  NILLD  G + L DFG+S + V
Sbjct: 139 VLALEHL-HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.6 bits (102), Expect = 2e-07
 Identities = 12/43 (27%), Positives = 21/43 (48%), Gaps = 6/43 (13%)

Query: 13  KALNYLKEELKIIHRDVKPSNILLDR-----RGAIKLCDFGIS 50
             +  +  E  +++RD+KP N L+ R        I + DFG+ 
Sbjct: 112 ARVQSI-HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (101), Expect = 2e-07
 Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++       + YL+E    +HRD+   N+LL  +   K+ DFG+S  L
Sbjct: 111 ELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (101), Expect = 2e-07
 Identities = 17/51 (33%), Positives = 28/51 (54%), Gaps = 4/51 (7%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQL 53
           ++  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + + 
Sbjct: 115 EIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.1 bits (101), Expect = 3e-07
 Identities = 16/44 (36%), Positives = 25/44 (56%), Gaps = 3/44 (6%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQL 53
            +AL +L     I H D++P NI+   R +  IK+ +FG + QL
Sbjct: 112 CEALQFL-HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 41.9 bits (97), Expect = 7e-07
 Identities = 15/54 (27%), Positives = 27/54 (50%), Gaps = 6/54 (11%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA------IKLCDFGISGQL 53
           Q++   +  L+Y+     IIH D+KP N+L++   +      IK+ D G +   
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 7e-07
 Identities = 17/48 (35%), Positives = 26/48 (54%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +  V   + + YL E  + IHRD+   N+LL  R  +K+ DFG+   L
Sbjct: 115 RYAVQVAEGMGYL-ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (97), Expect = 9e-07
 Identities = 11/31 (35%), Positives = 20/31 (64%)

Query: 23  KIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           K +HRD+   N +LD +  +K+ DFG++  +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (97), Expect = 1e-06
 Identities = 15/46 (32%), Positives = 28/46 (60%), Gaps = 1/46 (2%)

Query: 5   NQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
            ++     +A+ YL E  + +HRD+   N L++ +G +K+ DFG+S
Sbjct: 103 LEMCKDVCEAMEYL-ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (96), Expect = 1e-06
 Identities = 13/43 (30%), Positives = 23/43 (53%), Gaps = 1/43 (2%)

Query: 11  TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
             + + YL    K IHRD+   N+L+     +K+ DFG++  +
Sbjct: 144 VARGMEYL-ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 40.6 bits (94), Expect = 2e-06
 Identities = 16/40 (40%), Positives = 28/40 (70%), Gaps = 2/40 (5%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGA-IKLCDFGIS 50
           +KAL+Y    + I+HRDVKP N+++D     ++L D+G++
Sbjct: 139 LKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 3e-06
 Identities = 11/38 (28%), Positives = 19/38 (50%), Gaps = 1/38 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 49
              + YL    K +HRD+   N ++     +K+ DFG+
Sbjct: 143 ADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGM 179

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 39.8 bits (92), Expect = 3e-06
 Identities = 10/42 (23%), Positives = 20/42 (47%), Gaps = 2/42 (4%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++ +        I+H D+   N+L+   G I + DF  S ++
Sbjct: 113 LEEVAKFYHR-GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEV 152

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.4 bits (83), Expect = 7e-05
 Identities = 13/45 (28%), Positives = 22/45 (48%), Gaps = 4/45 (8%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQL 53
           +  + Y+      IHRDVKP N L+        + + DFG++ + 
Sbjct: 113 ISRIEYI-HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.6 bits (81), Expect = 1e-04
 Identities = 16/42 (38%), Positives = 26/42 (61%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +K L Y+     IIHRD+KP N+ ++    +K+ DFG++ Q 
Sbjct: 131 LKGLRYI-HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 35.5 bits (81), Expect = 1e-04
 Identities = 20/48 (41%), Positives = 31/48 (64%), Gaps = 1/48 (2%)

Query: 6   QVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           +V     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+  +
Sbjct: 115 EVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.9 bits (79), Expect = 2e-04
 Identities = 15/42 (35%), Positives = 26/42 (61%), Gaps = 1/42 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 53
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++   
Sbjct: 131 LRGLKYI-HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 34.2 bits (78), Expect = 4e-04
 Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 4/42 (9%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGIS 50
           + A+ YL +   I+HRD+KP N+L    D    I + DFG+S
Sbjct: 117 LDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.0 bits (77), Expect = 4e-04
 Identities = 15/37 (40%), Positives = 23/37 (62%), Gaps = 4/37 (10%)

Query: 21  ELKIIHRDVKPSNILLDRRGA----IKLCDFGISGQL 53
            L+I H D+KP NI+L  R      IK+ DFG++ ++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 33.0 bits (74), Expect = 0.001
 Identities = 15/39 (38%), Positives = 25/39 (64%), Gaps = 1/39 (2%)

Query: 12  VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 50
           +  + +L     IIHRD+KPSNI++     +K+ DFG++
Sbjct: 129 LCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLA 166

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	68
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.64
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.59
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.58
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.58
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.57
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.56
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.52
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.51
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.49
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.49
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.48
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.48
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.48
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.47
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.47
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.47
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.47
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.47
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.46
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.46
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.46
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.46
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.45
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.45
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.44
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.44
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.43
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.43
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.42
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.41
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.41
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.41
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.41
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.41
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.4
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.4
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.39
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.38
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.38
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.38
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.37
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.37
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.36
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.36
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.35
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.35
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.34
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.34
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.34
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.33
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.31
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.3
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.3
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.29
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.29
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.26
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.24
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.24
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.17
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.17
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.16
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.09
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	98.99
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	89.76
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	87.59
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	85.39

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=3.3e-16  Score=81.17  Aligned_cols=65  Identities=31%  Similarity=0.466  Sum_probs=54.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .++.++.|++.|+.|+|+. +++|||++++|+++.....+++.|||+++.+............+||
T Consensus       104 ~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT  168 (271)
T d1nvra_         104 DAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT  168 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeC
Confidence            4678899999999999996 9999999999999998899999999999987665444444455565

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=6.9e-16  Score=80.50  Aligned_cols=55  Identities=29%  Similarity=0.558  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVV   58 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~   58 (68)
                      .+..++.|++.|+.|+|+. +++|+|+|+.|++++....+++.|||+++.......
T Consensus       135 ~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  189 (299)
T d1ywna1         135 HLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  189 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECC------CCSCTT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeECCCCcEEEccCcchhhcccccc
Confidence            3567889999999999996 999999999999999989999999999987665443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=1.5e-15  Score=78.75  Aligned_cols=53  Identities=30%  Similarity=0.485  Sum_probs=45.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+|+++.|++++....+++.|||+++.....
T Consensus       105 ~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_         105 KLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             HHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            4567899999999999996 9999999999999999999999999999876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=3e-15  Score=78.24  Aligned_cols=54  Identities=39%  Similarity=0.661  Sum_probs=48.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|+. +++|+|+++.|+++...+.+++.|||+++.+....
T Consensus       117 ~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         117 QIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            4678899999999999996 99999999999999998999999999998876543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=1.9e-15  Score=79.74  Aligned_cols=54  Identities=22%  Similarity=0.508  Sum_probs=48.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|||+|+.|++++....+++.|||+++......
T Consensus       165 ~~~~i~~qi~~gl~yLH~~-~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  218 (325)
T d1rjba_         165 DLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS  218 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCchhccccccCCeEEEeeccccccccCCC
Confidence            3567899999999999996 99999999999999999999999999998876554

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=3.8e-15  Score=77.69  Aligned_cols=65  Identities=40%  Similarity=0.503  Sum_probs=49.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccccccccccccCC
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVVLPFLQINFGT   68 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~gt   68 (68)
                      .++.++.|++.|+.|+|+. +++|||++++|+++.....+++.|||+++.+............+||
T Consensus       109 ~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT  173 (288)
T d1uu3a_         109 CTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT  173 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCC
T ss_pred             HHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCC
Confidence            4677889999999999996 9999999999999999999999999999887654433334444554

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=1.2e-14  Score=77.12  Aligned_cols=53  Identities=32%  Similarity=0.586  Sum_probs=47.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++||+++|.|++++..+.+++.|||+++.....
T Consensus       106 ~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_         106 RARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             HHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            4677889999999999996 9999999999999999999999999999876543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=1e-14  Score=76.03  Aligned_cols=52  Identities=48%  Similarity=0.711  Sum_probs=47.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.|+.|+|+. +++|+|+++.|++++.+..+++.|||+++....
T Consensus       111 ~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1         111 QIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             HHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            4678899999999999996 999999999999999999999999999977644

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=3.4e-14  Score=74.04  Aligned_cols=54  Identities=37%  Similarity=0.671  Sum_probs=48.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|.. +++|+|++++|++++....+++.|||+++...+..
T Consensus       101 ~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_         101 HIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             HHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            4678899999999999996 99999999999999999999999999998776543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=4.2e-14  Score=73.09  Aligned_cols=54  Identities=22%  Similarity=0.440  Sum_probs=48.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|.. +++|+++++.|++++....+++.|||+++.+.+..
T Consensus       110 ~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_         110 KLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CcccCccchhheeeecccceeeccccceEEccCCc
Confidence            3568899999999999996 99999999999999999999999999998876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.1e-14  Score=76.68  Aligned_cols=54  Identities=61%  Similarity=1.061  Sum_probs=47.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+..+++|||+||+|+++.....+++.|||+|+.+.+.
T Consensus       105 ~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_         105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            467789999999999996337999999999999999999999999999887654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.5e-14  Score=76.00  Aligned_cols=54  Identities=30%  Similarity=0.545  Sum_probs=48.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|.. +++|+++++.|++++....+++.|||+++.+....
T Consensus       112 ~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_         112 YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            3567899999999999996 99999999999999999999999999998876544

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.48  E-value=2.4e-14  Score=74.81  Aligned_cols=54  Identities=26%  Similarity=0.447  Sum_probs=48.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|++++....+++.|||+++.+.+..
T Consensus       141 ~~~~i~~qi~~gl~ylH~~-~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~  194 (301)
T d1lufa_         141 EQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD  194 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred             HHHHHHHHHHHHhhhcccC-CeEeeEEcccceEECCCCcEEEccchhheeccCCc
Confidence            3677899999999999996 99999999999999999999999999998775544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=8.3e-14  Score=73.84  Aligned_cols=54  Identities=30%  Similarity=0.603  Sum_probs=48.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|+. +++|||+|+.|++++....+++.|||+++......
T Consensus       110 ~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_         110 HICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            4678899999999999996 99999999999999999999999999998765443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.47  E-value=6.8e-14  Score=74.84  Aligned_cols=54  Identities=24%  Similarity=0.469  Sum_probs=48.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|.. +++||++||.|++++....+++.|||+++.+....
T Consensus       108 ~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3         108 DMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            4677889999999999996 99999999999999999999999999998776543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=6.1e-14  Score=72.99  Aligned_cols=54  Identities=30%  Similarity=0.492  Sum_probs=48.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|+|+++.|++++....+++.|||+++.+....
T Consensus       110 ~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_         110 NVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            4678899999999999996 99999999999999999999999999998876543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=4.8e-14  Score=73.17  Aligned_cols=53  Identities=26%  Similarity=0.406  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+|+++.|++++.+..+++.|||+++.+.+.
T Consensus       111 ~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_         111 QLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             HHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            3567899999999999996 9999999999999999999999999999887553

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=4.8e-14  Score=72.69  Aligned_cols=54  Identities=35%  Similarity=0.576  Sum_probs=48.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|+|++|.|+++.....+++.|||+++......
T Consensus       107 ~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1         107 RTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            4677899999999999996 99999999999999999999999999998776543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.46  E-value=3.2e-14  Score=74.06  Aligned_cols=54  Identities=26%  Similarity=0.495  Sum_probs=48.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|+|+++.|++++....+++.|||+++....+.
T Consensus       116 ~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_         116 VLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            3567889999999999996 99999999999999999999999999998876543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.46  E-value=3.3e-14  Score=74.33  Aligned_cols=53  Identities=26%  Similarity=0.410  Sum_probs=41.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+|+++.|++++.+..+++.|||+++.+.+.
T Consensus       129 ~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         129 QLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             HHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            3567899999999999996 9999999999999999999999999999877654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.46  E-value=7.3e-14  Score=73.38  Aligned_cols=52  Identities=40%  Similarity=0.631  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.|+.|+|.. +++|||+++.|++++....+++.|||+++....
T Consensus       116 ~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_         116 EIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            4678899999999999996 999999999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.46  E-value=8.7e-14  Score=74.10  Aligned_cols=53  Identities=30%  Similarity=0.548  Sum_probs=48.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|||+++.|++++..+.+++.|||+++.+...
T Consensus       142 ~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         142 HARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            4677899999999999996 9999999999999999999999999999887643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=2e-14  Score=74.27  Aligned_cols=54  Identities=31%  Similarity=0.522  Sum_probs=40.5

Q ss_pred             HHHHHHHHHHHHHHHHhhC----CCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEE----LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~----~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+.    .+++|||++|.|++++....+++.|||+++.+...
T Consensus       110 ~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  167 (269)
T d2java1         110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD  167 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence            4678899999999999974    13999999999999999999999999999887654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.45  E-value=1.5e-13  Score=71.25  Aligned_cols=53  Identities=43%  Similarity=0.577  Sum_probs=48.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|.. +++|+++++.|++++.+...++.|||+++.+.+.
T Consensus       111 ~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  163 (277)
T d1phka_         111 ETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG  163 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCCCeEEccchheeEccCC
Confidence            5678899999999999986 9999999999999999999999999999887654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=6.9e-14  Score=72.92  Aligned_cols=53  Identities=32%  Similarity=0.677  Sum_probs=47.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|+|++++|+++.....+++.|||.++....+
T Consensus       103 ~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_         103 LIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            4678899999999999996 9999999999999999899999999999876543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.44  E-value=1.7e-13  Score=72.13  Aligned_cols=54  Identities=39%  Similarity=0.621  Sum_probs=48.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|+. +++|+++|+.|++++..+.+++.|||+++.+.+..
T Consensus       105 ~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_         105 VAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             HHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            3567889999999999996 99999999999999999999999999998876543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=1.7e-13  Score=71.83  Aligned_cols=54  Identities=22%  Similarity=0.411  Sum_probs=48.4

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVV   58 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~   58 (68)
                      +..++.|++.|+.|+|.. +++|+++++.|++++....+++.|||+++.+.....
T Consensus       135 ~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~  188 (308)
T d1p4oa_         135 MIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY  188 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC
T ss_pred             HHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCceEEEeecccceeccCCcc
Confidence            567899999999999996 899999999999999999999999999987765543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=1.1e-13  Score=71.71  Aligned_cols=53  Identities=28%  Similarity=0.486  Sum_probs=47.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+|+++.|+++.....+++.|||+++.+...
T Consensus       108 ~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_         108 NIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            4677899999999999996 9999999999999999999999999999877544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=2.5e-13  Score=70.91  Aligned_cols=55  Identities=24%  Similarity=0.434  Sum_probs=49.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEVV   58 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~~   58 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|+++.....+++.|||+++...+...
T Consensus       136 ~~~~~~~qi~~al~ylH~~-~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~  190 (299)
T d1fgka_         136 DLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY  190 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCT
T ss_pred             HHHHHHHHHHHHHHHhhhC-CEEeeeecccceeecCCCCeEeccchhhcccccccc
Confidence            4678899999999999996 999999999999999999999999999988766543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=3.4e-13  Score=71.06  Aligned_cols=53  Identities=32%  Similarity=0.561  Sum_probs=47.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|+++++.|+++.....+++.|||+++.....
T Consensus       104 ~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_         104 RATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            4678899999999999996 9999999999999999999999999999876543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=3.4e-13  Score=71.60  Aligned_cols=53  Identities=40%  Similarity=0.658  Sum_probs=46.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|+|+|+.|+++... ..+++.|||+++.+...
T Consensus       123 ~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_         123 YVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            4677899999999999996 99999999999999865 47999999999876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.41  E-value=2.4e-13  Score=72.48  Aligned_cols=54  Identities=26%  Similarity=0.496  Sum_probs=47.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc--CCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD--RRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~--~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|.. +++|+|+++.|+++.  ....+++.|||+++.+.+..
T Consensus       128 ~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         128 EVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            4677899999999999996 999999999999997  45789999999998876543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=9.5e-14  Score=71.41  Aligned_cols=53  Identities=26%  Similarity=0.493  Sum_probs=42.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|.. +++|+++++.|++++.+..+++.|||+++...+.
T Consensus       102 ~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_         102 TLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             HHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCC
Confidence            3567899999999999996 8999999999999999999999999999877554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=3e-13  Score=69.85  Aligned_cols=53  Identities=32%  Similarity=0.502  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-CCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|+|++++|+++.. ...+++.|||+++.....
T Consensus       111 ~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~  164 (273)
T d1xwsa_         111 LARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT  164 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEECccccceecccc
Confidence            4677899999999999996 9999999999999985 468999999999776543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=2.1e-13  Score=70.50  Aligned_cols=54  Identities=30%  Similarity=0.551  Sum_probs=47.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|+++.....+++.|||+++.+....
T Consensus       112 ~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_         112 TLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             HHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            4567899999999999996 99999999999999999999999999998875543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=4.2e-13  Score=70.26  Aligned_cols=54  Identities=33%  Similarity=0.652  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|+. +++|++++++|+++.....+++.|||+++.+....
T Consensus       118 ~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~  171 (318)
T d3blha1         118 EIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK  171 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCC--
T ss_pred             HHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeecceeeeccccc
Confidence            4677899999999999996 99999999999999999999999999998766433

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.39  E-value=3.5e-13  Score=71.76  Aligned_cols=54  Identities=28%  Similarity=0.460  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC--CCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~--~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|+++..  ...+++.|||+++.+....
T Consensus       125 ~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         125 EAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             HHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            4677899999999999996 9999999999999964  4679999999998876543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=2.7e-13  Score=71.09  Aligned_cols=54  Identities=28%  Similarity=0.511  Sum_probs=48.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|.. +++|++++++|++++....+++.|||.++......
T Consensus       146 ~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~  199 (311)
T d1t46a_         146 DLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS  199 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCT
T ss_pred             HHHHHHHHHHHHHHHHHhC-CeeecccccccccccccCcccccccchheeccCCC
Confidence            4667899999999999996 99999999999999999999999999998876544

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=5.3e-13  Score=68.98  Aligned_cols=52  Identities=29%  Similarity=0.509  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCC--ceeeccCCCcEEEc-CCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELK--IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~--~~h~~l~~~~~~~~-~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.|+.|+|+. +  ++|+|+++.|+++. ....+++.|||+++....
T Consensus       113 ~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_         113 VLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             HHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            4567899999999999986 6  99999999999996 467899999999976544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=7.2e-13  Score=69.00  Aligned_cols=53  Identities=32%  Similarity=0.693  Sum_probs=47.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|+|+||+|+++......++.|||+++.....
T Consensus       117 ~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~  169 (305)
T d1blxa_         117 TIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ  169 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhhhhccc
Confidence            4567899999999999996 9999999999999999999999999998765443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=2.8e-13  Score=69.87  Aligned_cols=53  Identities=28%  Similarity=0.473  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|+++.....+++.|||+++.+...
T Consensus       109 ~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_         109 SLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             HHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            3667889999999999996 9999999999999999999999999999876543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=3e-13  Score=70.37  Aligned_cols=53  Identities=21%  Similarity=0.422  Sum_probs=44.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|.. +++|+++++.|++++.+..+++.|||+++.+.+.
T Consensus       114 ~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3         114 QLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             HHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            4677899999999999996 9999999999999998899999999999876543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=1.2e-12  Score=69.38  Aligned_cols=54  Identities=31%  Similarity=0.532  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~~~   57 (68)
                      .++.++.|++.|+.|+|.. +++|||++++|+++..   ...+++.|||+++......
T Consensus       112 ~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1         112 EASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeeccCCC
Confidence            4678999999999999996 9999999999999975   3468999999998776543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.36  E-value=9.3e-13  Score=69.22  Aligned_cols=53  Identities=30%  Similarity=0.500  Sum_probs=46.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCC-CcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~-~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|++++++|+++... ..+++.|||+++.+.+.
T Consensus       130 ~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         130 DIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            4678899999999999996 99999999999999864 46899999999876554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=1.6e-12  Score=66.72  Aligned_cols=53  Identities=26%  Similarity=0.562  Sum_probs=47.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|++++....+++.|||+++.+...
T Consensus       101 ~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_         101 QLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             HHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            4668899999999999996 9999999999999999999999999999876544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.35  E-value=5.4e-13  Score=69.96  Aligned_cols=53  Identities=30%  Similarity=0.506  Sum_probs=39.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEc---CCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~---~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+|++|.|+++.   ....+++.|||+++...+.
T Consensus       108 ~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_         108 DASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             HHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            4677899999999999996 999999999999995   3567999999999876544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.34  E-value=5.9e-13  Score=68.90  Aligned_cols=53  Identities=26%  Similarity=0.701  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|.. +++|+|++++|+++.....+++.|||.+.....+
T Consensus       101 ~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_         101 TAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             hhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            4678899999999999996 9999999999999999999999999998776543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=1.4e-12  Score=68.50  Aligned_cols=54  Identities=24%  Similarity=0.463  Sum_probs=48.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|++++....+++.|||+++.+....
T Consensus       131 ~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         131 DLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             HHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            3567899999999999996 99999999999999999999999999998876543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=2.1e-12  Score=66.76  Aligned_cols=53  Identities=30%  Similarity=0.689  Sum_probs=47.8

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.++.|+|.. +++|+|++|+|+++......++.|||.++.....
T Consensus       102 ~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_         102 IVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             HHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            4678899999999999996 9999999999999999999999999999876543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=2e-12  Score=68.38  Aligned_cols=53  Identities=32%  Similarity=0.557  Sum_probs=48.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|+++++.|+++.....+++.|||.++.....
T Consensus       122 ~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~  174 (346)
T d1cm8a_         122 RIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE  174 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceeccCCc
Confidence            4678899999999999996 9999999999999999999999999999876543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.31  E-value=3.8e-12  Score=66.21  Aligned_cols=53  Identities=23%  Similarity=0.400  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC-----CCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR-----RGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~-----~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.++.|+|+. +++|+|+||.|+++..     ...+++.|||+++.+.+.
T Consensus       102 ~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_         102 TVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            3567889999999999996 9999999999999964     456899999999887644

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.30  E-value=3.2e-12  Score=66.48  Aligned_cols=54  Identities=24%  Similarity=0.460  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC---CCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~---~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.++.|+|+. +++|+|++|.|+++..   ...+++.|||+++.+.+..
T Consensus       104 ~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_         104 TVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            4677899999999999996 9999999999998753   4568999999998876543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.30  E-value=2.4e-12  Score=66.43  Aligned_cols=52  Identities=38%  Similarity=0.648  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .+..++.|++.|+.|+|+. +++|+|+||+|+++......++.|||.++....
T Consensus       112 ~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_         112 RAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             HHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccccceeehhhhhhhhcc
Confidence            4678899999999999996 999999999999999999999999998766543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=3.2e-12  Score=67.34  Aligned_cols=54  Identities=39%  Similarity=0.497  Sum_probs=47.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVEV   57 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~~   57 (68)
                      .+..++.|++.|+.|+|.. +++|+++++.|++++....+++.|||+++.+.+..
T Consensus       130 ~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~  183 (322)
T d1vzoa_         130 EVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE  183 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred             HHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence            3566789999999999996 99999999999999999999999999998775443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=6e-12  Score=65.41  Aligned_cols=53  Identities=30%  Similarity=0.503  Sum_probs=46.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC----cEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~----~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|+++++.|+++....    .+++.|||+++.+...
T Consensus       114 ~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~  170 (293)
T d1jksa_         114 EATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG  170 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS
T ss_pred             HHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEecchhhhhhcCCC
Confidence            4678899999999999996 999999999999997654    4899999999887544

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=5.6e-12  Score=66.39  Aligned_cols=53  Identities=28%  Similarity=0.437  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcC--CCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~--~~~~~~~~~g~~~~~~~~   56 (68)
                      .++.++.|++.|+.|+|+. +++|+|+++.|+++..  ...+++.|||+++.....
T Consensus       103 ~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_         103 EIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             HHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            4677899999999999996 9999999999999974  347899999999876543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=7.9e-12  Score=65.32  Aligned_cols=53  Identities=28%  Similarity=0.435  Sum_probs=46.6

Q ss_pred             HHHHHHHHHHHHHHHhhC-------CCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          4 TNQVTVATVKALNYLKEE-------LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~-------~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      +..++.|++.++.|+|..       .+++|+|+++.|++++....+++.|||+++.....
T Consensus       102 ~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_         102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            457889999999999962       37999999999999999999999999999887654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=6e-12  Score=65.87  Aligned_cols=53  Identities=28%  Similarity=0.483  Sum_probs=47.3

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|+++......++.|||+++.....
T Consensus       128 ~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~  180 (309)
T d1fvra_         128 QLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  180 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred             HHHHHHHHHHHHHHhhhcC-CccccccccceEEEcCCCceEEcccccccccccc
Confidence            3677899999999999996 9999999999999999999999999999765543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.17  E-value=3.2e-11  Score=59.29  Aligned_cols=50  Identities=20%  Similarity=0.286  Sum_probs=43.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          4 TNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         4 ~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      ...++.|++.++.++|.. +++|+|++|.|+++... .+++.|||.+.....
T Consensus       105 ~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~  154 (191)
T d1zara2         105 PDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGE  154 (191)
T ss_dssp             HHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-EEEECCCTTCEETTS
T ss_pred             HHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-CEEEEECCCcccCCC
Confidence            457889999999999996 99999999999999854 478899999877653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.17  E-value=1.6e-11  Score=64.80  Aligned_cols=52  Identities=29%  Similarity=0.547  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.|+.|+|+. +++|+|+|+.|+++.....+++.|||.+.....
T Consensus       122 ~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1         122 HVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             HHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhcccCc
Confidence            4678899999999999996 999999999999999999999999999876543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=3.3e-11  Score=61.96  Aligned_cols=53  Identities=23%  Similarity=0.500  Sum_probs=43.1

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCccccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVVE   56 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~~   56 (68)
                      .+..++.|++.|+.|+|+. +++|+++++.|+++.....+++.|||+++...+.
T Consensus       104 ~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_         104 CLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             HHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecCCC
Confidence            3567899999999999996 9999999999999999999999999999876543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=8.6e-11  Score=62.36  Aligned_cols=52  Identities=29%  Similarity=0.460  Sum_probs=43.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCCcEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.|+.|+|.. +++|++++|.|+++......++.|||+++....
T Consensus       120 ~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         120 RMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             HHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhcccc
Confidence            4678899999999999996 999999999999999999999999998776554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.99  E-value=3.4e-10  Score=59.77  Aligned_cols=53  Identities=28%  Similarity=0.486  Sum_probs=43.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCceeeccCCCcEEEcCCC------cEEEEecCCcccccc
Q psy14632          3 ITNQVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG------AIKLCDFGISGQLVV   55 (68)
Q Consensus         3 ~~~~~~~q~~~~~~~~~~~~~~~h~~l~~~~~~~~~~~------~~~~~~~g~~~~~~~   55 (68)
                      .++.++.|++.|+.|+|+..+++|+|+++.|+++....      .+++.|||.+.....
T Consensus       126 ~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~  184 (362)
T d1q8ya_         126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE  184 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred             HHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc
Confidence            46788999999999999854899999999999996432      378999999876544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=89.76  E-value=0.051  Score=27.64  Aligned_cols=30  Identities=23%  Similarity=0.302  Sum_probs=25.9

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      +++|.|+.+.|+++.......+.||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            689999999999999877778999987643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=87.59  E-value=0.16  Score=24.84  Aligned_cols=30  Identities=30%  Similarity=0.428  Sum_probs=24.5

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.|+.+.|+++.......+.||..+..
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhccc
Confidence            378999999999998766667999986654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=85.39  E-value=0.17  Score=24.64  Aligned_cols=30  Identities=23%  Similarity=0.292  Sum_probs=24.6

Q ss_pred             CceeeccCCCcEEEcCCCcEEEEecCCccc
Q psy14632         23 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ   52 (68)
Q Consensus        23 ~~~h~~l~~~~~~~~~~~~~~~~~~g~~~~   52 (68)
                      .++|.++.+.|+++.......+.||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            379999999999998766677999987644